#BEGIN_DRUGCARD DB03014

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
30413

# Chemical_Formula:
C34H32FeN4O4

# Chemical_IUPAC_Name:
(1R)-15,19-bis(2-carboxyethyl)-5,10-diethenyl-4,9,14,20-tetramethyl-2$l^{5},22,23$l^{5},25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Heme

# HET_ID:
HEM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+4/p-2/b25-13-,26-13-,27-14-,28-15-,29-14-,30-15-,31-16-,32-16-;

# InChI_Key:
InChIKey=YHLKGEDAGPGZPN-RGGAHWMASA-L

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3014

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
616.487

# Molecular_Weight_Mono:
616.177297665

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GGE

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.29

# Predicted_LogS:
-5.6

# Predicted_Water_Solubility:
1.61e-03 g/l

# Primary_Accession_No:
DB03014

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
4973

# PubChem_Substance_ID:
46505355

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01713
EXPT01726

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=C(CCC(O)=O)C2=CC3=[N+]4C(=CC5=C(C=C)C(C)=C6C=C7C(C=C)=C(C)C8=[N+]7[Fe@]4(N2C1=C8)N56)C(C)=C3CCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_100_Cellular_Location:
Not Available

# Drug_Target_100_Chromosome_Location:
Not Available

# Drug_Target_100_Drug_References:
Not Available

# Drug_Target_100_Essentiality:
Non-Essential

# Drug_Target_100_GenAtlas_ID:
Not Available

# Drug_Target_100_GenBank_ID_Gene:
AF456128

# Drug_Target_100_GenBank_ID_Protein:
Not Available

# Drug_Target_100_GeneCard_ID:
Not Available

# Drug_Target_100_Gene_Name:
cinA

# Drug_Target_100_Gene_Sequence:
>1215 bp
ATGACTGCGACAGTCGCTTCGACAAGTCTGTTCACCACCGCCGACCACTACCACACTCCG
TTGGGTCCCGACGGCACGCCACACGCATTCTTCGAGGCGTTGCGCGACGAGGCGGAGACC
ACCCCTATTGGATGGAGTGAGGCCTACGGTGGCCACTGGGTAGTTGCCGGATACAAGGAG
ATTCAGGCTGTCATCCAGAACACCAAGGCCTTCTCGAACAAGGGCGTGACCTTCCCTCGC
TACGAAACCGGCGAGTTCGAGCTCATGATGGCAGGGCAGGACGACCCCGTCCACAAGAAG
TACCGCCAGCTCGTGGCGAAACCGTTCTCGCCGGAGGCGACCGACCTGTTCACCGAACAG
TTGCGCCAGTCCACCAACGACCTGATCGACGCGCGGATCGAACTCGGAGAGGGTGACGCT
GCCACCTGGTTAGCCAACGAGATTCCTGCTCGGCTAACGGCCATCCTCCTCGGCCTTCCG
CCCGAAGACGGAGACACCTACCGCCGGTGGGTGTGGGCCATCACGCACGTAGAGAACCCG
GAGGAAGGCGCCGAAATTTTCGCCGAACTTGTGGCGCACGCGCGCACTCTGATCGCCGAG
CGCCGCACTAACCCAGGCAACGACATCATGTCTCGGGTCATCATGTCCAAGATCGACGGT
GAAAGCCTCTCCGAGGACGACCTGATCGGATTCTTCACCATCCTGCTTCTCGGCGGCATC
GACAACACCGCACGCTTCCTCAGCTCGGTGTTCTGGCGCTTGGCGTGGGACATCGAGCTC
CGCCGCCGACTCATCGCCCACCCCGAGCTTATCCCCAACGCCGTAGACGAACTGCTCCGC
TTCTACGGCCCCGCCATGGTCGGCCGCCTCGTCACCCAAGAGGTCACCGTGGGCGACATC
ACAATGAAGCCAGGCCAAACGGCCATGCTGTGGTTCCCGATCGCCAGCCGGGATCGTTCG
GCATTCGATTCACCCGACAACATCGTGATCGAACGCACGCCCAACCGGCACCTGTCTCTC
GGCCACGGCATCCACCGCTGCCTCGGAGCCCACCTGATCCGCGTCGAGGCCCGCGTGGCG
ATCACCGAGTTCCTCAAGCGCATTCCGGAGTTCTCCCTCGACCCGAACAAGGAATGTGAG
TGGTTAATGGGCCAGGTGGCCGGCATGCTGCACGTGCCGATCATCTTCCCTAAGGGCAAG
CGACTGTCGGAATGA

# Drug_Target_100_General_Function:
Involved in monooxygenase activity

# Drug_Target_100_General_References:
Not Available

# Drug_Target_100_HGNC_ID:
Not Available

# Drug_Target_100_HPRD_ID:
Not Available

# Drug_Target_100_ID:
4972

# Drug_Target_100_Locus:
Not Available

# Drug_Target_100_Molecular_Weight:
45266

# Drug_Target_100_Name:
P450cin

# Drug_Target_100_Number_of_Residues:
404

# Drug_Target_100_PDB_ID:
1T2B

# Drug_Target_100_Pathway:
Not Available

# Drug_Target_100_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_100_Protein_Sequence:
>P450cin
MTATVASTSLFTTADHYHTPLGPDGTPHAFFEALRDEAETTPIGWSEAYGGHWVVAGYKE
IQAVIQNTKAFSNKGVTFPRYETGEFELMMAGQDDPVHKKYRQLVAKPFSPEATDLFTEQ
LRQSTNDLIDARIELGEGDAATWLANEIPARLTAILLGLPPEDGDTYRRWVWAITHVENP
EEGAEIFAELVAHARTLIAERRTNPGNDIMSRVIMSKIDGESLSEDDLIGFFTILLLGGI
DNTARFLSSVFWRLAWDIELRRRLIAHPELIPNAVDELLRFYGPAMVGRLVTQEVTVGDI
TMKPGQTAMLWFPIASRDRSAFDSPDNIVIERTPNRHLSLGHGIHRCLGAHLIRVEARVA
ITEFLKRIPEFSLDPNKECEWLMGQVAGMLHVPIIFPKGKRLSE

# Drug_Target_100_Reaction:
Not Available

# Drug_Target_100_Signals:
None

# Drug_Target_100_Specific_Function:
Not Available

# Drug_Target_100_SwissProt_ID:
Q8VQF6

# Drug_Target_100_SwissProt_Name:
Q8VQF6_CITBR

# Drug_Target_100_Synonyms:
Not Available

# Drug_Target_100_Theoretical_pI:
5.19

# Drug_Target_100_Transmembrane_Regions:
None

# Drug_Target_101_Cellular_Location:
Cytoplasm

# Drug_Target_101_Chromosome_Location:
Not Available

# Drug_Target_101_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_101_Essentiality:
Non-Essential

# Drug_Target_101_GenAtlas_ID:
ALOX5

# Drug_Target_101_GenBank_ID_Gene:
J03600

# Drug_Target_101_GenBank_ID_Protein:
187193

# Drug_Target_101_GeneCard_ID:
ALOX5

# Drug_Target_101_Gene_Name:
ALOX5

# Drug_Target_101_Gene_Sequence:
>2025 bp
ATGCCCTCCTACACGGTCACCGTGGCCACTGGCAGCCAGTGGTTCGCCGGCACTGACGAC
TACATCTACCTCAGCCTCGTGGGCTCGGCGGGCTGCAGCGAGAAGCACCTGCTGGACAAG
CCCTTCTACAACGACTTCGAGCGTGGCGCGGTGGATTCATACGACGTGACTGTGGACGAG
GAACTGGGCGAGATCCAGCTGGTCAGAATCGAGAAGCGCAAGTACTGGCTGAATGACGAC
TGGTACCTGAAGTACATCACGCTGAAGACGCCCCACGGGGACTACATCGAGTTCCCCTGC
TACCGCTGGATCACCGGCGATGTCGAGGTTGTCCTGAGGGATGGACGCGCAAAGTTGGCC
CGAGATGACCAAATTCACATTCTCAAGCAACACCGACGTAAAGAACTGGAAACACGGCAA
AAACAATATCGATGGATGGAGTGGAACCCTGGCTTCCCCTTGAGCATCGATGCCAAATGC
CACAAGGATTTACCCCGTGATATCCAGTTTGATAGTGAAAAAGGAGTGGACTTTGTTCTG
AATTACTCCAAAGCGATGGAGAACCTGTTCATCAACCGCTTCATGCACATGTTCCAGTCT
TCTTGGAATGACTTCGCCGACTTTGAGAAAATCTTTGTCAAGATCAGCAACACTATTTCT
GAGCGGGTCATGAATCACTGGCAGGAAGACCTGATGTTTGGCTACCAGTTCCTGAATGGC
TGCAACCCTGTGTTGATCCGGCGCTGCACAGAGCTGCCCGAGAAGCTCCCGGTGACCACG
GAGATGGTAGAGTGCAGCCTGGAGCGGCAGCTCAGCTTGGAGCAGGAGGTCCAGCAAGGG
AACATTTTCATCGTGGACTTTGAGCTGCTGGATGGCATCGATGCCAACAAAACAGACCCC
TGCACACTCCAGTTCCTGGCCGCTCCCATCTGCTTGCTGTATAAGAACCTGGCCAACAAG
ATTGTCCCCATTGCCATCCAGCTCAACCAAATCCCGGGAGATGAGAACCCTATTTTCCTC
CCTTCGGATGCAAAATACGACTGGCTTTTGGCCAAAATCTGGGTGCGTTCCAGTGACTTC
CACGTCCACCAGACCATCACCCACCTTCTGCGAACACATCTGGTGTCTGAGGTTTTTGGC
ATTGCAATGTACCGCCAGCTGCCTGCTGTGCACCCCATTTTCAAGCTGCTGGTGGCACAC
GTGAGATTCACCATTGCAATCAACACCAAGGCCCGTGAGCAGCTCATCTGCGAGTGTGGC
CTCTTTGACAAGGCCAACGCCACAGGGGGCGGTGGGCACGTGCAGATGGTGCAGAGGGCC
ATGAAGGACCTGACCTATGCCTCCCTGTGCTTTCCCGAGGCCATCAAGGCCCGGGGCATG
GAGAGCAAAGAAGACATCCCCTACTACTTCTACCGGGACGACGGGCTCCTGGTGTGGGAA
GCCATCAGGACGTTCACGGCCGAGGTGGTAGACATCTACTACGAGGGCGACCAGGTGGTG
GAGGAGGACCCGGAGCTGCAGGACTTCGTGAACGATGTCTACGTGTACGGCATGCGGGGC
CGCAAGTCCTCAGGCTTCCCCAAGTCGGTCAAGAGCCGGGAGCAGCTGTCGGAGTACCTG
ACCGTGGTGATCTTCACCGCCTCCGCCCAGCACGCCGCGGTCAACTTCGGCCAGTACGAC
TGGTGCTCCTGGATCCCCAATGCGCCCCCAACCATGCGAGCCCCGCCACCGACTGCCAAG
GGCGTGGTGACCATTGAGCAGATCGTGGACACGCTGCCCGACCGCGGCCGCTCCTGCTGG
CATCTGGGTGCAGTGTGGGCGCTGAGCCAGTTCCAGGAAAACGAGCTGTTCCTGGGCATG
TACCCAGAAGAGCATTTTATCGAGAAGCCTGTGAAGGAAGCCATGGCCCGATTCCGCAAG
AACCTCGAGGCCATTGTCAGCGTGATTGCTGAGCGCAACAAGAAGAAGCAGCTGCCATAT
TACTACTTGTCCCCAGACCGGATTCCGAACAGTGTGGCCATCTGA

# Drug_Target_101_General_Function:
Involved in oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen

# Drug_Target_101_General_References:
11844797	Werz O, Szellas D, Steinhilber D, Radmark O: Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2). J Biol Chem. 2002 Apr 26;277(17):14793-800. Epub 2002 Feb 13.
1540191	Ishii S, Noguchi M, Miyano M, Matsumoto T, Noma M: Mutagenesis studies on the amino acid residues involved in the iron-binding and the activity of human 5-lipoxygenase. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1482-90.
1939225	Nguyen T, Falgueyret JP, Abramovitz M, Riendeau D: Evaluation of the role of conserved His and Met residues among lipoxygenases by site-directed mutagenesis of recombinant human 5-lipoxygenase. J Biol Chem. 1991 Nov 15;266(32):22057-62.
2251250	Hoshiko S, Radmark O, Samuelsson B: Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9073-7.
2526519	Matsumoto T, Funk CD, Radmark O, Hoog JO, Jornvall H, Samuelsson B: Molecular cloning and amino acid sequence of human 5-lipoxygenase. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:466-9.
2565035	Funk CD, Hoshiko S, Matsumoto T, Rdmark O, Samuelsson B: Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2587-91.
2829172	Matsumoto T, Funk CD, Radmark O, Hoog JO, Jornvall H, Samuelsson B: Molecular cloning and amino acid sequence of human 5-lipoxygenase. Proc Natl Acad Sci U S A. 1988 Jan;85(1):26-30.
3422434	Dixon RA, Jones RE, Diehl RE, Bennett CD, Kargman S, Rouzer CA: Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci U S A. 1988 Jan;85(2):416-20.

# Drug_Target_101_HGNC_ID:
HGNC:435

# Drug_Target_101_HPRD_ID:
01065

# Drug_Target_101_ID:
275

# Drug_Target_101_Locus:
10q11.2

# Drug_Target_101_Molecular_Weight:
77853

# Drug_Target_101_Name:
Arachidonate 5-lipoxygenase

# Drug_Target_101_Number_of_Residues:
673

# Drug_Target_101_PDB_ID:
Not Available

# Drug_Target_101_Pathway:
Not Available

# Drug_Target_101_Pfam_Domain_Function:
PF01477	PLAT

# Drug_Target_101_Protein_Sequence:
>Arachidonate 5-lipoxygenase
PSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEE
LGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLAR
DDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLN
YSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGC
NPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPC
TLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFH
VHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGL
FDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEA
IRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLT
VVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWH
LGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYY
YLSPDRIPNSVAI

# Drug_Target_101_Reaction:
arachidonate + O2 = (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxyicosa-6,8,11,14-tetraenoate

# Drug_Target_101_Signals:
None

# Drug_Target_101_Specific_Function:
Not Available

# Drug_Target_101_SwissProt_ID:
P09917

# Drug_Target_101_SwissProt_Name:
LOX5_HUMAN

# Drug_Target_101_Synonyms:
5-LO
5-lipoxygenase
EC 1.13.11.34

# Drug_Target_101_Theoretical_pI:
5.54

# Drug_Target_101_Transmembrane_Regions:
None

# Drug_Target_102_Cellular_Location:
Not Available

# Drug_Target_102_Chromosome_Location:
Not Available

# Drug_Target_102_Drug_References:
Not Available

# Drug_Target_102_Essentiality:
Non-Essential

# Drug_Target_102_GenAtlas_ID:
Not Available

# Drug_Target_102_GenBank_ID_Gene:
BX572605

# Drug_Target_102_GenBank_ID_Protein:
Not Available

# Drug_Target_102_GeneCard_ID:
Not Available

# Drug_Target_102_Gene_Name:
RPA3973

# Drug_Target_102_Gene_Sequence:
>450 bp
TTAGCCTTCCTTATCGCGGAAGTTCTCGTGGCAGTTTCCGCACGCCTTGCCGATCGGCTG
CATCGCGGCCTTCAACGTGTCGACGTCTTTGATCTTGCCCTTGGCGCCGTCGACCGCCTT
AGCGAAATCGGCGATCTCGGTGTCGAACTTGGCGCGCTCAGCCCAGATCTTCGGCGATGA
GCTGTACTTGCTGTCGAACGGCTTCAACCCTTTGACGCTGTCCGGAAACAGCTTCGGCAG
ATCCTTGGCGGTCTCGTCGAACTGCTTCAGCGCCGCGTCGACCGCGGCTTGATCGTAGGG
CTTCTCGCCCTTGGCGATGGCGCCGAGCACCATCATGTTCCGGCCGTTATCCTTCATCAG
TTTCTGGGTCTTATCGACCAGATCCTGCTGCGCCATCACGGCGCTCGCCGTCAACACCAG
GGCTCCGGCAACGATCACAGTGCGTAACAT

# Drug_Target_102_General_Function:
Involved in iron ion binding

# Drug_Target_102_General_References:
6273892	Ambler RP, Bartsch RG, Daniel M, Kamen MD, McLellan L, Meyer TE, Van Beeumen J: Amino acid sequences of bacterial cytochromes c' and c-556. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6854-7.

# Drug_Target_102_HGNC_ID:
Not Available

# Drug_Target_102_HPRD_ID:
Not Available

# Drug_Target_102_ID:
4975

# Drug_Target_102_Locus:
Not Available

# Drug_Target_102_Molecular_Weight:
16149

# Drug_Target_102_Name:
Cytochrome c-556

# Drug_Target_102_Number_of_Residues:
149

# Drug_Target_102_PDB_ID:
1S05

# Drug_Target_102_Pathway:
Not Available

# Drug_Target_102_Pfam_Domain_Function:
PF01322	Cytochrom_C_2

# Drug_Target_102_Protein_Sequence:
>Cytochrome c-556
MLRTVIVAGALVLTASAVMAQQDLVDKTQKLMKDNGRNMMVLGAIAKGEKPYDQAAVDAA
LKQFDETAKDLPKLFPDSVKGLKPFDSKYSSSPKIWAERAKFDTEIADFAKAVDGAKGKI
KDVDTLKAAMQPIGKACGNCHENFRDKEG

# Drug_Target_102_Reaction:
Not Available

# Drug_Target_102_Signals:
1-20

# Drug_Target_102_Specific_Function:
Low-spin monoheme cytochrome c

# Drug_Target_102_SwissProt_ID:
P00150

# Drug_Target_102_SwissProt_Name:
C556_RHOPA

# Drug_Target_102_Synonyms:
Cytochrome c-556 precursor
Cytochrome c556

# Drug_Target_102_Theoretical_pI:
9.13

# Drug_Target_102_Transmembrane_Regions:
None

# Drug_Target_103_Cellular_Location:
Cellular thylakoid membrane

# Drug_Target_103_Chromosome_Location:
Not Available

# Drug_Target_103_Drug_References:
Not Available

# Drug_Target_103_Essentiality:
Non-Essential

# Drug_Target_103_GenAtlas_ID:
Not Available

# Drug_Target_103_GenBank_ID_Gene:
Y09612

# Drug_Target_103_GenBank_ID_Protein:
Not Available

# Drug_Target_103_GeneCard_ID:
Not Available

# Drug_Target_103_Gene_Name:
petA

# Drug_Target_103_Gene_Sequence:
>1017 bp
ATGAACTTCAAGGTTTGCTCATTTCCCTCTCGTCGCCAGAGCATAGCTGCTTTTGTGCGG
GTGCTGATGGTGATTTTGCTGACGCTAGGGGCGCTAGTGTCGAGCGATGTCCTGCTGCCT
CAGCCCGCTGCTGCCTACCCCTTCTGGGCACAGCAAAACTACGCCAATCCTCGCGAAGCT
ACGGGCCGCATCGTCTGCGCCAACTGTCACCTAGCTGCGAAGCCTGCTGAGATCGAGGTT
CCCCAGGCCGTGCTGCCGGACTCTGTGTTCAAAGCAGTGGTGAAAATTCCCTACGACCAC
TCCGTGCAGCAGGTGCAGGCGGATGGCTCTAAGGGGCCGCTGAATGTGGGCGCAGTGCTA
ATGCTCCCGGAGGGCTTCACCATTGCCCCCGAAGACCGTATTCCTGAAGAGATGAAGGAA
GAGGTCGGCCCTAGCTATCTGTTCCAGCCCTATGCGGACGATAAGCAAAACATTGTGCTG
GTGGGGCCGCTGCCCGGCGACCAGTACGAAGAAATCGTCTTCCCAGTGCTATCGCCCAAC
CCAGCCACCAACAAGAGCGTGGCTTTCGGCAAATACTCGATTCACCTGGGCGCAAACCGA
GGGCGCGGCCAGATCTATCCCACGGGTGAAAAGAGCAACAACGCAGTTTACAACGCTTCA
GCAGCGGGCGTGATTACGGCAATCGCCAAGGCTGACGACGGCAGTGCCGAAGTCAAGATT
CGTACCGAAGACGGCACGACCATTGTAGACAAGATTCCGGCTGGCCCAGAGCTAATCGTG
TCTGAAGGCGAAGAGGTCGCCGCTGGCGCAGCGCTCACCAACAATCCTAACGTGGGCGGC
TTTGGGCAGAAGGATACCGAAATCGTGCTGCAAAGCCCGAACCGGGTTAAAGGTCGTATT
GCGTTCCTGGCAGCGATTACGCTGACGCAGATCCTGCTTGTTCTAAAGAAGAAGCAGGTC
GAGCGCGTCCAGGCTGGCCGAGATGACCTTCTAAAGGCTGCGTTCATCGCAGGTTGA

# Drug_Target_103_General_Function:
Involved in iron ion binding

# Drug_Target_103_General_References:
10423236	Carrell CJ, Schlarb BG, Bendall DS, Howe CJ, Cramer WA, Smith JL: Structure of the soluble domain of cytochrome f from the cyanobacterium Phormidium laminosum. Biochemistry. 1999 Jul 27;38(30):9590-9.
8856106	Wagner MJ, Packer JC, Howe CJ, Bendall DS: Some characteristics of cytochrome f in the cyanobacterium Phormidium laminosum: its sequence and charge properties in the reaction with plastocyanin. Biochim Biophys Acta. 1996 Sep 30;1276(3):246-52.

# Drug_Target_103_HGNC_ID:
Not Available

# Drug_Target_103_HPRD_ID:
Not Available

# Drug_Target_103_ID:
4976

# Drug_Target_103_Locus:
Not Available

# Drug_Target_103_Molecular_Weight:
36070

# Drug_Target_103_Name:
Apocytochrome f

# Drug_Target_103_Number_of_Residues:
338

# Drug_Target_103_PDB_ID:
1CI3

# Drug_Target_103_Pathway:
Not Available

# Drug_Target_103_Pfam_Domain_Function:
PF01333	Apocytochr_F_C

# Drug_Target_103_Protein_Sequence:
>Apocytochrome f
MNFKVCSFPSRRQSIAAFVRVLMVILLTLGALVSSDVLLPQPAAAYPFWAQQNYANPREA
TGRIVCANCHLAAKPAEIEVPQAVLPDSVFKAVVKIPYDHSVQQVQADGSKGPLNVGAVL
MLPEGFTIAPEDRIPEEMKEEVGPSYLFQPYADDKQNIVLVGPLPGDQYEEIVFPVLSPN
PATNKSVAFGKYSIHLGANRGRGQIYPTGEKSNNAVYNASAAGVITAIAKADDGSAEVKI
RTEDGTTIVDKIPAGPELIVSEGEEVAAGAALTNNPNVGGFGQKDTEIVLQSPNRVKGRI
AFLAAITLTQILLVLKKKQVERVQAGRDDLLKAAFIAG

# Drug_Target_103_Reaction:
Not Available

# Drug_Target_103_Signals:
1-45

# Drug_Target_103_Specific_Function:
Component of the cytochrome b6-f complex, which mediates electron transfer between photosystem II (PSII) and photosystem I (PSI), cyclic electron flow around PSI, and state transitions (By similarity)

# Drug_Target_103_SwissProt_ID:
P95522

# Drug_Target_103_SwissProt_Name:
CYF_PHOLA

# Drug_Target_103_Synonyms:
Apocytochrome f precursor

# Drug_Target_103_Theoretical_pI:
5.83

# Drug_Target_103_Transmembrane_Regions:
300-316

# Drug_Target_104_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_104_Chromosome_Location:
Not Available

# Drug_Target_104_Drug_References:
Not Available

# Drug_Target_104_Essentiality:
Non-Essential

# Drug_Target_104_GenAtlas_ID:
Not Available

# Drug_Target_104_GenBank_ID_Gene:
U67458

# Drug_Target_104_GenBank_ID_Protein:
Not Available

# Drug_Target_104_GeneCard_ID:
Not Available

# Drug_Target_104_Gene_Name:
katA

# Drug_Target_104_Gene_Sequence:
>1518 bp
ATGGTTAATAAAGATGTGAAACAAACCACTGCTTTTGGCGCTCCCGTTTGGGATGATAAC
AATGTGATTACGGCTGGTCCTAGAGGTCCTGTTTTATTACAAAGCACTTGGTTTTTGGAA
AAGTTAGCAGCGTTTGACAGAGAAAGGATCCCTGAAAGGGTAGTGCATGCTAAAGGAAGC
GGGGCTTATGGCACTTTCACCGTGACTAAAGACATCACTAAATACACTAAAGCGAAGATT
TTTTTTAAAGTGGGCAAAAAAACCGAATGCTTTTTCAGGTTTTTTACTGTGGCTGGTGAA
AGAGGCAGTGCGGATGCAGTGAGAGACCCTAGAGGTTTTGCGATGAAGTATTACACTGAA
GAAGGTAACTGGGATTTAGTAGGGAACAACACGCCTGTTTTCTTTATCCGTGATGCGATC
AAATTCCCTGATTTCATCCACACCCAAAAAAGAGACCCTCAAACCAATTTGCCTAACCAC
GACATGGTATGGGATTTTTGGAGTAATGTTCCTGAAAGCTTGTATCAAGTAACATGGGTT
ATGAGCGATAGAGGGATCCCTAAATCTTTCCGCCACATGGATGGTTTTGGCAGCCACACT
TTCAGTCTTATCAACGCTAAGGGCGAACGCTTTTGGGTGAAATTCCACTTTCACACCATG
CAAGGCGTTAAGCACTTGACTAACGAAGAAGCCGCAGAAGTCAGAAAATATGATCCTGAT
TCCAATCAAAGGGATTTATTCAATGCGATCGCTAGAGGGGATTTCCCAAAATGGAAATTA
AGCATTCAAGTGATGCCAGAAGAAGATGCTAAGAAGTATCGATTCCATCCGTTTGATGTT
ACTAAAATTTGGTATCTCCAAGATTATCCGTTGATGGAAGTGGGCATTGTAGAGTTGAAT
AAAAATCCTGAAAACTATTTTGCAGAAGTGGAGCAAGTGGCATTCACTCCGGCTAATGTC
GTTCCTGGAATTGGCTATAGCCCTGATAGGATGTTACAAGGACGCTTGTTCTCTTATGGG
GACACACACCGCTACCGCTTAGGGGTTAATTATCCTCAAATACCGGTTAATAAACCAAGA
TGCCCGTTCCACTCTTCTAGCAGAGATGGTTACATGCAAAACGGATACTACGGCTCTTTA
CAAAACTATACGCCTAGCTCATTGCCAGGTTATAAAGAAGATAAGAGCGCGAGAGATCCT
AAGTTCAACTTAGCTCATATTGAGAAAGAGTTTGAAGTGTGGAATTGGGATTACAGGGCT
GATGATAGCGATTACTACACCCAACCAGGTGATTACTACCGCTCATTGCCAGCTGATGAA
AAAGAAAGGTTGCATGACACTATTGGAGAGTCTTTGGCTCATGTTACCCATAAGGAAATT
GTGGATAAACAATTGGAGCATTTCAAGAAAGCTGATCCCAAATACGCTGAGGGAGTTAAA
AAAGCTCTTGAAAAACACCAAAAGATGATGAAAGACATGCATGGAAAAGACATGCACCAC
ACAAAAAAGAAAAAGTAA

# Drug_Target_104_General_Function:
Involved in catalase activity

# Drug_Target_104_General_References:
8955320	Odenbreit S, Wieland B, Haas R: Cloning and genetic characterization of Helicobacter pylori catalase and construction of a catalase-deficient mutant strain. J Bacteriol. 1996 Dec;178(23):6960-7.
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.
9546115	Manos J, Kolesnikow T, Hazell SL: An investigation of the molecular basis of the spontaneous occurrence of a catalase-negative phenotype in Helicobacter pylori. Helicobacter. 1998 Mar;3(1):28-38.

# Drug_Target_104_HGNC_ID:
Not Available

# Drug_Target_104_HPRD_ID:
Not Available

# Drug_Target_104_ID:
4539

# Drug_Target_104_Locus:
Not Available

# Drug_Target_104_Molecular_Weight:
58630

# Drug_Target_104_Name:
Catalase

# Drug_Target_104_Number_of_Residues:
505

# Drug_Target_104_PDB_ID:
1QWM

# Drug_Target_104_Pathway:
Not Available

# Drug_Target_104_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_104_Protein_Sequence:
>Catalase
MVNKDVKQTTAFGAPVWDDNNVITAGPRGPVLLQSTWFLEKLAAFDRERIPERVVHAKGS
GAYGTFTVTKDITKYTKAKIFSKVGKKTECFFRFSTVAGERGSADAVRDPRGFAMKYYTE
EGNWDLVGNNTPVFFIRDAIKFPDFIHTQKRDPQTNLPNHDMVWDFWSNVPESLYQVTWV
MSDRGIPKSFRHMDGFGSHTFSLINAKGERFWVKFHFHTMQGVKHLTNEEAAEVRKYDPD
SNQRDLFNAIARGDFPKWKLSIQVMPEEDAKKYRFHPFDVTKIWYLQDYPLMEVGIVELN
KNPENYFAEVEQAAFSPANVVPGIGYSPDRMLQGRLFSYGDTHRYRLGVNYPQIPVNKPR
CPFHSSSRDGYMQNGYYGSLQNYTPSSLPGYKEDKSARDPKFNLAHIEKEFEVWNWDYRA
DDSDYYTQPGDYYRSLPADEKERLHDTIGESLAHVTHKEIVDKQLEHFKKADPKYAEGVK
KALEKHQKMMKDMHGKDMHHTKKKK

# Drug_Target_104_Reaction:
Not Available

# Drug_Target_104_Signals:
None

# Drug_Target_104_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_104_SwissProt_ID:
P77872

# Drug_Target_104_SwissProt_Name:
CATA_HELPY

# Drug_Target_104_Synonyms:
EC 1.11.1.6

# Drug_Target_104_Theoretical_pI:
9.04

# Drug_Target_104_Transmembrane_Regions:
None

# Drug_Target_105_Cellular_Location:
Not Available

# Drug_Target_105_Chromosome_Location:
Not Available

# Drug_Target_105_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_105_Essentiality:
Non-Essential

# Drug_Target_105_GenAtlas_ID:
Not Available

# Drug_Target_105_GenBank_ID_Gene:
Not Available

# Drug_Target_105_GenBank_ID_Protein:
Not Available

# Drug_Target_105_GeneCard_ID:
Not Available

# Drug_Target_105_Gene_Name:
INPP5J

# Drug_Target_105_Gene_Sequence:
Not Available

# Drug_Target_105_General_Function:
Not Available

# Drug_Target_105_General_References:
Not Available

# Drug_Target_105_HGNC_ID:
Not Available

# Drug_Target_105_HPRD_ID:
Not Available

# Drug_Target_105_ID:
6960

# Drug_Target_105_Locus:
Not Available

# Drug_Target_105_Molecular_Weight:
Not Available

# Drug_Target_105_Name:
Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A

# Drug_Target_105_Number_of_Residues:
0

# Drug_Target_105_PDB_ID:
Not Available

# Drug_Target_105_Pathway:
Not Available

# Drug_Target_105_Pfam_Domain_Function:
Not Available

# Drug_Target_105_Protein_Sequence:
Not Available

# Drug_Target_105_Reaction:
Not Available

# Drug_Target_105_Signals:
Not Available

# Drug_Target_105_Specific_Function:
Not Available

# Drug_Target_105_SwissProt_ID:
Q15735

# Drug_Target_105_SwissProt_Name:
PI5PA_HUMAN

# Drug_Target_105_Synonyms:
Not Available

# Drug_Target_105_Theoretical_pI:
Not Available

# Drug_Target_105_Transmembrane_Regions:
Not Available

# Drug_Target_106_Cellular_Location:
Not Available

# Drug_Target_106_Chromosome_Location:
Not Available

# Drug_Target_106_Drug_References:
Not Available

# Drug_Target_106_Essentiality:
Non-Essential

# Drug_Target_106_GenAtlas_ID:
Not Available

# Drug_Target_106_GenBank_ID_Gene:
M59302

# Drug_Target_106_GenBank_ID_Protein:
Not Available

# Drug_Target_106_GeneCard_ID:
Not Available

# Drug_Target_106_Gene_Name:
cycA

# Drug_Target_106_Gene_Sequence:
>384 bp
ATGCGGAAATTGGTGTTCGGACTGTTCGTTCTCGCGGCAAGCGTCGCGCCGGCTGCGGCG
CAGGATGCGGCGTCGGGCGAGCAGGTGTTCAAGCAGTGTCTCGTCTGCCACTCGATCGGC
CCTGGCGCCAAGAACAAGGTTGGCCCGGTGCTGAACGGTCTGTTCGGTCGCCACTCCGGC
ACGATCGAGGGCTTCGCGTATTCGGACGCCAACAAGAACTCCGGAATCACCTGGACCGAA
GAGGTGTTCCGCGAGTACATCCGCGATCCGAAGGCCAAGATCCCCGGCACGAAGATGATC
TTCGCCGGCGTCAAGGACGAGCAGAAGGTCTCCGACCTGATCGCCTACATCAAGCAGTTC
AACGCCGACGGCTCGAAGAAGTAA

# Drug_Target_106_General_Function:
Involved in iron ion binding

# Drug_Target_106_General_References:
1697576	Grisshammer R, Wiessner C, Michel H: Sequence analysis and transcriptional organization of the Rhodopseudomonas viridis cytochrome c2 gene. J Bacteriol. 1990 Sep;172(9):5071-8.
174109	Ambler RP, Meyer TE, Kamen MD: Primary structure determination of two cytochromes c2: close similarity to functionally unrelated mitochondrial cytochrome C. Proc Natl Acad Sci U S A. 1976 Feb;73(2):472-5.
7674304	Sogabe S, Miki K: Refined crystal structure of ferrocytochrome c2 from Rhodopseudomonas viridis at 1.6 A resolution. J Mol Biol. 1995 Sep 15;252(2):235-47.

# Drug_Target_106_HGNC_ID:
Not Available

# Drug_Target_106_HPRD_ID:
Not Available

# Drug_Target_106_ID:
4979

# Drug_Target_106_Locus:
Not Available

# Drug_Target_106_Molecular_Weight:
13665

# Drug_Target_106_Name:
Cytochrome c2

# Drug_Target_106_Number_of_Residues:
127

# Drug_Target_106_PDB_ID:
1IO3

# Drug_Target_106_Pathway:
Not Available

# Drug_Target_106_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_106_Protein_Sequence:
>Cytochrome c2
MRKLVFGLFVLAASVAPAAAQDAASGEQVFKQCLVCHSIGPGAKNKVGPVLNGLFGRHSG
TIEGFAYSDANKNSGITWTEEVFREYIRDPKAKIPGTKMIFAGVKDEQKVSDLIAYIKQF
NADGSKK

# Drug_Target_106_Reaction:
Not Available

# Drug_Target_106_Signals:
1-20

# Drug_Target_106_Specific_Function:
Cytochrome c2 is found mainly in purple, non-sulfur, photosynthetic bacteria where it functions as the electron donor to the oxidized bacteriochlorophyll in the photophosphorylation pathway. However, it may also have a role in the respiratory chain and is found in some non-photosynthetic bacteria

# Drug_Target_106_SwissProt_ID:
P00083

# Drug_Target_106_SwissProt_Name:
CYC2_RHOVI

# Drug_Target_106_Synonyms:
Cytochrome c2 precursor

# Drug_Target_106_Theoretical_pI:
9.79

# Drug_Target_106_Transmembrane_Regions:
None

# Drug_Target_107_Cellular_Location:
Not Available

# Drug_Target_107_Chromosome_Location:
Not Available

# Drug_Target_107_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_107_Essentiality:
Non-Essential

# Drug_Target_107_GenAtlas_ID:
Not Available

# Drug_Target_107_GenBank_ID_Gene:
Not Available

# Drug_Target_107_GenBank_ID_Protein:
Not Available

# Drug_Target_107_GeneCard_ID:
Not Available

# Drug_Target_107_Gene_Name:
katG

# Drug_Target_107_Gene_Sequence:
Not Available

# Drug_Target_107_General_Function:
Not Available

# Drug_Target_107_General_References:
Not Available

# Drug_Target_107_HGNC_ID:
Not Available

# Drug_Target_107_HPRD_ID:
Not Available

# Drug_Target_107_ID:
7098

# Drug_Target_107_Locus:
Not Available

# Drug_Target_107_Molecular_Weight:
Not Available

# Drug_Target_107_Name:
Catalase-peroxidase

# Drug_Target_107_Number_of_Residues:
0

# Drug_Target_107_PDB_ID:
Not Available

# Drug_Target_107_Pathway:
Not Available

# Drug_Target_107_Pfam_Domain_Function:
Not Available

# Drug_Target_107_Protein_Sequence:
Not Available

# Drug_Target_107_Reaction:
Not Available

# Drug_Target_107_Signals:
Not Available

# Drug_Target_107_Specific_Function:
Not Available

# Drug_Target_107_SwissProt_ID:
Q31MN3

# Drug_Target_107_SwissProt_Name:
KATG_SYNE7

# Drug_Target_107_Synonyms:
Not Available

# Drug_Target_107_Theoretical_pI:
Not Available

# Drug_Target_107_Transmembrane_Regions:
Not Available

# Drug_Target_108_Cellular_Location:
Not Available

# Drug_Target_108_Chromosome_Location:
Not Available

# Drug_Target_108_Drug_References:
Not Available

# Drug_Target_108_Essentiality:
Non-Essential

# Drug_Target_108_GenAtlas_ID:
Not Available

# Drug_Target_108_GenBank_ID_Gene:
AF060193

# Drug_Target_108_GenBank_ID_Protein:
Not Available

# Drug_Target_108_GeneCard_ID:
Not Available

# Drug_Target_108_Gene_Name:
pigA

# Drug_Target_108_Gene_Sequence:
>597 bp
ATGGATACCCTGGCCCCTGAATCCACTCGGCAAAACCTGCGTTCGCAACGCCTCAACCTG
CTGACCAACGAGCCGCACCAGCGCCTGGAGAGCCTGGTGAAGAGCAAGGAACCCTTCGCC
AGCCGGGACAATTTCGCCCGCTTCGTCGCCGCCCAGTACCTCTTCCAGCATGACCTGGAG
CCGCTTTATCGCAACGAAGCGCTGGCCCGCCTGTTCCCCGGCCTGGCTTCCCGCGCCCGC
GACGACGCCGCTCGTGCAGACCTGGCGGACCTCGGCCATCCGGTACCGGAGGGCGACCAG
AGCGTGCGCGAGGCCGACCTGAGCCTGGCCGAGGCACTGGGCTGGCTGTTCGTTTCCGAA
GGTTCGAAGCTGGGCGCTGCGTTCCTGTTCAAGAAAGCCGCCGCGCTCGAACTCGACGAG
AACTTCGGCGCCCGCCATCTGGCCGAGCCGGAAGGCGGCCGCGCGCAAGGCTGGAAGAGC
TTCGTGGCGATCCTCGACGGCATCGAGCTGAACGAGGAGGAAGAGCGCCTGGCCGCCAAG
GGCGCCAGCGATGCCTTCAATCGTTTCGGCGACCTGCTGGAGCGTACCTTCGCCTGA

# Drug_Target_108_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_108_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
8633080	Ochsner UA, Vasil ML: Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron-regulated genes. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4409-14.

# Drug_Target_108_HGNC_ID:
Not Available

# Drug_Target_108_HPRD_ID:
Not Available

# Drug_Target_108_ID:
4981

# Drug_Target_108_Locus:
Not Available

# Drug_Target_108_Molecular_Weight:
21954

# Drug_Target_108_Name:
Iron-starvation protein PigA

# Drug_Target_108_Number_of_Residues:
198

# Drug_Target_108_PDB_ID:
1SK7

# Drug_Target_108_Pathway:
Not Available

# Drug_Target_108_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_108_Protein_Sequence:
>Iron-starvation protein PigA
MDTLAPESTRQNLRSQRLNLLTNEPHQRLESLVKSKEPFASRDNFARFVAAQYLFQHDLE
PLYRNEALARLFPGLASRARDDAARADLADLGHPVPEGDQSVREADLSLAEALGWLFVSE
GSKLGAAFLFKKAAALELDENFGARHLAEPEGGRAQGWKSFVAILDGIELNEEEERLAAK
GASDAFNRFGDLLERTFA

# Drug_Target_108_Reaction:
Not Available

# Drug_Target_108_Signals:
None

# Drug_Target_108_Specific_Function:
Not Available

# Drug_Target_108_SwissProt_ID:
O69002

# Drug_Target_108_SwissProt_Name:
O69002_PSEAE

# Drug_Target_108_Synonyms:
Heme oxygenase

# Drug_Target_108_Theoretical_pI:
4.78

# Drug_Target_108_Transmembrane_Regions:
None

# Drug_Target_109_Cellular_Location:
Not Available

# Drug_Target_109_Chromosome_Location:
Not Available

# Drug_Target_109_Drug_References:
Not Available

# Drug_Target_109_Essentiality:
Non-Essential

# Drug_Target_109_GenAtlas_ID:
Not Available

# Drug_Target_109_GenBank_ID_Gene:
BA000022

# Drug_Target_109_GenBank_ID_Protein:
Not Available

# Drug_Target_109_GeneCard_ID:
Not Available

# Drug_Target_109_Gene_Name:
pbsA2

# Drug_Target_109_Gene_Sequence:
>753 bp
CTATTCACCTACCATTAGGGTGATGGGATGACCAGCGGTACTGCGAGCCTCAGTACTGCC
TGGACGATCCTGGCGAGTTAACAAGTCAAATGTGTGCTCACCGATCGCCGCTTTGATCAG
GTCTTCGAGGTCATGCATAACTTCCCGATTGAGGGAAAAAGCATAATTGGCTTCTTCAAC
AATCCGGTTTATGGTGGCTTCATCTAAGGGCAAGCTGTTCAGCACATCCCGATAAATTTC
CTTGAATTGACGGCGATCGCCTGGGGTAGGCAAACTGTCAAATTCGTACATGGCCGTGCC
CTCTCCCTCCGGCAATTGTAAAGCGGAACGAATAATATTTTTCAGGCTTTGACCACCGGA
TAAGTCCCCTAGGTAACGGGTGTAACAATGGGCAATGAGTAGTTCCGGTTCACTTGCTGC
AATAGTTTTGAGGCGATCGACATAAATTTTTGCACAGGGAGTAGGCTGGATTATTTGTTG
CCAATTAGGGCCGTAATAGTAGGTCAAATCTTCAGCTAATTTATCAGTGCGATTCAATTC
TGGAAAATAAATTGCGCTAATAATTTCATTGTCCCGATGTTGGCGTAAAGCTGCTTCTAG
GGCACTGTAAAGATAATACAAATTAGCTAATAATTGCCGAAATGGTTCCCGCTCTACAAT
GCCTTTTAAAAAGCATTTCATGTAGGCAGTGTTTTCTGCCAAAGTGTGGGATTGTTGGGT
ACCGTAGCGGAGTTTTTGTGCAAGGTTAGTCAT

# Drug_Target_109_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_109_General_References:
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.

# Drug_Target_109_HGNC_ID:
Not Available

# Drug_Target_109_HPRD_ID:
Not Available

# Drug_Target_109_ID:
4982

# Drug_Target_109_Locus:
Not Available

# Drug_Target_109_Molecular_Weight:
28541

# Drug_Target_109_Name:
Heme oxygenase 2

# Drug_Target_109_Number_of_Residues:
250

# Drug_Target_109_PDB_ID:
1WOX

# Drug_Target_109_Pathway:
Not Available

# Drug_Target_109_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_109_Protein_Sequence:
>Heme oxygenase 2
MTNLAQKLRYGTQQSHTLAENTAYMKCFLKGIVEREPFRQLLANLYYLYSALEAALRQHR
DNEIISAIYFPELNRTDKLAEDLTYYYGPNWQQIIQPTPCAKIYVDRLKTIAASEPELLI
AHCYTRYLGDLSGGQSLKNIIRSALQLPEGEGTAMYEFDSLPTPGDRRQFKEIYRDVLNS
LPLDEATINRIVEEANYAFSLNREVMHDLEDLIKAAIGEHTFDLLTRQDRPGSTEARSTA
GHPITLMVGE

# Drug_Target_109_Reaction:
Not Available

# Drug_Target_109_Signals:
None

# Drug_Target_109_Specific_Function:
Catalyzes the opening of the heme ring with the release of iron. Key enzyme in the synthesis of the chromophoric part of the photosynthetic antennae (By similarity)

# Drug_Target_109_SwissProt_ID:
P74133

# Drug_Target_109_SwissProt_Name:
HO2_SYNY3

# Drug_Target_109_Synonyms:
EC 1.14.99.3

# Drug_Target_109_Theoretical_pI:
5.18

# Drug_Target_109_Transmembrane_Regions:
None

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
Z54247

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
bfr

# Drug_Target_10_Gene_Sequence:
>486 bp
ATGAAAGGCGACGCAAAGGTCATCGAGTTTCTCAATGCGGCACTGCGGTCGGAACTGACC
GCGATTTCGCAATATTGGGTGCATTTCCGGCTGCAGGAGGACTGGGGCCTCGCCAAGATG
GCGAAGAAAAGCCGCGAGGAATCGATCGAGGAAATGGGCCATGCCGACAAGATCATCGCC
CGGATCCTGTTCCTTGAAGGCCATCCGAACCTGCAGAAGCTTGACCCGCTGCGCATCGGC
GAGGGCCCGCGCGAGACGCTCGAATGCGATCTGGCGGGGGAACATGACGCGCTGAAGCTT
TACCGCGAGGCGCGCGATTACTGCGCCGAGGTGGGCGACATCGTCTCGAAGAACATCTTC
GAAAGCCTGATCACCGACGAGGAAGGCCACGTCGATTTCCTCGAAACGCAGATCTCGCTT
TATGACCGGCTCGGGCCGCAGGGCTTTGCGCTGCTCAATGCCGCGCCGATGGACGCGGCC
GAATAA

# Drug_Target_10_General_Function:
Involved in binding

# Drug_Target_10_General_References:
11752777	Cobessi D, Huang LS, Ban M, Pon NG, Daldal F, Berry EA: The 2.6 A resolution structure of Rhodobacter capsulatus bacterioferritin with metal-free dinuclear site and heme iron in a crystallographic 'special position'. Acta Crystallogr D Biol Crystallogr. 2002 Jan;58(Pt 1):29-38. Epub 2001 Dec 21.
8674981	Penfold CN, Ringeling PL, Davy SL, Moore GR, McEwan AG, Spiro S: Isolation, characterisation and expression of the bacterioferritin gene of Rhodobacter capsulatus. FEMS Microbiol Lett. 1996 Jun 1;139(2-3):143-8.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
4906

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
18173

# Drug_Target_10_Name:
Bacterioferritin

# Drug_Target_10_Number_of_Residues:
161

# Drug_Target_10_PDB_ID:
1JGC

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00210	Ferritin

# Drug_Target_10_Protein_Sequence:
>Bacterioferritin
MKGDAKVIEFLNAALRSELTAISQYWVHFRLQEDWGLAKMAKKSREESIEEMGHADKIIA
RILFLEGHPNLQKLDPLRIGEGPRETLECDLAGEHDALKLYREARDYCAEVGDIVSKNIF
ESLITDEEGHVDFLETQISLYDRLGPQGFALLNAAPMDAAE

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
May perform analogous functions in iron detoxification and storage to that of animal ferritins (By similarity)

# Drug_Target_10_SwissProt_ID:
Q59738

# Drug_Target_10_SwissProt_Name:
BFR_RHOCA

# Drug_Target_10_Synonyms:
BFR

# Drug_Target_10_Theoretical_pI:
4.49

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_110_Cellular_Location:
Not Available

# Drug_Target_110_Chromosome_Location:
Not Available

# Drug_Target_110_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_110_Essentiality:
Non-Essential

# Drug_Target_110_GenAtlas_ID:
NGB

# Drug_Target_110_GenBank_ID_Gene:
AJ245944

# Drug_Target_110_GenBank_ID_Protein:
Not Available

# Drug_Target_110_GeneCard_ID:
Not Available

# Drug_Target_110_Gene_Name:
NGB

# Drug_Target_110_Gene_Sequence:
>456 bp
ATGGAGCGCCCGGAGCCCGAGCTGATCCGGCAGAGCTGGCGGGCAGTGAGCCGCAGCCCG
CTGGAGCACGGCACCGTCCTGTTTGCCAGGCTGTTTGCCCTGGAGCCTGACCTGCTGCCC
CTCTTCCAGTACAACTGCCGCCAGTTCTCCAGCCCAGAGGACTGTCTCTCCTCGCCTGAG
TTCCTGGACCACATCAGGAAGGTGATGCTCGTGATTGATGCTGCAGTGACCAATGTGGAA
GACCTGTCCTCACTGGAGGAGTACCTTGCCAGCCTGGGCAGGAAGCACCGGGCAGTGGGT
GTGAAGCTCAGCTCCTTCTCGACAGTGGGTGAGTCTCTGCTCTACATGCTGGAGAAGTGT
CTGGGCCCTGCCTTCACACCAGCCACACGGGCTGCCTGGAGCCAACTCTACGGGGCCGTA
GTGCAGGCCATGAGTCGAGGCTGGGATGGCGAGTAA

# Drug_Target_110_General_Function:
Involved in iron ion binding

# Drug_Target_110_General_References:
11029004	Burmester T, Weich B, Reinhardt S, Hankeln T: A vertebrate globin expressed in the brain. Nature. 2000 Sep 28;407(6803):520-3.
11473128	Dewilde S, Kiger L, Burmester T, Hankeln T, Baudin-Creuza V, Aerts T, Marden MC, Caubergs R, Moens L: Biochemical characterization and ligand binding properties of neuroglobin, a novel member of the globin family. J Biol Chem. 2001 Oct 19;276(42):38949-55. Epub 2001 Jul 25.
11820779	Zhang C, Wang C, Deng M, Li L, Wang H, Fan M, Xu W, Meng F, Qian L, He F: Full-length cDNA cloning of human neuroglobin and tissue expression of rat neuroglobin. Biochem Biophys Res Commun. 2002 Feb 8;290(5):1411-9.
12351835	Pesce A, Nardini M, Dewilde S, Ascenzi P, Burmester T, Hankeln T, Moens L, Bolognesi M: Human neuroglobin: crystals and preliminary X-ray diffraction analysis. Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1848-50. Epub 2002 Sep 28.
12508121	Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico L, Levy M, Barbe V, de Berardinis V, Ureta-Vidal A, Pelletier E, Vico V, Anthouard V, Rowen L, Madan A, Qin S, Sun H, Du H, Pepin K, Artiguenave F, Robert C, Cruaud C, Bruls T, Jaillon O, Friedlander L, Samson G, Brottier P, Cure S, Segurens B, Aniere F, Samain S, Crespeau H, Abbasi N, Aiach N, Boscus D, Dickhoff R, Dors M, Dubois I, Friedman C, Gouyvenoux M, James R, Madan A, Mairey-Estrada B, Mangenot S, Martins N, Menard M, Oztas S, Ratcliffe A, Shaffer T, Trask B, Vacherie B, Bellemere C, Belser C, Besnard-Gonnet M, Bartol-Mavel D, Boutard M, Briez-Silla S, Combette S, Dufosse-Laurent V, Ferron C, Lechaplais C, Louesse C, Muselet D, Magdelenat G, Pateau E, Petit E, Sirvain-Trukniewicz P, Trybou A, Vega-Czarny N, Bataille E, Bluet E, Bordelais I, Dubois M, Dumont C, Guerin T, Haffray S, Hammadi R, Muanga J, Pellouin V, Robert D, Wunderle E, Gauguet G, Roy A, Sainte-Marthe L, Verdier J, Verdier-Discala C, Hillier L, Fulton L, McPherson J, Matsuda F, Wilson R, Scarpelli C, Gyapay G, Wincker P, Saurin W, Quetier F, Waterston R, Hood L, Weissenbach J: The DNA sequence and analysis of human chromosome 14. Nature. 2003 Feb 6;421(6923):601-7. Epub 2003 Jan 1.

# Drug_Target_110_HGNC_ID:
HGNC:14077

# Drug_Target_110_HPRD_ID:
Not Available

# Drug_Target_110_ID:
4984

# Drug_Target_110_Locus:
14q24

# Drug_Target_110_Molecular_Weight:
16934

# Drug_Target_110_Name:
Neuroglobin

# Drug_Target_110_Number_of_Residues:
151

# Drug_Target_110_PDB_ID:
1OJ6

# Drug_Target_110_Pathway:
Not Available

# Drug_Target_110_Pfam_Domain_Function:
PF00042	Globin

# Drug_Target_110_Protein_Sequence:
>Neuroglobin
MERPEPELIRQSWRAVSRSPLEHGTVLFARLFALEPDLLPLFQYNCRQFSSPEDCLSSPE
FLDHIRKVMLVIDAAVTNVEDLSSLEEYLASLGRKHRAVGVKLSSFSTVGESLLYMLEKC
LGPAFTPATRAAWSQLYGAVVQAMSRGWDGE

# Drug_Target_110_Reaction:
Not Available

# Drug_Target_110_Signals:
None

# Drug_Target_110_Specific_Function:
Involved in oxygen transport in the brain

# Drug_Target_110_SwissProt_ID:
Q9NPG2

# Drug_Target_110_SwissProt_Name:
NGB_HUMAN

# Drug_Target_110_Synonyms:
Not Available

# Drug_Target_110_Theoretical_pI:
5.24

# Drug_Target_110_Transmembrane_Regions:
None

# Drug_Target_111_Cellular_Location:
Isoform 1:Microsome
microsomal membrane
peripheral membrane protein. Isoform 2:Cytoplasm. Note=Bou

# Drug_Target_111_Chromosome_Location:
Not Available

# Drug_Target_111_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_111_Essentiality:
Non-Essential

# Drug_Target_111_GenAtlas_ID:
CYB5A

# Drug_Target_111_GenBank_ID_Gene:
M22865

# Drug_Target_111_GenBank_ID_Protein:
181227

# Drug_Target_111_GeneCard_ID:
CYB5A

# Drug_Target_111_Gene_Name:
CYB5A

# Drug_Target_111_Gene_Sequence:
>405 bp
ATGGCAGAGCAGTCGGACGAGGCCGTGAAGTACTACACCCTAGAGGAGATTCAGAAGCAC
AACCACAGCAAGAGCACCTGGCTGATCCTGCACCACAAGGTGTACGATTTGACCAAATTT
CTGGAAGAGCATCCTGGTGGGGAAGAAGTTTTAAGGGAACAAGCTGGAGGTGACGCTACT
GAGAACTTTGAGGATGTCGGGCACTCTACAGATGCCAGGGAAATGTCCAAAACATTCATC
ATTGGGGAGCTCCATCCAGATGACAGACCAAAGTTAAACAAGCCTCCGGAAACTCTTATC
ACTACTATTGATTCTAGTTCCAGTTGGTGGACCAACTGGGTGATCCCTGCCATCTCTGCA
GTGGCCGTCGCCTTGATGTATCGCCTATACATGGCAGAGGACTGA

# Drug_Target_111_General_Function:
Involved in heme binding

# Drug_Target_111_General_References:
1712589	Giordano SJ, Steggles AW: The human liver and reticulocyte cytochrome b5 mRNAs are products from a single gene. Biochem Biophys Res Commun. 1991 Jul 15;178(1):38-44.
2752049	Ozols J: Structure of cytochrome b5 and its topology in the microsomal membrane. Biochim Biophys Acta. 1989 Jul 27;997(1-2):121-30.
3178851	Yoo M, Steggles AW: The complete nucleotide sequence of human liver cytochrome b5 mRNA. Biochem Biophys Res Commun. 1988 Oct 14;156(1):576-80.
4030743	Abe K, Kimura S, Kizawa R, Anan FK, Sugita Y: Amino acid sequences of cytochrome b5 from human, porcine, and bovine erythrocytes and comparison with liver microsomal cytochrome b5. J Biochem (Tokyo). 1985 Jun;97(6):1659-68.
4770377	Rashid MA, Hagihara B, Kobayashi M, Tani S, Tsugita A: Structural studies of cytochrome b5. 3. Sequential studies on human liver cytochrome b5. J Biochem (Tokyo). 1973 Nov;74(5):985-1002.
4993957	Nobrega FG, Ozols J: Amino acid sequences of tryptic peptides of cytochromes b5 from microsomes of human, monkey, porcine, and chicken liver. J Biol Chem. 1971 Mar 25;246(6):1706-17.
5062820	Ozols J: Cytochrome b 5 from a normal human liver. Isolation and the partial amino acid sequence. J Biol Chem. 1972 Apr 10;247(7):2242-5.

# Drug_Target_111_HGNC_ID:
HGNC:2570

# Drug_Target_111_HPRD_ID:
08941

# Drug_Target_111_ID:
2119

# Drug_Target_111_Locus:
18q23

# Drug_Target_111_Molecular_Weight:
15330

# Drug_Target_111_Name:
Cytochrome b5

# Drug_Target_111_Number_of_Residues:
134

# Drug_Target_111_PDB_ID:
1HKO

# Drug_Target_111_Pathway:
Not Available

# Drug_Target_111_Pfam_Domain_Function:
PF00173	Cyt-b5

# Drug_Target_111_Protein_Sequence:
>Cytochrome b5
MAEQSDEAVKYYTLEEIQKHNHSKSTWLILHHKVYDLTKFLEEHPGGEEVLREQAGGDAT
ENFEDVGHSTDAREMSKTFIIGELHPDDRPKLNKPPETLITTIDSSSSWWTNWVIPAISA
VAVALMYRLYMAED

# Drug_Target_111_Reaction:
Not Available

# Drug_Target_111_Signals:
None

# Drug_Target_111_Specific_Function:
Cytochrome b5 is a membrane bound hemoprotein which function as an electron carrier for several membrane bound oxygenases

# Drug_Target_111_SwissProt_ID:
P00167

# Drug_Target_111_SwissProt_Name:
CYB5_HUMAN

# Drug_Target_111_Synonyms:
Not Available

# Drug_Target_111_Theoretical_pI:
4.61

# Drug_Target_111_Transmembrane_Regions:
None

# Drug_Target_112_Cellular_Location:
Endoplasmic reticulum membrane

# Drug_Target_112_Chromosome_Location:
1

# Drug_Target_112_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_112_Essentiality:
Non-Essential

# Drug_Target_112_GenAtlas_ID:
Not Available

# Drug_Target_112_GenBank_ID_Gene:
M61853

# Drug_Target_112_GenBank_ID_Protein:
Not Available

# Drug_Target_112_GeneCard_ID:
CYP2C18

# Drug_Target_112_Gene_Name:
CYP2C18

# Drug_Target_112_Gene_Sequence:
Not Available

# Drug_Target_112_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_112_General_References:
15164054	Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81.
15302935	Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn MA, Cantley LC, Gygi SP: Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12130-5. Epub 2004 Aug 9.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
2009263	Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55.
8095407	Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily. Biochemistry. 1993 Feb 9;32(5):1390.
8333835	de Morais SM, Schweikl H, Blaisdell J, Goldstein JA: Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. Biochem Biophys Res Commun. 1993 Jul 15;194(1):194-201.

# Drug_Target_112_HGNC_ID:
GNC:2620

# Drug_Target_112_HPRD_ID:
Not Available

# Drug_Target_112_ID:
6106

# Drug_Target_112_Locus:
10q24

# Drug_Target_112_Molecular_Weight:
55710.1

# Drug_Target_112_Name:
Cytochrome P450 2C18

# Drug_Target_112_Number_of_Residues:
490

# Drug_Target_112_PDB_ID:
Not Available

# Drug_Target_112_Pathway:
Not Available

# Drug_Target_112_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_112_Protein_Sequence:
>Cytochrome P450 2C18
MDPAVALVLCLSCLFLLSLWRQSSGRGRLPSGPTPLPIIGNILQLDVKDMSKSLTNFSKV
YGPVFTVYFGLKPIVVLHGYEAVKEALIDHGEEFSGRGSFPVAEKVNKGLGILFSNGKRW
KEIRRFCLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTNASPCDPTFILGCAPCNVICS
VIFHDRFDYKDQRFLNLMEKFNENLRILSSPWIQVCNNFPALIDYLPGSHNKIAENFAYI
KSYVLERIKEHQESLDMNSARDFIDCFLIKMEQEKHNQQSEFTVESLIATVTDMFGAGTE
TTSTTLRYGLLLLLKYPEVTAKVQEEIECVVGRNRSPCMQDRSHMPYTDAVVHEIQRYID
LLPTNLPHAVTCDVKFKNYLIPKGTTIITSLTSVLHNDKEFPNPEMFDPGHFLDKSGNFK
KSDYFMPFSAGKRMCMGEGLARMELFLFLTTILQNFNLKSQVDPKDIDITPIANAFGRVP
PLYQLCFIPV

# Drug_Target_112_Reaction:
Not Available

# Drug_Target_112_Signals:
None

# Drug_Target_112_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics

# Drug_Target_112_SwissProt_ID:
P33260

# Drug_Target_112_SwissProt_Name:
CP2CI_HUMAN

# Drug_Target_112_Synonyms:
CYPIIC18
P450-6B/29C

# Drug_Target_112_Theoretical_pI:
7.22

# Drug_Target_112_Transmembrane_Regions:
None

# Drug_Target_113_Cellular_Location:
Not Available

# Drug_Target_113_Chromosome_Location:
Not Available

# Drug_Target_113_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_113_Essentiality:
Non-Essential

# Drug_Target_113_GenAtlas_ID:
Not Available

# Drug_Target_113_GenBank_ID_Gene:
Not Available

# Drug_Target_113_GenBank_ID_Protein:
Not Available

# Drug_Target_113_GeneCard_ID:
Not Available

# Drug_Target_113_Gene_Name:
HPX

# Drug_Target_113_Gene_Sequence:
Not Available

# Drug_Target_113_General_Function:
Not Available

# Drug_Target_113_General_References:
Not Available

# Drug_Target_113_HGNC_ID:
Not Available

# Drug_Target_113_HPRD_ID:
Not Available

# Drug_Target_113_ID:
7019

# Drug_Target_113_Locus:
Not Available

# Drug_Target_113_Molecular_Weight:
Not Available

# Drug_Target_113_Name:
Hemopexin

# Drug_Target_113_Number_of_Residues:
0

# Drug_Target_113_PDB_ID:
Not Available

# Drug_Target_113_Pathway:
Not Available

# Drug_Target_113_Pfam_Domain_Function:
Not Available

# Drug_Target_113_Protein_Sequence:
Not Available

# Drug_Target_113_Reaction:
Not Available

# Drug_Target_113_Signals:
Not Available

# Drug_Target_113_Specific_Function:
Not Available

# Drug_Target_113_SwissProt_ID:
P02790

# Drug_Target_113_SwissProt_Name:
HEMO_HUMAN

# Drug_Target_113_Synonyms:
Not Available

# Drug_Target_113_Theoretical_pI:
Not Available

# Drug_Target_113_Transmembrane_Regions:
Not Available

# Drug_Target_114_Cellular_Location:
Mitochondrion

# Drug_Target_114_Chromosome_Location:
Not Available

# Drug_Target_114_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_114_Essentiality:
Non-Essential

# Drug_Target_114_GenAtlas_ID:
SUOX

# Drug_Target_114_GenBank_ID_Gene:
L31573

# Drug_Target_114_GenBank_ID_Protein:
Not Available

# Drug_Target_114_GeneCard_ID:
Not Available

# Drug_Target_114_Gene_Name:
SUOX

# Drug_Target_114_Gene_Sequence:
>1467 bp
ATGGGGACCCTATTAGGTCTCGGTGCAGTGTTGGCCTATCAGGACCATCGGTGTAGGGCT
GCTCAGGAGTCAACACACATATACACTAAGGAGGAAGTGAGTTCCCACACCAGCCCTGAG
ACTGGGATCTGGGTGACTCTGGGCTCTGAGGTCTTTGATGTCACAGAATTTGTGGACCTA
CATCCAGGGGGGCCTTCAAAGCTGATGCTAGCAGCTGGGGGTCCCCTAGAGCCCTTCTGG
GCCCTCTATGCTGTTCACAACCAGTCCCATGTGCGTGAGTTACTGGCTCAGTACAAGATT
GGGGAGCTGAATCCTGAAGACAAGGTAGCCCCCACCGTGGAGACCTCTGACCCTTATGCT
GATGATCCTGTACGTCACCCAGCCCTGAAGGTCAACAGCCAGCGGCCCTTTAATGCAGAG
CCTCCCCCTGAGCTGCTGACAGAAAACTACATCACACCCAACCCTATCTTCTTCACCCGG
AACCATCTGCCTGTACCTAACCTGGATCCAGACACCTATCGCTTACACGTAGTAGGAGCA
CCTGGGGGTCAGTCACTGTCTCTTTCCCTGGATGACTTGCACAACTTTCCCAGGTACGAG
ATCACAGTCACTCTGCAGTGTGCCGGCAACCGACGCTCTGAGATGACTCAGGTCAAAGAA
GTAAAAGGTCTGGAGTGGAGAACAGGAGCCATCAGCACTGCACGCTGGGCTGGGGCACGG
CTCTGTGATGTGTTAGCCCAGGCTGGCCACCAACTCTGTGAAACTGAGGCCCACGTCTGC
TTTGAGGGACTGGACTCAGACCCTACTGGGACTGCCTATGGAGCATCCATCCCTCTGGCT
CGGGCCATGGACCCTGAAGCTGAGGTCCTGCTGGCATATGAGATGAATGGGCAGCCTCTG
CCACGTGACCACGGCTTCCCTGTGCGTGTGGTGGTTCCTGGAGTGGTGGGTGCCCGCCAT
GTCAAATGGCTGGGCAGAGTGAGTGTGCAGCCAGAGGAAAGTTACAGCCACTGGCAACGG
CGGGATTACAAAGGCTTCTCTCCATCTGTGGACTGGGAGACTGTAGATTTTGACTCTGCT
CCATCCATTCAGGAACTTCCTGTCCAGTCCGCCATCACAGAGCCCCGGGATGGAGAGACT
GTAGAATCAGGGGAGGTGACCATCAAGGGCTATGCATGGAGTGGTGGTGGCAGGGCTGTG
ATCCGGGTGGATGTGTCTCTGGATGGGGGCCTAACCTGGCAGGTGGCTAAGCTGGATGGA
GAGGAACAGCGCCCCAGGAAGGCCTGGGCATGGCGTCTGTGGCAGTTGAAAGCCCCTGTG
CCAGCTGGACAAAAGGAACTGAACATTGTTTGTAAGGCTGTGGATGATGGTTACAATGTG
CAGCCAGACACCGTGGCCCCAATCTGGAACCTGCGAGGTGTTCTCAGCAATGCCTGGCAT
CGTGTCCATGTCTATGTCTCCCCATGA

# Drug_Target_114_General_Function:
Involved in heme binding

# Drug_Target_114_General_References:
10519592	Edwards MC, Johnson JL, Marriage B, Graf TN, Coyne KE, Rajagopalan KV, MacDonald IM: Isolated sulfite oxidase deficiency: review of two cases in one family. Ophthalmology. 1999 Oct;106(10):1957-61.
12112661	Johnson JL, Coyne KE, Garrett RM, Zabot MT, Dorche C, Kisker C, Rajagopalan KV: Isolated sulfite oxidase deficiency: identification of 12 novel SUOX mutations in 10 patients. Hum Mutat. 2002 Jul;20(1):74.
12368985	Lee HF, Mak BS, Chi CS, Tsai CR, Chen CH, Shu SG: A novel mutation in neonatal isolated sulphite oxidase deficiency. Neuropediatrics. 2002 Aug;33(4):174-9.
7599189	Garrett RM, Bellissimo DB, Rajagopalan KV: Molecular cloning of human liver sulfite oxidase. Biochim Biophys Acta. 1995 Jun 9;1262(2-3):147-9.
9428520	Kisker C, Schindelin H, Pacheco A, Wehbi WA, Garrett RM, Rajagopalan KV, Enemark JH, Rees DC: Molecular basis of sulfite oxidase deficiency from the structure of sulfite oxidase. Cell. 1997 Dec 26;91(7):973-83.
9600976	Garrett RM, Johnson JL, Graf TN, Feigenbaum A, Rajagopalan KV: Human sulfite oxidase R160Q: identification of the mutation in a sulfite oxidase-deficient patient and expression and characterization of the mutant enzyme. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6394-8.

# Drug_Target_114_HGNC_ID:
HGNC:11460

# Drug_Target_114_HPRD_ID:
Not Available

# Drug_Target_114_ID:
4988

# Drug_Target_114_Locus:
12q13.2

# Drug_Target_114_Molecular_Weight:
53885

# Drug_Target_114_Name:
Sulfite oxidase, mitochondrial

# Drug_Target_114_Number_of_Residues:
488

# Drug_Target_114_PDB_ID:
Not Available

# Drug_Target_114_Pathway:
Not Available

# Drug_Target_114_Pfam_Domain_Function:
PF00173	Cyt-b5
PF00174	Oxidored_molyb
PF03404	Mo-co_dimer

# Drug_Target_114_Protein_Sequence:
>Sulfite oxidase, mitochondrial
MGTLLGLGAVLAYQDHRCRAAQESTHIYTKEEVSSHTSPETGIWVTLGSEVFDVTEFVDL
HPGGPSKLMLAAGGPLEPFWALYAVHNQSHVRELLAQYKIGELNPEDKVAPTVETSDPYA
DDPVRHPALKVNSQRPFNAEPPPELLTENYITPNPIFFTRNHLPVPNLDPDTYRLHVVGA
PGGQSLSLSLDDLHNFPRYEITVTLQCAGNRRSEMTQVKEVKGLEWRTGAISTARWAGAR
LCDVLAQAGHQLCETEAHVCFEGLDSDPTGTAYGASIPLARAMDPEAEVLLAYEMNGQPL
PRDHGFPVRVVVPGVVGARHVKWLGRVSVQPEESYSHWQRRDYKGFSPSVDWETVDFDSA
PSIQELPVQSAITEPRDGETVESGEVTIKGYAWSGGGRAVIRVDVSLDGGLTWQVAKLDG
EEQRPRKAWAWRLWQLKAPVPAGQKELNIVCKAVDDGYNVQPDTVAPIWNLRGVLSNAWH
RVHVYVSP

# Drug_Target_114_Reaction:
Not Available

# Drug_Target_114_Signals:
None

# Drug_Target_114_Specific_Function:
Sulfite + O(2) + H(2)O = sulfate + H(2)O(2)

# Drug_Target_114_SwissProt_ID:
P51687

# Drug_Target_114_SwissProt_Name:
SUOX_HUMAN

# Drug_Target_114_Synonyms:
EC 1.8.3.1
Sulfite oxidase, mitochondrial precursor

# Drug_Target_114_Theoretical_pI:
5.31

# Drug_Target_114_Transmembrane_Regions:
None

# Drug_Target_115_Cellular_Location:
Periplasm (Probable)

# Drug_Target_115_Chromosome_Location:
Not Available

# Drug_Target_115_Drug_References:
Not Available

# Drug_Target_115_Essentiality:
Non-Essential

# Drug_Target_115_GenAtlas_ID:
Not Available

# Drug_Target_115_GenBank_ID_Gene:
BX321860

# Drug_Target_115_GenBank_ID_Protein:
Not Available

# Drug_Target_115_GeneCard_ID:
Not Available

# Drug_Target_115_Gene_Name:
ccp

# Drug_Target_115_Gene_Sequence:
>1005 bp
TCACTCATACGGCTGAGAACGTGGTGTATCGTTATTGGAAGGTGGCAGAATCGGCAACTT
GAAGTCAGGCTGATCGCCGGTCAGGGTTTTCAGGAAAGCAACGATTTTGGAAACTTCATC
CTTGTTGAACTCACGGTTCAATTGGATTCTTCCCATGGTCTCCACTGCCTGTTCCAGCGT
TGCGGCCCCTCCATCATGAAAATAGGGGTAGGTCAGCTCGATATTTCTCAACGTTGGCAC
TTTGAATACATTACGATCAGCTTCATTGCCGGTCACATCCATCCGCCCCGCGGCCGGGTT
TTTGGTCTCATAGGGTTTAAAAACACCCATTTTCTGATAAGAACTTCCACCCACGGCTGG
TCCATTATGACATTGCACGCAACCGCTGCCCTTGAACAGGTTGTAGCCTTCCAGCTCATC
CTGATTCAGTGCGTTTTTATCGCCTTCCAGCCATTTGTCGAATTTTGAACCCGGTGTCAC
CAGCGTTTCTTCAAATTGGGCAATTGCGGTGGTGATGCGATCGATCGTCACTTCATCGGA
ACCAAAGACTTTCTTGAATCGCTCACGATATTGAGGCATGGAAGCGACCACTTTTTCTGC
TATCTCATGGGTAGAGGCCATTTCCTTCGGGTTGGCAATCGGGCCGGCAGCCTGTTCTTT
CAGGTCTTTGGCTCTGCCATCCCAGAATTGCGCCAGATTCATGCTGGAATTCAGGACAGT
CGGAGCATTGATCGGGCCTTGCTGCCATTTGTGCCCGATCGAGGTGGTAATATTATCGGT
TCCGCCCATGCTCAGGTTATGACAGGAATTGCAGGAAATGAACCCCGATTTGGAAAGTCT
GGGGTCAAAAAACAGCATTTTCCCCAGCTCTGCCATATCGGCATTCTCCGGAGTCACCGC
CTTAATCGGTTGTATCGGTTCATTGGCAGCCATTACACCGGCAGACGCAAACATCGCCCC
CAGACTTAATGACAGCAGCGAAACAGTCAGTGTACGCTTGATCAT

# Drug_Target_115_General_Function:
Involved in iron ion binding

# Drug_Target_115_General_References:
12700255	Chain P, Lamerdin J, Larimer F, Regala W, Lao V, Land M, Hauser L, Hooper A, Klotz M, Norton J, Sayavedra-Soto L, Arciero D, Hommes N, Whittaker M, Arp D: Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea. J Bacteriol. 2003 May;185(9):2759-73.
8163487	Arciero DM, Hooper AB: A di-heme cytochrome c peroxidase from Nitrosomonas europaea catalytically active in both the oxidized and half-reduced states. J Biol Chem. 1994 Apr 22;269(16):11878-86.

# Drug_Target_115_HGNC_ID:
Not Available

# Drug_Target_115_HPRD_ID:
Not Available

# Drug_Target_115_ID:
4989

# Drug_Target_115_Locus:
Not Available

# Drug_Target_115_Molecular_Weight:
36633

# Drug_Target_115_Name:
Cytochrome c551 peroxidase

# Drug_Target_115_Number_of_Residues:
334

# Drug_Target_115_PDB_ID:
1IQC

# Drug_Target_115_Pathway:
Not Available

# Drug_Target_115_Pfam_Domain_Function:
PF03150	CCP_MauG

# Drug_Target_115_Protein_Sequence:
>Cytochrome c551 peroxidase
MIKRTLTVSLLSLSLGAMFASAGVMAANEPIQPIKAVTPENADMAELGKMLFFDPRLSKS
GFISCNSCHNLSMGGTDNITTSIGHKWQQGPINAPTVLNSSMNLAQFWDGRAKDLKEQAA
GPIANPKEMASTHEIAEKVVASMPQYRERFKKVFGSDEVTIDRITTAIAQFEETLVTPGS
KFDKWLEGDKNALNQDELEGYNLFKGSGCVQCHNGPAVGGSSYQKMGVFKPYETKNPAAG
RMDVTGNEADRNVFKVPTLRNIELTYPYFHDGGAATLEQAVETMGRIQLNREFNKDEVSK
IVAFLKTLTGDQPDFKLPILPPSNNDTPRSQPYE

# Drug_Target_115_Reaction:
Not Available

# Drug_Target_115_Signals:
1-26

# Drug_Target_115_Specific_Function:
2 ferrocytochrome c + H(2)O(2) = 2 ferricytochrome c + 2 H(2)O

# Drug_Target_115_SwissProt_ID:
P55929

# Drug_Target_115_SwissProt_Name:
CCPR_NITEU

# Drug_Target_115_Synonyms:
Cytochrome c peroxidase
Cytochrome c551 peroxidase precursor
EC 1.11.1.5

# Drug_Target_115_Theoretical_pI:
6.06

# Drug_Target_115_Transmembrane_Regions:
None

# Drug_Target_116_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_116_Chromosome_Location:
Not Available

# Drug_Target_116_Drug_References:
Not Available

# Drug_Target_116_Essentiality:
Non-Essential

# Drug_Target_116_GenAtlas_ID:
CYP3A4

# Drug_Target_116_GenBank_ID_Gene:
M18907

# Drug_Target_116_GenBank_ID_Protein:
Not Available

# Drug_Target_116_GeneCard_ID:
Not Available

# Drug_Target_116_Gene_Name:
CYP3A4

# Drug_Target_116_Gene_Sequence:
>1512 bp
ATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG
CTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG
CCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT
GACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT
GTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT
GTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA
GCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA
AAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG
AGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC
ATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA
GACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT
CTCTCAATAACAGTCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTG
TTTCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGC
CTCGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAAT
TCAAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATT
ATCTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAA
CTGGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCC
AATAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTG
AATGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGAT
GTTGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCT
CTTCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGC
AAGAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGA
AACTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTT
CAGAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGA
GGACTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTA
AGTGGAGCCTGA

# Drug_Target_116_General_Function:
Involved in monooxygenase activity

# Drug_Target_116_General_References:
10322772	Chen Q, Wu J, Yu Y: [Establishment of transgenic cell line CHL-3A4 and its metabolic activation] Zhonghua Yu Fang Yi Xue Za Zhi. 1998 Sep;32(5):281-4.
11181494	Hsieh KP, Lin YY, Cheng CL, Lai ML, Lin MS, Siest JP, Huang JD: Novel mutations of CYP3A4 in Chinese. Drug Metab Dispos. 2001 Mar;29(3):268-73.
11266076	Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21.
2463251	Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guengerich FP: Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem. 1989 Jan 15;264(2):910-9.
2563251	Spurr NK, Gough AC, Stevenson K, Wolf CR: The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter. Hum Genet. 1989 Jan;81(2):171-4.
3243766	Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6.
3267210	Gonzalez FJ, Schmid BJ, Umeno M, Mcbride OW, Hardwick JP, Meyer UA, Gelboin HV, Idle JR: Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA. 1988 Mar;7(2):79-86.
3464943	Beaune PH, Umbenhauer DR, Bork RW, Lloyd RS, Guengerich FP: Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064-8.
9088578	Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S: Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Br J Clin Pharmacol. 1997 Mar;43(3):245-52.

# Drug_Target_116_HGNC_ID:
HGNC:2637

# Drug_Target_116_HPRD_ID:
Not Available

# Drug_Target_116_ID:
4512

# Drug_Target_116_Locus:
7q21.1

# Drug_Target_116_Molecular_Weight:
57344

# Drug_Target_116_Name:
Cytochrome P450 3A4

# Drug_Target_116_Number_of_Residues:
503

# Drug_Target_116_PDB_ID:
1TQN

# Drug_Target_116_Pathway:
Clopidogrel Pathway	SMP00260
Cyclophosphamide Pathway	SMP00447
Etoposide Pathway	SMP00442
Ifosfamide Pathway	SMP00448
Imipramine Pathway	SMP00422
Prednisone Pathway	SMP00440
Tamoxifen Pathway	SMP00471
Teniposide Pathway	SMP00443

# Drug_Target_116_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_116_Protein_Sequence:
>Cytochrome P450 3A4
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA

# Drug_Target_116_Reaction:
Not Available

# Drug_Target_116_Signals:
None

# Drug_Target_116_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4- hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. The enzyme also hydroxylates etoposide

# Drug_Target_116_SwissProt_ID:
P08684

# Drug_Target_116_SwissProt_Name:
CP3A4_HUMAN

# Drug_Target_116_Synonyms:
CYPIIIA4
EC 1.14.13.67
EC 1.14.13.97
NF-25
Nifedipine oxidase
P450-PCN1
Quinine 3-monooxygenase
Taurochenodeoxycholate 6-alpha- hydroxylase

# Drug_Target_116_Theoretical_pI:
8.25

# Drug_Target_116_Transmembrane_Regions:
2-22

# Drug_Target_117_Cellular_Location:
Not Available

# Drug_Target_117_Chromosome_Location:
Not Available

# Drug_Target_117_Drug_References:
Not Available

# Drug_Target_117_Essentiality:
Non-Essential

# Drug_Target_117_GenAtlas_ID:
Not Available

# Drug_Target_117_GenBank_ID_Gene:
AF505790

# Drug_Target_117_GenBank_ID_Protein:
Not Available

# Drug_Target_117_GeneCard_ID:
Not Available

# Drug_Target_117_Gene_Name:
ppcA

# Drug_Target_117_Gene_Sequence:
>273 bp
ATGAAAAAGGTTATTGCTTCTCTCGCGCTGTCCGTATTCTGCGCCGGCCTCGCCTTTGCC
GCCGACGACATCGTCCTCAAGGCCAAGAACGGTGATGTGAAGTTCCCGCACAAGGCCCAC
CAGAAGGCTGTTCCCGACTGTAAGAAGTGCCACGAGAAAGGCCCGGGCAAGATCGAGGGC
TTCGGCAAAGAGATGGCTCATGGCAAGGGCTGCAAGGGGTGCCACGAAGAAATGAAGAAG
GGGCCGACGAAGTGCGGCGAGTGCCACAAGAAG

# Drug_Target_117_General_Function:
Involved in iron ion binding

# Drug_Target_117_General_References:
12356333	Lloyd JR, Leang C, Hodges Myerson AL, Coppi MV, Cuifo S, Methe B, Sandler SJ, Lovley DR: Biochemical and genetic characterization of PpcA, a periplasmic c-type cytochrome in Geobacter sulfurreducens. Biochem J. 2003 Jan 1;369(Pt 1):153-61.

# Drug_Target_117_HGNC_ID:
Not Available

# Drug_Target_117_HPRD_ID:
Not Available

# Drug_Target_117_ID:
4990

# Drug_Target_117_Locus:
Not Available

# Drug_Target_117_Molecular_Weight:
9748

# Drug_Target_117_Name:
PpcA

# Drug_Target_117_Number_of_Residues:
91

# Drug_Target_117_PDB_ID:
1OS6

# Drug_Target_117_Pathway:
Not Available

# Drug_Target_117_Pfam_Domain_Function:
Not Available

# Drug_Target_117_Protein_Sequence:
>PpcA
MKKVIASLALSVFCAGLAFAADDIVLKAKNGDVKFPHKAHQKAVPDCKKCHEKGPGKIEG
FGKEMAHGKGCKGCHEEMKKGPTKCGECHKK

# Drug_Target_117_Reaction:
Not Available

# Drug_Target_117_Signals:
None

# Drug_Target_117_Specific_Function:
Not Available

# Drug_Target_117_SwissProt_ID:
Q8GGK7

# Drug_Target_117_SwissProt_Name:
Q8GGK7_GEOSL

# Drug_Target_117_Synonyms:
Cytochrome c3

# Drug_Target_117_Theoretical_pI:
9.72

# Drug_Target_117_Transmembrane_Regions:
None

# Drug_Target_118_Cellular_Location:
Not Available

# Drug_Target_118_Chromosome_Location:
Not Available

# Drug_Target_118_Drug_References:
Not Available

# Drug_Target_118_Essentiality:
Non-Essential

# Drug_Target_118_GenAtlas_ID:
Not Available

# Drug_Target_118_GenBank_ID_Gene:
Not Available

# Drug_Target_118_GenBank_ID_Protein:
Not Available

# Drug_Target_118_GeneCard_ID:
Not Available

# Drug_Target_118_Gene_Name:
Not Available

# Drug_Target_118_Gene_Sequence:
Not Available

# Drug_Target_118_General_Function:
Involved in iron ion binding

# Drug_Target_118_General_References:
Not Available

# Drug_Target_118_HGNC_ID:
Not Available

# Drug_Target_118_HPRD_ID:
Not Available

# Drug_Target_118_ID:
4992

# Drug_Target_118_Locus:
Not Available

# Drug_Target_118_Molecular_Weight:
35355

# Drug_Target_118_Name:
Cytochrome c peroxidase

# Drug_Target_118_Number_of_Residues:
326

# Drug_Target_118_PDB_ID:
1RZ6

# Drug_Target_118_Pathway:
Not Available

# Drug_Target_118_Pfam_Domain_Function:
PF03150	CCP_MauG

# Drug_Target_118_Protein_Sequence:
>Cytochrome c peroxidase
DNLMERANSMFEPIPKYPPVIDGNELTQAKVELGKMEFFEPRLSSSHLISCNTCHNVGLG
GDDELPTSIGHGWQKGPRNSPTVFNAVFNAAQFWDGRAADLAEQAKGPVQAGVEMSSTPD
RVVATLKSMPEYIERFEDAFPGQENPVTFDNMAVAIEAYEATLITPEAPFDKYLRGDTSA
LNESEKEGLALFMDRGCTACHSGVNLGGQNYYPFGLVAKPGAEILPEGDKGRFSVTETAS
DEYVFRASPLRNIELTAPYFHSGAVWSLEEAVAVMGTAQLGTELNNDEVKSIVAFLKTLT
GNVPEVTYPVLPPSTANTPKPVDMIP

# Drug_Target_118_Reaction:
Not Available

# Drug_Target_118_Signals:
None

# Drug_Target_118_Specific_Function:
Not Available

# Drug_Target_118_SwissProt_ID:
P83787

# Drug_Target_118_SwissProt_Name:
P83787_MARHY

# Drug_Target_118_Synonyms:
Not Available

# Drug_Target_118_Theoretical_pI:
4.30

# Drug_Target_118_Transmembrane_Regions:
None

# Drug_Target_119_Cellular_Location:
Periplasm

# Drug_Target_119_Chromosome_Location:
Not Available

# Drug_Target_119_Drug_References:
Not Available

# Drug_Target_119_Essentiality:
Non-Essential

# Drug_Target_119_GenAtlas_ID:
Not Available

# Drug_Target_119_GenBank_ID_Gene:
BX321859

# Drug_Target_119_GenBank_ID_Protein:
Not Available

# Drug_Target_119_GeneCard_ID:
Not Available

# Drug_Target_119_Gene_Name:
hao1

# Drug_Target_119_Gene_Sequence:
>1713 bp
TCAAGCTCGGGTCTGCTTACGCTTGCGCCAGCCGATCAGAGCAAGGGCTCCTGCCAGCAA
CATACCACCACCCAAGCCTCCCAGGGAGATTTTCTCTCCGGTTCCCTTGAGGTCGAGCAG
ACTGGTCTGCTTGCCTTCCAGTTTGTTTACACGGGCCTGCAGGGCTGACAGTTCCTGCAT
TTTGGTGTATTCGTCCTGGATTTCAACATAGGCACGGTTCATCGGACCCCAGCCTTCAGT
GTAGGTCCAGCCACCCGGATTGACGTGAGCCAGTCCAACGTGCATCTTGGCCAGGTTGTT
TTCTGCCATTTCCAGAACTTTCAGTTCGAGTGAGGCAGGGTTGTTGCCTTTCGACCAGAA
CAGCTGGGTGAAGATACCAAATCCAGGTTTCTCCGGTTCCGGCGGATTCGGACGGTTGGT
CTTCTGTCCGGTCAGGGTGCCGTCTTCATACATTTTGTGTACGATTGCGTTCGCTTCCTG
GTATTTGGCCAGCCCTTCCAGGGTGCCTTTGTCCATCAGATCCAGGTAGGAGCGGGCAAA
CCGTTCCGAGTGACACTGGGTGCAGGTCAGTACCCAGGAGTCCAGACGGGCTTCCGACCA
GTCGCTGGTGATGTTCTCTGCAATGCCCGGAACGAACGGGTAGTTCGCCCAGCGAGTCTT
GCGGGTGATGTTGTGGGTGTATTCTCCTTCGTATTCCATGTGGCAGGCTGCACAGGTCGG
TGCATTCTGTCCACCTTTGGAGAAGGCGTCCTTGAGACGGACTTCCCAGTTCCATTTGTC
ACGGTTCATTTCGGCAAGTTTGCCATGCTTGGACATGGTGTACGCTTCCCAGTTGTTGTG
ATCCACCCCGCTGTGGCAGGTGGCACAGGCTTCCGGTTTGCGCGATTCCGCCGCCGAGAA
TTCATGACGGGTATGACAGTTGTCACATTTGTTCTGGTTGGTGTGACACATGGTGCAACC
TTCGGCAACTTCACGTTGCGGCATCGCTGCCCAAACAGTGGTCTCGATGTTGGCTGTGTA
GTCCAGTGCGTGGGAGGGGCGTCCGGCAGGCCATTGTCCGTTCGGCCAGACCATGGTGTC
CCGTTCCGATTCACGTTCGGCAAATTCTCTTAAGTGACAGGTTCCGCAGGTGTCCGCCGT
CGGCATGCGGATGTCTTTGGTATGATCCGCTTTGTCTTTTTTGTTGACGTCAACGTGACA
GTCGATACAGCCTACTTCCTTGAGGGTTTCTTTTTCCCCAAGCTTGCCCATCGAGCGCAG
GTTGTTTTCAACTTCTTCCAGCTTCCCTTTCTTGTAATACAGGGGATCGTCCGACTTGAG
GTTGCGAATCTTGTCAAGATTGGCGTGGGTGCTGCGCTTCCAGGCTCTTACCCATACCGG
GGTCTCGTCCGAGTGGCATTCCACGCAGTCTTTGCGTTCCGCAACTTCTTTGGGAGATAC
CGGTGGTTTGTAAAAAGTATTGGGATCCATATATATACTGATCGCTATCGGCTCCCAGTA
ATCTCCCATCGTCCCTTTCCCCGCTCCATGCGCCGGGTCCTTGTAACGCTTGACCAGCGC
TTCATACGTCTCTTTCGGGGTCGCCTTACCTCGATCCAGCTTCAACGCATCATACGTCTC
GTCCGGTACCGTCGATATGTCCGCATGAACCACCCCGCACATCATCAACCCCGCACAGAG
CAATAAACCCCTCATCCACTCCCCTATTCTCAT

# Drug_Target_119_General_Function:
Involved in protein binding

# Drug_Target_119_General_References:
12700255	Chain P, Lamerdin J, Larimer F, Regala W, Lao V, Land M, Hauser L, Hooper A, Klotz M, Norton J, Sayavedra-Soto L, Arciero D, Hommes N, Whittaker M, Arp D: Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea. J Bacteriol. 2003 May;185(9):2759-73.
8288544	Sayavedra-Soto LA, Hommes NG, Arp DJ: Characterization of the gene encoding hydroxylamine oxidoreductase in Nitrosomonas europaea. J Bacteriol. 1994 Jan;176(2):504-10.
9095195	Igarashi N, Moriyama H, Fujiwara T, Fukumori Y, Tanaka N: The 2.8 A structure of hydroxylamine oxidoreductase from a nitrifying chemoautotrophic bacterium, Nitrosomonas europaea. Nat Struct Biol. 1997 Apr;4(4):276-84.

# Drug_Target_119_HGNC_ID:
Not Available

# Drug_Target_119_HPRD_ID:
Not Available

# Drug_Target_119_ID:
4993

# Drug_Target_119_Locus:
Not Available

# Drug_Target_119_Molecular_Weight:
64259

# Drug_Target_119_Name:
Hydroxylamine oxidoreductase

# Drug_Target_119_Number_of_Residues:
570

# Drug_Target_119_PDB_ID:
1FGJ

# Drug_Target_119_Pathway:
Not Available

# Drug_Target_119_Pfam_Domain_Function:
Not Available

# Drug_Target_119_Protein_Sequence:
>Hydroxylamine oxidoreductase
MRIGEWMRGLLLCAGLMMCGVVHADISTVPDETYDALKLDRGKATPKETYEALVKRYKDP
AHGAGKGTMGDYWEPIAISIYMDPNTFYKPPVSPKEVAERKDCVECHSDETPVWVRAWKR
STHANLDKIRNLKSDDPLYYKKGKLEEVENNLRSMGKLGEKETLKEVGCIDCHVDVNKKD
KADHTKDIRMPTADTCGTCHLREFAERESERDTMVWPNGQWPAGRPSHALDYTANIETTV
WAAMPQREVAEGCTMCHTNQNKCDNCHTRHEFSAAESRKPEACATCHSGVDHNNWEAYTM
SKHGKLAEMNRDKWNWEVRLKDAFSKGGQNAPTCAACHMEYEGEYTHNITRKTRWANYPF
VPGIAENITSDWSEARLDSWVLTCTQCHSERFARSYLDLMDKGTLEGLAKYQEANAIVHK
MYEDGTLTGQKTNRPNPPEPEKPGFGIFTQLFWSKGNNPASLELKVLEMAENNLAKMHVG
LAHVNPGGWTYTEGWGPMNRAYVEIQDEYTKMQELSALQARVNKLEGKQTSLLDLKGTGE
KISLGGLGGGMLLAGALALIGWRKRKQTRA

# Drug_Target_119_Reaction:
Not Available

# Drug_Target_119_Signals:
1-24

# Drug_Target_119_Specific_Function:
Catalyzes the oxidation of hydroxylamine to nitrite. The electrons released in the reaction are partitioned to ammonium monooxygenase and to the respiratory chain. The immediate acceptor of electrons from HAO is cytochrome c-554

# Drug_Target_119_SwissProt_ID:
Q50925

# Drug_Target_119_SwissProt_Name:
HAO_NITEU

# Drug_Target_119_Synonyms:
EC 1.7.3.4
HAO
Hydroxylamine oxidoreductase precursor

# Drug_Target_119_Theoretical_pI:
7.03

# Drug_Target_119_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Periplasm (Potential)

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
X07856

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
moxG

# Drug_Target_11_Gene_Sequence:
>594 bp
ATGATGAACCGCGTAAAGATCGGAACCGCCCTTCTCGGCCTAACGCTCGCAGGCATTGCC
CTGCCCGCGCTCGCCCAGCCGCAATCCGGGCCGCAGACCGGCGTCGTGTTCCGCAACACC
GTGACCGGCGAGGCGCTCGACGTGTCGCAAGGCAAGGAAGGCGGCCGCGACACGCCCGCC
GTGAAGAAGTTCCTCGAGACCGGCGAGAACCTCTACATCGACGACAAGTCCTGCCTGCGG
AATGGCGAGAGTCTGTTCGCGACGTCCTGCTCGGGCTGCCACGGCCACCTCGCCGAGGGC
AAGCTCGGGCCGGGCCTGAACGACAATTACTGGACCTACCCGTCCAACACCACGGATGTG
GGCCTGTTCGCCACGATCTTCGGCGGCGCCAACGGCATGATGGGCCCGCACAACGAGAAT
CTGACGCCCGACGAGATGCTTCAGACCATCGCCTGGATTCGCCACCTCTATACGGGGCCG
AAGCAGGACGCCGTCTGGCTCAACGACGAGCAGAAGAAGGCCTACACGCCCTACAAGCAG
GGCGAAGTCATCCCGAAGGACGCCAAGGGCCAGTGCAAGCCGCTGGACGAGTGA

# Drug_Target_11_General_Function:
Involved in iron ion binding

# Drug_Target_11_General_References:
2842733	Nunn DN, Anthony C: The nucleotide sequence and deduced amino acid sequence of the genes for cytochrome cL and a hypothetical second subunit of the methanol dehydrogenase of Methylobacterium AM1. Nucleic Acids Res. 1988 Aug 11;16(15):7722.
2851998	Nunn DN, Anthony C: The nucleotide sequence and deduced amino acid sequence of the cytochrome cL gene of Methylobacterium extorquens AM1, a novel class of c-type cytochrome. Biochem J. 1988 Dec 1;256(2):673-6.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4907

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
21226

# Drug_Target_11_Name:
Cytochrome c-L

# Drug_Target_11_Number_of_Residues:
197

# Drug_Target_11_PDB_ID:
1UMM

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_11_Protein_Sequence:
>Cytochrome c-L
MMNRVKIGTALLGLTLAGIALPALAQPQSGPQTGVVFRNTVTGEALDVSQGKEGGRDTPA
VKKFLETGENLYIDDKSCLRNGESLFATSCSGCHGHLAEGKLGPGLNDNYWTYPSNTTDV
GLFATIFGGANGMMGPHNENLTPDEMLQTIAWIRHLYTGPKQDAVWLNDEQKKAYTPYKQ
GEVIPKDAKGQCKPLDE

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
1-25

# Drug_Target_11_Specific_Function:
Electron acceptor for MDH. Acts in methanol oxidation

# Drug_Target_11_SwissProt_ID:
P14774

# Drug_Target_11_SwissProt_Name:
CYCL_METEA

# Drug_Target_11_Synonyms:
Cytochrome c-L precursor

# Drug_Target_11_Theoretical_pI:
5.65

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_120_Cellular_Location:
Cell membrane

# Drug_Target_120_Chromosome_Location:
Not Available

# Drug_Target_120_Drug_References:
Not Available

# Drug_Target_120_Essentiality:
Non-Essential

# Drug_Target_120_GenAtlas_ID:
Not Available

# Drug_Target_120_GenBank_ID_Gene:
BX842580

# Drug_Target_120_GenBank_ID_Protein:
Not Available

# Drug_Target_120_GeneCard_ID:
Not Available

# Drug_Target_120_Gene_Name:
glbO

# Drug_Target_120_Gene_Sequence:
>387 bp
ATGCCGAAGTCTTTCTACGACGCGGTCGGCGGCGCCAAAACCTTCGACGCGATCGTGTCG
CGTTTCTATGCGCAGGTCGCCGAGGACGAAGTACTGCGGCGGGTGTACCCCGAAGATGAC
TTAGCCGGCGCCGAGGAACGATTGCGGATGTTCCTCGAGCAGTACTGGGGCGGCCCACGA
ACCTACTCGGAGCAGCGCGGCCACCCCCGATTGCGGATGCGGCATGCCCCGTTTCGGATC
TCGCTCATCGAACGCGACGCCTGGCTGCGGTGCATGCATACGGCTGTGGCCTCCATCGAC
TCAGAAACGCTCGATGACGAGCACCGTCGAGAGTTGCTGGATTATCTGGAGATGGCCGCT
CACTCGCTGGTCAACTCCCCGTTTTGA

# Drug_Target_120_General_Function:
Involved in oxygen binding

# Drug_Target_120_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_120_HGNC_ID:
Not Available

# Drug_Target_120_HPRD_ID:
Not Available

# Drug_Target_120_ID:
4994

# Drug_Target_120_Locus:
Not Available

# Drug_Target_120_Molecular_Weight:
14950

# Drug_Target_120_Name:
Hemoglobin-like protein HbO

# Drug_Target_120_Number_of_Residues:
128

# Drug_Target_120_PDB_ID:
1NGK

# Drug_Target_120_Pathway:
Not Available

# Drug_Target_120_Pfam_Domain_Function:
PF01152	Bac_globin

# Drug_Target_120_Protein_Sequence:
>Hemoglobin-like protein HbO
MPKSFYDAVGGAKTFDAIVSRFYAQVAEDEVLRRVYPEDDLAGAEERLRMFLEQYWGGPR
TYSEQRGHPRLRMRHAPFRISLIERDAWLRCMHTAVASIDSETLDDEHRRELLDYLEMAA
HSLVNSPF

# Drug_Target_120_Reaction:
Not Available

# Drug_Target_120_Signals:
None

# Drug_Target_120_Specific_Function:
When expressed in E.coli and M.smegmatis, HbO increases oxygen uptake. Membrane vesicles of E.coli carrying HbO show a respiration activity about twice that of membranes without HbO. HbO seems to interact with a terminal oxidase. Therefore, HbO could participate in oxygen/electron-transfer process, suggesting a function related to the facilitation of oxygen transfer during aerobic metabolism of M.tuberculosis

# Drug_Target_120_SwissProt_ID:
P0A595

# Drug_Target_120_SwissProt_Name:
TRHBO_MYCTU

# Drug_Target_120_Synonyms:
Truncated hemoglobin
trHbO

# Drug_Target_120_Theoretical_pI:
5.60

# Drug_Target_120_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
U00096

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
dosP

# Drug_Target_12_Gene_Sequence:
>2424 bp
TCAGATTTTCAGCGGTAACACGCTGCTCATCCAGCCTGGAATTTCTTCGGCGGGTAGGGG
GCGGGAAAAGAAATATCCCTGAATAACGCGACAGTGGATCTTGCGTAGCATCTCAAATTG
CTCTTTGGTTTCGACGCCTTCCGCCACGACGGTTAAATTGAGGCTTTGCCCAATGCTGGT
AATGGCTTCAAGTAAGGCAAGGATGCGTTTTTCGGTCAGACAACGATCGACAAAACTTTT
GTCAATTTTGATTTCCGTTACCGGAAGACTGACTAAGCGGGATAATCCGGAAAAGCCCGT
ACCAAAATCATCTACCGATAAGCCCACGCCCATATCACGCAGGATCTGAATGCGCTTAAA
GATTTCGGTATCGTGTTCCATCATCATGCTTTCCGTGATTTCTACCGTCAGCTGGTGGCC
GTCAATACCCCAGGCGTGCATTGCATCAGACACCTGATTAGGCAGTTGATTACTGCGAAA
GTGCAGCGCCGACAAGTTCACGGATAACGCCGGGATATGAATATTCTGGCTACGCCATTC
TGCTAACTGACGGCAAGCTTCCGCGATGACCCAGCGCCCAATATTTTCGATTTCACCAAT
CTCTTCTGCGAGAGGAATAAACCGTGAAGGGGGCACATGACCATGCAGGGGATCGTGCCA
GCGAGCAAGGGCTTCGATGCCGTACAGTTCACCCGTTTCTGCGAAGATTTGCGGCTGGTA
AACCAGTTTCAGTTGGTTATTGCTAATCGCTTCTTTCAGCGCTGCGCCTAAAACCAAACG
CTCTTTTACCATTTCGTTCATCGCCGGGCTGAAGAACTGCCAGCCGTTACCGCCATTCTT
GCGAATATAATCCATTGCATTGTGAGCAGTGGAGAGCAAGTAATCGCGGTTTTTACCCAG
GTCGTAGCTGATGCCAATACTCAAGGTAAGCGGGAAGGGTTTATCGTCAATCATTATCGG
CTTGCTGACCACATTCCGTAGCTCATCGGCGATTTGGGTAATGTTACTGACGTCGTTTTC
GAGGCTCACGAGGACAAACTGCGTACCTTCGATACGACAGAGATACTGATCCGGTTTGAG
TTTTTCACGAAAGCGATTGACCACTTCCAGCAATGCCTGATCGGCCCACGCATAGCCAAG
GCTATCAATCACATCCTGAATATGGTCAACACCGATGAGATACACCACGGGAGAGACGGC
TTTGTCGACCAGGTCATCGAGGTAATTGTGCAGGTTATTGCGATTTGGCAGACCGGTCAT
CGGATCAAATTGGATGAGTTGTTCAATATGCTGACGGCTTTTTTCCTGTTCCAGCGCCAG
CGCGGCCATATGCTGGCTGATATCTGCCACGCGTTCGATAAAGGCGCTGGTTTCTGCTCC
TGACGAGGTTTTAATTTGCAGGATCCCCGCAGGCGCGCCATCACGCTGACGAATGGTCGC
TGACCAGCTTTGCGCATTTTGAATTTCTGCACCGTGGGAAGATGACGCCCAGTGTATCGG
CATCCCGTTGCGCAGTGCGAACAGCGAAACATGCGATTCGTTGAGTACAGATTCGATGTT
ACGACAAATGATTTCCCCCATTTCATGAAATGGCGGGCTGCTGCACATGGCGGCGAGAAT
ATTGCCTTCAAGCTGGCGAATCTGCCGTTCTTCGGTGATATCCGAGAAAGTCATTACCAG
GTTCTGCAGATGCGCGAGCACGTCATAAACCGGGCTGATAGAGGCTTTAATCCAGATTTT
TTCACCGGTGCGCGTCAACAGCAGAAATTCGTCCTGATCGCGGGCGGTTTTCCATAGCAA
CTGTTGTAAACGAATGCGGTTATCGGCAGGGAATTCAGGAATGTTCAGGAGTGTATCGGG
CTGCATACCGCTGGCTTCGCTAATGCAGTAACCAAACATTTCGGTAAATGCGCGATTGCA
CTGCACAATATGGCGTTCCGGATCGAGGACAATCACCGGTCGGTCGAGATGGTCAACGGC
AATAATCAATTGTCGGGTCTGTTCTTTTTGCGCCATTTCTACGCTGGCATCCCGTACCAG
CGCCAGGTAATAAACTTTCCCCTCGGCGCTCACTTTCGATAGCGCAAAACGGGTCCAGAT
TTTACTGCCGTCTTTTTTCTCCAGCTGCAGCTCCCGACTCATCCCCTCAACACGCGCTTT
ACCGCCTTCACGGTTGTGACGAATGTATTCAGGATGCGCAGGACGCAAATCCCGCGGAAT
CAGCATATCAATGTTATTGCCAATGACTTCTTCACGTTTGTATCCCCAGAGCTTCTCTGC
GGCGGGGTTGAAAAACATCACTTCATCATTTTCGTTAATTAACACCGCACCCATCATATT
TTGCTCAAGGGCGGGGAAAAAAATGCCATCGGCGGCATTATCCGCATCGGTTAGCTTCAT
GATTACCTCTGCATCCTGGCGCAT

# Drug_Target_12_General_Function:
Involved in signal transducer activity

# Drug_Target_12_General_References:
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
4908

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
91205

# Drug_Target_12_Name:
Heme-regulated cyclic AMP phosphodiesterase

# Drug_Target_12_Number_of_Residues:
807

# Drug_Target_12_PDB_ID:
1VB6

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00563	EAL
PF00989	PAS
PF00990	GGDEF
PF08448	PAS_4

# Drug_Target_12_Protein_Sequence:
>Heme-regulated cyclic AMP phosphodiesterase
MRQDAEVIMKLTDADNAADGIFFPALEQNMMGAVLINENDEVMFFNPAAEKLWGYKREEV
IGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRELQLEKKDGSKIWTRFALSKVSA
EGKVYYLALVRDASVEMAQKEQTRQLIIAVDHLDRPVIVLDPERHIVQCNRAFTEMFGYC
ISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVY
DVLAHLQNLVMTFSDITEERQIRQLEGNILAAMCSSPPFHEMGEIICRNIESVLNESHVS
LFALRNGMPIHWASSSHGAEIQNAQSWSATIRQRDGAPAGILQIKTSSGAETSAFIERVA
DISQHMAALALEQEKSRQHIEQLIQFDPMTGLPNRNNLHNYLDDLVDKAVSPVVYLIGVD
HIQDVIDSLGYAWADQALLEVVNRFREKLKPDQYLCRIEGTQFVLVSLENDVSNITQIAD
ELRNVVSKPIMIDDKPFPLTLSIGISYDLGKNRDYLLSTAHNAMDYIRKNGGNGWQFFSP
AMNEMVKERLVLGAALKEAISNNQLKLVYQPQIFAETGELYGIEALARWHDPLHGHVPPS
RFIPLAEEIGEIENIGRWVIAEACRQLAEWRSQNIHIPALSVNLSALHFRSNQLPNQVSD
AMHAWGIDGHQLTVEITESMMMEHDTEIFKRIQILRDMGVGLSVDDFGTGFSGLSRLVSL
PVTEIKIDKSFVDRCLTEKRILALLEAITSIGQSLNLTVVAEGVETKEQFEMLRKIHCRV
IQGYFFSRPLPAEEIPGWMSSVLPLKI

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Has phosphodiesterase activity with cAMP but not with cGMP, bis(p-nitrophenyl) phosphate or p-nitrophenyl phosphate

# Drug_Target_12_SwissProt_ID:
P76129

# Drug_Target_12_SwissProt_Name:
DOSP_ECOLI

# Drug_Target_12_Synonyms:
Direct oxygen sensor protein
EC 3.1.4.-

# Drug_Target_12_Theoretical_pI:
5.19

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Cytoplasmic

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
U65510

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
cooA

# Drug_Target_13_Gene_Sequence:
>669 bp
ATGCCGCCTCGTTTCAACATCGCCAATGTCCTGTTGAGCCCCGACGGAGAGACGTTTTTC
CGCGGTTTCCGCAGTAAGATCCACGCCAAGGGCAGCCTTGTTTGCACCGGAGAAGGCGAC
GAGAACGGCGTGTTCGTCGTTGTCGATGGTCGCCTGCGGGTTTATCTGGTCGGCGAGGAG
CGCGAGATCAGCCTGTTTTACCTGACCTCGGGCGACATGTTTTGCATGCATTCGGGCTGT
CTGGTCGAGGCGACCGAGCGGACCGAGGTGCGCTTCGCCGATATCCGCACCTTTGAACAA
AAGCTACAGACCTGTCCGTCGATGGCCTGGGGGCTGATCGCCATCCTCGGCCGGGCGCTG
ACCTCGTGCATGCGCACCATCGAAGACCTGATGTTCCACGACATCAAGCAGCGCATCGCC
GGCTTTTTCATCGATCACGCCAATACCACCGGACGCCAGACCCAGGGCGGCGTCATCGTC
TCGGTCGATTTCACGGTCGAGGAAATCGCCAATCTCATCGGCTCGTCACGCCAAACCACC
TCGACGGCGCTCAACAGCCTGATCAAGGAAGGTTATATCTCGCGCCAGGGTCGCGGCCAT
TACACCATCCCCAACCTTGTTCGCCTGAAAGCCGCCGCCGATGGCGACCGCGACGACGAC
GACGATTAA

# Drug_Target_13_General_Function:
Involved in transcription factor activity

# Drug_Target_13_General_References:
11017196	Lanzilotta WN, Schuller DJ, Thorsteinsson MV, Kerby RL, Roberts GP, Poulos TL: Structure of the CO sensing transcription activator CooA. Nat Struct Biol. 2000 Oct;7(10):876-80.
7721706	Shelver D, Kerby RL, He Y, Roberts GP: Carbon monoxide-induced activation of gene expression in Rhodospirillum rubrum requires the product of cooA, a member of the cyclic AMP receptor protein family of transcriptional regulators. J Bacteriol. 1995 Apr;177(8):2157-63.
9079911	Kerby RL, Ludden PW, Roberts GP: In vivo nickel insertion into the carbon monoxide dehydrogenase of Rhodospirillum rubrum: molecular and physiological characterization of cooCTJ. J Bacteriol. 1997 Apr;179(7):2259-66.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
4909

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
24635

# Drug_Target_13_Name:
CooA protein

# Drug_Target_13_Number_of_Residues:
222

# Drug_Target_13_PDB_ID:
1FT9

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00027	cNMP_binding

# Drug_Target_13_Protein_Sequence:
>CooA protein
MPPRFNIANVLLSPDGETFFRGFRSKIHAKGSLVCTGEGDENGVFVVVDGRLRVYLVGEE
REISLFYLTSGDMFCMHSGCLVEATERTEVRFADIRTFEQKLQTCPSMAWGLIAILGRAL
TSCMRTIEDLMFHDIKQRIAGFFIDHANTTGRQTQGGVIVSVDFTVEEIANLIGSSRQTT
STALNSLIKEGYISRQGRGHYTIPNLVRLKAAADGDRDDDDD

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Not Available

# Drug_Target_13_SwissProt_ID:
P72322

# Drug_Target_13_SwissProt_Name:
P72322_RHORU

# Drug_Target_13_Synonyms:
Not Available

# Drug_Target_13_Theoretical_pI:
5.34

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
CYGB

# Drug_Target_14_GenBank_ID_Gene:
AJ315162

# Drug_Target_14_GenBank_ID_Protein:
Not Available

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
CYGB

# Drug_Target_14_Gene_Sequence:
>573 bp
ATGGAGAAAGTGCCAGGCGAGATGGAGATCGAGCGCAGGGAGCGGAGCGAGGAGCTGTCC
GAGGCGGAGAGGAAGGCGGTGCAGGCTATGTGGGCCCGGCTCTATGCCAACTGCGAGGAC
GTGGGGGTGGCCATCCTGGTGAGGTTCTTTGTGAACTTCCCCTCGGCCAAGCAGTACTTC
AGCCAGTTCAAGCACATGGAGGATCCCCTGGAGATGGAGCGGAGCCCCCAGCTGCGGAAG
CACGCCTGCCGAGTCATGGGGGCCCTCAACACTGTCGTGGAGAACCTGCATGACCCCGAC
AAGGTGTCCTCTGTGCTCGCCCTTGTGGGGAAAGCCCACGCCCTCAAGCACAAGGTGGAA
CCGGTGTACTTCAAGATCCTCTCTGGGGTCATTCTGGAGGTGGTCGCCGAGGAATTTGCC
AGTGACTTCCCACCTGAGACGCAGAGAGCCTGGGCCAAGCTGCGTGGCCTCATCTACAGC
CACGTGACCGCTGCCTACAAGGAAGTGGGCTGGGTGCAGCAGGTCCCCAACGCCACCACC
CCACCGGCCACACTGCCCTCTTCGGGGCCGTAG

# Drug_Target_14_General_Function:
Involved in iron ion binding

# Drug_Target_14_General_References:
11893755	Trent JT 3rd, Hargrove MS: A ubiquitously expressed human hexacoordinate hemoglobin. J Biol Chem. 2002 May 31;277(22):19538-45. Epub 2002 Mar 13.
11919282	Burmester T, Ebner B, Weich B, Hankeln T: Cytoglobin: a novel globin type ubiquitously expressed in vertebrate tissues. Mol Biol Evol. 2002 Apr;19(4):416-21.
12359339	Asahina K, Kawada N, Kristensen DB, Nakatani K, Seki S, Shiokawa M, Tateno C, Obara M, Yoshizato K: Characterization of human stellate cell activation-associated protein and its expression in human liver. Biochim Biophys Acta. 2002 Sep 27;1577(3):471-5.

# Drug_Target_14_HGNC_ID:
HGNC:16505

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
4910

# Drug_Target_14_Locus:
17q25.3

# Drug_Target_14_Molecular_Weight:
21405

# Drug_Target_14_Name:
Cytoglobin

# Drug_Target_14_Number_of_Residues:
190

# Drug_Target_14_PDB_ID:
1V5H

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00042	Globin

# Drug_Target_14_Protein_Sequence:
>Cytoglobin
MEKVPGEMEIERRERSEELSEAERKAVQAMWARLYANCEDVGVAILVRFFVNFPSAKQYF
SQFKHMEDPLEMERSPQLRKHACRVMGALNTVVENLHDPDKVSSVLALVGKAHALKHKVE
PVYFKILSGVILEVVAEEFASDFPPETQRAWAKLRGLIYSHVTAAYKEVGWVQQVPNATT
PPATLPSSGP

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
May have a protective function during conditions of oxidative stress. May be involved in intracellular oxygen storage or transfer

# Drug_Target_14_SwissProt_ID:
Q8WWM9

# Drug_Target_14_SwissProt_Name:
CYGB_HUMAN

# Drug_Target_14_Synonyms:
HGb
Histoglobin
Stellate cell activation-associated protein

# Drug_Target_14_Theoretical_pI:
6.80

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Periplasm

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
Not Available

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
AJ236923

# Drug_Target_15_GenBank_ID_Protein:
Not Available

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
ifcA

# Drug_Target_15_Gene_Sequence:
>1767 bp
ATGAAACTAAAATATCTGGTATCAGCGATGGCATTGGTTGTGCTTTCCTCTGGTACTGCA
ATGGCTAAAACCCCCGATATGGGGTCATTCCATGCTGACATGGGCAGTTGTCAATCTTGT
CACGCCAAACCTATCAAGGTTACTGATAGCGAAACTCATGAAAATGCTCAGTGTAAATCA
TGCCACGGAGAGTACGCTGAACTGGCTAATGACAAATTACAGTTTGACCCACACAATTCA
CATTTAGGTGACATTAACTGTACTAGTTGCCATAAAGGCCATGAAGAACCAAAATTTTAC
TGTAATGAGTGTCATTCATTTGATATCAAGCCGATGCCATTTTCTGATGCCAAGAAGAAA
AAATCTTGGGACGACGGATGGGATCAAGACAAAATTCAAAAAGCGATTGCTGCAGGCCCA
AGTGAAACAACGCAAGTATTAGTAGTCGGTGCGGGTAGTGCAGGTTTTAACGCATCATTA
GCCGCTAAAAAAGCCGGTGCTAATGTTATTTTGGTGGATAAAGCACCGTTCAGTGGTGGT
AATTCTATGATTTCAGCTGGTGGTATGAATGCTGTTGGAACTAAGCAGCAAACAGCTCAT
GGTGTTGAAGATAAAGTTGAATGGTTTATCGAAGATGCCATGAAAGGCGGCCGTCAACAG
AATGATATAAAACTGGTGACTATTCTTGCTGAACAGTCTGCTGATGGTGTGCAATGGTTA
GAGTCTTTAGGTGCAAACTTAGATGACTTAAAACGCTCAGGTGGTGCTCGTGTCGACCGT
ACTCATCGTCCACATGGAGGTAAAAGCTCTGGGCCAGAAATTATTGATACTTTACGCAAA
GCGGCCAAAGAACAGGGTATTGATACACGACTAAACTCTCGTGTAGTTAAGTTAGTGGTT
AATGACGATCATAGTGTTGTCGGCGCCGTGGTTCATGGTAAACATACTGGCTATTACATG
ATTGGTGCTAAATCTGTTGTGCTAGCAACGGGTGGTTATGGCATGAATAAAGAAATGATT
GCTTATTACCGTCCAACAATGAAAGACATGACCAGTTCGAACAACATTACCGCCACTGGT
GATGGTGTATTGATGGCAAAAGAAATTGGTGCCAGCATGACCGATATCGACTGGGTTCAA
GCTCACCCAACAGTGGGTAAAGACAGCCGTATTCTGATTTCAGAAACCGTCCGTGGTGTG
GGCGCTGTGATGGTAAACAAAGACGGTAATCGCTTTATTAGCGAGTTAACAACTCGTGAC
AAAGCATCTGATGCTATCTTAAAACAACCTGGCCAGTTTGCTTGGATTATTTTTGATAAC
CAGTTATACAAAAAAGCCAAAATGGTACGCGGTTATGACCATTTAGAAATGCTTTACAAA
GGCGATACTGTTGAACAGTTAGCGAAGAGCACCGGTATGAAAGTCGCTGATTTAGCTAAA
ACAGTCTCTGACTACAATGGTTATGTAGCATCTGGTAAAGACACTGCGTTTGGTCGTGCT
GATATGCCATTGAACATGACCCAAAGTCCTTACTATGCCGTTAAAGTTGCTCCTGGTATT
CATCACACTATGGGTGGTGTCGCGATTAACACAACAGCGTCTGTACTTGACCTTCAAAGT
AAGCCAATTGACGGTTTGTTTGCCGCAGGTGAAGTGACTGGTGGTGTTCATGGTTACAAC
CGTTTGGGCGGTAATGCAATAGCAGATACCGTGGTCTTCGGTCGAATTGCAGGAGATAAC
GCAGCCAAGCATGCTCTAGATAAATAG

# Drug_Target_15_General_Function:
Involved in oxidoreductase activity

# Drug_Target_15_General_References:
10455032	Dobbin PS, Butt JN, Powell AK, Reid GA, Richardson DJ: Characterization of a flavocytochrome that is induced during the anaerobic respiration of Fe3+ by Shewanella frigidimarina NCIMB400. Biochem J. 1999 Sep 1;342 ( Pt 2):439-48.
10581549	Bamford V, Dobbin PS, Richardson DJ, Hemmings AM: Open conformation of a flavocytochrome c3 fumarate reductase. Nat Struct Biol. 1999 Dec;6(12):1104-7.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
4912

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
62947

# Drug_Target_15_Name:
Fumarate reductase flavoprotein subunit

# Drug_Target_15_Number_of_Residues:
588

# Drug_Target_15_PDB_ID:
1QO8

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00890	FAD_binding_2

# Drug_Target_15_Protein_Sequence:
>Fumarate reductase flavoprotein subunit
MKLKYLVSAMALVVLSSGTAMAKTPDMGSFHADMGSCQSCHAKPIKVTDSETHENAQCKS
CHGEYAELANDKLQFDPHNSHLGDINCTSCHKGHEEPKFYCNECHSFDIKPMPFSDAKKK
KSWDDGWDQDKIQKAIAAGPSETTQVLVVGAGSAGFNASLAAKKAGANVILVDKAPFSGG
NSMISAGGMNAVGTKQQTAHGVEDKVEWFIEDAMKGGRQQNDIKLVTILAEQSADGVQWL
ESLGANLDDLKRSGGARVDRTHRPHGGKSSGPEIIDTLRKAAKEQGIDTRLNSRVVKLVV
NDDHSVVGAVVHGKHTGYYMIGAKSVVLATGGYGMNKEMIAYYRPTMKDMTSSNNITATG
DGVLMAKEIGASMTDIDWVQAHPTVGKDSRILISETVRGVGAVMVNKDGNRFISELTTRD
KASDAILKQPGQFAWIIFDNQLYKKAKMVRGYDHLEMLYKGDTVEQLAKSTGMKVADLAK
TVSDYNGYVASGKDTAFGRADMPLNMTQSPYYAVKVAPGIHHTMGGVAINTTASVLDLQS
KPIDGLFAAGEVTGGVHGYNRLGGNAIADTVVFGRIAGDNAAKHALDK

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
1-22

# Drug_Target_15_Specific_Function:
Catalyzes unidirectional fumarate reduction using artificial electron donors such as methyl viologen. The physiological reductant is unknown

# Drug_Target_15_SwissProt_ID:
Q9Z4P0

# Drug_Target_15_SwissProt_Name:
FRD2_SHEFN

# Drug_Target_15_Synonyms:
EC 1.3.99.1
Fumarate reductase flavoprotein subunit precursor
Ifc3
Iron(III)-induced flavocytochrome C3

# Drug_Target_15_Theoretical_pI:
7.69

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Not Available

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
Not Available

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
Not Available

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
psbV

# Drug_Target_16_Gene_Sequence:
Not Available

# Drug_Target_16_General_Function:
Involved in iron ion binding

# Drug_Target_16_General_References:
11478889	Sawaya MR, Krogmann DW, Serag A, Ho KK, Yeates TO, Kerfeld CA: Structures of cytochrome c-549 and cytochrome c6 from the cyanobacterium Arthrospira maxima. Biochemistry. 2001 Aug 7;40(31):9215-25.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
4915

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
14198

# Drug_Target_16_Name:
Cytochrome c-550

# Drug_Target_16_Number_of_Residues:
129

# Drug_Target_16_PDB_ID:
1F1C

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_16_Protein_Sequence:
>Cytochrome c-550
LTEELRTFPINAQGDTAVLSLKEIKKGQQVFNAACAQCHALGVTRTNPDVNLSPEALALA
TPPRDNIAALVDYIKNPTTYDGFVEISELHPSLKSSDIFPKMRNISEDDLYNVAGYILLQ
PKVRGEQWG

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
None

# Drug_Target_16_Specific_Function:
Low-potential cytochrome c that plays a possible role in water oxidation complex of photosystem II

# Drug_Target_16_SwissProt_ID:
P82603

# Drug_Target_16_SwissProt_Name:
CY550_SPIMA

# Drug_Target_16_Synonyms:
Cytochrome c-549
Cytochrome c549
Cytochrome c550

# Drug_Target_16_Theoretical_pI:
4.86

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Not Available

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
Not Available

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
BA000022

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
glbN

# Drug_Target_17_Gene_Sequence:
>375 bp
ATGTCAACTTTGTATGAAAAATTAGGTGGAACCACCGCTGTCGATCTAGCTGTGGACAAA
TTTTACGAGCGGGTGTTGCAGGATGACCGCATCAAACATTTTTTCGCCGACGTGGATATG
GCTAAACAACGGGCCCACCAAAAAGCCTTTTTAACCTATGCCTTTGGCGGTACGGATAAA
TATGATGGTCGCTATATGCGGGAAGCCCACAAAGAGTTGGTGGAAAACCATGGTTTGAAC
GGTGAACACTTCGACGCAGTGGCGGAGGATTTGCTGGCAACCTTGAAGGAAATGGGTGTT
CCCGAAGATTTAATTGCAGAAGTGGCCGCCGTGGCCGGGGCTCCAGCCCATAAACGGGAC
GTGCTTAATCAGTGA

# Drug_Target_17_General_Function:
Involved in oxygen binding

# Drug_Target_17_General_References:
10752621	Scott NL, Lecomte JT: Cloning, expression, purification, and preliminary characterization of a putative hemoglobin from the cyanobacterium Synechocystis sp. PCC 6803. Protein Sci. 2000 Mar;9(3):587-97.
10903511	Couture M, Das TK, Savard PY, Ouellet Y, Wittenberg JB, Wittenberg BA, Rousseau DL, Guertin M: Structural investigations of the hemoglobin of the cyanobacterium Synechocystis PCC6803 reveal a unique distal heme pocket. Eur J Biochem. 2000 Aug;267(15):4770-80.
12121092	Vu BC, Jones AD, Lecomte JT: Novel histidine-heme covalent linkage in a hemoglobin. J Am Chem Soc. 2002 Jul 24;124(29):8544-5.
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
4916

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
13868

# Drug_Target_17_Name:
Cyanoglobin

# Drug_Target_17_Number_of_Residues:
124

# Drug_Target_17_PDB_ID:
1S6A

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF01152	Bac_globin

# Drug_Target_17_Protein_Sequence:
>Cyanoglobin
MSTLYEKLGGTTAVDLAVDKFYERVLQDDRIKHFFADVDMAKQRAHQKAFLTYAFGGTDK
YDGRYMREAHKELVENHGLNGEHFDAVAEDLLATLKEMGVPEDLIAEVAAVAGAPAHKRD
VLNQ

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Forms a very stable complex with oxygen. The oxygen dissociation rate is 0.011 s(-1)

# Drug_Target_17_SwissProt_ID:
P73925

# Drug_Target_17_SwissProt_Name:
TRHBN_SYNY3

# Drug_Target_17_Synonyms:
Hb
Hemoglobin

# Drug_Target_17_Theoretical_pI:
5.21

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Not Available

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
Not Available

# Drug_Target_18_GenBank_ID_Protein:
Not Available

# Drug_Target_18_GeneCard_ID:
Not Available

# Drug_Target_18_Gene_Name:
MB

# Drug_Target_18_Gene_Sequence:
Not Available

# Drug_Target_18_General_Function:
Not Available

# Drug_Target_18_General_References:
Not Available

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
6977

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
Not Available

# Drug_Target_18_Name:
Myoglobin

# Drug_Target_18_Number_of_Residues:
0

# Drug_Target_18_PDB_ID:
Not Available

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
Not Available

# Drug_Target_18_Protein_Sequence:
Not Available

# Drug_Target_18_Reaction:
Not Available

# Drug_Target_18_Signals:
Not Available

# Drug_Target_18_Specific_Function:
Not Available

# Drug_Target_18_SwissProt_ID:
P02144

# Drug_Target_18_SwissProt_Name:
MYG_HUMAN

# Drug_Target_18_Synonyms:
Not Available

# Drug_Target_18_Theoretical_pI:
Not Available

# Drug_Target_18_Transmembrane_Regions:
Not Available

# Drug_Target_19_Cellular_Location:
Periplasm

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AE014299

# Drug_Target_19_GenBank_ID_Protein:
24346572

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
SO_0970

# Drug_Target_19_Gene_Sequence:
>1791 bp
TTAATTATCTTTAGCGAATTTAGCGGCAGATGCACCCGCGATACGGCCGTAGGTGACGAT
ATCAGAGATAGCGTTACCACCTAAACGGTTAGCACCGTGAACACCACCAGTCACTTCGCC
TGCAGCGTATAAACCAGTGATAGGTTTACCGGTTTTCTCACTCTTCACTTCGGCTTTAGT
ATCAATCACCAGACCACCCATAGTGTGGTGAACCGCTGGTGCAATTTCTAAGGCGTAGAA
AGGAGCTACCACTAATTCACGTGGTAAATCAGGACGTTCAAATTGAGCATCTTTACCTGA
TTTAACGAAACCGTTGTAGGCTGTTACTGTTTTTGCCAATTCAGCTGCAGGTACATCGAT
TTGTTTCGCTAACTCTTCGATGGTTTTACCTTCTTTTACAATGTTCAGGTGAACATAACC
TTCGATGGCCTTCAAGCTCTTACGGATAGAGTCATCGAATACTAGGTAAGCGCTTTCACC
TTTTTGTTGCAGAATCGCCGCAGACGCTTTATCACGGGTGGTGATTTCGTTCATAAAACG
ATTACCTTCACGGTTCACCACGATTGCACCGTTACCACGTACTGCCTCGGTGATCATCAC
GCCACCCGCTGGAGAGTAAGTTGGGTGAGCTTGGATGTATTCTAAGTCACGTGTTGCTGC
GCCCGCTTGTAGAGCTACGTCTAAGCCGTCACCCGTCGCACCTGGGTGGTTGGTCGCTTT
AAAGCCTTTTAACTTAGGATCGTATTTAGAAACACGTTCGTTGTTTTTCGCAAAACCACC
TGCTGCAATGACTACTGCATCGGCTTTGATCACATAGTAACCTGTGTATTCACCTTTCAC
TAAAACGCCGGTCACTTTACCGCTTGCATCTTCAAGGATGCGCACAACGCGGCTGTTTAA
GCGAATATCAGTACCACGCTTAACGGCGTTGTCCCACAGCACTTGTGCTACGTGAGCACC
AACACCTGCACCACCGGTTGGACGGTGACTACGGTTAACGCTCGCGCCACCCATACGACC
CACGTCAGTCATGTCGGCACCCATAGAGGTTAACCAATCGATTGAGTCTGAAGAGTTGTT
AGCCAGTACTTTAACTAATTCAGGATCGTTGATGTTGCGGCCACCTTTCATAGTGTCGTC
GATCATGATTTGTTTCTTATCTTCGATACCTAACTTAGCCTGTGGCTTAGTTTCTGCGGC
GTTCATACCACCGGCAGCCAGTTTAGTGTTACCACCTGGGATAGGTTCTTTTTCTAACAG
AATCACTTTCGCGCCAGCATCACGGGCAGATACGGCAGCGGCAAGACCAGCACCACCAGA
GCCGATAATTACAACGTCTGTGGTTTCTTTCACACCAGCAGCAATGGCTTTATCTTGTGC
TGCTTTGTCTGCATCAACAGGTACAAACTTACGTTCCCACTTGCCACCAAATGGCATATC
GAAGCCGAAGCTATGGCAAGCATCACAATAAGCTACTGATTTTTCGTGGCCTTTGTGGCA
GCTCGTACAAGCGATTTCACCAATTAAGTGAGATTTGTGCGGAGAAACTTTATCTTTAGG
CGCTGCTGCAGCCAGTTCTTTTAAGTCACCGTGGCAGCTAACACATTGGCCATTCTCATG
GGTCAGGTTGTCGTTAGTCACGCCACCTTTGTCTGATACGTGGCAGCTATCGCAGCCACC
CATTTCACCGTGAAAATCGGCTAGTACTTCTGGAGCGGCATAGGCTGTGCCTGCCATTGC
GCCAGAGATCAGCATGGCTAGTGCTGTTTTTTGAATCTTTCTTGTGAACAT

# Drug_Target_19_General_Function:
Energy production and conversion

# Drug_Target_19_General_References:
10581551	Leys D, Tsapin AS, Nealson KH, Meyer TE, Cusanovich MA, Van Beeumen JJ: Structure and mechanism of the flavocytochrome c fumarate reductase of Shewanella putrefaciens MR-1. Nat Struct Biol. 1999 Dec;6(12):1113-7.
11425747	Tsapin AI, Vandenberghe I, Nealson KH, Scott JH, Meyer TE, Cusanovich MA, Harada E, Kaizu T, Akutsu H, Leys D, Van Beeumen JJ: Identification of a small tetraheme cytochrome c and a flavocytochrome c as two of the principal soluble cytochromes c in Shewanella oneidensis strain MR1. Appl Environ Microbiol. 2001 Jul;67(7):3236-44.
12368813	Heidelberg JF, Paulsen IT, Nelson KE, Gaidos EJ, Nelson WC, Read TD, Eisen JA, Seshadri R, Ward N, Methe B, Clayton RA, Meyer T, Tsapin A, Scott J, Beanan M, Brinkac L, Daugherty S, DeBoy RT, Dodson RJ, Durkin AS, Haft DH, Kolonay JF, Madupu R, Peterson JD, Umayam LA, White O, Wolf AM, Vamathevan J, Weidman J, Impraim M, Lee K, Berry K, Lee C, Mueller J, Khouri H, Gill J, Utterback TR, McDonald LA, Feldblyum TV, Smith HO, Venter JC, Nealson KH, Fraser CM: Genome sequence of the dissimilatory metal ion-reducing bacterium Shewanella oneidensis. Nat Biotechnol. 2002 Nov;20(11):1118-23. Epub 2002 Oct 7.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
2709

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
62448

# Drug_Target_19_Name:
Fumarate reductase flavoprotein subunit

# Drug_Target_19_Number_of_Residues:
596

# Drug_Target_19_PDB_ID:
1D4C

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00890	FAD_binding_2

# Drug_Target_19_Protein_Sequence:
>Fumarate reductase flavoprotein subunit precursor
MFTRKIQKTALAMLISGAMAGTAYAAPEVLADFHGEMGGCDSCHVSDKGGVTNDNLTHEN
GQCVSCHGDLKELAAAAPKDKVSPHKSHLIGEIACTSCHKGHEKSVAYCDACHSFGFDMP
FGGKWERKFVPVDADKAAQDKAIAAGVKETTDVVIIGSGGAGLAAAVSARDAGAKVILLE
KEPIPGGNTKLAAGGMNAAETKPQAKLGIEDKKQIMIDDTMKGGRNINDPELVKVLANNS
SDSIDWLTSMGADMTDVGRMGGASVNRSHRPTGGAGVGAHVAQVLWDNAVKRGTDIRLNS
RVVRILEDASGKVTGVLVKGEYTGYYVIKADAVVIAAGGFAKNNERVSKYDPKLKGFKAT
NHPGATGDGLDVALQAGAATRDLEYIQAHPTYSPAGGVMITEAVRGNGAIVVNREGNRFM
NEITTRDKASAAILQQKGESAYLVFDDSIRKSLKAIEGYVHLNIVKEGKTIEELAKQIDV
PAAELAKTVTAYNGFVKSGKDAQFERPDLPRELVVAPFYALEIAPAVHHTMGGLVIDTKA
EVKSEKTGKPITGLYAAGEVTGGVHGANRLGGNAISDIVTYGRIAGASAAKFAKDN

# Drug_Target_19_Reaction:
succinate + acceptor = fumarate + reduced acceptor

# Drug_Target_19_Signals:
1-25

# Drug_Target_19_Specific_Function:
Catalyzes fumarate reduction using artificial electron donors such as methyl viologen. The physiological reductant is unknown, but evidence indicates that flavocytochrome c participates in electron transfer from formate to fumarate and possibly also to trimethylamine oxide (TMAO). This enzyme is essentially unidirectional

# Drug_Target_19_SwissProt_ID:
P83223

# Drug_Target_19_SwissProt_Name:
FRDA_SHEON

# Drug_Target_19_Synonyms:
EC 1.3.99.1
FL cyt
Flavocytochrome c
Fumarate reductase flavoprotein subunit precursor

# Drug_Target_19_Theoretical_pI:
7.64

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE014299

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
SO_2727

# Drug_Target_1_Gene_Sequence:
>351 bp
TTACTTCTTCAGAACAGACGCAGAAGTACGGCCATCGTCATGGCAGCTTTCACAAGTAGG
TTTTTGGCCTACATTCATATCATGTACCGCATGGCAGTCAGCGCACACTAAGTTGCCATC
GTGTGGCTTGTGTACTGCGTCCATTTCAGAAAGCTTACCGTGGCAGCTTTGGCATTGTGC
AAATTCAAAGGCACCGTCAGCAGAAGGGGTACCATCTTTATGACAGCTCTCACAACCACC
TGACTCAGCATGGAAGTCTGATAATTTTTGATCCGCGGCAAATGCGGTTGGCGACAGCGC
TAACGCTGCAAGACTTGCCCCGAAAAGCACACTTAATAGTTTTTTGCTCAC

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
12080059	Leys D, Meyer TE, Tsapin AS, Nealson KH, Cusanovich MA, Van Beeumen JJ: Crystal structures at atomic resolution reveal the novel concept of "electron-harvesting" as a role for the small tetraheme cytochrome c. J Biol Chem. 2002 Sep 20;277(38):35703-11. Epub 2002 Jun 21.
12368813	Heidelberg JF, Paulsen IT, Nelson KE, Gaidos EJ, Nelson WC, Read TD, Eisen JA, Seshadri R, Ward N, Methe B, Clayton RA, Meyer T, Tsapin A, Scott J, Beanan M, Brinkac L, Daugherty S, DeBoy RT, Dodson RJ, Durkin AS, Haft DH, Kolonay JF, Madupu R, Peterson JD, Umayam LA, White O, Wolf AM, Vamathevan J, Weidman J, Impraim M, Lee K, Berry K, Lee C, Mueller J, Khouri H, Gill J, Utterback TR, McDonald LA, Feldblyum TV, Smith HO, Venter JC, Nealson KH, Fraser CM: Genome sequence of the dissimilatory metal ion-reducing bacterium Shewanella oneidensis. Nat Biotechnol. 2002 Nov;20(11):1118-23. Epub 2002 Oct 7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4997

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
12148

# Drug_Target_1_Name:
Cytochrome c3

# Drug_Target_1_Number_of_Residues:
116

# Drug_Target_1_PDB_ID:
1M1R

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Cytochrome c3
MSKKLLSVLFGASLAALALSPTAFAADQKLSDFHAESGGCESCHKDGTPSADGAFEFAQC
QSCHGKLSEMDAVHKPHDGNLVCADCHAVHDMNVGQKPTCESCHDDGRTSASVLKK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q8EDL6

# Drug_Target_1_SwissProt_Name:
Q8EDL6_SHEON

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
6.28

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Not Available

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
Not Available

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
AY040244

# Drug_Target_20_GenBank_ID_Protein:
Not Available

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
katG

# Drug_Target_20_Gene_Sequence:
>2247 bp
ATGCCCGGCTCCGATGCCGGGCCCCGCAGGCGGGGCGTACACGAACAAAGGAGAAATCGC
ATGTCGAATGAAGCGAAGTGCCCGTTCCATCAAGCCGCAGGCAACGGCACGTCGAACCGG
GACTGGTGGCCCAATCAGCTGGACCTGAGCATCCTGCATCGGCACTCGTCGCTGTCCGAT
CCGATGGGCAAGGATTTCAACTACGCGCAGGCGTTCGAGAAGCTCGACCTCGCGGCGGTG
AAGCGCGACCTCCACGCGCTGATGACGACGTCGCAGGACTGGTGGCCGGCCGATTTCGGC
CACTACGGCGGCCTGTTCATCCGCATGGCATGGCACAGCGCGGGCACGTACCGCACGGCC
GACGGCCGCGGCGGCGCGGGCGAAGGGCAGCAGCGCTTCGCGCCGCTCAACAGCTGGCCC
GACAACGCGAACCTCGACAAGGCGCGCCGGCTGCTGTGGCCGATCAAGCAGAAGTACGGC
CGCGCCATCTCGTGGGCCGACCTGCTGATCCTGACGGGCAACGTCGCGCTCGAATCGATG
GGCTTCAAGACCTTCGGCTTCGCGGGCGGCCGCGCGGACACGTGGGAGCCCGAGGACGTC
TACTGGGGCTCGGAAAAGATCTGGCTGGAACTGAGCGGCGGCCCGAACAGCCGCTATTCG
GGCGACCGCCAGCTCGAGAACCCGCTCGCCGCCGTGCAGATGGGCCTCATCTACGTGAAT
CCGGAAGGCCCGGACGGCAATCCCGATCCGGTCGCCGCGGCGCGCGACATTCGTGACACC
TTCGCGCGCATGGCGATGAACGACGAAGAGACGGTCGCGCTGATCGCGGGCGGCCACACG
TTCGGCAAGACGCACGGCGCGGGGCCCGCGTCGAACGTCGGCGCCGAGCCGGAGGCCGCG
GGCATCGAAGCGCAGGGCCTCGGCTGGAAGAGCGCGTACCGCACGGGCAAGGGCGCGGAC
GCGATCACGAGCGGGCTCGAAGTCACGTGGACGACGACGCCGACGCAGTGGAGCCACAAC
TTCTTCGAGAACCTGTTCGGCTACGAGTGGGAGCTGACGAAGAGCCCGGCGGGCGCGCAC
CAGTGGGTCGCGAAGGGCGCCGACGCGGTGATTCCCGACGCGTTCGATCCGTCGAAGAAG
CATCGTCCGACGATGCTCACGACCGACCTGTCGCTGCGCTTCGATCCGGCGTACGAAAAG
ATCTCGCGCCGCTTCCACGAGAACCCGGAGCAGTTCGCCGACGCGTTCGCGCGCGCCTGG
TTCAAGCTCACGCACCGCGACATGGGCCCGCGCGCGCGCTATCTCGGCCCGGAAGTGCCG
GCCGAGGTGCTGCTGTGGCAGGACCCGATTCCGGCCGTCGACCATCCGCTGATCGACGCC
GCGGACGCCGCCGAGCTGAAGGCAAAGGTGCTCGCGTCGGGGCTGACCGTGTCGCAGCTC
GTTTCCACCGCGTGGGCGGCGGCGTCCACCTTCCGCGGCTCGGACAAGCGCGGCGGCGCG
AACGGCGCGCGCATTCGCCTTGCGCCGCAGAAGGACTGGGAGGCGAACCAGCCCGAGCAG
CTCGCGGCGGTGCTCGAGACGCTCGAGGCAATTCGCACGGCGTTCAACGGCGCGCAGCGC
GGCGGCAAGCAAGTGTCGCTCGCCGATCTGATCGTGCTGGCCGGCTGCGCGGGCGTCGAG
CAGGCGGCGAAGAACGCGGGCCACGCGGTGACCGTGCCGTTCGCGCCGGGCCGCGCGGAC
GCATCGCAGGAGCAGACCGACGTCGAATCGATGGCCGTGCTCGAGCCGGTGGCCGACGGT
TTTCGCAACTACCTGAAGGGCAAGTATCGGGTGCCCGCCGAGGTGCTGCTCGTCGACAAG
GCGCAACTGCTGACGCTGAGCGCGCCGGAGATGACGGTGCTGCTGGGCGGCCTGCGCGTG
CTGGGCGCGAACGTCGGGCAGAGCCGGCACGGCGTGTTCACCGCGCGCGAGCAGGCATTG
ACCAACGACTTCTTCGTGAACCTGCTCGACATGGGCACCGAGTGGAAGCCGACGGCGGCC
GACGCGGACGTGTTCGAAGGGCGCGACCGCGCGACGGGCGAGCTCAAGTGGACGGGCACG
CGCGTCGATCTCGTGTTCGGCTCGCACTCGCAGTTGCGCGCGCTCGCGGAGGTCTACGGC
AGCGCGGACGCGCAGGAGAAGTTCGTGCGCGACTTCGTCGCGGTCTGGAACAAGGTGATG
AACCTCGACCGCTTCGATCTCGCGTGA

# Drug_Target_20_General_Function:
Involved in catalase activity

# Drug_Target_20_General_References:
12383513	Loprasert S, Sallabhan R, Whangsuk W, Mongkolsuk S: The Burkholderia pseudomallei oxyR gene: expression analysis and mutant characterization. Gene. 2002 Aug 21;296(1-2):161-9.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
4920

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
81761

# Drug_Target_20_Name:
Peroxidase/catalase

# Drug_Target_20_Number_of_Residues:
748

# Drug_Target_20_PDB_ID:
1X7U

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00141	peroxidase

# Drug_Target_20_Protein_Sequence:
>Peroxidase/catalase
MPGSDAGPRRRGVHEQRRNRMSNEAKCPFHQAAGNGTSNRDWWPNQLDLSILHRHSSLSD
PMGKDFNYAQAFEKLDLAAVKRDLHALMTTSQDWWPADFGHYGGLFIRMAWHSAGTYRTA
DGRGGAGEGQQRFAPLNSWPDNANLDKARRLLWPIKQKYGRAISWADLLILTGNVALESM
GFKTFGFAGGRADTWEPEDVYWGSEKIWLELSGGPNSRYSGDRQLENPLAAVQMGLIYVN
PEGPDGNPDPVAAARDIRDTFARMAMNDEETVALIAGGHTFGKTHGAGPASNVGAEPEAA
GIEAQGLGWKSAYRTGKGADAITSGLEVTWTTTPTQWSHNFFENLFGYEWELTKSPAGAH
QWVAKGADAVIPDAFDPSKKHRPTMLTTDLSLRFDPAYEKISRRFHENPEQFADAFARAW
FKLTHRDMGPRARYLGPEVPAEVLLWQDPIPAVDHPLIDAADAAELKAKVLASGLTVSQL
VSTAWAAASTFRGSDKRGGANGARIRLAPQKDWEANQPEQLAAVLETLEAIRTAFNGAQR
GGKQVSLADLIVLAGCAGVEQAAKNAGHAVTVPFAPGRADASQEQTDVESMAVLEPVADG
FRNYLKGKYRVPAEVLLVDKAQLLTLSAPEMTVLLGGLRVLGANVGQSRHGVFTAREQAL
TNDFFVNLLDMGTEWKPTAADADVFEGRDRATGELKWTGTRVDLVFGSHSQLRALAEVYG
SADAQEKFVRDFVAVWNKVMNLDRFDLA

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Not Available

# Drug_Target_20_SwissProt_ID:
Q939D2

# Drug_Target_20_SwissProt_Name:
KATG_BURPS

# Drug_Target_20_Synonyms:
Catalase-peroxidase

# Drug_Target_20_Theoretical_pI:
6.25

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
M12546

# Drug_Target_21_GenBank_ID_Protein:
151115

# Drug_Target_21_GeneCard_ID:
Not Available

# Drug_Target_21_Gene_Name:
camC

# Drug_Target_21_Gene_Sequence:
>1248 bp
ATGACGACTGAAACCATACAAAGCAACGCCAATCTTGCCCCTCTGCCACCCCATGTGCCA
GAGCACCTGGTATTCGACTTCGACATGTACAATCCGTCGAATCTGTCTGCCGGCGTGCAG
GAGGCCTGGGCAGTTCTGCAAGAATCAAACGTACCGGATCTGGTGTGGACTCGCTGCAAC
GGCGGACACTGGATCGCCACTCGCGGCCAACTGATCCGTGAGGCCTATGAAGATTACCGC
CACTTTTCCAGCGAGTGCCCGTTCATCCCTCGTGAAGCCGGCGAAGCCTACGACTTCATT
CCCACCTCGATGGATCCGCCCGAGCAGCGCCAGTTTCGTGCGCTGGCCAACCAAGTGGTT
GGCATGCCGGTGGTGGATAAGCTGGAGAACCGGATCCAGGAGCTGGCCTGCTCGCTGATC
GAGAGCCTGCGCCCGCAAGGACAGTGCAACTTCACCGAGGACTACGCCGAACCCTTCCCG
ATACGCATCTTCATGCTGCTCGCAGGTCTACCGGAAGAAGATATCCCGCACTTGAAATAC
CTAACGGATCAGATGACCCGTCCGGATGGCAGCATGACCTTCGCAGAGGCCAAGGAGGCG
CTCTACGACTATCTGATACCGATCATCGAGCAACGCAGGCAGAAGCCGGGAACCGACGCT
ATCAGCATCGTTGCCAACGGCCAGGTCAATGGGCGACCGATCACCAGTGACGAAGCCAAG
AGGATGTGTGGCCTGTTACTGGTCGGCGGCCTGGATACGGTGGTCAATTTCCTCAGCTTC
AGCATGGAGTTCCTGGCCAAAAGCCCGGAGCATCGCCAGGAGCTGATCGAGCGTCCCGAG
CGTATTCCAGCCGCTTGCGAGGAACTACTCCGGCGCTTCTCGCTGGTTGCCGATGGCCGC
ATCCTCACCTCCGATTACGAGTTTCATGGCGTGCAACTGAAGAAAGGTGACCAGATCCTG
CTACCGCAGATGCTGTCTGGCCTGGATGAGCGCGAAAACGCCTGCCCGATGCACGTCGAC
TTCAGTCGCCAAAAGGTTTCACACACCACCTTTGGCCACGGCAGCCATCTGTGCCTTGGC
CAGCACCTGGCCCGCCGGGAAATCATCGTCACCCTCAAGGAATGGCTGACCAGGATTCCT
GACTTCTCCATTGCCCCGGGTGCCCAGATTCAGCACAAGAGCGGCATCGTCAGCGGCGTG
CAGGCACTCCCTCTGGTCTGGGATCCGGCGACTACCAAAGCGGTATAA

# Drug_Target_21_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_21_General_References:
10557259	Dmochowski IJ, Crane BR, Wilker JJ, Winkler JR, Gray HB: Optical detection of cytochrome P450 by sensitizer-linked substrates. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):12987-90.
10698731	Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG: The catalytic pathway of cytochrome p450cam at atomic resolution. Science. 2000 Mar 3;287(5458):1615-22.
11098139	Hishiki T, Shimada H, Nagano S, Egawa T, Kanamori Y, Makino R, Park SY, Adachi S, Shiro Y, Ishimura Y: X-ray crystal structure and catalytic properties of Thr252Ile mutant of cytochrome P450cam: roles of Thr252 and water in the active center. J Biochem (Tokyo). 2000 Dec;128(6):965-74.
11258878	Lee DS, Park SY, Yamane K, Obayashi E, Hori H, Shiro Y: Structural characterization of n-butyl-isocyanide complexes of cytochromes P450nor and P450cam. Biochemistry. 2001 Mar 6;40(9):2669-77.
11606730	Dunn AR, Dmochowski IJ, Bilwes AM, Gray HB, Crane BR: Probing the open state of cytochrome P450cam with ruthenium-linker substrates. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12420-5. Epub 2001 Oct 16.
12237225	Deprez E, Gill E, Helms V, Wade RC, Hui Bon Hoa G: Specific and non-specific effects of potassium cations on substrate-protein interactions in cytochromes P450cam and P450lin. J Inorg Biochem. 2002 Sep 20;91(4):597-606.
12464241	Fedorov R, Ghosh DK, Schlichting I: Crystal structures of cyanide complexes of P450cam and the oxygenase domain of inducible nitric oxide synthase-structural models of the short-lived oxygen complexes. Arch Biochem Biophys. 2003 Jan 1;409(1):25-31.
1610873	Nolting B, Jung C, Snatzke G: Multichannel circular dichroism investigations of the structural stability of bacterial cytochrome P-450. Biochim Biophys Acta. 1992 May 20;1100(2):171-6.
2578028	Hui Bon Hoa G, Di Primo C, Dondaine I, Sligar SG, Gunsalus IC, Douzou P: Conformational changes of cytochromes P-450cam and P-450lin induced by high pressure. Biochemistry. 1989 Jan 24;28(2):651-6.
2613690	Koga H, Yamaguchi E, Matsunaga K, Aramaki H, Horiuchi T: Cloning and nucleotide sequences of NADH-putidaredoxin reductase gene (camA) and putidaredoxin gene (camB) involved in cytochrome P-450cam hydroxylase of Pseudomonas putida. J Biochem (Tokyo). 1989 Nov;106(5):831-6.
3003058	Unger BP, Gunsalus IC, Sligar SG: Nucleotide sequence of the Pseudomonas putida cytochrome P-450cam gene and its expression in Escherichia coli. J Biol Chem. 1986 Jan 25;261(3):1158-63.
3813557	Marden MC, Hoa GH: P-450 binding to substrates camphor and linalool versus pressure. Arch Biochem Biophys. 1987 Feb 15;253(1):100-7.
4066706	Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, Kraut J: The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem. 1985 Dec 25;260(30):16122-30.
7130171	Haniu M, Armes LG, Yasunobu KT, Shastry BA, Gunsalus IC: Amino acid sequence of the Pseudomonas putida cytochrome P-450. II. Cyanogen bromide peptides, acid cleavage peptides, and the complete sequence. J Biol Chem. 1982 Nov 10;257(21):12664-71.
9315686	Mouro C, Bondon A, Simonneaux G, Jung C: 1H-NMR study of diamagnetic cytochrome P450cam: assignment of heme resonances and substrate dependance of one cysteinate beta proton. FEBS Lett. 1997 Sep 8;414(2):203-8.
9357977	Schlichting I, Jung C, Schulze H: Crystal structure of cytochrome P-450cam complexed with the (1S)-camphor enantiomer. FEBS Lett. 1997 Oct 6;415(3):253-7.
9649301	Vidakovic M, Sligar SG, Li H, Poulos TL: Understanding the role of the essential Asp251 in cytochrome p450cam using site-directed mutagenesis, crystallography, and kinetic solvent isotope effect. Biochemistry. 1998 Jun 30;37(26):9211-9.

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
2298

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
46670

# Drug_Target_21_Name:
Cytochrome P450-cam

# Drug_Target_21_Number_of_Residues:
415

# Drug_Target_21_PDB_ID:
1IWI

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_21_Protein_Sequence:
>Cytochrome P450-cam
MTTETIQSNANLAPLPPHVPEHLVFDFDMYNPSNLSAGVQEAWAVLQESNVPDLVWTRCN
GGHWIATRGQLIREAYEDYRHFSSECPFIPREAGEAYDFIPTSMDPPEQRQFRALANQVV
GMPVVDKLENRIQELACSLIESLRPQGQCNFTEDYAEPFPIRIFMLLAGLPEEDIPHLKY
LTDQMTRPDGSMTFAEAKEALYDYLIPIIEQRRQKPGTDAISIVANGQVNGRPITSDEAK
RMCGLLLVGGLDTVVNFLSFSMEFLAKSPEHRQELIERPERIPAACEELLRRFSLVADGR
ILTSDYEFHGVQLKKGDQILLPQMLSGLDERENACPMHVDFSRQKVSHTTFGHGSHLCLG
QHLARREIIVTLKEWLTRIPDFSIAPGAQIQHKSGIVSGVQALPLVWDPATTKAV

# Drug_Target_21_Reaction:
(+)-camphor + putidaredoxin + O2 = (+)-exo-5-hydroxycamphor + oxidized putidaredoxin + H2O

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Involved in a camphor oxidation system

# Drug_Target_21_SwissProt_ID:
P00183

# Drug_Target_21_SwissProt_Name:
CPXA_PSEPU

# Drug_Target_21_Synonyms:
Camphor 5-monooxygenase
EC 1.14.15.1
P450cam

# Drug_Target_21_Theoretical_pI:
5.08

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Not Available

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
Not Available

# Drug_Target_22_GenBank_ID_Protein:
Not Available

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
CYB5B

# Drug_Target_22_Gene_Sequence:
Not Available

# Drug_Target_22_General_Function:
Not Available

# Drug_Target_22_General_References:
Not Available

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
6984

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
Not Available

# Drug_Target_22_Name:
Cytochrome b5 type B

# Drug_Target_22_Number_of_Residues:
0

# Drug_Target_22_PDB_ID:
Not Available

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
Not Available

# Drug_Target_22_Protein_Sequence:
Not Available

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
Not Available

# Drug_Target_22_Specific_Function:
Not Available

# Drug_Target_22_SwissProt_ID:
O43169

# Drug_Target_22_SwissProt_Name:
CYB5B_HUMAN

# Drug_Target_22_Synonyms:
Not Available

# Drug_Target_22_Theoretical_pI:
Not Available

# Drug_Target_22_Transmembrane_Regions:
Not Available

# Drug_Target_23_Cellular_Location:
Sarcolemma
peripheral membrane protein. In skeletal muscle, it is localized b
sarcolemmal membrane

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
NOS1

# Drug_Target_23_GenBank_ID_Gene:
U17327

# Drug_Target_23_GenBank_ID_Protein:
642526

# Drug_Target_23_GeneCard_ID:
NOS1

# Drug_Target_23_Gene_Name:
NOS1

# Drug_Target_23_Gene_Sequence:
>4305 bp
ATGGAGGATCACATGTTCGGTGTTCAGCAAATCCAGCCCAATGTCATTTCTGTTCGTCTC
TTCAAGCGCAAAGTTGGGGGCCTGGGATTTCTGGTGAAGGAGCGGGTCAGTAAGCCGCCC
GTGATCATCTCTGACCTGATTCGTGGGGGCGCCGCAGAGCAGAGTGGCCTCATCCAGGCC
GGAGACATCATTCTTGCGGTCAACGGCCGGCCCTTGGTGGACCTGAGCTATGACAGCGCC
CTGGAGGTACTCAGAGGCATTGCCTCTGAGACCCACGTGGTCCTCATTCTGAGGGGCCCT
GAAGGTTTCACCACGCACCTGGAGACCACCTTTACAGGTGATGGGACCCCCAAGACCATC
CGGGTGACACAGCCCCTGGGTCCCCCCACCAAAGCCGTGGATCTGTCCCACCAGCCACCG
GCCGGCAAAGAACAGCCCCTGGCAGTGGATGGGGCCTCGGGTCCCGGGAATGGGCCTCAG
CATGCCTACGATGATGGGCAGGAGGCTGGCTCACTCCCCCATGCCAACGGCCTGGCCCCC
AGGCCCCCAGGCCAGGACCCCGCGAAGAAAGCAACCAGAGTCAGCCTCCAAGGCAGAGGG
GAGAACAATGAACTGCTCAAGGAGATAGAGCCTGTGCTGAGCCTTCTCACCAGTGGGAGC
AGAGGGGTCAAGGGAGGGGCACCTGCCAAGGCAGAGATGAAAGATATGGGAATCCAGGTG
GACAGAGATTTGGACGGCAAGTCACACAAACCTCTGCCCCTCGGCGTGGAGAACGACCGA
GTCTTCAATGACCTATGGGGGAAGGGCAATGTGCCTGTCGTCCTCAACAACCCATATTCA
GAGAAGGAGCAGCCCCCCACCTCAGGAAAACAGTCCCCCACAAAGAATGGCAGCCCCTCC
AAGTGTCCACGCTTCCTCAAGGTCAAGAACTGGGAGACTGAGGTGGTTCTCACTGACACC
CTCCACCTTAAGAGCACATTGGAAACGGGATGCACTGAGTACATCTGCATGGGCTCCATC
ATGCATCCTTCTCAGCATGCAAGGAGGCCTGAAGACGTCCGCACAAAAGGACAGCTCTTC
CCTCTCGCCAAAGAGTTTATTGATCAATACTATTCATCAATTAAAAGATTTGGCTCCAAA
GCCCACATGGAAAGGCTGGAAGAGGTGAACAAAGAGATCGACACCACTAGCACTTACCAG
CTCAAGGACACAGAGCTCATCTATGGGGCCAAGCACGCCTGGCGGAATGCCTCGCGCTGT
GTGGGCAGGATCCAGTGGTCCAAGCTGCAGGTATTCGATGCCCGTGACTGCACCACGGCC
CACGGGATGTTCAACTACATCTGTAACCATGTCAAGTATGCCACCAACAAAGGGAACCTC
AGGTCTGCCATCACCATATTCCCCCAGAGGACAGACGGCAAGCACGACTTCCGAGTCTGG
AACTCCCAGCTCATCCGCTACGCTGGCTACAAGCAGCCTGACGGCTCCACCCTGGGGGAC
CCAGCCAATGTGCAGTTCACAGAGATATGCATACAGCAGGGCTGGAAACCGCCTAGAGGC
CGCTTCGATGTCCTGCCGCTCCTGCTTCAGGCCAACGGCAATGACCCTGAGCTCTTCCAG
ATTCCTCCAGAGCTGGTGTTGGAAGTTCCCATCAGGCACCCCAAGTTTGAGTGGTTCAAG
GACCTGGGGCTGAAGTGGTACGGCCTCCCCGCCGTGTCCAACATGCTCCTAGAGATTGGC
GGCCTGGAGTTCAGCGCCTGTCCCTTCAGTGGCTGGTACATGGGCACAGAGATTGGTGTC
CGCGACTACTGTGACAACTCCCGCTACAATATCCTGGAGGAAGTGGCCAAGAAGATGAAC
TTAGACATGAGGAAGACGTCCTCCCTGTGGAAGGACCAGGCGCTGGTGGAGATCAATATC
GCGGTTCTCTATAGCTTCCAGAGTGACAAAGTGACCATTGTTGACCATCACTCCGCCACC
GAGTCCTTCATTAAGCACATGGAGAATGAGTACCGCTGCCGGGGGGGCTGCCCTGCCGAC
TGGGTGTGGATCGTGCCCCCCATGTCCGGAAGCATCACCCCTGTGTTCCACCAGGAGATG
CTCAACTACCGGCTCACCCCCTCCTTCGAATACCAGCCTGATCCCTGGAACACGCATGTC
TGGAAAGGCACCAACGGGACCCCCACAAAGCGGCGAGCCATCGGCTTCAAGAAGCTAGCA
GAAGCTGTCAAGTTCTCGGCCAAGCTGATGGGGCAGGCTATGGCCAAGAGGGTGAAAGCG
ACCATCCTCTATGCCACAGAGACAGGCAAATCGCAAGCTTATGCCAAGACCTTGTGTGAG
ATCTTCAAACACGCCTTTGATGCCAAGGTGATGTCCATGGAAGAATATGACATTGTGCAC
CTGGAACATGAAACTCTGGTCCTTGTGGTCACCAGCACCTTTGGCAATGGAGATCCCCCT
GAGAATGGGGAGAAATTCGGCTGTGCTTTGATGGAAATGAGGCACCCCAACTCTGTGCAG
GAAGAAAGGAAGAGCTACAAGGTCCGATTCAACAGCGTCTCCTCCTACTCTGACTCCCAA
AAATCATCAGGCGATGGGCCCGACCTCAGAGACAACTTTGAGAGTGCTGGACCCCTGGCC
AATGTGAGGTTCTCAGTTTTTGGCCTCGGCTCACGAGCATACCCTCACTTTTGCGCCTTC
GGACACGCTGTGGACACCCTCCTGGAAGAACTGGGAGGGGAGAGGATCCTGAAGATGAGG
GAAGGGGATGAGCTCTGTGGGCAGGAAGAGGCTTTCAGGACCTGGGCCAAGAAGGTCTTC
AAGGCAGCCTGTGATGTCTTCTGTGTGGGAGATGATGTCAACATTGAAAAGGCCAACAAT
TCCCTCATCAGCAATGATCGCAGCTGGAAGAGAAACAAGTTCCGCCTCACCTTTGTGGCC
GAAGCTCCAGAACTCACACAAGGTCTATCCAATGTCCACAAAAAGCGAGTCTCAGCTGCC
CGGCTCCTTAGCCGTCAAAACCTCCAGAGCCCTAAATCCAGTCGGTCAACTATCTTCGTG
CGTCTCCACACCAACGGGAGCCAGGAGCTGCAGTACCAGCCTGGGGACCACCTGGGTGTC
TTCCCTGGCAACCACGAGGACCTCGTGAATGCCCTGATCGAGCGGCTGGAGGACGCGCCG
CCTGTCAACCAGATGGTGAAAGTGGAACTGCTGGAGGAGCGGAACACGGCTTTAGGTGTC
ATCAGTAACTGGACAGACGAGCTCCGCCTCCCGCCCTGCACCATCTTCCAGGCCTTCAAG
TACTACCTGGACATCACCACGCCACCAACGCCTCTGCAGCTGCAGCAGTTTGCCTCCCTA
GCTACCAGCGAGAAGGAGAAGCAGCGTCTGCTGGTCCTCAGCAAGGGTTTGCAGGAGTAC
GAGGAATGGAAATGGGGCAAGAACCCCACCATCGTGGAGGTGCTGGAGGAGTTCCCATCT
ATCCAGATGCCGGCCACCCTGCTCCTGACCCAGCTGTCCCTGCTGCAGCCCCGCTACTAT
TCCATCAGCTCCTCCCCAGACATGTACCCTGATGAAGTGCACCTCACTGTGGCCATCGTT
TCCTACCGCACTCGAGATGGAGAAGGACCAATTCACCACGGCGTATGCTCCTCCTGGCTC
AACCGGATACAGGCTGACGAACTGGTCCCCTGTTTCGTGAGAGGAGCACCCAGCTTCCAC
CTGCCCCGGAACCCCCAAGTCCCCTGCATCCTCGTTGGACCAGGCACCGGCATTGCCCCT
TTCCGAAGCTTCTGGCAACAGCGGCAATTTGATATCCAACACAAAGGAATGAACCCCTGC
CCCATGGTCCTGGTCTTCGGGTGCCGGCAATCCAAGATAGATCATATCTACAGGGAAGAG
ACCCTGCAGGCCAAGAACAAGGGGGTCTTCAGAGAGCTGTACACGGCTTACTCCCGGGAG
CCAGACAAACCAAAGAAGTACGTGCAGGACATCCTGCAGGAGCAGCTGGCGGAGTCTGTG
TACCGAGCCCTGAAGGAGCAAGGGGGCCACATATACGTCTGTGGGGACGTCACCATGGCT
GCTGATGTCCTCAAAGCCATCCAGCGCATCATGACCCAGCAGGGGAAGCTCTCGGCAGAG
GACGCCGGCGTATTCATCAGCCGGATGAGGGATGACAACCGATACCATGAGGATATTTTT
GGAGTCACCCTGCGAACGTACGAAGTGACCAACCGCCTTAGATCTGAGTCCATTGCCTTC
ATTGAAGAGAGCAAAAAAGACACCGATGAGGTTTTCAGCTCCTAA

# Drug_Target_23_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_23_General_References:
7515942	Fujisawa H, Ogura T, Kurashima Y, Yokoyama T, Yamashita J, Esumi H: Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines. J Neurochem. 1994 Jul;63(1):140-5.
7528745	Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM, Olson SL, Lu WC, Kau CL, Marsden PA: Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem. 1994 Dec 30;269(52):33082-90.
7678401	Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 1993 Jan 25;316(2):175-80.
8879752	Park CS, Gianotti C, Park R, Krishna G: Neuronal isoform of nitric oxide synthase is expressed at low levels in human retina. Cell Mol Neurobiol. 1996 Aug;16(4):499-515.
9111048	Wang Y, Goligorsky MS, Lin M, Wilcox JN, Marsden PA: A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase. J Biol Chem. 1997 Apr 25;272(17):11392-401.

# Drug_Target_23_HGNC_ID:
HGNC:7872

# Drug_Target_23_HPRD_ID:
01226

# Drug_Target_23_ID:
76

# Drug_Target_23_Locus:
12q24.2-q24.31

# Drug_Target_23_Molecular_Weight:
160972

# Drug_Target_23_Name:
Nitric-oxide synthase, brain

# Drug_Target_23_Number_of_Residues:
1434

# Drug_Target_23_PDB_ID:
1TLL

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF00175	NAD_binding_1
PF00258	Flavodoxin_1
PF00595	PDZ
PF00667	FAD_binding_1
PF02898	NO_synthase

# Drug_Target_23_Protein_Sequence:
>Nitric-oxide synthase, brain
MEDHMFGVQQIQPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGGAAEQSGLIQA
GDIILAVNGRPLVDLSYDSALEVLRGIASETHVVLILRGPEGFTTHLETTFTGDGTPKTI
RVTQPLGPPTKAVDLSHQPPAGKEQPLAVDGASGPGNGPQHAYDDGQEAGSLPHANGLAP
RPPGQDPAKKATRVSLQGRGENNELLKEIEPVLSLLTSGSRGVKGGAPAKAEMKDMGIQV
DRDLDGKSHKPLPLGVENDRVFNDLWGKGNVPVVLNNPYSEKEQPPTSGKQSPTKNGSPS
KCPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVRTKGQLF
PLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRC
VGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVW
NSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQ
IPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGV
RDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSAT
ESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHV
WKGTNGTPTKRRAIGFKKLAEAVKFSAKLMGQAMAKRVKATILYATETGKSQAYAKTLCE
IFKHAFDAKVMSMEEYDIVHLEHETLVLVVTSTFGNGDPPENGEKFGCALMEMRHPNSVQ
EERKSYKVRFNSVSSYSDSQKSSGDGPDLRDNFESAGPLANVRFSVFGLGSRAYPHFCAF
GHAVDTLLEELGGERILKMREGDELCGQEEAFRTWAKKVFKAACDVFCVGDDVNIEKANN
SLISNDRSWKRNKFRLTFVAEAPELTQGLSNVHKKRVSAARLLSRQNLQSPKSSRSTIFV
RLHTNGSQELQYQPGDHLGVFPGNHEDLVNALIERLEDAPPVNQMVKVELLEERNTALGV
ISNWTDELRLPPCTIFQAFKYYLDITTPPTPLQLQQFASLATSEKEKQRLLVLSKGLQEY
EEWKWGKNPTIVEVLEEFPSIQMPATLLLTQLSLLQPRYYSISSSPDMYPDEVHLTVAIV
SYRTRDGEGPIHHGVCSSWLNRIQADELVPCFVRGAPSFHLPRNPQVPCILVGPGTGIAP
FRSFWQQRQFDIQHKGMNPCPMVLVFGCRQSKIDHIYREETLQAKNKGVFRELYTAYSRE
PDKPKKYVQDILQEQLAESVYRALKEQGGHIYVCGDVTMAADVLKAIQRIMTQQGKLSAE
DAGVFISRMRDDNRYHEDIFGVTLRTYEVTNRLRSESIAFIEESKKDTDEVFSS

# Drug_Target_23_Reaction:
L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In the brain and peripheral nervous system, NO displays many properties of a neurotransmitter

# Drug_Target_23_SwissProt_ID:
P29475

# Drug_Target_23_SwissProt_Name:
NOS1_HUMAN

# Drug_Target_23_Synonyms:
Constitutive NOS
EC 1.14.13.39
N-NOS
NC-NOS
NOS type I
Neuronal NOS
bNOS
nNOS

# Drug_Target_23_Theoretical_pI:
7.44

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Not Available

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
Not Available

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
AE014299

# Drug_Target_24_GenBank_ID_Protein:
Not Available

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
SO_4144

# Drug_Target_24_Gene_Sequence:
>1386 bp
ATGAAACAACTTCTCTTTATCGCCTTAGCGGGTATGGCACTGCAAGCGCAAGCCGCCAAT
CCCCATAAAGACGTGCTCAAAGGGCCCTTCACCACAGGTTCTGAGGTGACAACTCAGTGC
TTAACCTGCCACGAAGAACAAGCCACAGATATGATGAAAACCTCCCACTGGACATGGGAG
TTAGAACAAAAGCTACCCGATAGAACCGTGGTTCGGGGTAAGAAAAACAGTATTAATAAC
TTCTGTGTCGCCATATCCAGCAACGAGCCTCGCTGTACTAGCTGTCACGCTGGCTATGGT
TGGAAGGACAATACCTTTGACTTTAAAGATAAAACTAAAGTTGACTGCTTAATTTGTCAC
GACACTACTGGCACCTATGTAAAAGATCCTGCGGGCGCTGGCGAACCTATGGCTAAGCTC
GATCTAGCGAAGATAGCCCAAAATGTCGGAGCGCCAGTGCGGGATAACTGCGGTAGCTGC
CACTTCTACGGCGGCGGTGGTGATGCGGTCAAACACGGCGATCTCGACTCTTCCATGGCC
TATCCCGATAAAGCAACCGATGTTCACATGGACAGTGATGGCAATAACTTCCAATGCCAA
AACTGCCATACCACTGAAAAACATCAAATATCAGGTAATGCCATGGGCGTATCACCAGGT
GGTATCGACCATATCGGTTGTGAAAACTGCCACGATAGCGCGCCGCACAGCAACAAAAAG
CTCAATACCCATACCGCCACCGTGGCTTGCCAAACCTGCCATATTCCCTTCTTTGCTAAG
AATGAACCCACCAAGATGCAGTGGGATTGGTCAACTGCGGGGGATGATAAGCCTGAAACT
GTTGATCAATATGGCAAACATACTTACCAGAAGAAAAAAGGTAACTTCGTTTGGGAAAAA
ATGGTTAAGCCTCAATACGCTTGGTATAACGGCACTGCAAACGCATATATGGCTGGGGAC
AAAATGGACTCGAATGTCGTCACTAAACTGACCTACCCCATGGGCGACATTAACGATGCC
AAAGCCAAAATTTATCCCTTTAAGGTCCATACTGGTAAGCAAATTTACGATAAAAAGCTC
AACATTTTTATCACGCCAAAAACCTATGGCAAAGGCGGATATTGGAGCGAGTTTGATTGG
AATTTAGCGGCGAAACTGGGTATGGAAGCTAACCCAACCATGTTGGAAAAAGGCATCAAA
TACAGCGGTGAATATGACTTTGCAGCCACTGAAATGTGGTGGCGTATCAACCACATGGTG
TCACCTAAAGAGCAAGCGCTTAACTGTAATGATTGCCACAACAAAGGCACACGCCTCGAC
TGGCAAGCTTTAGGATATCAAGGCGACCCAATGAAAAACAAACAAGGCCCTAAACATAAG
CAATAA

# Drug_Target_24_General_Function:
Involved in sugar binding

# Drug_Target_24_General_References:
12368813	Heidelberg JF, Paulsen IT, Nelson KE, Gaidos EJ, Nelson WC, Read TD, Eisen JA, Seshadri R, Ward N, Methe B, Clayton RA, Meyer T, Tsapin A, Scott J, Beanan M, Brinkac L, Daugherty S, DeBoy RT, Dodson RJ, Durkin AS, Haft DH, Kolonay JF, Madupu R, Peterson JD, Umayam LA, White O, Wolf AM, Vamathevan J, Weidman J, Impraim M, Lee K, Berry K, Lee C, Mueller J, Khouri H, Gill J, Utterback TR, McDonald LA, Feldblyum TV, Smith HO, Venter JC, Nealson KH, Fraser CM: Genome sequence of the dissimilatory metal ion-reducing bacterium Shewanella oneidensis. Nat Biotechnol. 2002 Nov;20(11):1118-23. Epub 2002 Oct 7.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
4922

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
51400

# Drug_Target_24_Name:
Cytochrome c, putative

# Drug_Target_24_Number_of_Residues:
461

# Drug_Target_24_PDB_ID:
1SP3

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
Not Available

# Drug_Target_24_Protein_Sequence:
>Cytochrome c, putative
MKQLLFIALAGMALQAQAANPHKDVLKGPFTTGSEVTTQCLTCHEEQATDMMKTSHWTWE
LEQKLPDRTVVRGKKNSINNFCVAISSNEPRCTSCHAGYGWKDNTFDFKDKTKVDCLICH
DTTGTYVKDPAGAGEPMAKLDLAKIAQNVGAPVRDNCGSCHFYGGGGDAVKHGDLDSSMA
YPDKATDVHMDSDGNNFQCQNCHTTEKHQISGNAMGVSPGGIDHIGCENCHDSAPHSNKK
LNTHTATVACQTCHIPFFAKNEPTKMQWDWSTAGDDKPETVDQYGKHTYQKKKGNFVWEK
MVKPQYAWYNGTANAYMAGDKMDSNVVTKLTYPMGDINDAKAKIYPFKVHTGKQIYDKKL
NIFITPKTYGKGGYWSEFDWNLAAKLGMEANPTMLEKGIKYSGEYDFAATEMWWRINHMV
SPKEQALNCNDCHNKGTRLDWQALGYQGDPMKNKQGPKHKQ

# Drug_Target_24_Reaction:
Not Available

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
Not Available

# Drug_Target_24_SwissProt_ID:
Q8E9W8

# Drug_Target_24_SwissProt_Name:
Q8E9W8_SHEON

# Drug_Target_24_Synonyms:
Not Available

# Drug_Target_24_Theoretical_pI:
7.65

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Periplasm

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
Not Available

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
D31702

# Drug_Target_25_GenBank_ID_Protein:
Not Available

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
DvMF_2499

# Drug_Target_25_Gene_Sequence:
>393 bp
ATGAAAAAGATGTTCCTCACCGGTGTGCTCGCGCTGGCCGTTGCCATCGCCATGCCCGCC
CTTGCCGCCGCCCCGAAGGCCCCTGCCGACGGTCTGAAGATGGACAAGACCAAGCAGCCC
GTGGTCTTCAACCACTCGACCCACAAGGCCGTGAAGTGTGGCGACTGTCACCACCCGGTC
AACGGCAAGGAAGACTACCAGAAGTGCGCCACCGCCGGTTGCCACGACAACATGGACAAG
AAGGACAAGTCCGCCAAGGGCTACTACCACGCCATGCATGACAAGGGCACCAAGTTCAAG
AGCTGCGTGGGCTGCCACCTTGAAACCGCCGGCGCCGACGCCGCCAAGAAAAAGGAACTG
ACGGGCTGCAAGGGCTCCAAGTGCCATAGCTAG

# Drug_Target_25_General_Function:
Involved in iron ion binding

# Drug_Target_25_General_References:
1668723	Park JS, Kano K, Morimoto Y, Higuchi Y, Yasuoka N, Ogata M, Niki K, Akutsu H: 1H NMR studies on ferricytochrome c3 from Desulfovibrio vulgaris Miyazaki F and its interaction with ferredoxin I. J Biomol NMR. 1991 Sep;1(3):271-82.
6249799	Shinkai W, Hase T, Yagi T, Matsubara H: Amino acid sequence of cytochrome c3 from Desulfovibrio vulgaris, Miyazaki. J Biochem. 1980 Jun;87(6):1747-56.
6268619	Higuchi Y, Bando S, Kusunoki M, Matsuura Y, Yasuoka N, Kakudo M, Yamanaka T, Yagi T, Inokuchi H: The structure of cytochrome c3 from Desulfovibrio vulgaris Miyazaki at 2.5 A resolution. J Biochem. 1981 May;89(5):1659-62.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
4923

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
13843

# Drug_Target_25_Name:
Cytochrome c3

# Drug_Target_25_Number_of_Residues:
130

# Drug_Target_25_PDB_ID:
1J0O

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_25_Protein_Sequence:
>Cytochrome c3
MKKMFLTGVLALAVAIAMPALAAAPKAPADGLKMDKTKQPVVFNHSTHKAVKCGDCHHPV
NGKEDYQKCATAGCHDNMDKKDKSAKGYYHAMHDKGTKFKSCVGCHLETAGADAAKKKEL
TGCKGSKCHS

# Drug_Target_25_Reaction:
Not Available

# Drug_Target_25_Signals:
1-23

# Drug_Target_25_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_25_SwissProt_ID:
P00132

# Drug_Target_25_SwissProt_Name:
CYC3_DESVM

# Drug_Target_25_Synonyms:
Cytochrome c3 precursor

# Drug_Target_25_Theoretical_pI:
9.54

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Periplasm

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
Not Available

# Drug_Target_26_GenBank_ID_Gene:
AJ132010

# Drug_Target_26_GenBank_ID_Protein:
4539587

# Drug_Target_26_GeneCard_ID:
Not Available

# Drug_Target_26_Gene_Name:
fccA

# Drug_Target_26_Gene_Sequence:
>1683 bp
AACCAAGAATGTGATAGCTGCCATACACCAGATGGTGAACTGTCAAATGACAGCTTAACT
TATGAAAATACACAATGTGTATCTTGCCATGGCACACTAGAGGAAGTCGCTGAAACGACA
AAACATGAACACTATAATGCTCATGCTTCTCATTTCCCTGGCGAAGTAGCTTGTACCTCA
TGCCACAGCGCACACGAAAAATCGATGGTGTATTGTGACTCTTGCCATAGCTTCGATTTC
AACATGCCTTATGCTAAAAAATGGCAACGTGACGAGCCTACTATTGCTGAACTGGCCAAA
GATAAATCAGAACGTCAGGCTGCTCTTGCTAGCGCACCTCACGATACTGTTGACGTAGTG
GTTGTCGGTTCTGGCGGCGCAGGTTTCTCAGCAGCAATATCTGCAACAGACAGTGGTGCT
AAAGTCATTCTTATTGAAAAAGAGCCTGTTATTGGTGGTAATGCTAAGTTAGCTGCGGGT
GGCATGAACGCTGCTTGGACTGATCAACAAAAAGCCAAAAAAATTACTGACAGCCCAGAG
TTAATGTTCGAAGACACCATGAAAGGTGGCCAAAACATAAATGATCCTGCATTAGTTAAA
GTATTAAGCTCACACTCTAAAGACTCTGTTGATTGGATGACCGCTATGGGTGCCGATTTA
ACTGATGTTGGCATGATGGGTGGCGCATCTGTTAATCGTGCGCATCGTCCAACCGGTGGT
GCTGGTGTAGGTGCTCATGTTGTTCAAGTACTTTATGATAATGCAGTGAAACGCAATATC
GACTTACGCATGAACACTCGCGGCATTGAAGTGCTTAAAGATGATAAAGGCACTGTTAAA
GGTATTCTGGTTAAGGGTATGTATAAAGGTTACTACTGGGTGAAAGCCGATGCGGTAATC
TTAGCAACGGGTGGTTTCGCTAAAAATAACGAGCGTGTCGCTAAGCTTGATCCTTCACTA
AAAGGCTTTATCTCTACTAACCAACCTGGTGCAGTAGGTGATGGACTGGATGTAGCGGAA
AATGCGGGCGGCGCATTGAAAGACATGCAGTATATCCAAGCTCACCCAACACTATCTGTT
AAAGGTGGCGTAATGGTCACTGAAGCGGTTCGTGGTAATGGTGCGATTTTGGTTAACCGT
GAAGGTAAGCGTTTCGTTAACGAAATTACTACTCGTGATAAAGCATCTGCCGCTATCTTA
GCGCAAACCGGTAAATCAGCTTATTTGATTTTTGATGATTCTGTGCGTAAGTCACTGTCA
AAAATTGATAAGTATATTGGTTTAGGTGTTGCACCAACCGCAGATAGCCTAGTTAAATTA
GGTAAAATGGAAGGTATTGACGGCAAAGCATTGACTGAAACTGTCGCGCGTTACAACAGC
TTAGTGAGTAGCGGTAAAGACACTGATTTTGAGCGTCCAAACCTACCGCGCGCACTTAAC
GAAGGTAACTACTATGCAATTGAAGTTACACCTGGTGTTCACCACACTATGGGTGGCGTG
ATGATCGACACTAAAGCTGAAGTCATGAATGCTAAGAAGCAGGTTATCCCTGGCTTGTAT
GGTGCTGGTGAGGTTACTGGCGGTGTTCATGGTGCTAACCGCTTAGGTGGTAATGCTATT
TCAGACATCATCACCTTCGGTCGCTTAGCGGGTGAAGAAGCTGCAAAATATTCTAAAAAG
AAC

# Drug_Target_26_General_Function:
Energy production and conversion

# Drug_Target_26_General_References:
10479620	Pealing SL, Lysek DA, Taylor P, Alexeev D, Reid GA, Chapman SK, Walkinshaw MD: Crystallization and preliminary X-ray analysis of flavocytochrome c(3), the fumarate reductase from Shewanella frigidimarina. J Struct Biol. 1999 Aug;127(1):76-8.
12093271	Pankhurst KL, Mowat CG, Miles CS, Leys D, Walkinshaw MD, Reid GA, Chapman SK: Role of His505 in the soluble fumarate reductase from Shewanella frigidimarina. Biochemistry. 2002 Jul 9;41(27):8551-6.
12356299	Mowat CG, Pankhurst KL, Miles CS, Leys D, Walkinshaw MD, Reid GA, Chapman SK: Engineering water to act as an active site acid catalyst in a soluble fumarate reductase. Biochemistry. 2002 Oct 8;41(40):11990-6.

# Drug_Target_26_HGNC_ID:
Not Available

# Drug_Target_26_HPRD_ID:
Not Available

# Drug_Target_26_ID:
3673

# Drug_Target_26_Locus:
Not Available

# Drug_Target_26_Molecular_Weight:
60622

# Drug_Target_26_Name:
Fumarate reductase flavoprotein subunit

# Drug_Target_26_Number_of_Residues:
571

# Drug_Target_26_PDB_ID:
1QJD

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
PF00890	FAD_binding_2

# Drug_Target_26_Protein_Sequence:
>Fumarate reductase flavoprotein subunit
ADNLAEFHVQNQECDSCHTPDGELSNDSLTYENTQCVSCHGTLEEVAETTKHEHYNAHAS
HFPGEVACTSCHSAHEKSMVYCDSCHSFDFNMPYAKKWQRDEPTIAELAKDKSERQAALA
SAPHDTVDVVVVGSGGAGFSAAISATDSGAKVILIEKEPVIGGNAKLAAGGMNAAWTDQQ
KAKKITDSPELMFEDTMKGGQNINDPALVKVLSSHSKDSVDWMTAMGADLTDVGMMGGAS
VNRAHRPTGGAGVGAHVVQVLYDNAVKRNIDLRMNTRGIEVLKDDKGTVKGILVKGMYKG
YYWVKADAVILATGGFAKNNERVAKLDPSLKGFISTNQPGAVGDGLDVAENAGGALKDMQ
YIQAHPTLSVKGGVMVTEAVRGNGAILVNREGKRFVNEITTRDKASAAILAQTGKSAYLI
FDDSVRKSLSKIDKYIGLGVAPTADSLVKLGKMEGIDGKALTETVARYNSLVSSGKDTDF
ERPNLPRALNEGNYYAIEVTPGVHHTMGGVMIDTKAEVMNAKKQVIPGLYGAGEVTGGVH
GANRLGGNAISDIITFGRLAGEEAAKYSKKN

# Drug_Target_26_Reaction:
succinate + acceptor = fumarate + reduced acceptor

# Drug_Target_26_Signals:
None

# Drug_Target_26_Specific_Function:
Catalyzes fumarate reduction using artificial electron donors such as methyl viologen. The physiological reductant is unknown, but evidence indicates that flavocytochrome c participates in electron transfer from formate to fumarate and possibly also to trimethylamine oxide (TMAO). This enzyme is essentially unidirectional

# Drug_Target_26_SwissProt_ID:
P0C278

# Drug_Target_26_SwissProt_Name:
FRDA_SHEFR

# Drug_Target_26_Synonyms:
EC 1.3.99.1
Fcc3
Flavocytochrome c
Flavocytochrome c3

# Drug_Target_26_Theoretical_pI:
6.51

# Drug_Target_26_Transmembrane_Regions:
None

# Drug_Target_27_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
Not Available

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
CYP2C8

# Drug_Target_27_GenBank_ID_Gene:
M17397

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
CYP2C8

# Drug_Target_27_Gene_Sequence:
>1473 bp
ATGGAACCTTTTGTGGTCCTGGTGCTGTGTCTCTCTTTTATGCTTCTCTTTTCACTCTGG
AGACAGAGCTGTAGGAGAAGGAAGCTCCCTCCTGGCCCCACTCCTCTTCCTATTATTGGA
AATATGCTACAGATAGATGTTAAGGACATCTGCAAATCTTTCACCAATTTCTCAAAAGTC
TATGGTCCTGTGTTCACCGTGTATTTTGGCATGAATCCCATAGTGGTGTTTCATGGATAT
GAGGCAGTGAAGGAAGCCCTGATTGATAATGGAGAGGAGTTTTCTGGAAGAGGCAATTCC
CCAATATCTCAAAGAATTACTAAAGGACTTGGAATCATTTCCAGCAATGGAAAGAGATGG
AAGGAGATCCGGCGTTTCTCCCTCACAAACTTGCGGAATTTTGGGATGGGGAAGAGGAGC
ATTGAGGACCGTGTTCAAGAGGAAGCTCACTGCCTTGTGGAGGAGTTGAGAAAAACCAAG
GCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC
GTTGTTTTCCAGAAACGATTTGATTATAAAGATCAGAATTTTCTCACCCTGATGAAAAGA
TTCAATGAAAACTTCAGGATTCTGAACTCCCCATGGATCCAGGTCTGCAATAATTTCCCT
CTACTCATTGATTGTTTCCCAGGAACTCACAACAAAGTGCTTAAAAATGTTGCTCTTACA
CGAAGTTACATTAGGGAGAAAGTAAAAGAACACCAAGCATCACTGGATGTTAACAATCCT
CGGGACTTTATGGATTGCTTCCTGATCAAAATGGAGCAGGAAAAGGACAACCAAAAGTCA
GAATTCAATATTGAAAACTTGGTTGGCACTGTAGCTGATCTATTTGTTGCTGGAACAGAG
ACAACAAGCACCACTCTGAGATATGGACTCCTGCTCCTGCTGAAGCACCCAGAGGTCACA
GCTAAAGTCCAGGAAGAGATTGATCATGTAATTGGCAGACACAGGAGCCCCTGCATGCAG
GATAGGAGCCACATGCCTTACACTGATGCTGTAGTGCACGAGATCCAGAGATACAGTGAC
CTTGTCCCCACCGGTGTGCCCCATGCAGTGACCACTGATACTAAGTTCAGAAACTACCTC
ATCCCCAAGGGCACAACCATAATGGCATTACTGACTTCCGTGCTACATGATGACAAAGAA
TTTCCTAATCCAAATATCTTTGACCCTGGCCACTTTCTAGATAAGAATGGCAACTTTAAG
AAAAGTGACTACTTCATGCCTTTCTCAGCAGGAAAACGAATTTGTGCAGGAGAAGGACTT
GCCCGCATGGAGCTATTTTTATTTCTAACCACAATTTTACAGAACTTTAACCTGAAATCT
GTTGATGATTTAAAGAACCTCAATACTACTGCAGTTACCAAAGGGATTGTTTCTCTGCCA
CCCTCATACCAGATCTGCTTCATCCCTGTCTGA

# Drug_Target_27_General_Function:
Involved in monooxygenase activity

# Drug_Target_27_General_References:
1707679	Ged C, Beaune P: Isolation of the human cytochrome P-450 IIC8 gene: multiple glucocorticoid responsive elements in the 5' region. Biochim Biophys Acta. 1991 Mar 26;1088(3):433-5.
2009263	Romkes M, Faletto MB, Blaisdell JA, Raucy JL, Goldstein JA: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry. 1991 Apr 2;30(13):3247-55.
2216732	Kolyada AY: Sequence of a human liver cytochrome P-450 cDNA clone. Nucleic Acids Res. 1990 Sep 25;18(18):5550.
2729895	Shephard EA, Phillips IR, Santisteban I, Palmer CN, Povey S: Cloning, expression and chromosomal localization of a member of the human cytochrome P450IIC gene sub-family. Ann Hum Genet. 1989 Jan;53(Pt 1):23-31.
3196692	Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40.
3500169	Okino ST, Quattrochi LC, Pendurthi UR, McBride OW, Tukey RH: Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing. J Biol Chem. 1987 Nov 25;262(33):16072-9.
3697070	Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4.
7574697	Zeldin DC, DuBois RN, Falck JR, Capdevila JH: Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys. 1995 Sep 10;322(1):76-86.

# Drug_Target_27_HGNC_ID:
HGNC:2622

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
4924

# Drug_Target_27_Locus:
10q23.33

# Drug_Target_27_Molecular_Weight:
55825

# Drug_Target_27_Name:
Cytochrome P450 2C8

# Drug_Target_27_Number_of_Residues:
490

# Drug_Target_27_PDB_ID:
1PQ2

# Drug_Target_27_Pathway:
Cyclophosphamide Pathway	SMP00447

# Drug_Target_27_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_27_Protein_Sequence:
>Cytochrome P450 2C8
MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKV
YGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRW
KEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICS
VVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALT
RSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTE
TTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSD
LVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFK
KSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLP
PSYQICFIPV

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti- cancer drug paclitaxel (taxol)

# Drug_Target_27_SwissProt_ID:
P10632

# Drug_Target_27_SwissProt_Name:
CP2C8_HUMAN

# Drug_Target_27_Synonyms:
CYPIIC8
EC 1.14.14.1
P450 IIC2
P450 MP- 12/MP-20
P450 form 1
S-mephenytoin 4-hydroxylase

# Drug_Target_27_Theoretical_pI:
8.62

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Peroxisome

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
CAT

# Drug_Target_28_GenBank_ID_Gene:
X04085

# Drug_Target_28_GenBank_ID_Protein:
1228085

# Drug_Target_28_GeneCard_ID:
CAT

# Drug_Target_28_Gene_Name:
CAT

# Drug_Target_28_Gene_Sequence:
>1584 bp
ATGGCTGACAGCCGGGATCCCGCCAGCGACCAGATGCAGCACTGGAAGGAGCAGCGGGCC
GCGCAGAAAGCTGATGTCCTGACCACTGGAGCTGGTAACCCAGTAGGAGACAAACTTAAT
GTTATTACAGTAGGGCCCCGTGGGCCCCTTCTTGTTCAGGATGTGGTTTTCACTGATGAA
ATGGCTCATTTTGACCGAGAGAGAATTCCTGAGAGAGTTGTGCATGCTAAAGGAGCAGGG
GCCTTTGGCTACTTTGAGGTCACACATGACATTACCAAATACTCCAAGGCAAAGGTATTT
GAGCATATTGGAAAGAAGACTCCCATCGCAGTTCGGTTCTCCACTGTTGCTGGAGAATCG
GGTTCAGCTGACACAGTTCGGGACCCTCGTGGGTTTGCAGTGAAATTTTACACAGAAGAT
GGTAACTGGGATCTCGTTGGAAATAACACCCCCATTTTCTTCATCAGGGATCCCATATTG
TTTCCATCTTTTATCCACAGCCAAAAGAGAAATCCTCAGACACATCTGAAGGATCCGGAC
ATGGTCTGGGACTTCTGGAGCCTACGTCCTGAGTCTCTGCATCAGGTTTCTTTCTTGTTC
AGTGATCGGGGGATTCCAGATGGACATCGCCACATGAATGGATATGGATCACATACTTTC
AAGCTGGTTAATGCAAATGGGGAGGCAGTTTATTGCAAATTCCATTATAAGACTGACCAG
GGCATCAAAAACCTTTCTGTTGAAGATGCGGCGAGACTTTCCCAGGAAGATCCTGACTAT
GGCATCCGGGATCTTTTTAACGCCATTGCCACAGGAAAGTACCCCTCCTGGACTTTTTAC
ATCCAGGTCATGACATTTAATCAGGCAGAAACTTTTCCATTTAATCCATTCGATCTCACC
AAGGTTTGGCCTCACAAGGACTACCCTCTCATCCCAGTTGGTAAACTGGTCTTAAACCGG
AATCCAGTTAATTACTTTGCTGAGGTTGAACAGATAGCCTTCGACCCAAGCAACATGCCA
CCTGGCATTGAGGCCAGTCCTGACAAAATGCTTCAGGGCCGCCTTTTTGCCTATCCTGAC
ACTCACCGCCATCGCCTGGGACCCAATTATCTTCATATACCTGTGAACTGTCCCTACCGT
GCTCGAGTGGCCAACTACCAGCGTGATGGCCCGATGTGCATGCAGGACAATCAGGGTGGT
GCTCCAAATTACTACCCCAACAGCTTTGGTGCTCCGGAACAACAGCCTTCTGCCCTGGAG
CACAGCATCCAATATTCTGGAGAAGTGCGGAGATTCAACACTGCCAATGATGATAACGTT
ACTCAGGTGCGGGCATTCTATGTGAACGTGCTGAATGAGGAACAGAGGAAACGTCTGTGT
GAGAACATTGCCGGCCACCTGAAGGATGCACAAATTTTCATCCAGAAGAAAGCGGTCAAG
AACTTCACTGAGGTCCACCCTGACTACGGGAGCCACATCCAGGCTCTTCTGGACAAGTAC
AATGCTGAGAAGCCTAAGAATGCGATTCACACCTTTGTGCAGTCCGGATCTCACTTGGCG
GCAAGGGAGAAGGCAAATCTGTGA

# Drug_Target_28_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_28_General_References:
10656833	Putnam CD, Arvai AS, Bourne Y, Tainer JA: Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. J Mol Biol. 2000 Feb 11;296(1):295-309.
10666617	Ko TP, Safo MK, Musayev FN, Di Salvo ML, Wang C, Wu SH, Abraham DJ: Structure of human erythrocyte catalase. Acta Crystallogr D Biol Crystallogr. 2000 Feb;56(Pt 2):241-5.
11134921	Safo MK, Musayev FN, Wu SH, Abraham DJ, Ko TP: Structure of tetragonal crystals of human erythrocyte catalase. Acta Crystallogr D Biol Crystallogr. 2001 Jan;57(Pt 1):1-7.
11728823	Jin LH, Bahn JH, Eum WS, Kwon HY, Jang SH, Han KH, Kang TC, Won MH, Kang JH, Cho SW, Park J, Choi SY: Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med. 2001 Dec 1;31(11):1509-19.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
3755525	Quan F, Korneluk RG, Tropak MB, Gravel RA: Isolation and characterization of the human catalase gene. Nucleic Acids Res. 1986 Jul 11;14(13):5321-35.
3755526	Bell GI, Najarian RC, Mullenbach GT, Hallewell RA: cDNA sequence coding for human kidney catalase. Nucleic Acids Res. 1986 Jul 11;14(13):5561-2.
6548744	Korneluk RG, Quan F, Lewis WH, Guise KS, Willard HF, Holmes MT, Gravel RA: Isolation of human fibroblast catalase cDNA clones. Sequence of clones derived from spliced and unspliced mRNA. J Biol Chem. 1984 Nov 25;259(22):13819-23.
8282800	Yoo JH, Erzurum SC, Hay JG, Lemarchand P, Crystal RG: Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest. 1994 Jan;93(1):297-302.

# Drug_Target_28_HGNC_ID:
HGNC:1516

# Drug_Target_28_HPRD_ID:
00282

# Drug_Target_28_ID:
2230

# Drug_Target_28_Locus:
11p13

# Drug_Target_28_Molecular_Weight:
59757

# Drug_Target_28_Name:
Catalase

# Drug_Target_28_Number_of_Residues:
527

# Drug_Target_28_PDB_ID:
1F4J

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_28_Protein_Sequence:
>Catalase
MADSRDPASDQMQHWKEQRAAQKADVLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDE
MAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFSTVAGES
GSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPD
MVWDFWSLRPESLHQVSFLFSDRGIPDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQ
GIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFNPFDLT
KVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPD
THRHRLGPNYLHIPVNCPYRARVANYQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALE
HSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQKKAVK
NFTEVHPDYGSHIQALLDKYNAEKPKNAIHTFVQSGSHLAAREKANL

# Drug_Target_28_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_28_Signals:
None

# Drug_Target_28_Specific_Function:
Occurs in almost all aerobically respiring organisms and serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_28_SwissProt_ID:
P04040

# Drug_Target_28_SwissProt_Name:
CATA_HUMAN

# Drug_Target_28_Synonyms:
EC 1.11.1.6

# Drug_Target_28_Theoretical_pI:
7.41

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Periplasm

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
Not Available

# Drug_Target_29_GenBank_ID_Gene:
S74736

# Drug_Target_29_GenBank_ID_Protein:
241593

# Drug_Target_29_GeneCard_ID:
Not Available

# Drug_Target_29_Gene_Name:
cybC

# Drug_Target_29_Gene_Sequence:
>387 bp
ATGCGTAAAAGCCTGTTAGCTATTCTTGCAGTCTCCTCGTTGGTATTCAGTTCTGCGTCG
TTTGCCGCTGATCTTGAAGACAATATGGAAACCCTCAACGACAATTTAAAAGTGATCGAA
AAAGCGGATAACGCGGCGCAAGTCAAAGACGCGTTAACGAAGATGCGCGCCGCAGCCCTG
GATGCGCAAAAAGCAACGCCGCCGAAGCTCGAAGATAAATCACCGGACAGCCCGGAAATG
AAAGATTTCCGCCACGGTTTCGACATTCTGGTCGGTCAGATTGACGACGCGCTGAAGCTG
GCAAATGAAGGTAAAGTAAAAGAAGCGCAGGCTGCTGCAGAGCAACTGAAAACGACCCGC
AACGCCTATCACCAGAAGTATCGTTAA

# Drug_Target_29_General_Function:
Energy production and conversion

# Drug_Target_29_General_References:
10393541	Arnesano F, Banci L, Bertini I, Faraone-Mennella J, Rosato A, Barker PD, Fersht AR: The solution structure of oxidized Escherichia coli cytochrome b562. Biochemistry. 1999 Jul 6;38(27):8657-70.
11669612	Assfalg M, Banci L, Bertini I, Ciofi-Baffoni S, Barker PD: (15)N backbone dynamics of ferricytochrome b(562): comparison with the reduced protein and the R98C variant. Biochemistry. 2001 Oct 30;40(43):12761-71.
11914078	Springs SL, Bass SE, Bowman G, Nodelman I, Schutt CE, McLendon GL: A multigeneration analysis of cytochrome b(562) redox variants: evolutionary strategies for modulating redox potential revealed using a library approach. Biochemistry. 2002 Apr 2;41(13):4321-8.
1761034	Nikkila H, Gennis RB, Sligar SG: Cloning and expression of the gene encoding the soluble cytochrome b562 of Escherichia coli. Eur J Biochem. 1991 Dec 5;202(2):309-13.
368073	Mathews FS, Bethge PH, Czerwinski EW: The structure of cytochrome b562 from Escherichia coli at 2.5 A resolution. J Biol Chem. 1979 Mar 10;254(5):1699-706.
4882876	Itagaki E, Hager LP: The amino acid sequence of cytochrome b562 of Escherichia coli. Biochem Biophys Res Commun. 1968 Sep 30;32(6):1013-9.
7031264	Lederer F, Glatigny A, Bethge PH, Bellamy HD, Matthew FS: Improvement of the 2.5 A resolution model of cytochrome b562 by redetermining the primary structure and using molecular graphics. J Mol Biol. 1981 Jun 5;148(4):427-48.
7610040	Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL, Blattner FR: Analysis of the Escherichia coli genome VI: DNA sequence of the region from 92.8 through 100 minutes. Nucleic Acids Res. 1995 Jun 25;23(12):2105-19.
7723042	Hamada K, Bethge PH, Mathews FS: Refined structure of cytochrome b562 from Escherichia coli at 1.4 A resolution. J Mol Biol. 1995 Apr 14;247(5):947-62.
8499452	Trower MK: PCR cloning, sequence analysis and expression of the cybC genes encoding soluble cytochrome b-562 from Escherichia coli B strain OP7 and K strain NM522. Biochim Biophys Acta. 1993 Jun 10;1143(1):109-11.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_29_HGNC_ID:
Not Available

# Drug_Target_29_HPRD_ID:
Not Available

# Drug_Target_29_ID:
3670

# Drug_Target_29_Locus:
Not Available

# Drug_Target_29_Molecular_Weight:
14061

# Drug_Target_29_Name:
Soluble cytochrome b562 precursor

# Drug_Target_29_Number_of_Residues:
128

# Drug_Target_29_PDB_ID:
1QPU

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF07361	Cytochrom_B562

# Drug_Target_29_Protein_Sequence:
>Soluble cytochrome b562 precursor
MRKSLLAILAVSSLVFSSASFAADLEDNMETLNDNLKVIEKADNAAQVKDALTKMRAAAL
DAQKATPPKLEDKSPDSPEMKDFRHGFDILVGQIDDALKLANEGKVKEAQAAAEQLKTTR
NAYHQKYR

# Drug_Target_29_Reaction:
Not Available

# Drug_Target_29_Signals:
1-22

# Drug_Target_29_Specific_Function:
Electron-transport protein of unknown function

# Drug_Target_29_SwissProt_ID:
P0ABE7

# Drug_Target_29_SwissProt_Name:
C562_ECOLX

# Drug_Target_29_Synonyms:
Cytochrome b-562

# Drug_Target_29_Theoretical_pI:
6.54

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Z99110

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
yjbI

# Drug_Target_2_Gene_Sequence:
>399 bp
TCAAGATGATCGATCCTCCGCTTCCGTTTGATTCACCATATGCCTTGCTGTCAACTCCAG
CCGGCCAAACAAAAACTCACGAATTTCGCCCTCCAGCCCTACATGGTCCATTGCGTCCTT
CATACAGCTGAGCCACGCATCAGCTCTCTCGTTTGTAATTGGAAAGGGAAGATGCCTTGC
TCTGAGCATAGGATGGCCGTGTTCCTCAGTATAAAGAGGAGGCCCGCCTAAATACTGAGT
TAAGAATTGCTTCTGTTTCCTGGCGGTTTCTGTCAAATCGCTTGGAAAAATCGGCTTCAG
CAAAGGATGAGACGCGACACGCTCATAAAAAGTATCAACAAGTTGCGATAGAAGTTCCTC
TCCAATCGCTTCATAAGGTGCGTTAAACGATTGTCCCAT

# Drug_Target_2_General_Function:
Involved in oxygen binding

# Drug_Target_2_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4998

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
15116

# Drug_Target_2_Name:
Hemoglobin-like protein yjbI

# Drug_Target_2_Number_of_Residues:
132

# Drug_Target_2_PDB_ID:
1UX8

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01152	Bac_globin

# Drug_Target_2_Protein_Sequence:
>Hemoglobin-like protein yjbI
MGQSFNAPYEAIGEELLSQLVDTFYERVASHPLLKPIFPSDLTETARKQKQFLTQYLGGP
PLYTEEHGHPMLRARHLPFPITNERADAWLSCMKDAMDHVGLEGEIREFLFGRLELTARH
MVNQTEAEDRSS

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Hemoglobin-like protein that exhibits a low peroxidase activity. Its very high oxygen affinity may rule out the possibility that it is involved in oxygen transport

# Drug_Target_2_SwissProt_ID:
O31607

# Drug_Target_2_SwissProt_Name:
TRHBO_BACSU

# Drug_Target_2_Synonyms:
Truncated BHb
trBHb

# Drug_Target_2_Theoretical_pI:
5.21

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Not Available

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
Not Available

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
CP000143

# Drug_Target_30_GenBank_ID_Protein:
Not Available

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
shp

# Drug_Target_30_Gene_Sequence:
>390 bp
TCATTGGGCCGCGAGCCAGGCCAGAAGATCGGCCTTCTCGCCCGGCGTGCAGTCGCGGCC
GATCACGCTGTTGCAGTTGCGGCCGAGCCATTTCTCGACCCTGGCGCTGTCGGTGAAGCG
GTCGGGCGTGGCCGAGGGCGCGAGCGGCGCGATCTCCTTGCCGGTGCGGGTCTGGCCCGC
CCGCGTCACGTCCGCACCGTGGCAGGTGGTGCAGGAGGGCGTGTCGGGCTTGCCGCCGGT
CTGGGTCGACAGGAAGAGCGCGCGGCCCCGTTCGGCATCGGCGGGCGCGCCGGCGGCGGC
CTCGTAGCCTGCGATGAGCTGCGCGGGGCTGGTGTCTCCGGCCAGTGCGGGACCGGCCAG
AACGGCCGAGAGGATGAGGAAACGGGTCAC

# Drug_Target_30_General_Function:
Involved in iron ion binding

# Drug_Target_30_General_References:
10821858	Leys D, Backers K, Meyer TE, Hagen WR, Cusanovich MA, Van Beeumen JJ: Crystal structures of an oxygen-binding cytochrome c from Rhodobacter sphaeroides. J Biol Chem. 2000 May 26;275(21):16050-6.
9558336	Klarskov K, Van Driessche G, Backers K, Dumortier C, Meyer TE, Tollin G, Cusanovich MA, Van Beeumen JJ: Ligand binding and covalent structure of an oxygen-binding heme protein from Rhodobacter sphaeroides, a representative of a new structural family of c-type cytochromes. Biochemistry. 1998 Apr 28;37(17):5995-6002.

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
4925

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
13283

# Drug_Target_30_Name:
Cytochrome c-type protein SHP

# Drug_Target_30_Number_of_Residues:
129

# Drug_Target_30_PDB_ID:
1DW3

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
PF09086	DUF1924

# Drug_Target_30_Protein_Sequence:
>Cytochrome c-type protein SHP
MTRFLILSAVLAGPALAGDTSPAQLIAGYEAAAGAPADAERGRALFLSTQTGGKPDTPSC
TTCHGADVTRAGQTRTGKEIAPLAPSATPDRFTDSARVEKWLGRNCNSVIGRDCTPGEKA
DLLAWLAAQ

# Drug_Target_30_Reaction:
Not Available

# Drug_Target_30_Signals:
1-17

# Drug_Target_30_Specific_Function:
High-spin cytochrome. Transiently bind oxygen during autoxidation, which occurs with a half-life of 3 min with a 4-fold excess of O(2). Also binds carbon monoxide, azide and cyanide

# Drug_Target_30_SwissProt_ID:
P81238

# Drug_Target_30_SwissProt_Name:
SHP_RHOS4

# Drug_Target_30_Synonyms:
Cytochrome c-type protein SHP precursor
Oxygen-binding heme protein
Sphaeroides heme protein

# Drug_Target_30_Theoretical_pI:
7.13

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Microsome

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
HMOX1

# Drug_Target_31_GenBank_ID_Gene:
X06985

# Drug_Target_31_GenBank_ID_Protein:
35173

# Drug_Target_31_GeneCard_ID:
HMOX1

# Drug_Target_31_Gene_Name:
HMOX1

# Drug_Target_31_Gene_Sequence:
>867 bp
ATGGAGCGTCCGCAACCCGACAGCATGCCCCAGGATTTGTCAGAGGCCCTGAAGGAGGCC
ACCAAGGAGGTGCACACCCAGGCAGAGAATGCTGAGTTCATGAGGAACTTTCAGAAGGGC
CAGGTGACCCGAGACGGCTTCAAGCTGGTGATGGCCTCCCTGTACCACATCTATGTGGCC
CTGGAGGAGGAGATTGAGCGCAACAAGGAGAGCCCAGTCTTCGCCCCTGTCTACTTCCCA
GAAGAGCTGCACCGCAAGGCTGCCCTGGAGCAGGACCTGGCCTTCTGGTACGGGCCCCGC
TGGCAGGAGGTCATCCCCTACACACCAGCCATGCAGCGCTATGTGAAGCGGCTCCACGAG
GTGGGGCGCACAGAGCCCGAGCTGCTGGTGGCCCACGCCTACACCCGCTACCTGGGTGAC
CTGTCTGGGGGCCAGGTGCTCAAAAAGATTGCCCAGAAAGCCCTGGACCTGCCCAGCTCT
GGCGAGGGCCTGGCCTTCTTCACCTTCCCCAACATTGCCAGTGCCACCAAGTTCAAGCAG
CTCTACCGCTCCCGCATGAACTCCCTGGAGATGACTCCCGCAGTCAGGCAGAGGGTGATA
GAAGAGGCCAAGACTGCGTTCCTGCTCAACATCCAGCTCTTTGAGGAGTTGCAGGAGCTG
CTGACCCATGACACCAAGGACCAGAGCCCCTCACGGGCACCAGGGCTTCGCCAGCGGGCC
AGCAACAAAGTGCAAGATTCTGCCCCCGTGGAGACTCCCAGAGGGAAGCCCCCACTCAAC
ACCCGCTCCCAGGCTCCGCTTCTCCGATGGGTCCTTACACTCAGCTTTCTGGTGGCGACA
GTTGCTGTAGGGCTTTATGCCATGTGA

# Drug_Target_31_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_31_General_References:
10467099	Schuller DJ, Wilks A, Ortiz de Montellano PR, Poulos TL: Crystal structure of human heme oxygenase-1. Nat Struct Biol. 1999 Sep;6(9):860-7.
10591208	Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95.
2537723	Shibahara S, Sato M, Muller RM, Yoshida T: Structural organization of the human heme oxygenase gene and the function of its promoter. Eur J Biochem. 1989 Feb 15;179(3):557-63.
2911585	Keyse SM, Tyrrell RM: Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A. 1989 Jan;86(1):99-103.
3345742	Yoshida T, Biro P, Cohen T, Muller RM, Shibahara S: Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem. 1988 Feb 1;171(3):457-61.

# Drug_Target_31_HGNC_ID:
HGNC:5013

# Drug_Target_31_HPRD_ID:
00782

# Drug_Target_31_ID:
810

# Drug_Target_31_Locus:
22q12|22q13.1

# Drug_Target_31_Molecular_Weight:
32819

# Drug_Target_31_Name:
Heme oxygenase 1

# Drug_Target_31_Number_of_Residues:
288

# Drug_Target_31_PDB_ID:
1T5P

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_31_Protein_Sequence:
>Heme oxygenase 1
MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVA
LEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKRLHE
VGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATKFKQ
LYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRAPGLRQRA
SNKVQDSAPVETPRGKPPLNTRSQAPLLRWVLTLSFLVATVAVGLYAM

# Drug_Target_31_Reaction:
heme + 3 AH2 + 3 O2 = biliverdin + Fe2+ + CO + 3 A + 3 H2O

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliverdin. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Under physiological conditions, the activity of heme oxygenase is highest in the spleen, where senescent erythrocytes are sequestrated and destroyed

# Drug_Target_31_SwissProt_ID:
P09601

# Drug_Target_31_SwissProt_Name:
HMOX1_HUMAN

# Drug_Target_31_Synonyms:
EC 1.14.99.3
HO-1

# Drug_Target_31_Theoretical_pI:
8.68

# Drug_Target_31_Transmembrane_Regions:
265-287

# Drug_Target_32_Cellular_Location:
Not Available

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
Not Available

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
Y14084

# Drug_Target_32_GenBank_ID_Protein:
Not Available

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
hemAT

# Drug_Target_32_Gene_Sequence:
>1299 bp
TTATTCTTCTGTCAGGATGACAAGCGAATCAACGGAAGCGGCCACATGGGAAACGGCGCG
GCTGACTTCCTGAAGCCCTCCAAGAAAGGCTTGCAGATCGACGTCGATTTTGCCTGATTG
CTCTTTGCTGATTTTCATGCTGTGGACGATTTCATCGAATAAGCGGTTAATTTGCGTCAT
TTTTTCTTTACTTTCGCTGACTAGCTCATTCACGTCTTTGATATGCTTGGATACAATGTT
GATTTGTGTATTCGTATTGTTCACAAGCTCAGAAACAGTAGAGACGGTTTTTTTCGTATC
CTCAGAAAGCTTCCGCACTTCATTTGCCACGACAGCAAAGCCTTTGCCGTGTTCTCCGGC
GCGGGCGGATTCAATAGATGCATTGAGCGAGAGAAGGTTTGTTTGTTCAGCTATGCCTGT
GACGATGCCGAAGATTTTTTCAATTTGCTGCGCGATTTCATCCAGCTTGACCATTTCTTT
TTCGATTTGGACAAGGCTTGTGTCAATTTTGTTCATCTGTTTTTGCTGGACTTCTAGCTC
TTTTTTTCCGCCGATCGACTTTTCTTCAACAGTGCTGGATGTTACAGTGCCGGCTTTGGA
TGCTTGAGAAATGCCTTCAGATTTGTCCACAAGCTCTTGAACTGATCTGCTTGTTTCTGA
AAACAGATTGGCAATCGATCCAGAGGTTTCTTGAATTTTCTGATGAAGAAGGTTTTTCTT
TTCTTCTTGTTCATCACGGGTCTGGTTGTACTCGCTTTGAAACGCTTCAAGGACAAGCTG
CTGTTCTAAGTTCAAGATTTTTGTTGTTGCTTTAATGGCTTTTAGCAGTTCTTGCTGATT
TGTAATGGACGCTTCATAAATGTCAATCATTGACAAAAGGAGCTCTTGAAACGCACCCAT
ATACCATTTTGGCAAAAGGCCGATTCTTAAATGGATGGAGGCGATTCGGTTACGCTTTTC
AATAAATTCATCATCGATAACGCCTGCAAACATTTCCTGAATATGCCGTTTTAACGTTTG
TTTTAAGCGGTCAACTGAGCTGTGATCATTAATGATATCCATCAATGAGCTTTCATGGTC
AAGGTTTTTATAAAACGCATCGACGATATTTACGATATTTTCTTGAATGAGTGGCTGAAG
CTGCTCTAACACATAAAGCTCAGCATCTCCCAACCTGACCATTTTGAGCTGTTTTTTGAC
ATCTGCATGTTTGTTTGTGAGCTGAATGCGGTTTTTTTGTTGTCCGTTTGAATCTGAAAA
GTAAGCTGTTTCTTGTTTTCTGTCTTTTTTAAATAACAA

# Drug_Target_32_General_Function:
Involved in signal transducer activity

# Drug_Target_32_General_References:
10676961	Hou S, Larsen RW, Boudko D, Riley CW, Karatan E, Zimmer M, Ordal GW, Alam M: Myoglobin-like aerotaxis transducers in Archaea and Bacteria. Nature. 2000 Feb 3;403(6769):540-4.
11821422	Aono S, Kato T, Matsuki M, Nakajima H, Ohta T, Uchida T, Kitagawa T: Resonance Raman and ligand binding studies of the oxygen-sensing signal transducer protein HemAT from Bacillus subtilis. J Biol Chem. 2002 Apr 19;277(16):13528-38. Epub 2002 Jan 30.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9579061	Noback MA, Holsappel S, Kiewiet R, Terpstra P, Wambutt R, Wedler H, Venema G, Bron S: The 172 kb prkA-addAB region from 83 degrees to 97 degrees of the Bacillus subtilis chromosome contains several dysfunctional genes, the glyB marker, many genes encoding transporter proteins, and the ubiquitous hit gene. Microbiology. 1998 Apr;144 ( Pt 4):859-75.

# Drug_Target_32_HGNC_ID:
Not Available

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
4926

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
48768

# Drug_Target_32_Name:
Heme-based aerotactic transducer hemAT

# Drug_Target_32_Number_of_Residues:
432

# Drug_Target_32_PDB_ID:
1OR6

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
PF00015	MCPsignal

# Drug_Target_32_Protein_Sequence:
>Heme-based aerotactic transducer hemAT
MLFKKDRKQETAYFSDSNGQQKNRIQLTNKHADVKKQLKMVRLGDAELYVLEQLQPLIQE
NIVNIVDAFYKNLDHESSLMDIINDHSSVDRLKQTLKRHIQEMFAGVIDDEFIEKRNRIA
SIHLRIGLLPKWYMGAFQELLLSMIDIYEASITNQQELLKAIKATTKILNLEQQLVLEAF
QSEYNQTRDEQEEKKNLLHQKIQETSGSIANLFSETSRSVQELVDKSEGISQASKAGTVT
SSTVEEKSIGGKKELEVQQKQMNKIDTSLVQIEKEMVKLDEIAQQIEKIFGIVTGIAEQT
NLLSLNASIESARAGEHGKGFAVVANEVRKLSEDTKKTVSTVSELVNNTNTQINIVSKHI
KDVNELVSESKEKMTQINRLFDEIVHSMKISKEQSGKIDVDLQAFLGGLQEVSRAVSHVA
ASVDSLVILTEE

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
None

# Drug_Target_32_Specific_Function:
Heme-containing signal transducer responsible for aerotaxis, the migratory response toward or away from oxygen

# Drug_Target_32_SwissProt_ID:
O07621

# Drug_Target_32_SwissProt_Name:
HEMAT_BACSU

# Drug_Target_32_Synonyms:
Not Available

# Drug_Target_32_Theoretical_pI:
5.54

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Periplasm

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
Not Available

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
Not Available

# Drug_Target_33_GenBank_ID_Protein:
Not Available

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
nrfA

# Drug_Target_33_Gene_Sequence:
Not Available

# Drug_Target_33_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_33_General_References:
10440380	Einsle O, Messerschmidt A, Stach P, Bourenkov GP, Bartunik HD, Huber R, Kroneck PM: Structure of cytochrome c nitrite reductase. Nature. 1999 Jul 29;400(6743):476-80.
7999130	Schumacher W, Hole U, Kroneck PM: Ammonia-forming cytochrome c nitrite reductase from Sulfurospirillum deleyianum is a tetraheme protein: new aspects of the molecular composition and spectroscopic properties. Biochem Biophys Res Commun. 1994 Nov 30;205(1):911-6.

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
4927

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
57612

# Drug_Target_33_Name:
Cytochrome c-552

# Drug_Target_33_Number_of_Residues:
514

# Drug_Target_33_PDB_ID:
1QDB

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF02335	Cytochrom_C552

# Drug_Target_33_Protein_Sequence:
>Cytochrome c-552
MKFKLLLAGSLVAVGAMALLASNINEKEKQRVELAKAPSEAGIAGKEKSEEWAKYYPRQF
DSWKKTKEYDSFTDMLAKDPALVIAWSGYAFSKDYNSPRGHYYALQDNVNSLRTGAPVDA
KTGPLPTACWTCKSPDVPRLIEEDGELEYFTGKWAKYGSQIVNVIGCANCHDDKTAELKV
RVPHLNRGLQAAGLKTFEESTHQDKRTLVCAQCHVEYYFKKTEWKDAKGADKTAMVVTLP
WANGVGKDGNAGVEGMIKYYDEINFSDWTHNISKTPMLKAQHPGFEFWKSGIHGQKGVSC
ADCHMPYTQEGSVKYSDHQVKENPLDSMDQSCMNCHRESESKLRGIVHQKYERKEFLNKV
AFDNIGKAHLETGKAIEAGASDEELKEVRKLIRHGQFKADMAIAAHGNYFHAPEETLRLL
AAGSDDAQKARLLLVKILAKHGVMDYIAPDFDTKDKAQKLAKVDIAALAAEKMKFKQTLE
QEWKKEAKAKGRANPELYKDVDTINDGKSSWNKK

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
1-21

# Drug_Target_33_Specific_Function:
Plays a role in nitrite reduction

# Drug_Target_33_SwissProt_ID:
Q9Z4P4

# Drug_Target_33_SwissProt_Name:
NRFA_SULDE

# Drug_Target_33_Synonyms:
Ammonia-forming cytochrome c nitrite reductase
Cytochrome c nitrite reductase
Cytochrome c-552 precursor
EC 1.7.2.2

# Drug_Target_33_Theoretical_pI:
8.37

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Cytoplasm

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
CBS

# Drug_Target_34_GenBank_ID_Gene:
L19501

# Drug_Target_34_GenBank_ID_Protein:
388716

# Drug_Target_34_GeneCard_ID:
CBS

# Drug_Target_34_Gene_Name:
CBS

# Drug_Target_34_Gene_Sequence:
>1656 bp
ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGG
CCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAG
CCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCC
TCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATT
CTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGC
CTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGAC
CGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGAC
ACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTG
AGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTG
CTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCG
GAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTA
GACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATC
CTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACC
ATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTG
GATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACC
TACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTG
GACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCG
CAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCT
GCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAAC
TACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAG
GACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCA
GCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAG
AAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACG
CTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGC
AAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCG
CACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGC
ACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTG
AACTTCGTGGCCGCCCAGGAGCGGGACCAGAAGTGA

# Drug_Target_34_General_Function:
Amino acid transport and metabolism

# Drug_Target_34_General_References:
10338090	Kraus JP, Janosik M, Kozich V, Mandell R, Shih V, Sperandeo MP, Sebastio G, de Franchis R, Andria G, Kluijtmans LA, Blom H, Boers GH, Gordon RB, Kamoun P, Tsai MY, Kruger WD, Koch HG, Ohura T, Gaustadnes M: Cystathionine beta-synthase mutations in homocystinuria. Hum Mutat. 1999;13(5):362-75.
10408774	de Franchis R, Kraus E, Kozich V, Sebastio G, Kraus JP: Four novel mutations in the cystathionine beta-synthase gene: effect of a second linked mutation on the severity of the homocystinuric phenotype. Hum Mutat. 1999;13(6):453-7.
11483494	Meier M, Janosik M, Kery V, Kraus JP, Burkhard P: Structure of human cystathionine beta-synthase: a unique pyridoxal 5'-phosphate-dependent heme protein. EMBO J. 2001 Aug 1;20(15):3910-6.
12173932	Taoka S, Lepore BW, Kabil O, Ojha S, Ringe D, Banerjee R: Human cystathionine beta-synthase is a heme sensor protein. Evidence that the redox sensor is heme and not the vicinal cysteines in the CXXC motif seen in the crystal structure of the truncated enzyme. Biochemistry. 2002 Aug 20;41(33):10454-61.
1301198	Kozich V, Kraus JP: Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency. Hum Mutat. 1992;1(2):113-23.
681363	Kraus J, Packman S, Fowler B, Rosenberg LE: Purification and properties of cystathionine beta-synthase from human liver. Evidence for identical subunits. J Biol Chem. 1978 Sep 25;253(18):6523-8.
7506602	Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE: Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet. 1993 Nov;2(11):1857-60.
7564249	Sperandeo MP, Panico M, Pepe A, Candito M, de Franchis R, Kraus JP, Andria G, Sebastio G: Molecular analysis of patients affected by homocystinuria due to cystathionine beta-synthase deficiency: report of a new mutation in exon 8 and a deletion in intron 11. J Inherit Metab Dis. 1995;18(2):211-4.
7598711	Chasse JF, Paly E, Paris D, Paul V, Sinet PM, Kamoun P, London J: Genomic organization of the human cystathionine beta-synthase gene: evidence for various cDNAs. Biochem Biophys Res Commun. 1995 Jun 26;211(3):826-32.
7611293	Shih VE, Fringer JM, Mandell R, Kraus JP, Berry GT, Heidenreich RA, Korson MS, Levy HL, Ramesh V: A missense mutation (I278T) in the cystathionine beta-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet. 1995 Jul;57(1):34-9.
7635485	Kluijtmans LA, Blom HJ, Boers GH, van Oost BA, Trijbels FJ, van den Heuvel LP: Two novel missense mutations in the cystathionine beta-synthase gene in homocystinuric patients. Hum Genet. 1995 Aug;96(2):249-50.
7762555	Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G: The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet. 1995 Jun;56(6):1324-33.
7849717	Marble M, Geraghty MT, de Franchis R, Kraus JP, Valle D: Characterization of a cystathionine beta-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria. Hum Mol Genet. 1994 Oct;3(10):1883-6.
7903580	Kraus JP, Le K, Swaroop M, Ohura T, Tahara T, Rosenberg LE, Roper MD, Kozich V: Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells. Hum Mol Genet. 1993 Oct;2(10):1633-8.
7967489	Kraus JP: Komrower Lecture. Molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis. 1994;17(4):383-90.
7981678	de Franchis R, Kozich V, McInnes RR, Kraus JP: Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine beta-synthase using an improved bacterial expression system. Hum Mol Genet. 1994 Jul;3(7):1103-8.
8022826	Kruger WD, Cox DR: A yeast system for expression of human cystathionine beta-synthase: structural and functional conservation of the human and yeast genes. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6614-8.
8353501	Kozich V, de Franchis R, Kraus JP: Molecular defect in a patient with pyridoxine-responsive homocystinuria. Hum Mol Genet. 1993 Jun;2(6):815-6.
8528202	Kruger WD, Cox DR: A yeast assay for functional detection of mutations in the human cystathionine beta-synthase gene. Hum Mol Genet. 1995 Jul;4(7):1155-61.
8755636	Kluijtmans LA, Boers GH, Stevens EM, Renier WO, Kraus JP, Trijbels FJ, van den Heuvel LP, Blom HJ: Defective cystathionine beta-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest. 1996 Jul 15;98(2):285-9.
8803779	Sperandeo MP, Candito M, Sebastio G, Rolland MO, Turc-Carel C, Giudicelli H, Dellamonica P, Andria G: Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations. J Inherit Metab Dis. 1996;19(3):351-6.
8990018	Aral B, Coude M, London J, Aupetit J, Chasse JF, Zabot MT, Chadefaux-Vekemans B, Kamoun P: Two novel mutations (K384E and L539S) in the C-terminal moiety of the cystathionine beta-synthase protein in two French pyridoxine-responsive homocystinuria patients. Hum Mutat. 1997;9(1):81-2.
9156316	Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB: Characterisation of five missense mutations in the cystathionine beta-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet. 1997 Jan-Feb;5(1):15-21.
9266356	Kozich V, Janosik M, Sokolova J, Oliveriusova J, Orendac M, Kraus JP, Elleder D: Analysis of CBS alleles in Czech and Slovak patients with homocystinuria: report on three novel mutations E176K, W409X and 1223 + 37 del99. J Inherit Metab Dis. 1997 Jul;20(3):363-6.
9361025	Kim CE, Gallagher PM, Guttormsen AB, Refsum H, Ueland PM, Ose L, Folling I, Whitehead AS, Tsai MY, Kruger WD: Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet. 1997 Dec;6(13):2213-21.
9383285	Chasse JF, Paul V, Escanez R, Kamoun P, London J: Human cystathionine beta-synthase: gene organization and expression of different 5' alternative splicing. Mamm Genome. 1997 Dec;8(12):917-21.
9790750	Kraus JP, Oliveriusova J, Sokolova J, Kraus E, Vlcek C, de Franchis R, Maclean KN, Bao L, Bukovsk, Patterson D, Paces V, Ansorge W, Kozich V: The human cystathionine beta-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms. Genomics. 1998 Sep 15;52(3):312-24.

# Drug_Target_34_HGNC_ID:
HGNC:1550

# Drug_Target_34_HPRD_ID:
01994

# Drug_Target_34_ID:
358

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
60456

# Drug_Target_34_Name:
Cystathionine beta-synthase

# Drug_Target_34_Number_of_Residues:
550

# Drug_Target_34_PDB_ID:
1JBQ

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
PF00291	PALP
PF00571	CBS

# Drug_Target_34_Protein_Sequence:
>Cystathionine beta-synthase
PSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPAS
ESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDR
ISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVL
RALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEIL
QQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTY
EVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAA
QELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSA
PLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGK
VIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLN
FVAAQERDQK

# Drug_Target_34_Reaction:
L-serine + L-homocysteine = L-cystathionine + H2O

# Drug_Target_34_Signals:
None

# Drug_Target_34_Specific_Function:
Not Available

# Drug_Target_34_SwissProt_ID:
P35520

# Drug_Target_34_SwissProt_Name:
CBS_HUMAN

# Drug_Target_34_Synonyms:
Beta- thionase
EC 4.2.1.22
Serine sulfhydrase

# Drug_Target_34_Theoretical_pI:
6.63

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Not Available

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
Not Available

# Drug_Target_35_GenBank_ID_Gene:
D86417

# Drug_Target_35_GenBank_ID_Protein:
2443234

# Drug_Target_35_GeneCard_ID:
Not Available

# Drug_Target_35_Gene_Name:
nos

# Drug_Target_35_Gene_Sequence:
>1011 bp
TTACTCATAAGGCTTATCTTGATAAAAATAGTTCGGCTTAACGATTGAGTTATCATAGGA
GCGGTGGAAGATATGAGTGGCAGCGGGTGAAATTGGCGGAATCAGCCACGTCCAGTCCCC
CGTCAGCTTTCTGCCCGCTTCTTCCTCCTGTTCTTCAAACCGTTTAAACTGGCTTGCCGC
TGTATGATGGTCAACGATGCTGACACCCTGCTTTTTATACGAGTGCAGCACAGCTTTATT
CAATTCAACTAGCGCTTGATCCTTCCATAAATCCGTATTGTAATCAGCGGCGATGCCGAT
CACGGACGCTACTTTTTTGAGCTTGTCGTACCGCTTTTCATCTGCGAGGTTTCTCGCTCC
GATCTCCGTGCCCATATACCAGCCGTTAAATGGCGCGGCATTATAATGAATGCCCCCGAC
CTCAAGCTTCATATCAGAAATAATAGGCACGCCGTACCACTTCAGCTCCAAATCAGAAAA
CGCCTCGATGTCCGGATGTGTGATTGGAACCTCAATCACAAGTGAACGCGGCAGCTCATA
CCAGACAGGCTGCTCGTCCCCTTTCATGCGAAAAATGAGCGGCAGCAGGTCAAAATCCGT
TCGCTCTCCGCGCCAGCCGAGCTCTTCGCAGGCTGCTGTCAGGGAACAGGAAGCCGGGTC
GCCGATTCTTTCTCCGTCTGACTCATATCCAGCGTACCGGATCAGCTGATGATTCCAGAT
CTCGACTTGCTTTTCACCCTTCTCTTCCGGAGGGAAAATCGTAATGGTCGGTCTGATTTT
CCCGTTATTGGTGGCGGTTTCAATATGGTGAAAGAGGGCATCACGCACTTCCTCCTTCGT
CCGGACGTCTCGTCTGTCGATAACATTCAGCGAATTCCAGAACAATCTGCCGATGCAGCG
GTTGCTGTTTCTCCAAGCCATTTTCGCTCCGTGCTCCAGCTCTTCCTTCGTATGTACATA
GCTTCCGGTCAGGTCAATTTCACTTTTAATGTCCGCGAGACGGTCTTTCAC

# Drug_Target_35_General_Function:
Involved in nitric-oxide synthase activity

# Drug_Target_35_General_References:
11856757	Adak S, Aulak KS, Stuehr DJ: Direct evidence for nitric oxide production by a nitric-oxide synthase-like protein from Bacillus subtilis. J Biol Chem. 2002 May 3;277(18):16167-71. Epub 2002 Feb 20.
12220171	Pant K, Bilwes AM, Adak S, Stuehr DJ, Crane BR: Structure of a nitric oxide synthase heme protein from Bacillus subtilis. Biochemistry. 2002 Sep 17;41(37):11071-9.
9272861	Yamamoto H, Uchiyama S, Nugroho FA, Sekiguchi J: Cloning and sequencing of a 35.7 kb in the 70 degree-73 degree region of the Bacillus subtilis genome reveal genes for a new two-component system, three spore germination proteins, an iron uptake system and a general stress response protein. Gene. 1997 Jul 31;194(2):191-9.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_35_HGNC_ID:
Not Available

# Drug_Target_35_HPRD_ID:
Not Available

# Drug_Target_35_ID:
2617

# Drug_Target_35_Locus:
Not Available

# Drug_Target_35_Molecular_Weight:
38751

# Drug_Target_35_Name:
Nitric oxide synthase oxygenase

# Drug_Target_35_Number_of_Residues:
336

# Drug_Target_35_PDB_ID:
1M7V

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
PF02898	NO_synthase

# Drug_Target_35_Protein_Sequence:
>Nitric oxide synthase oxygenase
MKDRLADIKSEIDLTGSYVHTKEELEHGAKMAWRNSNRCIGRLFWNSLNVIDRRDVRTKE
EVRDALFHHIETATNNGKIRPTITIFPPEEKGEKQVEIWNHQLIRYAGYESDGERIGDPA
SCSLTAACEELGWRGERTDFDLLPLIFRMKGDEQPVWYELPRSLVIEVPITHPDIEAFSD
LELKWYGVPIISDMKLEVGGIHYNAAPFNGWYMGTEIGARNLADEKRYDKLKKVASVIGI
AADYNTDLWKDQALVELNKAVLHSYKKQGVSIVDHHTAASQFKRFEEQEEEAGRKLTGDW
TWLIPPISPAATHIFHRSYDNSIVKPNYFYQDKPYE

# Drug_Target_35_Reaction:
Not Available

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
Catalyzes the production of nitric oxide

# Drug_Target_35_SwissProt_ID:
O34453

# Drug_Target_35_SwissProt_Name:
NOSO_BACSU

# Drug_Target_35_Synonyms:
EC 1.-.-.-
NOSoxy-like protein

# Drug_Target_35_Theoretical_pI:
5.78

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Not Available

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
Not Available

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
Not Available

# Drug_Target_36_GenBank_ID_Gene:
AF210843

# Drug_Target_36_GenBank_ID_Protein:
Not Available

# Drug_Target_36_GeneCard_ID:
Not Available

# Drug_Target_36_Gene_Name:
CYP167A1

# Drug_Target_36_Gene_Sequence:
>1260 bp
ATGACACAGGAGCAAGCGAATCAGAGTGAGACGAAGCCTGCTTTCGACTTCAAGCCGTTC
GCGCCTGGGTACGCGGAGGACCCGTTCCCCGCGATCGAGCGCCTGAGAGAGGCAACCCCC
ATCTTCTACTGGGATGAAGGCCGCTCCTGGGTCCTCACCCGATACCACGACGTGTCGGCG
GTGTTCCGCGACGAACGCTTCGCGGTCAGTCGAGAAGAGTGGGAATCGAGCGCGGAGTAC
TCGTCGGCCATTCCCGAGCTCAGCGATATGAAGAAGTACGGATTGTTCGGGCTGCCGCCG
GAGGATCACGCTCGGGTCCGCAAGCTCGTCAACCCGTCGTTTACGTCACGCGCCATCGAC
CTGCTGCGCGCCGAAATACAGCGCACCGTCGACCAGCTGCTCGATGCTCGCTCCGGACAA
GAGGAGTTCGACGTTGTGCGGGATTACGCGGAGGGAATCCCGATGCGCGCGATCAGCGCT
CTGTTGAAGGTTCCGGCCGAGTGTGACGAGAAGTTCCGTCGCTTCGGCTCGGCGACTGCG
CGCGCGCTCGGCGTGGGTTTGGTGCCCCAGGTCGATGAGGAGACCAAGACCCTGGTCGCG
TCCGTCACCGAGGGGCTCGCGCTGCTCCATGACGTCCTCGATGAGCGGCGCAGGAACCCG
CTCGAAAATGACGTCTTGACGATGCTGCTTCAGGCCGAGGCCGACGGCAGCAGGCTGAGC
ACGAAGGAGCTGGTCGCGCTCGTGGGTGCGATTATCGCTGCTGGCACCGATACCACGATC
TACCTTATCGCGTTCGCTGTGCTCAACCTGCTGCGGTCGCCCGAGGCGCTCGAGCTGGTG
AAGGCCGAGCCCGGGCTCATGAGGAACGCGCTCGATGAGGTGCTCCGCTTCGACAATATC
CTCAGAATAGGAACTGTGCGTTTCGCCAGGCAGGACCTGGAGTACTGCGGGGCATCGATC
AAGAAAGGGGAGATGGTCTTTCTCCTGATCCCGAGCGCCCTGAGAGATGGGACTGTATTC
TCCAGGCCAGACGTGTTTGATGTGCGACGGGACACGGGCGCGAGCCTCGCGTACGGTAGA
GGCCCCCATGTCTGCCCCGGGGTGTCCCTTGCTCGCCTCGAGGCGGAGATCGCCGTGGGC
ACCATCTTCCGTAGGTTCCCCGAGATGAAGCTGAAAGAAACTCCCGTGTTTGGATACCAC
CCCGCGTTCCGGAACATCGAATCACTCAACGTCATCTTGAAGCCCTCCAAAGCTGGATAG

# Drug_Target_36_General_Function:
Involved in monooxygenase activity

# Drug_Target_36_General_References:
10649995	Tang L, Shah S, Chung L, Carney J, Katz L, Khosla C, Julien B: Cloning and heterologous expression of the epothilone gene cluster. Science. 2000 Jan 28;287(5453):640-2.
10662695	Molnar I, Schupp T, Ono M, Zirkle R, Milnamow M, Nowak-Thompson B, Engel N, Toupet C, Stratmann A, Cyr DD, Gorlach J, Mayo JM, Hu A, Goff S, Schmid J, Ligon JM: The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem Biol. 2000 Feb;7(2):97-109.
10831849	Julien B, Shah S, Ziermann R, Goldman R, Katz L, Khosla C: Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene. 2000 May 16;249(1-2):153-60.

# Drug_Target_36_HGNC_ID:
Not Available

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
4931

# Drug_Target_36_Locus:
Not Available

# Drug_Target_36_Molecular_Weight:
46751

# Drug_Target_36_Name:
Cytochrome P450 167A1

# Drug_Target_36_Number_of_Residues:
419

# Drug_Target_36_PDB_ID:
1Q5E

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_36_Protein_Sequence:
>Cytochrome P450 167A1
MTQEQANQSETKPAFDFKPFAPGYAEDPFPAIERLREATPIFYWDEGRSWVLTRYHDVSA
VFRDERFAVSREEWESSAEYSSAIPELSDMKKYGLFGLPPEDHARVRKLVNPSFTSRAID
LLRAEIQRTVDQLLDARSGQEEFDVVRDYAEGIPMRAISALLKVPAECDEKFRRFGSATA
RALGVGLVPRVDEETKTLVASVTEGLALLHGVLDERRRNPLENDVLTMLLQAEADGSRLS
TKELVALVGAIIAAGTDTTIYLIAFAVLNLLRSPEALELVKAEPGLMRNALDEVLRFDNI
LRIGTVRFARQDLEYCGASIKKGEMVFLLIPSALRDGTVFSRPDVFDVRRDTSASLAYGR
GPHVCPGVSLARLEAEIAVGTIFRRFPEMKLKETPVFGYHPAFRNIESLNVILKPSKAG

# Drug_Target_36_Reaction:
Not Available

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Involved in the biosynthesis of epothilones, macrolactones which have a narrow anti-fungal spectrum and microtubule-stabilizing activity. Responsible for the epooxidation of epothilones C and D to epothilones A and B, respectively

# Drug_Target_36_SwissProt_ID:
Q9KIZ4

# Drug_Target_36_SwissProt_Name:
C167_SORCE

# Drug_Target_36_Synonyms:
Cytochrome P450epoK
EC 1.14.-.-
Epothilone epoxidase

# Drug_Target_36_Theoretical_pI:
5.28

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Not Available

# Drug_Target_37_Chromosome_Location:
Not Available

# Drug_Target_37_Drug_References:
Not Available

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
Not Available

# Drug_Target_37_GenBank_ID_Gene:
AL939108

# Drug_Target_37_GenBank_ID_Protein:
Not Available

# Drug_Target_37_GeneCard_ID:
Not Available

# Drug_Target_37_Gene_Name:
SCO1207

# Drug_Target_37_Gene_Sequence:
>1215 bp
ATGACTGAAGAAACGATTTCCCAGGCCGTGCCACCCGTCCGGGACTGGCCGGCCGTCGAC
CTTCCCGGCAGCGACTTCGACCCGGTGCTGACCGAGCTGATGCGCGAGGGTCCCGTCACC
CGGATCTCGCTGCCCAACGGCGAGGGCTGGGCCTGGCTCGTGACCCGCCACGACGACGTC
CGCCTGGTCACCAACGACCCCCGGTTCGGGCGCGAGGCCGTCATGGACCGCCAGGTCACC
CGGCTGGCCCCGCACTTCATCCCGGCGCGCGGCGCGGTGGGCTTCCTGGACCCGCCCGAC
CACACCCGGCTGCGCCGCTCGGTGGCCGCGGCCTTCACCGCGCGGGGCGTGGAGCGGGTG
CGCGAGCGGTCCCGGGGCATGCTCGACGAGCTGGTCGACGCCATGCTGAGGGCCGGTCCG
CCCGCCGACCTCACCGAGGCGGTGCTGAGCCCGTTCCCCATCGCGGTGATCTGCGAGCTG
ATGGGTGTGCCGGCCACCGACCGGCACTCCATGCACACCTGGACCCAGCTGATCCTGTCC
TCCTCGCACGGCGCCGAGGTCAGCGAGCGGGCCAAGAACGAGATGAACGCCTACTTCTCG
GATCTCATCGGGCTCCGCTCCGACAGCGCGGGCGAGGACGTCACCTCGCTGCTGGGTGCC
GCCGTGGGGCGGGACGAGATCACGCTGTCGGAGGCCGTCGGGCTCGCGGTGCTGCTCCAG
ATCGGCGGCGAGGCGGTCACCAACAACAGCGGGCAGATGTTCCACCTGCTGCTGAGCCGC
CCGGAGCTGGCCGAACGCCTGCGCTCCGAGCCGGAGATCCGCCCCCGGGCCATCGACGAG
CTGCTGCGCTGGATCCCGCACCGCAACGCCGTGGGGCTGTCCCGGATCGCCCTGGAGGAC
GTGGAGATCAAGGGGGTGCGGATCCGCGCGGGCGACGCCGTCTACGTCTCGTACCTGGCG
GCCAACCGCGACCCGGAGGTGTTCCCCGACCCGGACCGCATCGACTTCGAGCGCTCCCCC
AACCCGCACGTCTCCTTCGGCTTCGGCCCGCACTACTGTCCCGGCGGCATGCTGGCGCGG
CTGGAGTCGGAGCTGCTCGTCGACGCGGTCCTGGACCGCGTGCCGGGGCTGAAGCTCGCG
GTGGCGCCGGAGGACGTGCCCTTCAAGAAGGGTGCGCTGATCCGCGGGCCCGAGGCCCTG
CCGGTGACGTGGTGA

# Drug_Target_37_General_Function:
Involved in monooxygenase activity

# Drug_Target_37_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.

# Drug_Target_37_HGNC_ID:
Not Available

# Drug_Target_37_HPRD_ID:
Not Available

# Drug_Target_37_ID:
4608

# Drug_Target_37_Locus:
Not Available

# Drug_Target_37_Molecular_Weight:
44355

# Drug_Target_37_Name:
Putative cytochrome P450

# Drug_Target_37_Number_of_Residues:
404

# Drug_Target_37_PDB_ID:
1T93

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_37_Protein_Sequence:
>Putative cytochrome P450
MTEETISQAVPPVRDWPAVDLPGSDFDPVLTELMREGPVTRISLPNGEGWAWLVTRHDDV
RLVTNDPRFGREAVMDRQVTRLAPHFIPARGAVGFLDPPDHTRLRRSVAAAFTARGVERV
RERSRGMLDELVDAMLRAGPPADLTEAVLSPFPIAVICELMGVPATDRHSMHTWTQLILS
SSHGAEVSERAKNEMNAYFSDLIGLRSDSAGEDVTSLLGAAVGRDEITLSEAVGLAVLLQ
IGGEAVTNNSGQMFHLLLSRPELAERLRSEPEIRPRAIDELLRWIPHRNAVGLSRIALED
VEIKGVRIRAGDAVYVSYLAANRDPEVFPDPDRIDFERSPNPHVSFGFGPHYCPGGMLAR
LESELLVDAVLDRVPGLKLAVAPEDVPFKKGALIRGPEALPVTW

# Drug_Target_37_Reaction:
Not Available

# Drug_Target_37_Signals:
None

# Drug_Target_37_Specific_Function:
Not Available

# Drug_Target_37_SwissProt_ID:
Q9FCA6

# Drug_Target_37_SwissProt_Name:
Q9FCA6_STRCO

# Drug_Target_37_Synonyms:
Not Available

# Drug_Target_37_Theoretical_pI:
5.02

# Drug_Target_37_Transmembrane_Regions:
None

# Drug_Target_38_Cellular_Location:
Peroxisome

# Drug_Target_38_Chromosome_Location:
2

# Drug_Target_38_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_38_Essentiality:
Non-Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
AF244134

# Drug_Target_38_GenBank_ID_Protein:
7530485

# Drug_Target_38_GeneCard_ID:
HAO1

# Drug_Target_38_Gene_Name:
HAO1

# Drug_Target_38_Gene_Sequence:
Not Available

# Drug_Target_38_General_Function:
Energy production and conversion

# Drug_Target_38_General_References:
10777549	Jones JM, Morrell JC, Gould SJ: Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem. 2000 Apr 28;275(17):12590-7.
10978532	Williams E, Cregeen D, Rumsby G: Identification and expression of a cDNA for human glycolate oxidase. Biochim Biophys Acta. 2000 Sep 7;1493(1-2):246-8.
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.

# Drug_Target_38_HGNC_ID:
GNC:4809

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
6268

# Drug_Target_38_Locus:
20p12

# Drug_Target_38_Molecular_Weight:
40923.9

# Drug_Target_38_Name:
Hydroxyacid oxidase 1

# Drug_Target_38_Number_of_Residues:
370

# Drug_Target_38_PDB_ID:
Not Available

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF01070	FMN_dh

# Drug_Target_38_Protein_Sequence:
>Hydroxyacid oxidase 1
MLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAET
DLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAE
AGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQ
LRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILR
GDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDV
LKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLV
RKNPLAVSKI

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Has 2-hydroxyacid oxidase activity. Most active on the 2-carbon substrate glycolate, but is also active on 2-hydroxy fatty acids

# Drug_Target_38_SwissProt_ID:
Q9UJM8

# Drug_Target_38_SwissProt_Name:
HAOX1_HUMAN

# Drug_Target_38_Synonyms:
GOX
Glycolate oxidase
HAOX1

# Drug_Target_38_Theoretical_pI:
8.29

# Drug_Target_38_Transmembrane_Regions:
None

# Drug_Target_39_Cellular_Location:
Not Available

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
NOS3

# Drug_Target_39_GenBank_ID_Gene:
M93718

# Drug_Target_39_GenBank_ID_Protein:
189212

# Drug_Target_39_GeneCard_ID:
NOS3

# Drug_Target_39_Gene_Name:
NOS3

# Drug_Target_39_Gene_Sequence:
>3612 bp
ATGGGCAACTTGAAGAGCGTGGCCCAGGAGCCTGGGCCACCCTGCGGCCTGGGGCTGGGG
CTGGGCCTTGGGCTGTGCGGCAAGCAGGGCCCAGCCACCCCGGCCCCTGAGCCCAGCCGG
GCCCCAGCATCCCTACTCCCACCAGCGCCAGAACACAGCCCCCCGAGCTCCCCGCTAACC
CAGCCCCCAGAGGGGCCCAAGTTCCCTCGTGTGAAGAACTGGGAGGTGGGGAGCATCACC
TATGACACCCTCAGCGCCCAGGCGCAGCAGGATGGGCCCTGCACCCCAAGACGCTGCCTG
GGCTCCCTGGTATTTCCACGGAAACTACAGGGCCGGCCCTCCCCCGGCCCCCCGGCCCCT
GAGCAGCTGCTGAGTCAGGCCCGGGACTTCATCAACCAGTACTACAGCTCCATTAAGAGG
AGCGGCTCCCAGGCCCACGAACAGCGGCTTCAAGAGGTGGAAGCCGAGGTGGCAGCCACA
GGCACCTACCAGCTTAGGGAGAGCGAGCTGGTGTTCGGGGCTAAGCAGGCCTGGCGCAAC
GCTCCCCGCTGCGTGGGCCGGATCCAGTGGGGGAAGCTGCAGGTGTTCGATGCCCGGGAC
TGCAGGTCTGCACAGGAAATGTTCACCTACATCTGCAACCACATCAAGTATGCCACCAAC
CGGGGCAACCTTCGCTCGGCCATCACAGTGTTCCCGCAGCGCTGCCCTGGCCGAGGAGAC
TTCCGAATCTGGAACAGCCAGCTGGTGCGCTACGCGGGCTACCGGCAGCAGGACGGCTCT
GTGCGGGGGGACCCAGCCAACGTGGAGATCACCGAGCTCTGCATTCAGCACGGCTGGACC
CCAGGAAACGGTCGCTTCGACGTGCTGCCCCTGCTGCTGCAGGCCCCAGATGAGCCCCCA
GAACTCTTCCTTCTGCCCCCCGAGCTGGTCCTTGAGGTGCCCCTGGAGCACCCCACGCTG
GAGTGGTTTGCAGCCCTGGGCCTGCGCTGGTACGCCCTCCCGGCAGTGTCCAACATGCTG
CTGGAAATTGGGGGCCTGGAGTTCCCCGCAGCCCCCTTCAGTGGCTGGTACATGAGCACT
GAGATCGGCACGAGGAACCTGTGTGACCCTCACCGCTACAACATCCTGGAGGATGTGGCT
GTCTGCATGGACCTGGATACCCGGACCACCTCGTCCCTGTGGAAAGACAAGGCAGCAGTG
GAAATCAACGTGGCCGTGCTGCACAGTTACCAGCTAGCCAAAGTCACCATCGTGGACCAC
CACGCCGCCACGGCCTCTTTCATGAAGCACCTGGAGAATGAGCAGAAGGCCAGGGGGGGC
TGCCCTGCAGACTGGGCCTGGATCGTGCCCCCCATCTCGGGCAGCCTCACTCCTGTTTTC
CATCAGGAGATGGTCAACTATTTCCTGTCCCCGGCCTTCCGCTACCAGCCAGACCCCTGG
AAGGGGAGTGCCGCCAAGGGCACCGGCATCACCAGGAAGAAGACCTTTAAAGAAGTGGCC
AACGCCGTGAAGATCTCCGCCTCGCTCATGGGCACGGTGATGGCGAAGCGAGTGAAGGCG
ACAATCCTGTATGGCTCCGAGACCGGCCGGGCCCAGAGCTACGCACAGCAGCTGGGGAGA
CTCTTCCGGAAGGCTTTTGATCCCCGGGTCCTGTGTATGGATGAGTATGACGTGGTGTCC
CTCGAACACGAGACGCTGGTGCTGGTGGTAACCAGCACATTTGGGAATGGGGATCCCCCG
GAGAATGGAGAGAGCTTTGCAGCTGCCCTGATGGAGATGTCCGGCCCCTACAACAGCTCC
CCTCGGCCGGAACAGCACAAGAGTTATAAGATCCGCTTCAACAGCATCTCCTGCTCAGAC
CCACTGGTGTCCTCTTGGCGGCGGAAGAGGAAGGAGTCCAGTAACACAGACAGTGCAGGG
GCCCTGGGCACCCTCAGGTTCTGTGTGTTCGGGCTCGGCTCCCGGGCATACCCCCACTTC
TGCGCCTTTGCTCGTGCCGTGGACACACGGCTGGAGGAACTGGGCGGGGAGCGGCTGCTG
CAGCTGGGCCAGGGCGACGAGCTGTGCGGCCAGGAGGAGGCCTTCCGAGGCTGGGCCCAG
GCTGCCTTCCAGGCCGCCTGTGAGACCTTCTGTGTGGGAGAGGATGCCAAGGCCGCCGCC
CGAGACATCTTCAGCCCCAAACGGAGCTGGAAGCGCCAGAGGTACCGGCTGAGCGCCCAG
GCCGAGGGCCTGCAGTTGCTGCCAGGTCTGATCCACGTGCACAGGCGGAAGATGTTCCAG
GCTACAATCCGCTCAGTGGAAAACCTGCAAAGCAGCAAGTCCACGAGGGCCACCATCCTG
GTGCGCCTGGACACCGGAGGCCAGGAGGGGCTGCAGTACCAGCCGGGGGACCACATAGGT
GTCTGCCCGCCCAACCGGCCCGGCCTTGTGGAGGCGCTGCTGAGCCGCGTGGAGGACCCG
CCGGCGCCCACTGAGCCCGTGGCAGTAGAGCAGCTGGAGAAGGGCAGCCCTGGTGGCCCT
CCCCCCGGCTGGGTGCGGGACCCCCGGCTGCCCCCGTGCACGCTGCGCCAGGCTCTCACC
TTCTTCCTGGACATCACCTCCCCACCCAGCCCTCAGCTCTTGCGGCTGCTCAGCACCTTG
GCAGAAGAGCCCAGGGAACAGCAGGAGCTGGAGGCCCTCAGCCAGGATCCCCGACGCTAC
GAGGAGTGGAAGTGGTTCCGCTGCCCCACGCTGCTGGAGGTGCTGGAGCAGTTCCCGTCG
GTGGCGCTGCCTGCCCCACTGCTCCTCACCCAGCTGCCTCTGCTCCAGCCCCGGTACTAC
TCAGTCAGCTCGGCACCCAGCACCCACCCAGGAGAGATCCACCTCACTGTAGCTGTGCTG
GCATACAGGACTCAGGATGGGCTGGGCCCCCTGCACTATGGAGTCTGCTCCACGTGGCTA
AGCCAGCTCAAGCCCGGAGACCCTGTGCCCTGCTTCATCCGGGGGGCTCCCTCCTTCCGG
CTGCCACCCGATCCCAGCTTGCCCTGCATCCTGGTGGGTCCAGGCACTGGCATTGCCCCC
TTCCGGGGATTCTGGCAGGAGCGGCTGCATGACATTGAGAGCAAAGGGCTGCAGCCCACT
CCCATGACTTTGGTGTTCGGCTGCCGATGCTCCCAACTTGACCATCTCTACCGCGACGAG
GTGCAGAACGCCCAGCAGCGCGGGGTGTTTGGCCGAGTCCTCACCGCCTTCTCCCGGGAA
CCTGACAACCCCAAGACCTACGTGCAGGACATCCTGAGGACGGAGCTGGCTGCGGAGGTG
CACCGCGTGCTGTGCCTCGAGCGGGGCCACATGTTTGTCTGCGGCGATGTTACCATGGCA
ACCAACGTCCTGCAGACCGTGCAGCGCATCCTGGCGACGGAGGGCGACATGGAGCTGGAC
GAGGCCGGCGACGTCATCGGCGTGCTGCGGGATCAGCAACGCTACCACGAAGACATTTTC
GGGCTCACGCTGCGCACCCAGGAGGTGACAAGCCGCATACGCACCCAGAGCTTTTCCTTG
CAGGAGCGTCAGTTGCGGGGCGCAGTGCCCTGGGCGTTCGACCCTCCCGGCTCAGACACC
AACAGCCCCTGA

# Drug_Target_39_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_39_General_References:
10074942	Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC: Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999 Mar;6(3):233-42.
12437348	Rosenfeld RJ, Garcin ED, Panda K, Andersson G, Aberg A, Wallace AV, Morris GM, Olson AJ, Stuehr DJ, Tainer JA, Getzoff ED: Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency. Biochemistry. 2002 Nov 26;41(47):13915-25.
1378832	Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992 Jul 25;267(21):14519-22.
1379542	Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T: Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett. 1992 Aug 3;307(3):287-93.
7475956	Sase K, Michel T: Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci. 1995;57(22):2049-55.
7509596	Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F: Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1027-33.
7514568	Robinson LJ, Weremowicz S, Morton CC, Michel T: Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics. 1994 Jan 15;19(2):350-7.
7519987	Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y, et al.: Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem. 1994 Aug 1;223(3):719-26.
7688726	Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT: Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993 Aug 15;268(23):17478-88.
9737779	Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998 Jul;103(1):65-9.

# Drug_Target_39_HGNC_ID:
HGNC:7876

# Drug_Target_39_HPRD_ID:
01224

# Drug_Target_39_ID:
291

# Drug_Target_39_Locus:
7q36

# Drug_Target_39_Molecular_Weight:
133159

# Drug_Target_39_Name:
Nitric-oxide synthase, endothelial

# Drug_Target_39_Number_of_Residues:
1202

# Drug_Target_39_PDB_ID:
3NOS

# Drug_Target_39_Pathway:
Bevacizumab Pathway	SMP00420
Vatalanib Pathway	SMP00421

# Drug_Target_39_Pfam_Domain_Function:
PF00175	NAD_binding_1
PF00258	Flavodoxin_1
PF00667	FAD_binding_1
PF02898	NO_synthase

# Drug_Target_39_Protein_Sequence:
>Nitric-oxide synthase, endothelial
GNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLTQ
PPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPE
QLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNA
PRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDF
RIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPE
LFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTE
IGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHH
AATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPWK
GSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGRL
FRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSSP
RPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHFC
AFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAAR
DIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATILV
RLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGPP
PGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRYE
EWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVLA
YRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAPF
RGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSREP
DNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELDE
AGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDTN
SP

# Drug_Target_39_Reaction:
L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+

# Drug_Target_39_Signals:
None

# Drug_Target_39_Specific_Function:
Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. No mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets

# Drug_Target_39_SwissProt_ID:
P29474

# Drug_Target_39_SwissProt_Name:
NOS3_HUMAN

# Drug_Target_39_Synonyms:
Constitutive NOS
EC 1.14.13.39
EC-NOS
Endothelial NOS
NOS type III
NOSIII
cNOS
eNOS

# Drug_Target_39_Theoretical_pI:
7.27

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AF486630

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
CYP165B3

# Drug_Target_3_Gene_Sequence:
>1197 bp
TTGAGCGAGGACGACCCGCGCCCGCTGCACATTCGCAGGCAGGGCTTGGATCCGGCGGAC
GAACTGCTCGCCGCCGGAGCGCTGACGAGGGTCACCATCGGATCCGGAGCGGACGCCGAG
ACCCATTGGATGGCCACCGCGCACGCCGTCGTCCGGCAGGTGATGGGTGATCACCAGCAG
TTCAGCACCCGGCGCCGCTGGGACCCGCGGGACGAGATCGGCGGGAAGGGCATCTTCCGG
CCGCGGGAACTGGTCGGCAACCTGATGGACTACGACCCGCCCGAGCACACGCGGCTGCGG
CGGAAACTGACGCCCGGCTTCACCCTCCGGAAAATGCAGCGGATGGCGCCGTACATCGAG
CAGATCGTGAACGACCGCCTCGACGAGATGGAGCGGGCGGGATCCCCCGCGGATCTGATC
GCGTTCGTCGCCGACAAGGTGCCCGGCGCCGTGCTGTGCGAGCTGGTCGGGGTGCCGAGG
GACGACCGCGACATGTTCATGAAGCTCTGTCACGGGCATCTCGACGCCTCGCTGAGTCAA
AAGCGCCGGGCGGCGCTCGGCGACAAGTTCTCGCGCTATCTGCTGGCGATGATCGCCAGG
GAACGCAAGGAGCCGGGTGAGGGGATGATCGGCGCGGTCGTCGCCGAATACGGGGACGAC
GCCACGGACGAGGAGCTACGCGGTTTCTGCGTTCAGGTGATGCTGGCGGGCGACGACAAC
ATCTCCGGCATGATCGGCCTCGGTGTGCTGGCGATGCTGCGCCATCCCGAGCAGATCGAC
GCTTTCCGCGGCGACGAGCAGTCGGCGCAACGGGCGGTCGACGAGCTGATCCGGTACCTG
ACCGTGCCGTACAGCCCGACTCCCCGGATCGCCAGGGAGGACCTCACCCTCGCGGGGCAG
GAGATCAAGAAGGGGGACAGCGTCATCTGCTCGCTCCCCGCGGCCAACCGTGATCCCGCG
CTGGCACCGGATGTGGACCGCCTCGACGTCACCCGCGAGCCCATCCCGCATGTCGCCTTC
GGGCACGGAGTCCACCATTGCCTCGGCGCCGCGCTGGCCCGGCTCGAACTGCGCACGGTC
TTCACCGAGCTGTGGCGGCGTTTCCCGGCGCTGAGGCTCGCGGATCCCGCACAGGACACC
GAATTCCGGCTGACCACTCCCGCGTACGGATTGACCGAGCTGATGGTCGCCTGGTGA

# Drug_Target_3_General_Function:
Involved in monooxygenase activity

# Drug_Target_3_General_References:
12207020	Zerbe K, Pylypenko O, Vitali F, Zhang W, Rouset S, Heck M, Vrijbloed JW, Bischoff D, Bister B, Sussmuth RD, Pelzer S, Wohlleben W, Robinson JA, Schlichting I: Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis. J Biol Chem. 2002 Dec 6;277(49):47476-85. Epub 2002 Aug 30.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4999

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
44367

# Drug_Target_3_Name:
Cytochrome P450 165B3

# Drug_Target_3_Number_of_Residues:
398

# Drug_Target_3_PDB_ID:
1LGF

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_3_Protein_Sequence:
>Cytochrome P450 165B3
MSEDDPRPLHIRRQGLDPADELLAAGALTRVTIGSGADAETHWMATAHAVVRQVMGDHQQ
FSTRRRWDPRDEIGGKGIFRPRELVGNLMDYDPPEHTRLRRKLTPGFTLRKMQRMAPYIE
QIVNDRLDEMERAGSPADLIAFVADKVPGAVLCELVGVPRDDRDMFMKLCHGHLDASLSQ
KRRAALGDKFSRYLLAMIARERKEPGEGMIGAVVAEYGDDATDEELRGFCVQVMLAGDDN
ISGMIGLGVLAMLRHPEQIDAFRGDEQSAQRAVDELIRYLTVPYSPTPRIAREDLTLAGQ
EIKKGDSVICSLPAANRDPALAPDVDRLDVTREPIPHVAFGHGVHHCLGAALARLELRTV
FTELWRRFPALRLADPAQDTEFRLTTPAYGLTELMVAW

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Involved in the coupling of aromatic side chains of the heptapeptide of vancomycin

# Drug_Target_3_SwissProt_ID:
Q8RN04

# Drug_Target_3_SwissProt_Name:
C5B3_AMYOR

# Drug_Target_3_Synonyms:
EC 1.14.-.-
Vancomycin biosynthesis protein oxyB

# Drug_Target_3_Theoretical_pI:
5.95

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_40_Cellular_Location:
Periplasm

# Drug_Target_40_Chromosome_Location:
Not Available

# Drug_Target_40_Drug_References:
Not Available

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
AE004091

# Drug_Target_40_GenBank_ID_Protein:
Not Available

# Drug_Target_40_GeneCard_ID:
Not Available

# Drug_Target_40_Gene_Name:
nirM

# Drug_Target_40_Gene_Sequence:
>315 bp
TCATTTCTGCGACAGGACCCACTTCGCCAGGGTCTGCGCCTCGTCGTCGCTGACCGCGTT
CGGCGGCATCGGGATCGGGCCCCAGACGCCCTGGCTGCCGTTCTTGATCCGCTGCGCGAG
TTCCGCTTCGGCGCCGGCCTGGCCGGCGAACTTGGCGGCGACGTCCTTGTAGGCCGGGCC
GACCATCTTGGTGTCGATGGCATGGCAGGCCACGCAGCCCTTGTTCTTGAACAGCACTTC
GGGGTCTTCGGCCCAGGCGCCCTGGGCGAGCAGGGTGCCGGTGGCGAGCAGCGAAAGCAG
TGCGTACGGTTTCAT

# Drug_Target_40_General_Function:
Involved in iron ion binding

# Drug_Target_40_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1654086	Detlefsen DJ, Thanabal V, Pecoraro VL, Wagner G: Solution structure of Fe(II) cytochrome c551 from Pseudomonas aeruginosa as determined by two-dimensional 1H NMR. Biochemistry. 1991 Sep 17;30(37):9040-6.
2152881	Nordling M, Young S, Karlsson BG, Lundberg LG: The structural gene for cytochrome c551 from Pseudomonas aeruginosa. The nucleotide sequence shows a location downstream of the nitrite reductase gene. FEBS Lett. 1990 Jan 1;259(2):230-2.
2155133	Arai H, Sanbongi Y, Igarashi Y, Kodama T: Cloning and sequencing of the gene encoding cytochrome c-551 from Pseudomonas aeruginosa. FEBS Lett. 1990 Feb 12;261(1):196-8.
2174259	Detlefsen DJ, Thanabal V, Pecoraro VL, Wagner G: Sequential 1H NMR assignments of iron(II) cytochrome c551 from Pseudomonas aeruginosa. Biochemistry. 1990 Oct 9;29(40):9377-86.
4362497	Ambler RP: The evolutionary stability of cytochrome c-551 in Pseudomonas aeruginosa and Pseudomonas fluorescens biotype C. Biochem J. 1974 Jan;137(1):3-14.
6283101	Matsuura Y, Takano T, Dickerson RE: Structure of cytochrome c551 from Pseudomonas aeruginosa refined at 1.6 A resolution and comparison of the two redox forms. J Mol Biol. 1982 Apr 5;156(2):389-409.
8218218	Timkovich R, Cai M: Investigation of the structure of oxidized Pseudomonas aeruginosa cytochrome c-551 by NMR: comparison of observed paramagnetic shifts and calculated pseudocontact shifts. Biochemistry. 1993 Nov 2;32(43):11516-23.
96440	Almassy RJ, Dickerson RE: Pseudomonas cytochrome c551 at 2.0 A resolution: enlargement of the cytochrome c family. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2674-8.

# Drug_Target_40_HGNC_ID:
Not Available

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
4934

# Drug_Target_40_Locus:
Not Available

# Drug_Target_40_Molecular_Weight:
10967

# Drug_Target_40_Name:
Cytochrome c-551

# Drug_Target_40_Number_of_Residues:
104

# Drug_Target_40_PDB_ID:
451C

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_40_Protein_Sequence:
>Cytochrome c-551
MKPYALLSLLATGTLLAQGAWAEDPEVLFKNKGCVACHAIDTKMVGPAYKDVAAKFAGQA
GAEAELAQRIKNGSQGVWGPIPMPPNAVSDDEAQTLAKWVLSQK

# Drug_Target_40_Reaction:
Not Available

# Drug_Target_40_Signals:
1-22

# Drug_Target_40_Specific_Function:
Electron donor for cytochrome cd1 in nitrite and nitrate respiration

# Drug_Target_40_SwissProt_ID:
P00099

# Drug_Target_40_SwissProt_Name:
CY551_PSEAE

# Drug_Target_40_Synonyms:
Cytochrome C8
Cytochrome c-551 precursor
Cytochrome c551

# Drug_Target_40_Theoretical_pI:
7.26

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Microsome
microsomal membrane
peripheral membrane protein

# Drug_Target_41_Chromosome_Location:
Not Available

# Drug_Target_41_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
PTGS1

# Drug_Target_41_GenBank_ID_Gene:
M31822

# Drug_Target_41_GenBank_ID_Protein:
387018

# Drug_Target_41_GeneCard_ID:
PTGS1

# Drug_Target_41_Gene_Name:
PTGS1

# Drug_Target_41_Gene_Sequence:
>1800 bp
ATGAGCCGGAGTCTCTTGCTCCGGTTCTTGCTGTTGCTGCTCCTGCTCCCGCCGCTCCCC
GTCCTGCTCGCGGACCCAGGGGCGCCCACGCCAGTGAATCCCTGTTGTTACTATCCATGC
CAGCACCAGGGCATCTGTGTCCGCTTCGGCCTTGACCGCTACCAGTGTGACTGCACCCGC
ACGGGCTATTCCGGCCCCAACTGCACCATCCCTGGCCTGTGGACCTGGCTCCGGAATTCA
CTGCGGCCCAGCCCCTCTTTCACCCACTTCCTGCTCACTCACGGGCGCTGGTTCTGGGAG
TTTGTCAATGCCACCTTCATCCGAGAGATGCTCATGCTCCTGGTACTCACAGTGCGCTCC
AACCTTATCCCCAGTCCCCCCACCTACAACTCTGCACATGACTACATCAGCTGGGAGTCT
TTCTCCAACGTGAGCTATTACACTCGTATTCTGCCCTCTGTGCCTAAAGATTGCCCCACA
CCCATGGGAACCAAAGGGAAGAAGCAGTTGCCAGATGCCCAGCTCCTGGCCCGCCGCTTC
CTGCTCAGGAGGAAGTTCATACCTGACCCCCAAGGCACCAACCTCATGTTTGCCTTCTTT
GCACAACACTTCACCCACCAGTTCTTCAAAACTTCTGGCAAGATGGGTCCTGGCTTCACC
AAGGCCTTGGGCCATGGGGTAGACCTCGGCCACATTTATGGAGACAATCTGGAGCGTCAG
TATCAACTGCGGCTCTTTAAGGATGGGAAACTCAAGTACCAGGTGCTGGATGGAGAAATG
TACCCGCCCTCGGTAGAAGAGGCGCCTGTGTTGATGCACTACCCCCGAGGCATCCCGCCC
CAGAGCCAGATGGCTGTGGGCCAGGAGGTGTTTGGGCTGCTTCCTGGGCTCATGCTGTAT
GCCACGCTCTGGCTACGTGAGCACAACCGTGTGTGTGACCTGCTGAAGGCTGAGCACCCC
ACCTGGGGCGATGAGCAGCTTTTCCAGACGACCCGCCTCATCCTCATAGGGGAGACCATC
AAGATTGTCATCGAGGAGTACGTGCAGCAGCTGAGTGGCTATTTCCTGCAGCTGAAATTT
GACCCAGAGCTGCTGTTCGGTGTCCAGTTCCAATACCGCAACCGCATTGCCACGGAGTTC
AACCATCTCTACCACTGGCACCCCCTCATGCCTGACTCCTTCAAGGTGGGCTCCCAGGAG
TACAGCTACGAGCAGTTCTTGTTCAACACCTCCATGTTGGTGGACTATGGGGTTGAGGCC
CTGGTGGATGCCTTCTCTCGCCAGATTGCTGGCCGGATCGGTGGGGGCAGGAACATGGAC
CACCACATCCTGCATGTGGCTGTGGATGTCATCAGGGAGTCTCGGGAGATGCGGCTGCAG
CCCTTCAATGAGTACCGCAAGAGGTTTGGCATGAAACCCTACACCTCCTTCCAGGAGCTC
GTAGGAGAGAAGGAGATGGCAGCAGAGTTGGAGGAATTGTATGGAGACATTGATGCGTTG
GAGTTCTACCCTGGACTGCTTCTTGAAAAGTGCCATCCAAACTCTATCTTTGGGGAGAGT
ATGATAGAGATTGGGGCTCCCTTTTCCCTCAAGGGTCTCCTAGGGAATCCCATCTGTTCT
CCGGAGTACTGGAAGCCGAGCACATTTGGCGGCGAGGTGGGCTTTAACATTGTCAAGACG
GCCACACTGAAGAAGCTGGTCTGCCTCAACACCAAGACCTGTCCCTACGTTTCCTTCCGT
GTGCCGGATGCCAGTCAGGATGATGGGCCTGCTGTGGAGCGACCATCCACAGAGCTCTGA

# Drug_Target_41_General_Function:
Involved in peroxidase activity

# Drug_Target_41_General_References:
1587858	Diaz A, Reginato AM, Jimenez SA: Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha. J Biol Chem. 1992 May 25;267(15):10816-22.
1734857	Takahashi Y, Ueda N, Yoshimoto T, Yamamoto S, Yokoyama C, Miyata A, Tanabe T, Fuse I, Hattori A, Shibata A: Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochem Biophys Res Commun. 1992 Jan 31;182(2):433-8.
1907252	Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA: Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991 Jun;5(9):2304-12.
2512924	Yokoyama C, Tanabe T: Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun. 1989 Dec 15;165(2):888-94.

# Drug_Target_41_HGNC_ID:
HGNC:9604

# Drug_Target_41_HPRD_ID:
07518

# Drug_Target_41_ID:
20

# Drug_Target_41_Locus:
9q32-q33.3

# Drug_Target_41_Molecular_Weight:
68657

# Drug_Target_41_Name:
Prostaglandin G/H synthase 1

# Drug_Target_41_Number_of_Residues:
599

# Drug_Target_41_PDB_ID:
Not Available

# Drug_Target_41_Pathway:
Abciximab Pathway	SMP00265
Acetylsalicylic Acid Pathway	SMP00083
Bromfenac Pathway	SMP00102
Celecoxib Pathway	SMP00096
Cilostazol Pathway	SMP00263
Clopidogrel Pathway	SMP00260
Diclofenac Pathway	SMP00093
Diflunisal Pathway	SMP00289
Dipyridamole (Antiplatelet) Pathway	SMP00264
Eptifibatide Pathway	SMP00266
Etodolac Pathway	SMP00084
Ibuprofen Pathway	SMP00086
Indomethacin Pathway	SMP00104
Ketoprofen Pathway	SMP00085
Ketorolac Pathway	SMP00098
Mefanamic Acid Pathway	SMP00109
Meloxicam Pathway	SMP00106
Nabumetone Pathway	SMP00114
Naproxen Pathway	SMP00120
Oxaprozin Pathway	SMP00113
Piroxicam Pathway	SMP00077
Rofecoxib Pathway	SMP00087
Sulindac Pathway	SMP00094
Suprofen Pathway	SMP00101
Ticlopidine Pathway	SMP00261
Tirofiban Pathway	SMP00267
Valdecoxib Pathway	SMP00116

# Drug_Target_41_Pfam_Domain_Function:
PF00008	EGF
PF03098	An_peroxidase

# Drug_Target_41_Protein_Sequence:
>Prostaglandin G/H synthase 1 precursor
MSRSLLLRFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTR
TGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRS
NLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRF
LLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQ
YQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLY
ATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKF
DPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEA
LVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQEL
VGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICS
PEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL

# Drug_Target_41_Reaction:
arachidonate + AH2 + 2 O2 = prostaglandin H2 + A + H2O

# Drug_Target_41_Signals:
1-23

# Drug_Target_41_Specific_Function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells

# Drug_Target_41_SwissProt_ID:
P23219

# Drug_Target_41_SwissProt_Name:
PGH1_HUMAN

# Drug_Target_41_Synonyms:
COX-1
Cyclooxygenase- 1
EC 1.14.99.1
PGH synthase 1
PGHS-1
PHS 1
Prostaglandin G/H synthase 1 precursor
Prostaglandin H2 synthase 1
Prostaglandin-endoperoxide synthase 1

# Drug_Target_41_Theoretical_pI:
7.39

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Not Available

# Drug_Target_42_Chromosome_Location:
Not Available

# Drug_Target_42_Drug_References:
Not Available

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
Not Available

# Drug_Target_42_GenBank_ID_Gene:
BX842577

# Drug_Target_42_GenBank_ID_Protein:
Not Available

# Drug_Target_42_GeneCard_ID:
Not Available

# Drug_Target_42_Gene_Name:
glbN

# Drug_Target_42_Gene_Sequence:
>411 bp
TCAGACTGGTGCCGTGGTGCTCTCGCCCGATGTGACGTCGACCGCCAGCGGCGCGATGAC
GCCGAGGATTTCCGTGATCGTTTCGGAGGGCACGCCGGCTGCGGTCAGCGCGTCGGCCAA
GTGTCCGGCGACCAGGCTGAAGTGGTGCATGGTAATTCCGCGCCCCTGATGGACTTGCTT
CATCGGCGCACCGGTATAGGGCTCGGGCCCGCCAAGCGCGGCCGCGAAAAACTCCACCTG
CTTGCCCTTGAGGCGGCTCATGTTCGTACCGCTGAAGAAGGCCGATAGTTGGTCATCGGC
AAGCACACGAACATAGAAGTCCTCGACGACGACTTCGATGGCCTCATGCCCGCCGATCTT
GTCGTAGATGCTGATCGGCTCACGTTTGCGCAAGCGTGACAGTAGTCCCAT

# Drug_Target_42_General_Function:
Involved in oxygen binding

# Drug_Target_42_General_References:
10636862	Yeh SR, Couture M, Ouellet Y, Guertin M, Rousseau DL: A cooperative oxygen binding hemoglobin from Mycobacterium tuberculosis. Stabilization of heme ligands by a distal tyrosine residue. J Biol Chem. 2000 Jan 21;275(3):1679-84.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_42_HGNC_ID:
Not Available

# Drug_Target_42_HPRD_ID:
Not Available

# Drug_Target_42_ID:
4386

# Drug_Target_42_Locus:
Not Available

# Drug_Target_42_Molecular_Weight:
14449

# Drug_Target_42_Name:
Hemoglobin-like protein HbN

# Drug_Target_42_Number_of_Residues:
136

# Drug_Target_42_PDB_ID:
1RTE

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF01152	Bac_globin

# Drug_Target_42_Protein_Sequence:
>Hemoglobin-like protein HbN
MGLLSRLRKREPISIYDKIGGHEAIEVVVEDFYVRVLADDQLSAFFSGTNMSRLKGKQVE
FFAAALGGPEPYTGAPMKQVHQGRGITMHHFSLVAGHLADALTAAGVPSETITEILGVIA
PLAVDVTSGESTTAPV

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
None

# Drug_Target_42_Specific_Function:
Binds oxygen cooperatively with very high affinity (P(50) = 0.013 mmHg at 20 degrees Celsius) because of a fast combination (25 microM(-1).s(-1)) and a slow dissociation (0.2 s(- 1)) rate

# Drug_Target_42_SwissProt_ID:
P0A592

# Drug_Target_42_SwissProt_Name:
TRHBN_MYCTU

# Drug_Target_42_Synonyms:
Flavohemoglobin
Truncated hemoglobin
trHbN

# Drug_Target_42_Theoretical_pI:
5.98

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Not Available

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
NOS2A

# Drug_Target_43_GenBank_ID_Gene:
L09210

# Drug_Target_43_GenBank_ID_Protein:
292242

# Drug_Target_43_GeneCard_ID:
NOS2A

# Drug_Target_43_Gene_Name:
NOS2

# Drug_Target_43_Gene_Sequence:
>3462 bp
ATGGCCTGTCCTTGGAAATTTCTGTTCAAGACCAAATTCCACCAGTATGCAATGAATGGG
GAAAAAGACATCAACAACAATGTGGAGAAAGCCCCCTGTGCCACCTCCAGTCCAGTGACA
CAGGATGACCTTCAGTATCACAACCTCAGCAAGCAGCAGAATGAGTCCCCGCAGCCCCTC
GTGGAGACGGGAAAGAAGTCTCCAGAATCTCTGGTCAAGCTGGATGCAACCCCATTGTCC
TCCCCACGGCATGTGAGGATCAAAAACTGGGGCAGCGGGATGACTTTCCAAGACACACTT
CACCATAAGGCCAAAGGGATTTTAACTTGCAGGTCCAAATCTTGCCTGGGGTCCATTATG
ACTCCCAAAAGTTTGACCAGAGGACCCAGGGACAAGCCTACCCCTCCAGATGAGCTTCTA
CCTCAAGCTATCGAATTTGTCAACCAATATTACGGCTCCTTCAAAGAGGCAAAAATAGAG
GAACATCTGGCCAGGGTGGAAGCGGTAACAAAGGAGATAGAAACAACAGGAACCTACCAA
CTGACGGGAGATGAGCTCATCTTCGCCACCAAGCAGGCCTGGCGCAATGCCCCACGCTGC
ATTGGGAGGATCCAGTGGTCCAACCTGCAGGTCTTCGATGCCCGCAGCTGTTCCACTGCC
CGGGAAATGTTTGAACACATCTGCAGACACGTGCGTTACTCCACCAACAATGGCAACATC
AGGTCGGCCATCACCGTGTTCCCCCAGCGGAGTGATGGCAAGCACGACTTCCGGGTGTGG
AATGCTCAGCTCATCCGCTATGCTGGCTACCAGATGCCAGATGGCAGCATCAGAGGGGAC
CCTGCCAACGTGGAATTCACTCAGCTGTGCATCGACCTGGGCTGGAAGCCCAAGTACGGC
CGCTTCGATGTGGTCCCCCTGGTCCTGCAGGCCAATGGCCGTGACCCTGAGCTCTTCGAA
ATCCCACCTGACCTTGTGCTTGAGGTGGCCATGGAACATCCCAAATACGAGTGGTTTCGG
GAACTGGAGCTAAAGTGGTACGCCCTGCCTGCAGTGGCCAACATGCTGCTTGAGGTGGGC
GGCCTGGAGTTCCCAGGGTGCCCCTTCAATGGCTGGTACATGGGCACAGAGATCGGAGTC
CGGGACTTCTGTGACGTCCAGCGCTACAACATCCTGGAGGAAGTGGGCAGGAGAATGGGC
CTGGAAACGCACAAGCTGGCCTCGCTCTGGAAAGACCAGGCTGTCGTTGAGATCAACATT
GCTGTGATCCATAGTTTTCAGAAGCAGAATGTGACCATCATGGACCACCACTCGGCTGCA
GAATCCTTCATGAAGTACATGCAGAATGAATACCGGTCCCGTGGGGGCTGCCCGGCAGAC
TGGATTTGGCTGGTCCCTCCCATGTCTGGGAGCATCACCCCCGTGTTTCACCAGGAGATG
CTGAACTACGTCCTGTCCCCTTTCTACTACTATCAGGTAGAGGCCTGGAAAACCCATGTC
TGGCAGGACGAGAAGCGGAGACCCAAGAGAAGAGAGATTCCATTGAAAGTCTTGGTCAAA
GCTGTGCTCTTTGCCTGTATGCTGATGCGCAAGACAATGGCGTCCCGAGTCAGAGTCACC
ATCCTCTTTGCGACAGAGACAGGAAAATCAGAGGCGCTGGCCTGGGACCTGGGGGCCTTA
TTCAGCTGTGCCTTCAACCCCAAGGTTGTCTGCATGGATAAGTACAGGCTGAGCTGCCTG
GAGGAGGAACGGCTGCTGTTGGTGGTGACCAGTACGTTTGGCAATGGAGACTGCCCTGGC
AATGGAGAGAAACTGAAGAAATCGCTCTTCATGCTGAAAGAGCTCAACAACAAATTCAGG
TACGCTGTGTTTGGCCTCGGCTCCAGCATGTACCCTCGGTTCTGCGCCTTTGCTCATGAC
ATTGATCAGAAGCTGTCCCACCTGGGGGCCTCTCAGCTCACCCCGATGGGAGAAGGGGAT
GAGCTCAGTGGGCAGGAGGACGCCTTCCGCAGCTGGGCCGTGCAAACCTTCAAGGCAGCC
TGTGAGACGTTTGATGTCCGAGGCAAACAGCACATTCAGATCCCCAAGCTCTACACCTCC
AATGTGACCTGGGACCCGCACCACTACAGGCTCGTGCAGGACTCACAGCCTTTGGACCTC
AGCAAAGCCCTCAGCAGCATGCATGCCAAGAACGTGTTCACCATGAGGCTCAAATCTCGG
CAGAATCTACAAAGTCCGACATCCAGCCGTGCCACCATCCTGGTGGAACTCTCCTGTGAG
GATGGCCAAGGCCTGAACTACCTGCCGGGGGAGCACCTTGGGGTTTGCCCAGGCAACCAG
CCGGCCCTGGTCCAAGGCATCCTGGAGCGAGTGGTGGATGGCCCCACACCCCACCAGACA
GTGCGCCTGGAGGACCTGGATGAGAGTGGCAGCTACTGGGTCAGTGACAAGAGGCTGCCC
CCCTGCTCACTCAGCCAGGCCCTCACCTACTCCCCGGACATCACCACACCCCCAACCCAG
CTGCTGCTCCAAAAGCTGGCCCAGGTGGCCACAGAAGAGCCTGAGAGACAGAGGCTGGAG
GCCCTGTGCCAGCCCTCAGAGTACAGCAAGTGGAAGTTCACCAACAGCCCCACATTCCTG
GAGGTGCTAGAGGAGTTCCCGTCCCTGCGGGTGTCTGCTGGCTTCCTGCTTTCCCAGCTC
CCCATTCTGAAGCCCAGGTTCTACTCCATCAGCTCCTCCCGGGATCACACGCCCACGGAG
ATCCACCTGACTGTGGCCGTGGTCACCTACCACACCGGAGATGGCCAGGGTCCCCTGCAC
CACGGTGTCTGCAGCACATGGCTCAACAGCCTGAAGCCCCAAGACCCAGTGCCCTGCTTT
GTGCGGAATGCCAGCGCCTTCCACCTCCCCGAGGATCCCTCCCATCCTTGCATCCTCATC
GGGCCTGGCACAGGCATCGTGCCCTTCCGCAGTTTCTGGCAGCAACGGCTCCATGACTCC
CAGCACAAGGGAGTGCGGGGAGGCCGCATGACCTTGGTGTTTGGGTGCCGCCGCCCAGAT
GAGGACCACATCTACCAGGAGGAGATGCTGGAGATGGCCCAGAAGGGGGTGCTGCATGCG
GTGCACACAGCCTATTCCCGCCTGCCTGGCAAGCCCAAGGTCTATGTTCAGGACATCCTG
CGGCAGCAGCTGGCCAGCGAGGTGCTCCGTGTGCTCCACAAGGAGCCAGGCCACCTCTAT
GTTTGCGGGGATGTGCGCATGGCCCGGGACGTGGCCCACACCCTGAAGCAGCTGGTGGCT
GCCAAGCTGAAATTGAATGAGGAGCAGGTCGAGGACTATTTCTTTCAGCTCAAGAGCCAG
AAGCGCTATCACGAAGATATCTTCGGTGCTGTATTTCCTTACGAGGCGAAGAAGGACAGG
GTGGCGGTGCAGCCCAGCAGCCTGGAGATGTCAGCGCTCTGA

# Drug_Target_43_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_43_General_References:
10074942	Fischmann TO, Hruza A, Niu XD, Fossetta JD, Lunn CA, Dolphin E, Prongay AJ, Reichert P, Lundell DJ, Narula SK, Weber PC: Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol. 1999 Mar;6(3):233-42.
10409685	Li H, Raman CS, Glaser CB, Blasko E, Young TA, Parkinson JF, Whitlow M, Poulos TL: Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. J Biol Chem. 1999 Jul 23;274(30):21276-84.
12080081	Glynne PA, Darling KE, Picot J, Evans TJ: Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output. J Biol Chem. 2002 Sep 6;277(36):33132-8. Epub 2002 Jun 21.
7504305	Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11419-23.
7522054	Maier R, Bilbe G, Rediske J, Lotz M: Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta. 1994 Sep 21;1208(1):145-50.
7528017	Park CS, Pardhasaradhi K, Gianotti C, Villegas E, Krishna G: Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA. Biochem Biophys Res Commun. 1994 Nov 30;205(1):85-91.
7531687	Hokari A, Zeniya M, Esumi H: Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. J Biochem (Tokyo). 1994 Sep;116(3):575-81.
7532248	McLay JS, Chatterjee P, Nicolson AG, Jardine AG, McKay NG, Ralston SH, Grabowski P, Haites NE, MacLeod AM, Hawksworth GM: Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism? Kidney Int. 1994 Oct;46(4):1043-9.
7544004	Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC: Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7809-13.
7558036	Bloch KD, Wolfram JR, Brown DM, Roberts JD Jr, Zapol DG, Lepore JJ, Filippov G, Thomas JE, Jacob HJ, Bloch DB: Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics. 1995 Jun 10;27(3):526-30.
7682706	Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3491-5.
7692964	Sherman PA, Laubach VE, Reep BR, Wood ER: Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry. 1993 Nov 2;32(43):11600-5.
9160867	Luss H, Li RK, Shapiro RA, Tzeng E, McGowan FX, Yoneyama T, Hatakeyama K, Geller DA, Mickle DA, Simmons RL, Billiar TR: Dedifferentiated human ventricular cardiac myocytes express inducible nitric oxide synthase mRNA but not protein in response to IL-1, TNF, IFNgamma, and LPS. J Mol Cell Cardiol. 1997 Apr;29(4):1153-65.
9721329	Taylor BS, Alarcon LH, Billiar TR: Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc). 1998 Jul;63(7):766-81.

# Drug_Target_43_HGNC_ID:
HGNC:7873

# Drug_Target_43_HPRD_ID:
01225

# Drug_Target_43_ID:
7

# Drug_Target_43_Locus:
17q11.2-q12

# Drug_Target_43_Molecular_Weight:
131119

# Drug_Target_43_Name:
Nitric oxide synthase, inducible

# Drug_Target_43_Number_of_Residues:
1153

# Drug_Target_43_PDB_ID:
2NSI

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
PF00175	NAD_binding_1
PF00258	Flavodoxin_1
PF00667	FAD_binding_1
PF02898	NO_synthase

# Drug_Target_43_Protein_Sequence:
>Nitric oxide synthase, inducible
MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPL
VETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIM
TPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQ
LTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNI
RSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYG
RFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVG
GLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINI
AVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEM
LNYVLSPFYYYQVEAWKTHVWQDEKRRPKRREIPLKVLVKAVLFACMLMRKTMASRVRVT
ILFATETGKSEALAWDLGALFSCAFNPKVVCMDKYRLSCLEEERLLLVVTSTFGNGDCPG
NGEKLKKSLFMLKELNNKFRYAVFGLGSSMYPRFCAFAHDIDQKLSHLGASQLTPMGEGD
ELSGQEDAFRSWAVQTFKAACETFDVRGKQHIQIPKLYTSNVTWDPHHYRLVQDSQPLDL
SKALSSMHAKNVFTMRLKSRQNLQSPTSSRATILVELSCEDGQGLNYLPGEHLGVCPGNQ
PALVQGILERVVDGPTPHQTVRLEALDESGSYWVSDKRLPPCSLSQALTYFLDITTPPTQ
LLLQKLAQVATEEPERQRLEALCQPSEYSKWKFTNSPTFLEVLEEFPSLRVSAGFLLSQL
PILKPRFYSISSSRDHTPTEIHLTVAVVTYHTRDGQGPLHHGVCSTWLNSLKPQDPVPCF
VRNASGFHLPEDPSHPCILIGPGTGIAPFRSFWQQRLHDSQHKGVRGGRMTLVFGCRRPD
EDHIYQEEMLEMAQKGVLHAVHTAYSRLPGKPKVYVQDILRQQLASEVLRVLHKEPGHLY
VCGDVRMARDVAHTLKQLVAAKLKLNEEQVEDYFFQLKSQKRYHEDIFGAVFPYEAKKDR
VAVQPSSLEMSAL

# Drug_Target_43_Reaction:
L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+

# Drug_Target_43_Signals:
None

# Drug_Target_43_Specific_Function:
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In macrophages, NO mediates tumoricidal and bactericidal actions

# Drug_Target_43_SwissProt_ID:
P35228

# Drug_Target_43_SwissProt_Name:
NOS2_HUMAN

# Drug_Target_43_Synonyms:
EC 1.14.13.39
HEP- NOS
Hepatocyte NOS
Inducible NO synthase
Inducible NOS
NOS type II
iNOS

# Drug_Target_43_Theoretical_pI:
8.01

# Drug_Target_43_Transmembrane_Regions:
None

# Drug_Target_44_Cellular_Location:
Periplasm

# Drug_Target_44_Chromosome_Location:
Not Available

# Drug_Target_44_Drug_References:
Not Available

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
Not Available

# Drug_Target_44_GenBank_ID_Gene:
U05951

# Drug_Target_44_GenBank_ID_Protein:
Not Available

# Drug_Target_44_GeneCard_ID:
Not Available

# Drug_Target_44_Gene_Name:
cycA1

# Drug_Target_44_Gene_Sequence:
>708 bp
ATGAAAATAATGATAGCCTGCGGGCTGGTTGCTGCAGCTTTGTTCACACTGACGAGTGGA
CAAAGTCTGGCAGCAGACGCCCCGTTTGAAGGCCGCAAGAAATGCAGTTCCTGTCACAAA
GCCCAGGCGCAATCGTGGAAAGACACAGCGCATGCCAAAGCGATGGAATCGCTCAAGCCC
AATGTCAAGAAAGAAGCCAAACAGAAAGCCAAACTGGATCCGGCCAAGGACTACACCCAG
GACAAAGACTGCGTAGGTTGTCACGTGGATGGATTTGGTCAGAAAGGGGGCTATACGATC
GAATCGCCCAAACCGATGCTGACGGGTGTAGGCTGTGAATCCTGCCATGGACCTGGACGT
AACTTCCGGGGAGATCATCGTAAGAGCGGGCAGGCTTTTGAGAAATCGGGCAAGAAAACG
CCTCGCAAAGATCTGGCAAAGAAAGGACAGGACTTCCACTTTGAAGAACGCTGCAGTGCG
TGCCATCTGAACTACGAAGGTTCACCGTGGAAAGGAGCCAAAGCGCCTTACACCCCGTTT
ACACCGGAAGTGGATGCGAAATACACCTTCAAGTTTGATGAAATGGTCAAGGAAGTCAAA
GCCATGCATGAACATTACAAACTGGAAGGCGTATTTGAAGGAGAGCCGAAATTCAAATTC
CATGATGAATTCCAGGCCAGTGCCAAACCTGCCAAAAAAGGAAAATAG

# Drug_Target_44_General_Function:
Not Available

# Drug_Target_44_General_References:
11372197	Iverson TM, Arciero DM, Hooper AB, Rees DC: High-resolution structures of the oxidized and reduced states of cytochrome c554 from Nitrosomonas europaea. J Biol Inorg Chem. 2001 Apr;6(4):390-7.
12700255	Chain P, Lamerdin J, Larimer F, Regala W, Lao V, Land M, Hauser L, Hooper A, Klotz M, Norton J, Sayavedra-Soto L, Arciero D, Hommes N, Whittaker M, Arp D: Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea. J Bacteriol. 2003 May;185(9):2759-73.
8063110	Hommes NG, Sayavedra-Soto LA, Arp DJ: Sequence of hcy, a gene encoding cytochrome c-554 from Nitrosomonas europaea. Gene. 1994 Aug 19;146(1):87-9.
8195067	Bergmann DJ, Arciero DM, Hooper AB: Organization of the hao gene cluster of Nitrosomonas europaea: genes for two tetraheme c cytochromes. J Bacteriol. 1994 Jun;176(11):3148-53.
9808046	Iverson TM, Arciero DM, Hsu BT, Logan MS, Hooper AB, Rees DC: Heme packing motifs revealed by the crystal structure of the tetra-heme cytochrome c554 from Nitrosomonas europaea. Nat Struct Biol. 1998 Nov;5(11):1005-12.

# Drug_Target_44_HGNC_ID:
Not Available

# Drug_Target_44_HPRD_ID:
Not Available

# Drug_Target_44_ID:
4935

# Drug_Target_44_Locus:
Not Available

# Drug_Target_44_Molecular_Weight:
25999

# Drug_Target_44_Name:
Cytochrome c-554

# Drug_Target_44_Number_of_Residues:
235

# Drug_Target_44_PDB_ID:
1FT6

# Drug_Target_44_Pathway:
Not Available

# Drug_Target_44_Pfam_Domain_Function:
Not Available

# Drug_Target_44_Protein_Sequence:
>Cytochrome c-554
MKIMIACGLVAAALFTLTSGQSLAADAPFEGRKKCSSCHKAQAQSWKDTAHAKAMESLKP
NVKKEAKQKAKLDPAKDYTQDKDCVGCHVDGFGQKGGYTIESPKPMLTGVGCESCHGPGR
NFRGDHRKSGQAFEKSGKKTPRKDLAKKGQDFHFEERCSACHLNYEGSPWKGAKAPYTPF
TPEVDAKYTFKFDEMVKEVKAMHEHYKLEGVFEGEPKFKFHDEFQASAKPAKKGK

# Drug_Target_44_Reaction:
Not Available

# Drug_Target_44_Signals:
1-24

# Drug_Target_44_Specific_Function:
Involved in ammonia oxidation; accepts electrons directly from hydroxylamine oxidoreductase (HAO)

# Drug_Target_44_SwissProt_ID:
Q57142

# Drug_Target_44_SwissProt_Name:
C554_NITEU

# Drug_Target_44_Synonyms:
Cytochrome c-554 precursor
Cytochrome c554
Hydroxylamine oxidoreductase-linked cytochrome

# Drug_Target_44_Theoretical_pI:
9.50

# Drug_Target_44_Transmembrane_Regions:
None

# Drug_Target_45_Cellular_Location:
Not Available

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
Not Available

# Drug_Target_45_GenBank_ID_Gene:
BA000033

# Drug_Target_45_GenBank_ID_Protein:
21205025

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
nos

# Drug_Target_45_Gene_Sequence:
>1077 bp
ATGTTATTTAAAGAGGCTCAAGCTTTCATAGAAAACATGTATAAAGAGTGTCATTATGAA
ACGCAAATTATCAATAAACGTTTACATGACATTGAACTAGAAATAAAAGAAACTGGGACA
TATACACATACAGAAGAAGAACTTATTTATGGTGCTAAAATGGCTTGGCGTAATTCAAAT
CGTTGCATTGGTCGTTTATTTTGGGATTCGTTAAATGTCATTGATGCAAGAGATGTTACT
GACGAAGCATCGTTCTTATCATCAATTACTTATCATATTACACAGGCTACAAATGAAGGT
AAATTAAAGCCGTATATTACTATATATGCTCCAAAGGATGGACCTAAAATTTTCAACAAT
CAATTAATTCGCTATGCTGGCTATGACAATTGTGGTGATCCTGCTGAAAAAGAAGTTACA
CGCTTAGCAAATCACTTAGGTTGGAAAGGAAAAGGTACTAATTTTGACGTGTTACCACTG
ATTTACCAATTACCTAATGAGTCAGTTAAATTTTACGAATATCCTACTTCATTAATTAAA
GAAGTACCTATTGAACATAATCATTATCCAAAATTAAGAAAATTGAACTTAAAATGGTAT
GCAGTCCCTATCATTTCCAATATGGACTTAAAAATCGGTGGCATTGTATATCCAACTGCA
CCCTTTAACGGTTGGTATATGGTAACTGAAATTGGCGTACGTAACTTTATTGATGATTAC
CGTTACAATTTACTAGAAAAAGTTGCAGATGCGTTTGAATTTGATACACTTAAAAATAAT
TCATTTAATAAAGATCGAGCACTTGTTGAATTGAACTATGCTGTGTATCATTCCTTTAAA
AAAGAAGGCGTATCAATTGTCGATCATTTGACCGCTGCAAAGCAATTCGAACTATTCGAA
CGTAATGAAGCACAACAAGGTCGTCAAGTTACCGGAAAATGGTCTTGGCTAGCGCCGCCA
TTATCTCCAACATTGACGTCAAATTATCATCATGGATATGACAATACAGTAAAAGATCCA
AACTTTTTCTATAAAAAGAAAGAATCAAATGCTAACCAGTGCCCTTTCCATCATTAA

# Drug_Target_45_General_Function:
Involved in nitric-oxide synthase activity

# Drug_Target_45_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_45_HGNC_ID:
Not Available

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
2701

# Drug_Target_45_Locus:
Not Available

# Drug_Target_45_Molecular_Weight:
41711

# Drug_Target_45_Name:
Nitric oxide synthase oxygenase

# Drug_Target_45_Number_of_Residues:
358

# Drug_Target_45_PDB_ID:
1MJT

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
PF02898	NO_synthase

# Drug_Target_45_Protein_Sequence:
>Nitric oxide synthase oxygenase
MLFKEAQAFIENMYKECHYETQIINKRLHDIELEIKETGTYTHTEEELIYGAKMAWRNSN
RCIGRLFWDSLNVIDARDVTDEASFLSSITYHITQATNEGKLKPYITIYAPKDGPKIFNN
QLIRYAGYDNCGDPAEKEVTRLANHLGWKGKGTNFDVLPLIYQLPNESVKFYEYPTSLIK
EVPIEHNHYPKLRKLNLKWYAVPIISNMDLKIGGIVYPTAPFNGWYMVTEIGVRNFIDDY
RYNLLEKVADAFEFDTLKNNSFNKDRALVELNYAVYHSFKKEGVSIVDHLTAAKQFELFE
RNEAQQGRQVTGKWSWLAPPLSPTLTSNYHHGYDNTVKDPNFFYKKKESNANQCPFHH

# Drug_Target_45_Reaction:
Not Available

# Drug_Target_45_Signals:
None

# Drug_Target_45_Specific_Function:
Catalyzes the production of nitric oxide

# Drug_Target_45_SwissProt_ID:
P0A094

# Drug_Target_45_SwissProt_Name:
NOSO_STAAW

# Drug_Target_45_Synonyms:
EC 1.-.-.-
NOSoxy-like protein
SANOS

# Drug_Target_45_Theoretical_pI:
7.00

# Drug_Target_45_Transmembrane_Regions:
None

# Drug_Target_46_Cellular_Location:
Not Available

# Drug_Target_46_Chromosome_Location:
Not Available

# Drug_Target_46_Drug_References:
Not Available

# Drug_Target_46_Essentiality:
Non-Essential

# Drug_Target_46_GenAtlas_ID:
Not Available

# Drug_Target_46_GenBank_ID_Gene:
AF486630

# Drug_Target_46_GenBank_ID_Protein:
Not Available

# Drug_Target_46_GeneCard_ID:
Not Available

# Drug_Target_46_Gene_Name:
CYP165C4

# Drug_Target_46_Gene_Sequence:
>1221 bp
ATGGGGCACGATATCGATCAGGTCGCGCCGCTCCTGCGGGAGCCGGCGAACTTTCAGCTG
AGGACGAACTGCGATCCGCACGAGGACAATTTCGGGCTCAGGGCGCACGGCCCTTTGGTG
CGGATAGTCGGCGAATCGTCCACCCAGCTGGGCAGGGACTTCGTCTGGCAGGCCCACGGT
TACGAGGTCGTGCGCAGGATATTGGGTGATCACGAACATTTCACGACGCGGCCGCAATTC
ACCCAGTCGAAATCCGGCGCCCATGTGGAGGCCCAGTTCGTCGGGCAGATCTCCACTTAT
GACCCACCCGAGCACACCCGTTTGCGGAAAATGCTCACGCCGGAGTTCACGGTCCGCCGG
ATCCGCCGGATGGAGCCCGCGATCCAAAGTCTCATCGATGATCGCCTCGATCTGCTGGAG
GCCGAGGGGCCGTCCGCGGACCTCCAGGGCCTGTTCGCCGATCCGGTCGGCGCGCACGCC
CTGTGCGAACTGCTCGGCATCCCGCGCGACGACCAGCGTGAGTTCGTCCGGCGGATCAGG
CGGAACGCCGACCTGAGCCGGGGACTCAAGGCACGGGCCGCCGACAGCGCGGCGTTCAAC
CGGTATTTGGACAACCTCCTCGCCAGGCAGCGCGCCGACCCCGACGACGGTCTCCTCGGC
ATGATCGTGCGGGACCACGGCGACAACGTCACGGACGAGGAACTGAAGGGCCTCTGCACG
GCGCTGATCCTCGGCGGTGTCGAAACCGTCGCCGGGATGATCGGTTTCGGTGTCCTCGCC
CTCCTGGACAATCCCGGACAGATCGAGTTGCTTTTCGAGTCCCCCGAAAAGGCCGAACGC
GTCGTCAACGAACTCGTCCGGTATCTGTCCCCGGTGCAGGCGCCGAATCCGCGTCTCGCC
ATCAAGGACGTGGTCATCGACGGGCAGCTGATCAAGGCGGGGGACTACGTCCTGTGCTCG
ATTCTCATGGCCAACCGGGATGAGGCGCTGACCCCGGATCCCGACGTCCTCGACGCGAAT
CGCGCCGCGGTGTCGGACGTCGGATTCGGGCACGGCATCCATTACTGCGTCGGCGCGGCC
TTGGCCAGATCCATGCTGCGCATGGCTTATCAGACTTTGTGGCGGCGATTCCCGGGACTG
CGGCTGGCAGTGCCCATCGAAGAAGTGAAGTACCGCAGCGCGTTCGTAGATTGCCCTGAT
CAGGTACCGGTCACCTGGTGA

# Drug_Target_46_General_Function:
Involved in monooxygenase activity

# Drug_Target_46_General_References:
12207020	Zerbe K, Pylypenko O, Vitali F, Zhang W, Rouset S, Heck M, Vrijbloed JW, Bischoff D, Bister B, Sussmuth RD, Pelzer S, Wohlleben W, Robinson JA, Schlichting I: Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis. J Biol Chem. 2002 Dec 6;277(49):47476-85. Epub 2002 Aug 30.

# Drug_Target_46_HGNC_ID:
Not Available

# Drug_Target_46_HPRD_ID:
Not Available

# Drug_Target_46_ID:
4764

# Drug_Target_46_Locus:
Not Available

# Drug_Target_46_Molecular_Weight:
45188

# Drug_Target_46_Name:
Cytochrome P450 165C4

# Drug_Target_46_Number_of_Residues:
406

# Drug_Target_46_PDB_ID:
1UED

# Drug_Target_46_Pathway:
Not Available

# Drug_Target_46_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_46_Protein_Sequence:
>Cytochrome P450 165C4
MGHDIDQVAPLLREPANFQLRTNCDPHEDNFGLRAHGPLVRIVGESSTQLGRDFVWQAHG
YEVVRRILGDHEHFTTRPQFTQSKSGAHVEAQFVGQISTYDPPEHTRLRKMLTPEFTVRR
IRRMEPAIQSLIDDRLDLLEAEGPSADLQGLFADPVGAHALCELLGIPRDDQREFVRRIR
RNADLSRGLKARAADSAAFNRYLDNLLARQRADPDDGLLGMIVRDHGDNVTDEELKGLCT
ALILGGVETVAGMIGFGVLALLDNPGQIELLFESPEKAERVVNELVRYLSPVQAPNPRLA
IKDVVIDGQLIKAGDYVLCSILMANRDEALTPDPDVLDANRAAVSDVGFGHGIHYCVGAA
LARSMLRMAYQTLWRRFPGLRLAVPIEEVKYRSAFVDCPDQVPVTW

# Drug_Target_46_Reaction:
Not Available

# Drug_Target_46_Signals:
None

# Drug_Target_46_Specific_Function:
Involved in the coupling of aromatic side chains of the heptapeptide of vancomycin

# Drug_Target_46_SwissProt_ID:
Q8RN03

# Drug_Target_46_SwissProt_Name:
C5C4_AMYOR

# Drug_Target_46_Synonyms:
EC 1.14.-.-
Vancomycin biosynthesis protein oxyC

# Drug_Target_46_Theoretical_pI:
5.61

# Drug_Target_46_Transmembrane_Regions:
None

# Drug_Target_47_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_47_Chromosome_Location:
Not Available

# Drug_Target_47_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_47_Essentiality:
Non-Essential

# Drug_Target_47_GenAtlas_ID:
CYCS

# Drug_Target_47_GenBank_ID_Gene:
M22877

# Drug_Target_47_GenBank_ID_Protein:
181242

# Drug_Target_47_GeneCard_ID:
CYCS

# Drug_Target_47_Gene_Name:
CYCS

# Drug_Target_47_Gene_Sequence:
>318 bp
ATGGGTGATGTTGAGAAAGGCAAGAAGATTTTTATTATGAAGTGTTCCCAGTGCCACACC
GTTGAAAAGGGAGGCAAGCACAAGACTGGGCCAAATCTCCATGGTCTCTTTGGGCGGAAG
ACAGGTCAGGCCCCTGGATACTCTTACACAGCCGCCAATAAGAACAAAGGCATCATCTGG
GGAGAGGATACACTGATGGAGTATTTGGAGAATCCCAAGAAGTACATCCCTGGAACAAAA
ATGATCTTTGTCGGCATTAAGAAGAAGGAAGAAAGGGCAGACTTAATAGCTTATCTCAAA
AAAGCTACTAATGAGTAA

# Drug_Target_47_General_Function:
Energy production and conversion

# Drug_Target_47_General_References:
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
2849112	Evans MJ, Scarpulla RC: The human somatic cytochrome c gene: two classes of processed pseudogenes demarcate a period of rapid molecular evolution. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9625-9.
9515723	Skulachev VP: Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998 Feb 27;423(3):275-80.

# Drug_Target_47_HGNC_ID:
HGNC:19986

# Drug_Target_47_HPRD_ID:
00479

# Drug_Target_47_ID:
1507

# Drug_Target_47_Locus:
7p15.2

# Drug_Target_47_Molecular_Weight:
11749

# Drug_Target_47_Name:
Cytochrome c

# Drug_Target_47_Number_of_Residues:
105

# Drug_Target_47_PDB_ID:
1J3S

# Drug_Target_47_Pathway:
Not Available

# Drug_Target_47_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_47_Protein_Sequence:
>Cytochrome c
MGDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIW
GEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE

# Drug_Target_47_Reaction:
Not Available

# Drug_Target_47_Signals:
None

# Drug_Target_47_Specific_Function:
Plays a role in apoptosis. Suppression of the anti- apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases

# Drug_Target_47_SwissProt_ID:
P99999

# Drug_Target_47_SwissProt_Name:
CYC_HUMAN

# Drug_Target_47_Synonyms:
Not Available

# Drug_Target_47_Theoretical_pI:
10.16

# Drug_Target_47_Transmembrane_Regions:
None

# Drug_Target_48_Cellular_Location:
Not Available

# Drug_Target_48_Chromosome_Location:
Not Available

# Drug_Target_48_Drug_References:
Not Available

# Drug_Target_48_Essentiality:
Non-Essential

# Drug_Target_48_GenAtlas_ID:
Not Available

# Drug_Target_48_GenBank_ID_Gene:
Not Available

# Drug_Target_48_GenBank_ID_Protein:
Not Available

# Drug_Target_48_GeneCard_ID:
Not Available

# Drug_Target_48_Gene_Name:
Not Available

# Drug_Target_48_Gene_Sequence:
Not Available

# Drug_Target_48_General_Function:
Involved in iron ion binding

# Drug_Target_48_General_References:
9659396	Samyn B, Fitch J, Meyer TE, Cusanovich MA, Van Beeumen JJ: Purification and primary structure analysis of two cytochrome c2 isozymes from the purple phototrophic bacterium Rhodospirillum centenum. Biochim Biophys Acta. 1998 May 19;1384(2):345-55.

# Drug_Target_48_HGNC_ID:
Not Available

# Drug_Target_48_HPRD_ID:
Not Available

# Drug_Target_48_ID:
4936

# Drug_Target_48_Locus:
Not Available

# Drug_Target_48_Molecular_Weight:
13035

# Drug_Target_48_Name:
Cytochrome c2 iso-2

# Drug_Target_48_Number_of_Residues:
121

# Drug_Target_48_PDB_ID:
1JDL

# Drug_Target_48_Pathway:
Not Available

# Drug_Target_48_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_48_Protein_Sequence:
>Cytochrome c2 iso-2
EDGDPAKGEAVFKKCMACHRVGPDAKNLVGPALTGVIDRQAGTAPGFNYSAINHAAGEAG
LHWTPENIIAYLPDPNAFLRKFLADAGHAEQAKGSTKMVFKLPDEQERKDVVAYLKQFSP
Q

# Drug_Target_48_Reaction:
Not Available

# Drug_Target_48_Signals:
None

# Drug_Target_48_Specific_Function:
Cytochrome c2 is found mainly in purple, non-sulfur, photosynthetic bacteria where it functions as the electron donor to the oxidized bacteriochlorophyll in the photophosphorylation pathway. However, it may also have a role in the respiratory chain and is found in some non-photosynthetic bacteria

# Drug_Target_48_SwissProt_ID:
P81154

# Drug_Target_48_SwissProt_Name:
CYC22_RHOCE

# Drug_Target_48_Synonyms:
Cytochrome c552

# Drug_Target_48_Theoretical_pI:
6.94

# Drug_Target_48_Transmembrane_Regions:
None

# Drug_Target_49_Cellular_Location:
Not Available

# Drug_Target_49_Chromosome_Location:
Not Available

# Drug_Target_49_Drug_References:
Not Available

# Drug_Target_49_Essentiality:
Non-Essential

# Drug_Target_49_GenAtlas_ID:
Not Available

# Drug_Target_49_GenBank_ID_Gene:
AJ249578

# Drug_Target_49_GenBank_ID_Protein:
Not Available

# Drug_Target_49_GeneCard_ID:
Not Available

# Drug_Target_49_Gene_Name:
rcoxA

# Drug_Target_49_Gene_Sequence:
>951 bp
ATGTCCGGGATGATTCTGCTGCAGAATACGGCCTGGCTGCCCGAAGCGGCTTCTTCGATC
GCGCCGGAAGTGGACAGCCTGTTTCACTTCTGGACGCTGGTGAGCGCGATTATTTTCGTC
GGCGTCGTCGGCGCCATGACGTTCTTCGTGGTGCGCTATCGGCGCCGCCGGCGCGACGAA
GTGCCGGAGCCGGTGCAAGAGAAGAAGGTGGTCGAACTGGCCTGGATCGTGGTCCCGACG
ATCCTCGTGCTGATCGTCTTTGCCTGGGGCTTCCGGGTGTACATCAAGATGTACACGGCG
CCCCCGGATGCCTACGAAATCCTGGTTCACGGCTATCAGTGGTACTGGGAGTTCGAATAT
CCGAACGGGGTCAAGACCACGAACGAACTGCACGTGCCGGCCGGTCAGCCGGTGAAGCTC
CGCATGACCAGCGTCGACGTGATTCACAGCTTCTACGTGCCGGCCTTCCGGGTCAAACAG
GATGTGCTGCCCGATCGCTACTCGGCACTCTGGTTCGAGGCCACCAGACCCGGCGAGTAC
ACGGTCTTCTGCACGGAGTACTGCGGTACGCAGCACTCGGGCATGCTGGCCAAAGTGATC
GTGCATCCGCGTGAAGAGTTCGAGCAGTGGCTGGAAAGCGCCGGCATTCCCGAAGACATG
CCGCTGGCCGAGCTGGGCGCCCGGCTTTATCGAGAGAAGGCCTGCTTCAGCTGCCACAGC
ATCGACGGATCGCGCCTGGTAGGGCCTTCGTTCAAAGGCCTGTATGGTTCGACGCGTACG
TTCGAAGATGGCACCACGGCGGTCGCCGACGAAAACTATCTCCGGGAATCCATTCTACAA
CCCGGAGCTAAGGTTGTCCAGGGTTATCCGAATGTTATGCCGGCCAGCTACGCTTCGTTG
AGCGAACGCGAAGTGGCCGCGTTGATCGAGTTCATCAAGCAGCAGCAGTAA

# Drug_Target_49_General_Function:
Involved in copper ion binding

# Drug_Target_49_General_References:
11133964	Santana M, Pereira MM, Elias NP, Soares CM, Teixeira M: Gene cluster of Rhodothermus marinus high-potential iron-sulfur Protein: oxygen oxidoreductase, a caa(3)-type oxidase belonging to the superfamily of heme-copper oxidases. J Bacteriol. 2001 Jan;183(2):687-99.

# Drug_Target_49_HGNC_ID:
Not Available

# Drug_Target_49_HPRD_ID:
Not Available

# Drug_Target_49_ID:
4937

# Drug_Target_49_Locus:
Not Available

# Drug_Target_49_Molecular_Weight:
35924

# Drug_Target_49_Name:
Cytochrome oxidase subunit II

# Drug_Target_49_Number_of_Residues:
316

# Drug_Target_49_PDB_ID:
1W2L

# Drug_Target_49_Pathway:
Not Available

# Drug_Target_49_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF00116	COX2
PF02790	COX2_TM

# Drug_Target_49_Protein_Sequence:
>Cytochrome oxidase subunit II
MSGMILLQNTAWLPEAASSIAPEVDSLFHFWTLVSAIIFVGVVGAMTFFVVRYRRRRRDE
VPEPVQEKKVVELAWIVVPTILVLIVFAWGFRVYIKMYTAPPDAYEILVHGYQWYWEFEY
PNGVKTTNELHVPAGQPVKLRMTSVDVIHSFYVPAFRVKQDVLPDRYSALWFEATRPGEY
TVFCTEYCGTQHSGMLAKVIVHPREEFEQWLESAGIPEDMPLAELGARLYREKACFSCHS
IDGSRLVGPSFKGLYGSTRTFEDGTTAVADENYLRESILQPGAKVVQGYPNVMPASYASL
SEREVAALIEFIKQQQ

# Drug_Target_49_Reaction:
Not Available

# Drug_Target_49_Signals:
None

# Drug_Target_49_Specific_Function:
4 ferrocytochrome c + O(2) = 4 ferricytochrome c + 2 H(2)O

# Drug_Target_49_SwissProt_ID:
Q9F3S9

# Drug_Target_49_SwissProt_Name:
Q9F3S9_RHOMR

# Drug_Target_49_Synonyms:
EC 1.9.3.1

# Drug_Target_49_Theoretical_pI:
5.66

# Drug_Target_49_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AF133695

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
hemO

# Drug_Target_4_Gene_Sequence:
>693 bp
ATGCGGGCAAGTGCGGATTTTGCCCGCCCCGCATCCTTATCCCTTACCGACAAAGGAAAA
CTTATGAGTGAAACCGAAAATCAAGCCCTGACGTTTGCCAAACGTCTGAAGGCGGATACC
ACGGCGGTTCACGACAGCGTGGATAATCTCGTTATGTCTGTCCAACCGTTTGTCAGCAAA
GAAAACTACATCAAATTTTTGAAACTCCAATCCGTTTTCCACAAGGCGGTCGATCATATT
TATAAAGATGCCGAATTAAACAAAGCCATTCCCGAGCTGGAATACATGGCGCGATACGAT
GCCGTAACGCAAGACTTGAAAGACTTGGGCGAAGAGCCTTACAAATTCGACAAAGAATTG
CCATACGAAGCCGGCAACAAAGCAATCGGCTGGCTTTATTGCGCCGAAGGATCCAATTTG
GGCGCGGCGTTTTTGTTCAAACACGCGCAAAAACTCGATTACAACGGCGAACACGGCGCG
CGCCACCTCGCTCCGCATCCCGACGGGCGCGGCAAACACTGGCGCGCCTTCGTCGAGCAT
CTGAACGCTTTGAACCTGACTCCCGAAGCCGAAGCGGAAGCCATCCAAGGCGCGCGCGAA
GCCTTTGCATTCTACAAAGTCGTGTTGCGCGAAACCTTCGGTTTGGCAGCCGATGCCGAA
GCACCGGAAGGAATGATGCCGCACAGGCACTAA

# Drug_Target_4_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_4_General_References:
10629191	Zhu W, Hunt DJ, Richardson AR, Stojiljkovic I: Use of heme compounds as iron sources by pathogenic neisseriae requires the product of the hemO gene. J Bacteriol. 2000 Jan;182(2):439-47.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
5000

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
25792

# Drug_Target_4_Name:
HemO

# Drug_Target_4_Number_of_Residues:
230

# Drug_Target_4_PDB_ID:
1P3V

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_4_Protein_Sequence:
>HemO
MRASADFARPASLSLTDKGKLMSETENQALTFAKRLKADTTAVHDSVDNLVMSVQPFVSK
ENYIKFLKLQSVFHKAVDHIYKDAELNKAIPELEYMARYDAVTQDLKDLGEEPYKFDKEL
PYEAGNKAIGWLYCAEGSNLGAAFLFKHAQKLDYNGEHGARHLAPHPDGRGKHWRAFVEH
LNALNLTPEAEAEAIQGAREAFAFYKVVLRETFGLAADAEAPEGMMPHRH

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
Q9RGD9

# Drug_Target_4_SwissProt_Name:
Q9RGD9_NEIME

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
6.44

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_50_Cellular_Location:
Not Available

# Drug_Target_50_Chromosome_Location:
Not Available

# Drug_Target_50_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_50_Essentiality:
Non-Essential

# Drug_Target_50_GenAtlas_ID:
Not Available

# Drug_Target_50_GenBank_ID_Gene:
X68081

# Drug_Target_50_GenBank_ID_Protein:
581368

# Drug_Target_50_GeneCard_ID:
Not Available

# Drug_Target_50_Gene_Name:
katG

# Drug_Target_50_Gene_Sequence:
>2223 bp
GTGCCCGAGCAACACCCACCCATTACAGAAACCACCACCGGAGCCGCTAGCAACGGCTGT
CCCGTCGTGGGTCATATGAAATACCCCGTCGAGGGCGGCGGAAACCAGGACTGGTGGCCC
AACCGGCTCAATCTGAAGGTACTGCACCAAAACCCGGCCGTCGCTGACCCGATGGGTGCG
GCGTTCGACTATGCCGCGGAGGTCGCGACCATCGACGTTGACGCCCTGACGCGGGACATC
GAGGAAGTGATGACCACCTCGCAGCCGTGGTGGCCCGCCGACTACGGCCACTACGGGCCG
CTGTTTATCCGGATGGCGTGGCACGCTGCCGGCACCTACCGCATCCACGACGGCCGCGGC
GGCGCCGGGGGCGGCATGCAGCGGTTCGCGCCGCTTAACAGCTGGCCCGACAACGCCAGC
TTGGACAAGGCGCGCCGGCTGCTGTGGCCGGTCAAGAAGAAGTACGGCAAGAAGCTCTCA
TGGGCGGACCTGATTGTTTTCGCCGGCAACTGCGCGCTGGAATCGATGGGCTTCAAGACG
TTCGGGTTCGGCTTCGGCCGGGTCGACCAGTGGGAGCCCGATGAGGTCTATTGGGGCAAG
GAAGCCACCTGGCTCGGCGATGAGCGTTACAGCGGTAAGCGGGATCTGGAGAACCCGCTG
GCCGCGGTGCAGATGGGGCTGATCTACGTGAACCCGGAGGCGCCGAACGGCAACCCGGAC
CCCATGGCCGCGGCGGTCGACATTCGCGAGACGTTTCGGCGCATGGCCATGAACGACGTC
GAAACAGCGGCGCTGATCGTCGGCGGTCACACTTTCGGTAAGACCCATGGCGCCGGCCCG
GCCGATCTGGTCGGCCCCGAACCCGAGGCTGCTCCGCTGGAGCAGATGGGCTTGGGCTGG
AAGAGCTCGTATGGCACCGGAACCGGTAAGGACGCGATCACCAGCGGCATCGAGGTCGTA
TGGACGAACACCCCGACGAAATGGGACAACAGTTTCCTCGAGATCCTGTACGGCTACGAG
TGGGAGCTGACGAAGAGCCCTGCTGGCGCTTGGCAATACACCGCCAAGGACGGCGCCGGT
GCCGGCACCATCCCGGACCCGTTCGGCGGGCCAGGGCGCTCCCCGACGATGCTGGCCACT
GACCTCTCGCTGCGGGTGGATCCGATCTATGAGCGGATCACGCGTCGCTGGCTGGAACAC
CCCGAGGAATTGGCCGACGAGTTCGCCAAGGCCTGGTACAAGCTGATCCACCGAGACATG
GGTCCCGTTGCGAGATACCTTGGGCCGCTGGTCCCCAAGCAGACCCTGCTGTGGCAGGAT
CCGGTCCCTGCGGTCAGCCACGACCTCGTCGGCGAAGCCGAGATTGCCAGCCTTAAGAGC
CAGATCCGGGCATCGGGATTGACTGTCTCACAGCTAGTTTCGACCGCATGGGCGGCGGCG
TCGTCGTTCCGTGGTAGCGACAAGCGCGGCGGCGCCAACGGTGGTCGCATCCGCCTGCAG
CCACAAGTCGGGTGGGAGGTCAACGACCCCGACGGGGATCTGCGCAAGGTCATTCGCACC
CTGGAAGAGATCCAGGAGTCATTCAACTCCGCGGCGCCGGGGAACATCAAAGTGTCCTTC
GCCGACCTCGTCGTGCTCGGTGGCTGTGCCGCCATAGAGAAAGCAGCAAAGGCGGCTGGC
CACAACATCACGGTGCCCTTCACCCCGGGCCGCACGGATGCGTCGCAGGAACAAACCGAC
GTGGAATCCTTTGCCGTGCTGGAGCCCAAGGCAGATGGCTTCCGAAACTACCTCGGAAAG
GGCAACCCGTTGCCGGCCGAGTACATGCTGCTCGACAAGGCGAACCTGCTTACGCTCAGT
GCCCCTGAGATGACGGTGCTGGTAGGTGGCCTGCGCGTCCTCGGCGCAAACTACAAGCGC
TTACCGCTGGGCGTGTTCACCGAGGCCTCCGAGTCACTGACCAACGACTTCTTCGTGAAC
CTGCTCGACATGGGTATCACCTGGGAGCCCTCGCCAGCAGATGACGGGACCTACCAGGGC
AAGGATGGCAGTGGCAAGGTGAAGTGGACCGGCAGCCGCGTGGACCTGGTCTTCGGGTCC
AACTCGGAGTTGCGGGCGCTTGTCGAGGTCTATGGCGCCGATGACGCGCAGCCGAAGTTC
GTGCAGGACTTCGTCGCTGCCTGGGACAAGGTGATGAACCTCGACAGGTTCGACGTGCGC
TGA

# Drug_Target_50_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_50_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
1501713	Zhang Y, Heym B, Allen B, Young D, Cole S: The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992 Aug 13;358(6387):591-3.
8320241	Heym B, Zhang Y, Poulet S, Young D, Cole ST: Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol. 1993 Jul;175(13):4255-9.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_50_HGNC_ID:
Not Available

# Drug_Target_50_HPRD_ID:
Not Available

# Drug_Target_50_ID:
518

# Drug_Target_50_Locus:
Not Available

# Drug_Target_50_Molecular_Weight:
80605

# Drug_Target_50_Name:
Peroxidase/catalase T

# Drug_Target_50_Number_of_Residues:
740

# Drug_Target_50_PDB_ID:
1SJ2

# Drug_Target_50_Pathway:
Not Available

# Drug_Target_50_Pfam_Domain_Function:
PF00141	peroxidase

# Drug_Target_50_Protein_Sequence:
>Peroxidase/catalase T
MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGA
AFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRG
GAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKT
FGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPD
PMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGW
KSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAG
AGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDM
GPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAA
SSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSF
ADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGK
GNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVN
LLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKF
VQDFVAAWDKVMNLDRFDVR

# Drug_Target_50_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_50_Signals:
None

# Drug_Target_50_Specific_Function:
Bifunctional, exhibiting both a catalase and broad- spectrum peroxidase activities. May play a role in the intracellular survival of mycobacteria

# Drug_Target_50_SwissProt_ID:
Q08129

# Drug_Target_50_SwissProt_Name:
KATG_MYCTU

# Drug_Target_50_Synonyms:
Catalase-peroxidase T
EC 1.11.1.6

# Drug_Target_50_Theoretical_pI:
4.87

# Drug_Target_50_Transmembrane_Regions:
None

# Drug_Target_51_Cellular_Location:
Not Available

# Drug_Target_51_Chromosome_Location:
Not Available

# Drug_Target_51_Drug_References:
Not Available

# Drug_Target_51_Essentiality:
Non-Essential

# Drug_Target_51_GenAtlas_ID:
Not Available

# Drug_Target_51_GenBank_ID_Gene:
M93437

# Drug_Target_51_GenBank_ID_Protein:
Not Available

# Drug_Target_51_GeneCard_ID:
Not Available

# Drug_Target_51_Gene_Name:
cycA

# Drug_Target_51_Gene_Sequence:
>447 bp
ATGAAACGGACGCTCATGGCTTTCTTGCTGCTCGGCGGCCTGGCCCTGGCCCAGGCGGAC
GGGGCCAAGATCTACGCCCAGTGCGCGGGGTGCCACCAGCAAAACGGCCAAGGCATCCCC
GGGGCCTTCCCGCCCCTCGCGGGCCACGTGGCGGAGATCCTCGCCAAGGAAGGCGGTAGG
GAGTACCTCATCCTGGTCCTTCTCTACGGCCTCCAGGGCCAGATTGAGGTCAAGGGCATG
AAGTACAACGGCGTCATGTCCTCCTTCGCCCAGCTCAAGGACGAGGAGATCGCCGCCGTC
CTCAACCACATCGCCACCGCCTGGGGCGACGCAAAGAAGGTCAAGGGCTTCAAGCCCTTC
ACCGCCGAGGAGGTGAAGAAGCTCCGGGCCAAGAAGCTCACCCCCCAGCAGGTGCTGGCA
GAGCGGAAGAAGCTCGGCCTGAAGTAA

# Drug_Target_51_General_Function:
Involved in iron ion binding

# Drug_Target_51_General_References:
11152119	Fee JA, Chen Y, Todaro TR, Bren KL, Patel KM, Hill MG, Gomez-Moran E, Loehr TM, Ai J, Thony-Meyer L, Williams PA, Stura E, Sridhar V, McRee DE: Integrity of thermus thermophilus cytochrome c552 synthesized by Escherichia coli cells expressing the host-specific cytochrome c maturation genes, ccmABCDEFGH: biochemical, spectral, and structural characterization of the recombinant protein. Protein Sci. 2000 Nov;9(11):2074-84.
2986626	Titani K, Ericsson LH, Hon-nami K, Miyazawa T: Amino acid sequence of cytochrome c-552 from Thermus thermophilus HB8. Biochem Biophys Res Commun. 1985 Apr 30;128(2):781-7.

# Drug_Target_51_HGNC_ID:
Not Available

# Drug_Target_51_HPRD_ID:
Not Available

# Drug_Target_51_ID:
4938

# Drug_Target_51_Locus:
Not Available

# Drug_Target_51_Molecular_Weight:
15974

# Drug_Target_51_Name:
Cytochrome c-552

# Drug_Target_51_Number_of_Residues:
148

# Drug_Target_51_PDB_ID:
1FOC

# Drug_Target_51_Pathway:
Not Available

# Drug_Target_51_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_51_Protein_Sequence:
>Cytochrome c-552
MKRTLMAFLLLGGLALAQADGAKIYAQCAGCHQQNGQGIPGAFPPLAGHVAEILAKEGGR
EYLILVLLYGLQGQIEVKGMKYNGVMSSFAQLKDEEIAAVLNHIATAWGDAKKVKGFKPF
TAEEVKKLRAKKLTPQQVLAERKKLGLK

# Drug_Target_51_Reaction:
Not Available

# Drug_Target_51_Signals:
1-17

# Drug_Target_51_Specific_Function:
This monoheme basic protein appears to function as an electron donor to cytochrome oxidase in T.thermophilus

# Drug_Target_51_SwissProt_ID:
Q5SME3

# Drug_Target_51_SwissProt_Name:
CY552_THET8

# Drug_Target_51_Synonyms:
Cytochrome c-552 precursor
Cytochrome c552

# Drug_Target_51_Theoretical_pI:
10.25

# Drug_Target_51_Transmembrane_Regions:
None

# Drug_Target_52_Cellular_Location:
Not Available

# Drug_Target_52_Chromosome_Location:
Not Available

# Drug_Target_52_Drug_References:
Not Available

# Drug_Target_52_Essentiality:
Non-Essential

# Drug_Target_52_GenAtlas_ID:
Not Available

# Drug_Target_52_GenBank_ID_Gene:
M12776

# Drug_Target_52_GenBank_ID_Protein:
Not Available

# Drug_Target_52_GeneCard_ID:
Not Available

# Drug_Target_52_Gene_Name:
cycA

# Drug_Target_52_Gene_Sequence:
>414 bp
ATGAAGATCAGCCTCACTGCCGCCACTGTCGCCGCGCTCGTGCTCGCCGCCCCCGCTTTC
GCGGGCGACGCCGCGAAGGGCGAAAAAGAATTCAACAAGTGCAAGACCTGCCACTCGATC
ATCGCGCCCGACGGGACCGAGATCGTGAAAGGCGCGAAGACCGGCCCGAACCTCTACGGC
GTCGTCGGCCGCACCGCCGGCACCTACCCGGAGTTCAAATACAAGGACTCGATCGTCGCG
CTCGGCGCCTCGGGCTTCGCCTGGACCGAGGAAGACATCGCGACCTATGTGAAAGACCCG
GGCGCCTTCCTGAAGGAAAAACTCGACGACAAGAAAGCCAAGACCGGCATGGCGTTCAAA
CTCGCCAAGGGCGGCGAAGACGTCGCGGCCTATCTGGCCTCGGTCGTGAAATAA

# Drug_Target_52_General_Function:
Involved in iron ion binding

# Drug_Target_52_General_References:
1651396	Benning MM, Wesenberg G, Caffrey MS, Bartsch RG, Meyer TE, Cusanovich MA, Rayment I, Holden HM: Molecular structure of cytochrome c2 isolated from Rhodobacter capsulatus determined at 2.5 A resolution. J Mol Biol. 1991 Aug 5;220(3):673-85.
2159796	Gooley PR, Caffrey MS, Cusanovich MA, MacKenzie NE: Assignment of the 1H and 15N NMR spectra of Rhodobacter capsulatus ferrocytochrome c2. Biochemistry. 1990 Mar 6;29(9):2278-90.
221822	Ambler RP, Daniel M, Hermoso J, Meyer TE, Bartsch RG, Kamen MD: Cytochrome c2 sequence variation among the recognised species of purple nonsulphur photosynthetic bacteria. Nature. 1979 Apr 12;278(5705):659-60.
9698552	Cordier F, Caffrey M, Brutscher B, Cusanovich MA, Marion D, Blackledge M: Solution structure, rotational diffusion anisotropy and local backbone dynamics of Rhodobacter capsulatus cytochrome c2. J Mol Biol. 1998 Aug 14;281(2):341-61.

# Drug_Target_52_HGNC_ID:
Not Available

# Drug_Target_52_HPRD_ID:
Not Available

# Drug_Target_52_ID:
4939

# Drug_Target_52_Locus:
Not Available

# Drug_Target_52_Molecular_Weight:
14280

# Drug_Target_52_Name:
Cytochrome c2

# Drug_Target_52_Number_of_Residues:
137

# Drug_Target_52_PDB_ID:
1C2N

# Drug_Target_52_Pathway:
Not Available

# Drug_Target_52_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_52_Protein_Sequence:
>Cytochrome c2
MKISLTAATVAALVLAAPAFAGDAAKGEKEFNKCKTCHSIIAPDGTEIVKGAKTGPNLYG
VVGRTAGTYPEFKYKDSIVALGASGFAWTEEDIATYVKDPGAFLKEKLDDKKAKTGMAFK
LAKGGEDVAAYLASVVK

# Drug_Target_52_Reaction:
Not Available

# Drug_Target_52_Signals:
1-21

# Drug_Target_52_Specific_Function:
Cytochrome c2 is found mainly in purple, non-sulfur, photosynthetic bacteria where it functions as the electron donor to the oxidized bacteriochlorophyll in the photophosphorylation pathway. However, it may also have a role in the respiratory chain and is found in some non-photosynthetic bacteria

# Drug_Target_52_SwissProt_ID:
P00094

# Drug_Target_52_SwissProt_Name:
CYC2_RHOCA

# Drug_Target_52_Synonyms:
Cytochrome c2 precursor

# Drug_Target_52_Theoretical_pI:
9.04

# Drug_Target_52_Transmembrane_Regions:
None

# Drug_Target_53_Cellular_Location:
Periplasm (Probable)

# Drug_Target_53_Chromosome_Location:
Not Available

# Drug_Target_53_Drug_References:
Not Available

# Drug_Target_53_Essentiality:
Non-Essential

# Drug_Target_53_GenAtlas_ID:
Not Available

# Drug_Target_53_GenBank_ID_Gene:
AF001355

# Drug_Target_53_GenBank_ID_Protein:
Not Available

# Drug_Target_53_GeneCard_ID:
Not Available

# Drug_Target_53_Gene_Name:
katB

# Drug_Target_53_Gene_Sequence:
>1533 bp
TCAGTCCTTGAGGCTTGCAGCCAGGGACTTGACCTTGCTCAGATCGCCTTTGGCGACTTC
GGCTACCCGAGTGCCGTAGTGCCGGTCTTCCTTGTACAGGACCGACAGCATGATGTTCTT
GCTTTCAGTATGGGTGTCGGCCAACGACTCGCCGAATCTCTGCACCAGGTCAGTCTTCTC
TTTCGCGCTGTAGGAGCGAAACAGATCACCCGCCTGCTTGAAGTTCTGCTCACGCGTGAT
CTTCGCCTGCTGGGTAGTTCCACTGAGCGGCAGTTCGCTGTAGCGCGCCTTGTCATCCGC
TGGACGAGGTTCCAGACGGCTCGGCTCATAGTTGACCCCGCTGGTGGTGTGGCCAGTGTT
CAGCGCACCGTCCTGATTACCGTTGTTGACCGCAACCTTGGGCTGGTTGACAGGCAGGCT
CAGACCAATCGCGCCAAGGCGATACATCTGGGTGTCAGCGTAGGAGAACACACGGCCTTG
CAACAGGCGGTCTTCGGAAGGTTCGATACCTGGAACCAGGTTGGCCGGGGCCATGGCGAC
CTGCTCGGTTTCCTGGAAGAAGTTATCGACGTTCTTGTTCAAGACCATCTGCCCGATCTT
CTTCTCGGGAACGTCCGGCCAGATCTTGGTGGCGTCCAATGGATCGAAGTCGAATTTCGC
CAGCTCTTCAGGCTTCAGGACCTGAACGTACAAATCCCATTTCGGGAAGTCACCCTTTTT
GATCGCACCAACCAGGTCGTTGGTCAGGTGGCTGTAGTCCTTGGACTGGACCTGAGCGAC
TTCCTTGGGATCAAGGTTCTTGATGCCCTGCAGGGATTTCCAGTGGAACTTGACGTAGTG
CACTTCGCCCTTGGCATTGACCAGTTTGTAGGCGTGTACACCGTTGCCATCCATGAAGCG
ATAGCCTGCTGGGGTGCCCTCGTTCGAATACAACAGGGTCAGCGTACGGGTGGCTTCCGG
TACGTGGGAGAAGAAGTCGAAGCGACGCGAGTCGTTGTCCAGGTTGGTACGTGGATCAGG
TTTGAACGCGTGGACCATGTCCGGGAACTTGATGGCATCACGAATGAAGAACGTCGGGAA
GTTGTTGCCAACCAGGTCCCAGTTACCGTCAGCCGTGTAGAACTTGGTGGCGAAGCCGTG
CGGGTCGCGCAGGGTTTCAGGCGAGTGATTGCCGTGAACCACGGAGGAGAAGCGTACAAA
TACCGGCGTCTTCTCACCGGATTTGAAAACGGTCGCCTTGCTCAGATCACTGATGTCGGC
AGAGGCCGTAAACTCGCCTTTGACGCCGGTGCCGCGCGCATGCACGACGCGCTCGGGGAT
GCGTTCGCGATCAAAGCGCTGCAGCTTTTGCAGCAACTGAACGTCTTGCAGCAGGACAGG
GCCCTGGGCGCCTGCGGTCTGAGAGTTCTGATTGTCGCCGACGACGGCGCCATTGTCGCG
GGTCAGGGTGTCGGTTGCATAAACGGTCGGAACAGTAATCAGACCGGCTGCAGTCAGGCA
CACCATGTGTCTGGACCAGTTTAATAACGGCAT

# Drug_Target_53_General_Function:
Involved in catalase activity

# Drug_Target_53_General_References:
7546603	Klotz MG, Kim YC, Katsuwon J, Anderson AJ: Cloning, characterization and phenotypic expression in Escherichia coli of catF, which encodes the catalytic subunit of catalase isozyme CatF of Pseudomonas syringae. Appl Microbiol Biotechnol. 1995 Aug-Sep;43(4):656-66.

# Drug_Target_53_HGNC_ID:
Not Available

# Drug_Target_53_HPRD_ID:
Not Available

# Drug_Target_53_ID:
4941

# Drug_Target_53_Locus:
Not Available

# Drug_Target_53_Molecular_Weight:
56866

# Drug_Target_53_Name:
Catalase

# Drug_Target_53_Number_of_Residues:
510

# Drug_Target_53_PDB_ID:
1M7S

# Drug_Target_53_Pathway:
Not Available

# Drug_Target_53_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_53_Protein_Sequence:
>Catalase
MPLLNWSRHMVCLTAAGLITVPTVYATDTLTRDNGAVVGDNQNSQTAGAQGPVLLQDVQL
LQKLQRFDRERIPERVVHARGTGVKGEFTASADISDLSKATVFKSGEKTPVFVRFSSVVH
GNHSPETLRDPHGFATKFYTADGNWDLVGNNFPTFFIRDAIKFPDMVHAFKPDPRTNLDN
DSRRFDFFSHVPEATRTLTLLYSNEGTPAGYRFMDGNGVHAYKLVNAKGEVHYVKFHWKS
LQGIKNLDPKEVAQVQSKDYSHLTNDLVGAIKKGDFPKWDLYVQVLKPEELAKFDFDPLD
ATKIWPDVPEKKIGQMVLNKNVDNFFQETEQVAMAPANLVPGIEPSEDRLLQGRVFSYAD
TQMYRLGAIGLSLPVNQPKVAVNNGNQDGALNTGHTTSGVNYEPSRLEPRPADDKARYSE
LPLSGTTQQAKITREQNFKQAGDLFRSYSAKEKTDLVQRFGESLADTHTESKNIMLSVLY
KEDRHYGTRVAEVAKGDLSKVKSLAASLKD

# Drug_Target_53_Reaction:
Not Available

# Drug_Target_53_Signals:
1-26

# Drug_Target_53_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_53_SwissProt_ID:
P46206

# Drug_Target_53_SwissProt_Name:
CATB_PSESY

# Drug_Target_53_Synonyms:
Catalase precursor
EC 1.11.1.6

# Drug_Target_53_Theoretical_pI:
7.52

# Drug_Target_53_Transmembrane_Regions:
None

# Drug_Target_54_Cellular_Location:
Periplasm (By similarity)

# Drug_Target_54_Chromosome_Location:
Not Available

# Drug_Target_54_Drug_References:
Not Available

# Drug_Target_54_Essentiality:
Non-Essential

# Drug_Target_54_GenAtlas_ID:
Not Available

# Drug_Target_54_GenBank_ID_Gene:
L42023

# Drug_Target_54_GenBank_ID_Protein:
Not Available

# Drug_Target_54_GeneCard_ID:
Not Available

# Drug_Target_54_Gene_Name:
napB

# Drug_Target_54_Gene_Sequence:
>453 bp
GTGATTAATATGACTAAACAGGTATCTAAAATTTTAGCGGGATTATTTACCGCACTTTTT
GCTGGCTCACTGATGGCATCTGATGCACCAGCAGTGGGAAAAGATTTAACTCAAGCGGCA
GAAAATATTCCACCCGCATTTCATAATGCACCGCGTCAAGGCGAATTACCCGCATTGAAC
TATGTAAATCAGCCTCCAATGGTTCCACATAGTGTGGCAAACTATCAAGTGACAAAAAAT
GTAAATCAATGTTTAAATTGCCACAGCCCAGAAAATTCTCGTTTGAGCGGTGCAACTCGA
ATCAGCCCAACTCACTTTATGGATCGTGATGGAAAAGTAGGTTCAAGTTCATCGCCACGT
CGTTATTTCTGTTTACAATGTCACGTTTCTCAAGCAAACGTAGATCCGATTGTTCCAAAT
GATTTCAAACCGATGAAAGGTTACGGAAACTAA

# Drug_Target_54_General_Function:
Energy production and conversion

# Drug_Target_54_General_References:
11223519	Brige A, Leys D, Van Beeumen JJ: Crystallization and preliminary X-ray analysis of the recombinant dihaem cytochrome c (NapB) from Haemophilus influenzae. Acta Crystallogr D Biol Crystallogr. 2001 Mar;57(Pt 3):418-20.
11389694	Brige A, Cole JA, Hagen WR, Guisez Y, Van Beeumen JJ: Overproduction, purification and novel redox properties of the dihaem cytochrome c, NapB, from Haemophilus influenzae. Biochem J. 2001 Jun 15;356(Pt 3):851-8.
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_54_HGNC_ID:
Not Available

# Drug_Target_54_HPRD_ID:
Not Available

# Drug_Target_54_ID:
4942

# Drug_Target_54_Locus:
Not Available

# Drug_Target_54_Molecular_Weight:
16255

# Drug_Target_54_Name:
Diheme cytochrome c napB

# Drug_Target_54_Number_of_Residues:
150

# Drug_Target_54_PDB_ID:
1JNI

# Drug_Target_54_Pathway:
Not Available

# Drug_Target_54_Pfam_Domain_Function:
PF03892	NapB

# Drug_Target_54_Protein_Sequence:
>Diheme cytochrome c napB
MINMTKQVSKILAGLFTALFAGSLMASDAPAVGKDLTQAAENIPPAFHNAPRQGELPALN
YVNQPPMVPHSVANYQVTKNVNQCLNCHSPENSRLSGATRISPTHFMDRDGKVGSSSSPR
RYFCLQCHVSQANVDPIVPNDFKPMKGYGN

# Drug_Target_54_Reaction:
Not Available

# Drug_Target_54_Signals:
1-26

# Drug_Target_54_Specific_Function:
Small subunit of the periplasmic nitrate reductase (NAP). Only expressed at high levels during aerobic growth. NapAB complex receives electrons from the membrane-anchored tetraheme napC protein, thus allowing electron flow between membrane and periplasm. Essential function for nitrate assimilation and may have a role in anaerobic metabolism (By similarity)

# Drug_Target_54_SwissProt_ID:
P44654

# Drug_Target_54_SwissProt_Name:
NAPB_HAEIN

# Drug_Target_54_Synonyms:
Diheme cytochrome c napB precursor

# Drug_Target_54_Theoretical_pI:
8.95

# Drug_Target_54_Transmembrane_Regions:
None

# Drug_Target_55_Cellular_Location:
Cellular thylakoid lumen (Potential)

# Drug_Target_55_Chromosome_Location:
Not Available

# Drug_Target_55_Drug_References:
Not Available

# Drug_Target_55_Essentiality:
Non-Essential

# Drug_Target_55_GenAtlas_ID:
Not Available

# Drug_Target_55_GenBank_ID_Gene:
Not Available

# Drug_Target_55_GenBank_ID_Protein:
Not Available

# Drug_Target_55_GeneCard_ID:
Not Available

# Drug_Target_55_Gene_Name:
petJ

# Drug_Target_55_Gene_Sequence:
Not Available

# Drug_Target_55_General_Function:
Involved in iron ion binding

# Drug_Target_55_General_References:
11478889	Sawaya MR, Krogmann DW, Serag A, Ho KK, Yeates TO, Kerfeld CA: Structures of cytochrome c-549 and cytochrome c6 from the cyanobacterium Arthrospira maxima. Biochemistry. 2001 Aug 7;40(31):9215-25.
12077429	Kerfeld CA, Sawaya MR, Krogmann DW, Yeates TO: Structure of cytochrome c6 from Arthrospira maxima: an assembly of 24 subunits in a nearly symmetric shell. Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1104-10. Epub 2002 Jun 20.
803642	Ambler RP, Bartsch RG: Amino acid sequence similarity between cytochrome f from a blue-green bacterium and algal chloroplasts. Nature. 1975 Jan 24;253(5489):285-8.

# Drug_Target_55_HGNC_ID:
Not Available

# Drug_Target_55_HPRD_ID:
Not Available

# Drug_Target_55_ID:
4943

# Drug_Target_55_Locus:
Not Available

# Drug_Target_55_Molecular_Weight:
9236

# Drug_Target_55_Name:
Cytochrome c6

# Drug_Target_55_Number_of_Residues:
89

# Drug_Target_55_PDB_ID:
1KIB

# Drug_Target_55_Pathway:
Not Available

# Drug_Target_55_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_55_Protein_Sequence:
>Cytochrome c6
GDVAAGASVFSANCAACHMGGRNVIVANKTLSKSDLAKYLKGFDDDAVAAVAYQVTNGKN
AMPGFNGRLSPKQIEDVAAYVVDQAEKGW

# Drug_Target_55_Reaction:
Not Available

# Drug_Target_55_Signals:
None

# Drug_Target_55_Specific_Function:
Functions as an electron carrier between membrane-bound cytochrome b6-f and photosystem I in oxygenic photosynthesis

# Drug_Target_55_SwissProt_ID:
P00118

# Drug_Target_55_SwissProt_Name:
CYC6_SPIMA

# Drug_Target_55_Synonyms:
Cytochrome c- 553
Cytochrome c553
Soluble cytochrome f

# Drug_Target_55_Theoretical_pI:
7.25

# Drug_Target_55_Transmembrane_Regions:
None

# Drug_Target_56_Cellular_Location:
Periplasm

# Drug_Target_56_Chromosome_Location:
Not Available

# Drug_Target_56_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_56_Essentiality:
Non-Essential

# Drug_Target_56_GenAtlas_ID:
Not Available

# Drug_Target_56_GenBank_ID_Gene:
U05988

# Drug_Target_56_GenBank_ID_Protein:
516878

# Drug_Target_56_GeneCard_ID:
Not Available

# Drug_Target_56_Gene_Name:
cc4

# Drug_Target_56_Gene_Sequence:
>633 bp
ATGAACAAAGTACTCGTGAGTCTGCTGTTGACCCTTGGCATCACCGGTATGGCCCACGCG
GCTGGAGACGCCGAAGCTGGTCAGGGCAAAGTTGCAGTGTGTGGTGCGTGCCACGGTGTC
GATGGCAACAGCCCGGCGCCGAATTTCCCGAAACTGGCTGGCCAGGGTGAGCGTTACCTG
CTCAAGCAACTGCAGGACATCAAGGCTGGCAGCACACCGGGTGCCCCGGAAGGCGTAGGT
CGCAAGGTGTTGGAAATGACCGGCATGCTGGACCCGCTGAGTGATCAGGATCTGGAAGAC
ATCGCCGCCTACTTCTCAAGCCAGAAGGGCAGTGTTGGTTACGCCGATCCGGCTCTGGCA
AAGCAGGGCGAGAAACTGTTCCGTGGTGGCAAGCTCGATCAGGGCATGCCGGCGTGCACC
GGTTGCCACGCACCCAACGGCGTCGGTAACGACCTGGCTGGCTTCCCCAAGCTGGGTGGG
CAGCACGCGGCGTACACCGCCAAGCAGCTGACCGACTTCCGCGAAGGCAATCGCACCAAC
GACGGCGACACCATGATCATGCGTGGCGTCGCCGCCAAGCTGAGCAACAAGGACATCGAA
GCGCTGTCCAGCTACATCCAGGGCCTGCACTGA

# Drug_Target_56_General_Function:
Energy production and conversion

# Drug_Target_56_General_References:
8026750	Christensen HE: Cloning and characterisation of the gene encoding cytochrome c4 from Pseudomonas stutzeri. Gene. 1994 Jun 24;144(1):139-40.
9032080	Kadziola A, Larsen S: Crystal structure of the dihaem cytochrome c4 from Pseudomonas stutzeri determined at 2.2A resolution. Structure. 1997 Feb 15;5(2):203-16.

# Drug_Target_56_HGNC_ID:
Not Available

# Drug_Target_56_HPRD_ID:
Not Available

# Drug_Target_56_ID:
3221

# Drug_Target_56_Locus:
Not Available

# Drug_Target_56_Molecular_Weight:
21742

# Drug_Target_56_Name:
Cytochrome c4

# Drug_Target_56_Number_of_Residues:
210

# Drug_Target_56_PDB_ID:
1M70

# Drug_Target_56_Pathway:
Not Available

# Drug_Target_56_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_56_Protein_Sequence:
>Cytochrome c4 precursor
MNKVLVSLLLTLGITGMAHAAGDAEAGQGKVAVCGACHGVDGNSPAPNFPKLAGQGERYL
LKQLQDIKAGSTPGAPEGVGRKVLEMTGMLDPLSDQDLEDIAAYFSSQKGSVGYADPALA
KQGEKLFRGGKLDQGMPACTGCHAPNGVGNDLAGFPKLGGQHAAYTAKQLTDFREGNRTN
DGDTMIMRGVAAKLSNKDIEALSSYIQGLH

# Drug_Target_56_Reaction:
Not Available

# Drug_Target_56_Signals:
1-20

# Drug_Target_56_Specific_Function:
Diheme, high potential cytochrome c believed to be an intermediate electron donor to terminal oxidation systems

# Drug_Target_56_SwissProt_ID:
Q52369

# Drug_Target_56_SwissProt_Name:
CYC4_PSEST

# Drug_Target_56_Synonyms:
Cytochrome c4 precursor

# Drug_Target_56_Theoretical_pI:
6.67

# Drug_Target_56_Transmembrane_Regions:
None

# Drug_Target_57_Cellular_Location:
Cell inner membrane

# Drug_Target_57_Chromosome_Location:
Not Available

# Drug_Target_57_Drug_References:
Not Available

# Drug_Target_57_Essentiality:
Non-Essential

# Drug_Target_57_GenAtlas_ID:
Not Available

# Drug_Target_57_GenBank_ID_Gene:
Z21854

# Drug_Target_57_GenBank_ID_Protein:
Not Available

# Drug_Target_57_GeneCard_ID:
Not Available

# Drug_Target_57_Gene_Name:
fixL

# Drug_Target_57_Gene_Sequence:
>1518 bp
ATGCTTTCAAAAAGCGGTATTGAGCGGACTCAGTGGGGACGGCGGGTCGTCAGGTGGAGA
GGCGACGGCGTCGCAGCCTATATTGTCGCCGCGATCGTCACGTCGAGCGTTCTTGCGATC
AGAATGATACGCGCCGAACCAATCGGCGAAGGCCTTCTTCTCTTCTCGTTTATCCCGGCC
ATCCTCGTTGTGGCGCTGATCGGCGGCCGCAATCCGATCCTCTTTGCAGCCGGGCTGTCG
CTCGTTGCAGCGGTGTCTCATCAGCAGATCTCGAGCGCCGACGGTCCGAGTGTCGTGGAA
CTGCTGGTCTTCGGGTCGGCAGTGCTTCTGATCGTGGCACTGGGAGAAGTGCTTGAGGCG
GCAAGACGCGCCATCGACCGGACCGAGGACGTCGTAAGGGCCCGCGACGCTCATCTGAGA
TCCATACTGGATACTGTTCCGGACGCTACAGTGGTCAGCGCTACCGACGGCACAATCGTG
TCCTTCAACGCCGCGGCCGTCCGGCAGTTCGGATACGCGGAGGAGGAGGTCATCGGCCAG
AACCTGCGCATATTGATGCCGGAACCCTACCGCCACGAACACGACGGATATCTGCAGCGC
TACATGGCAACCGGGGAAAAGCGCATCATCGGTATCGATCGCGTTGTCTCGGGGCAGCGG
AAGGATGGATCGACGTTTCCGATGAAGCTCGCCGTGGGGGAGATGCGGTCGGGCGGCGAG
AGGTTCTTCACGGGCTTCATCAGAGACCTGACGGAGCGGGAGGAGTCTGCCGCAAGGCTC
GAGCAGATACAGGCTGAACTGGCGCGCCTTGCCCGCCTAAATGAGATGGGCGAAATGGCT
TCGACGCTTGCCCACGAACTGAACCAGCCGTTGTCGGCGATCGCCAACTATTCGCATGGC
TGTACGAGGCTGTTGCGTGACATGGACGACGCCGTCGCTACGCGAATACGCGAGGCGCTC
GAAGAGGTGGCGAGCCAGTCGCTGCGGGCCGGCCAGATCATCAAACATCTGAGGGAATTC
GTCACCAAGGGCGAGACGGAGAAGGCTCCGGAAGACATTCGCAAGCTGGTCGAGGAGTCT
GCGGCCTTGGCTCTGGTCGGTTCGCGCGAGCAGGGCGTCCGCACCGTATTCGAGTATCTG
CCCGGTGCCGAAATGGTATTGGTCGACCGTATCCAGGTGCAGCAGGTCCTCATCAATCTG
ATGCGCAACGCGATCGAGGCGATGCGCCACGTCGACCGCCGAGAACTGACGATCCGCACG
ATGCCGGCCGATCCGGGCGAGGTAGCAGTCGTCGTTGAAGACACCGGCGGAGGCATTCCG
GAAGAAGTCGCCGGTCAGCTCTTCAAGCCGTTCGTCACGACGAAGGCAAGCGGAATGGGC
ATCGGGCTGTCCATTTCTAAGCGGATCGTCGAGGCGCACGGCGGTGAGATGACTGTTTCG
AAAAATGAGGCCGGCGGAGCCACTTTCCGGTTCACGCTTCCCGCCTATCTAGATGAACGG
ATCGTTGCAAATGACTGA

# Drug_Target_57_General_Function:
Involved in ATP binding

# Drug_Target_57_General_References:
11481432	Barnett MJ, Fisher RF, Jones T, Komp C, Abola AP, Barloy-Hubler F, Bowser L, Capela D, Galibert F, Gouzy J, Gurjal M, Hong A, Huizar L, Hyman RW, Kahn D, Kahn ML, Kalman S, Keating DH, Palm C, Peck MC, Surzycki R, Wells DH, Yeh KC, Davis RW, Federspiel NA, Long SR: Nucleotide sequence and predicted functions of the entire Sinorhizobium meliloti pSymA megaplasmid. Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9883-8. Epub 2001 Jul 31.
2842062	David M, Daveran ML, Batut J, Dedieu A, Domergue O, Ghai J, Hertig C, Boistard P, Kahn D: Cascade regulation of nif gene expression in Rhizobium meliloti. Cell. 1988 Aug 26;54(5):671-83.
8432704	Lois AF, Ditta GS, Helinski DR: The oxygen sensor FixL of Rhizobium meliloti is a membrane protein containing four possible transmembrane segments. J Bacteriol. 1993 Feb;175(4):1103-9.

# Drug_Target_57_HGNC_ID:
Not Available

# Drug_Target_57_HPRD_ID:
Not Available

# Drug_Target_57_ID:
4944

# Drug_Target_57_Locus:
Not Available

# Drug_Target_57_Molecular_Weight:
55074

# Drug_Target_57_Name:
Sensor protein fixL

# Drug_Target_57_Number_of_Residues:
505

# Drug_Target_57_PDB_ID:
1EW0

# Drug_Target_57_Pathway:
Not Available

# Drug_Target_57_Pfam_Domain_Function:
PF00512	HisKA
PF00989	PAS
PF02518	HATPase_c

# Drug_Target_57_Protein_Sequence:
>Sensor protein fixL
MLSKSGIERTQWGRRVVRWRGDGVAAYIVAAIVTSSVLAIRMIRAEPIGEGLLLFSFIPA
ILVVALIGGRNPILFAAGLSLVAAVSHQQISSADGPSVVELLVFGSAVLLIVALGEVLEA
ARRAIDRTEDVVRARDAHLRSILDTVPDATVVSATDGTIVSFNAAAVRQFGYAEEEVIGQ
NLRILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE
RFFTGFIRDLTEREESAARLEQIQAELARLARLNEMGEMASTLAHELNQPLSAIANYSHG
CTRLLRDMDDAVATRIREALEEVASQSLRAGQIIKHLREFVTKGETEKAPEDIRKLVEES
AALALVGSREQGVRTVFEYLPGAEMVLVDRIQVQQVLINLMRNAIEAMRHVDRRELTIRT
MPADPGEVAVVVEDTGGGIPEEVAGQLFKPFVTTKASGMGIGLSISKRIVEAHGGEMTVS
KNEAGGATFRFTLPAYLDERIVAND

# Drug_Target_57_Reaction:
Not Available

# Drug_Target_57_Signals:
None

# Drug_Target_57_Specific_Function:
Putative oxygen sensor; modulates the activity of fixJ, a transcriptional activator of nitrogen fixation fixK gene. FixL probably acts as a kinase that phosphorylates fixJ

# Drug_Target_57_SwissProt_ID:
P10955

# Drug_Target_57_SwissProt_Name:
FIXL_RHIME

# Drug_Target_57_Synonyms:
EC 2.7.13.3

# Drug_Target_57_Theoretical_pI:
5.74

# Drug_Target_57_Transmembrane_Regions:
21-40
47-67
71-86
97-118

# Drug_Target_58_Cellular_Location:
Not Available

# Drug_Target_58_Chromosome_Location:
Not Available

# Drug_Target_58_Drug_References:
Not Available

# Drug_Target_58_Essentiality:
Non-Essential

# Drug_Target_58_GenAtlas_ID:
Not Available

# Drug_Target_58_GenBank_ID_Gene:
Not Available

# Drug_Target_58_GenBank_ID_Protein:
Not Available

# Drug_Target_58_GeneCard_ID:
Not Available

# Drug_Target_58_Gene_Name:
Not Available

# Drug_Target_58_Gene_Sequence:
Not Available

# Drug_Target_58_General_Function:
Involved in iron ion binding

# Drug_Target_58_General_References:
8819167	Matias PM, Morais J, Coelho R, Carrondo MA, Wilson K, Dauter Z, Sieker L: Cytochrome c3 from Desulfovibrio gigas: crystal structure at 1.8 A resolution and evidence for a specific calcium-binding site. Protein Sci. 1996 Jul;5(7):1342-54.

# Drug_Target_58_HGNC_ID:
Not Available

# Drug_Target_58_HPRD_ID:
Not Available

# Drug_Target_58_ID:
4945

# Drug_Target_58_Locus:
Not Available

# Drug_Target_58_Molecular_Weight:
11978

# Drug_Target_58_Name:
Cytochrome c3

# Drug_Target_58_Number_of_Residues:
112

# Drug_Target_58_PDB_ID:
1WAD

# Drug_Target_58_Pathway:
Not Available

# Drug_Target_58_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_58_Protein_Sequence:
>Cytochrome c3
VDVPADGAKIDFIAGGEKNLTVVFNHSTHKDVKCDDCHHDPGDKQYAGCTTDGCHNILDK
ADKSVNSWYKVVHDAKGGAKPTCISCHKDKAGDDKELKKKLTGCKGSACHPS

# Drug_Target_58_Reaction:
Not Available

# Drug_Target_58_Signals:
None

# Drug_Target_58_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_58_SwissProt_ID:
P00133

# Drug_Target_58_SwissProt_Name:
CYC3_DESGI

# Drug_Target_58_Synonyms:
Not Available

# Drug_Target_58_Theoretical_pI:
7.47

# Drug_Target_58_Transmembrane_Regions:
None

# Drug_Target_59_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_59_Chromosome_Location:
Not Available

# Drug_Target_59_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_59_Essentiality:
Non-Essential

# Drug_Target_59_GenAtlas_ID:
Not Available

# Drug_Target_59_GenBank_ID_Gene:
M55161

# Drug_Target_59_GenBank_ID_Protein:
146533

# Drug_Target_59_GeneCard_ID:
Not Available

# Drug_Target_59_Gene_Name:
katE

# Drug_Target_59_Gene_Sequence:
>2262 bp
ATGTCGCAACATAACGAAAAGAACCCACATCAGCACCAGTCACCACTACACGATTCCAGC
GAAGCGAAACCGGGGATGGACTCACTGGCACCTGAGGACGGCTCTCATCGTCCAGCGGCT
GAACCAACACCGCCAGGTGCACAACCTACCGCCCCAGGGAGCCTGAAAGCCCCTGATACG
CGTAACGAAAAACTTAATTCTCTGGAAGACGTACGCAAAGGCAGTGAAAATTATGCGCTG
ACCACTAATCAGGGCGTGCGCATCGCCGACGATCAAAACTCACTGCGTGCCGGTAGCCGT
GGTCCAACGCTGCTGGAAGATTTTATTCTGCGCGAGAAAATCACCCACTTTGACCATGAG
CGCATTCCGGAACGTATTGTTCATGCACGCGGATCAGCCGCTCACGGTTATTTCCAGCCA
TATAAAAGCTTAAGCGATATTACCAAAGCGGATTTCCTCTCAGATCCGAACAAAATCACC
CCAGTATTTGTACGTTTCTCTACCGTTCAGGGTGGTGCTGGCTCTGCTGATACCGTGCGT
GATATCCGTGGCTTTGCCACCAAGTTCTATACCGAAGAGGGTATTTTTGACCTCGTTGGC
AATAACACGCCAATCTTCTTTATCCAGGATGCGCATAAATTCCCCGATTTTGTTCATGCG
GTAAAACCAGAACCGCACTGGGCAATTCCACAAGGGCAAAGTGCCCACGATACTTTCTGG
GATTATGTTTCTCTGCAACCTGAAACTCTGCACAACGTGATGTGGGCGATGTCGGATCGC
GGCATCCCCCGCAGTTACCGCACCATGGAAGGCTTCGGTATTCACACCTTCCGCCTGATT
AATGCCGAAGGGAAGGCAACGTTTGTACGTTTCCACTGGAAACCACTGGCAGGTAAAGCC
TCACTCGTTTGGGATGAAGCACAAAAACTCACCGGACGTGACCCGGACTTCCACCGCCGC
GAGTTGTGGGAAGCCATTGAAGCAGGCGATTTTCCGGAATACGAACTGGGCTTCCAGTTG
ATTCCTGAAGAAGATGAATTCAAGTTCGACTTCGATCTTCTCGATCCAACCAAACTTATC
CCGGAAGAACTGGTGCCCGTTCAGCGTGTCGGCAAAATGGTGCTCAATCGCAACCCGGAT
AACTTCTTTGCTGAAAACGAACAGGCGGCTTTCCATCCTGGGCATATCGTGCCGGGACTG
GACTTCACCAACGATCCGCTGTTGCAGGGACGTTTGTTCTCCTATACCGATACACAAATC
AGTCGTCTTGGTGGGCCGAATTTCCATGAGATTCCGATTAACCGTCCGACCTGCCCTTAC
CATAATTTCCAGCGTGACGGCATGCATCGCATGGGGATCGACACTAACCCGGCGAATTAC
GAACCGAACTCGATTAACGATAACTGGCCGCGCGAAACACCGCCGGGGCCGAAACGCGGC
GGTTTTGAATCATACCAGGAGCGCGTGGAAGGCAATAAAGTTCGCGAGCGCAGCCCATCG
TTTGGCGAATATTATTCCCATCCGCGTCTGTTCTGGCTAAGTCAGACGCCATTTGAGCAG
CGCCATATTGTCGATGGTTTCAGTTTTGAGTTAAGCAAAGTCGTTCGTCCGTATATTCGT
GAGCGCGTTGTTGACCAGCTGGCGCATATTGATCTCACTCTGGCCCAGGCGGTGGCGAAA
AATCTCGGTATCGAACTGACTGACGACCAGCTGAATATCACCCCACCTCCGGACGTCAAC
GGTCTGAAAAAGGATCCATCCTTAAGTTTGTACGCCATTCCTGACGGTGATGTGAAAGGT
CGCGTGGTAGCGATTTTACTTAATGATGAAGTGAGATCGGCAGACCTTCTGGCCATTCTC
AAGGCGCTGAAGGCCAAAGGCGTTCATGCCAAACTGCTCTACTCCCGAATGGGTGAAGTG
ACTGCGGATGACGGAACGGTGTTGCCTATAGCCGCTACCTTTGCCGGTGCACCTTCGCTG
ACGGTCGATGCGGTCATTGTCCCTTGCGGCAATATCGCGGATATCGCTGACAACGGCGAT
GCCAACTACTACCTGATGGAAGCCTACAAACACCTTAAACCGATTGCGCTGGCGGGTGAC
GCGCGCAAGTTTAAAGCAACAATCAAGATCGCTGACCAGGGTGAAGAAGGGATTGTGGAA
GCTGACAGCGCTGACGGTAGTTTTATGGATGAACTGCTAACGCTGATGGCAGCACACCGC
GTGTGGTCACGCATTCCTAAGATTGACAAAATTCCTGCCTGA

# Drug_Target_59_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_59_General_References:
10091651	Sevinc MS, Mate MJ, Switala J, Fita I, Loewen PC: Role of the lateral channel in catalase HPII of Escherichia coli. Protein Sci. 1999 Mar;8(3):490-8.
11455600	Melik-Adamyan W, Bravo J, Carpena X, Switala J, Mate MJ, Fita I, Loewen PC: Substrate flow in catalases deduced from the crystal structures of active site variants of HPII from Escherichia coli. Proteins. 2001 Aug 15;44(3):270-81.
1987146	von Ossowski I, Mulvey MR, Leco PA, Borys A, Loewen PC: Nucleotide sequence of Escherichia coli katE, which encodes catalase HPII. J Bacteriol. 1991 Jan;173(2):514-20.
7663946	Bravo J, Verdaguer N, Tormo J, Betzel C, Switala J, Loewen PC, Fita I: Crystal structure of catalase HPII from Escherichia coli. Structure. 1995 May 15;3(5):491-502.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9144772	Bravo J, Fita I, Ferrer JC, Ens W, Hillar A, Switala J, Loewen PC: Identification of a novel bond between a histidine and the essential tyrosine in catalase HPII of Escherichia coli. Protein Sci. 1997 May;6(5):1016-23.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_59_HGNC_ID:
Not Available

# Drug_Target_59_HPRD_ID:
Not Available

# Drug_Target_59_ID:
3093

# Drug_Target_59_Locus:
Not Available

# Drug_Target_59_Molecular_Weight:
84163

# Drug_Target_59_Name:
Catalase HPII

# Drug_Target_59_Number_of_Residues:
753

# Drug_Target_59_PDB_ID:
1GGE

# Drug_Target_59_Pathway:
Not Available

# Drug_Target_59_Pfam_Domain_Function:
PF00199	Catalase
PF06628	Catalase-rel

# Drug_Target_59_Protein_Sequence:
>Catalase HPII
MSQHNEKNPHQHQSPLHDSSEAKPGMDSLAPEDGSHRPAAEPTPPGAQPTAPGSLKAPDT
RNEKLNSLEDVRKGSENYALTTNQGVRIADDQNSLRAGSRGPTLLEDFILREKITHFDHE
RIPERIVHARGSAAHGYFQPYKSLSDITKADFLSDPNKITPVFVRFSTVQGGAGSADTVR
DIRGFATKFYTEEGIFDLVGNNTPIFFIQDAHKFPDFVHAVKPEPHWAIPQGQSAHDTFW
DYVSLQPETLHNVMWAMSDRGIPRSYRTMEGFGIHTFRLINAEGKATFVRFHWKPLAGKA
SLVWDEAQKLTGRDPDFHRRELWEAIEAGDFPEYELGFQLIPEEDEFKFDFDLLDPTKLI
PEELVPVQRVGKMVLNRNPDNFFAENEQAAFHPGHIVPGLDFTNDPLLQGRLFSYTDTQI
SRLGGPNFHEIPINRPTCPYHNFQRDGMHRMGIDTNPANYEPNSINDNWPRETPPGPKRG
GFESYQERVEGNKVRERSPSFGEYYSHPRLFWLSQTPFEQRHIVDGFSFELSKVVRPYIR
ERVVDQLAHIDLTLAQAVAKNLGIELTDDQLNITPPPDVNGLKKDPSLSLYAIPDGDVKG
RVVAILLNDEVRSADLLAILKALKAKGVHAKLLYSRMGEVTADDGTVLPIAATFAGAPSL
TVDAVIVPCGNIADIADNGDANYYLMEAYKHLKPIALAGDARKFKATIKIADQGEEGIVE
ADSADGSFMDELLTLMAAHRVWSRIPKIDKIPA

# Drug_Target_59_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_59_Signals:
None

# Drug_Target_59_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_59_SwissProt_ID:
P21179

# Drug_Target_59_SwissProt_Name:
CATE_ECOLI

# Drug_Target_59_Synonyms:
EC 1.11.1.6
Hydroxyperoxidase II

# Drug_Target_59_Theoretical_pI:
5.72

# Drug_Target_59_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Periplasm

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AF186393

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
Ddes_2038

# Drug_Target_5_Gene_Sequence:
>981 bp
ATGAGGAACGGCACATCACTGCTTCTGCTGGCGGCTATAGCCCTGGCTGGCGCGGCGTGT
CTCACGGCGATGGGAGGCACGGCCAAGGCCGCAGCCCTGGAGCCAACAGACAGCGGCGCG
CCATCGGCTATAGTCATGTTTCCGGTCGGCGAAAAGCCCAATCCCAAGGGCGCGGCCATG
AAACCCGTGGTTTTCAACCATCTTATCCACGAAAAGAAGATTGACAACTGCGAGACCTGT
CACCACACGGGCGATCCGGTGTCCTGTAGCACCTGTCACACGGTAGAAGGCAAGGCCGAG
GGCAATTACATCACCCTTGACCGCGCCATGCATGCCACCAATATCGCCAAACGCGCCAAG
GGCAACACGCCCGTCAGCTGCGTGAGCTGTCACGAACAGCAAACCAAAGAGCGGCGCGAA
TGCGCGGGTTGTCACGCCATTGTCACGCCCAAGCGTGACGAGGCATGGTGCGCCACCTGC
CACAACATCACGCCTTCAATGACGCCCGAACAGATGCAGAAGGGCATTAACGGCACCCTG
CTGCCCGGCGATAACGAAGCTCTGGCGGCAGAAACCGTGCTGGCCCAGAAGACCGTTGAG
CCTGTTTCCCCCATGCTGGCCCCCTACAAGGTGGTCATTGATGCCCTGGCTGACAAGTAC
GAGCCGAGCAACTTTACCCACCGCCGCCACCTCACGTCCCTTATGGAAAGAATCAAGGAC
GACAAGCTGGCCCAGGCTTTCCACAACAAGCCTGAAATCCTGTGCGCTACCTGCCACCAC
AGAAGCCCGCTTTCCCTTACGCCTCCCAAGTGCGGCAGCTGCCACACCAAGGAGATCGAC
AAGGCCAATCCCGGTCGTCCCAACCTTATGGCCGCCTACCATCTGCAGTGCATGGGTTGC
CACAAGGGCATGGATGTCGCGCGTCCTCGTGACACCGACTGCACCACTTGCCATAAGGCT
GCGCCCAAGAGCGCCGACTAG

# Drug_Target_5_General_Function:
Involved in iron ion binding

# Drug_Target_5_General_References:
10368280	Matias PM, Coelho R, Pereira IA, Coelho AV, Thompson AW, Sieker LC, Gall JL, Carrondo MA: The primary and three-dimensional structures of a nine-haem cytochrome c from Desulfovibrio desulfuricans ATCC 27774 reveal a new member of the Hmc family. Structure. 1999 Feb 15;7(2):119-30.
10471375	Saraiva LM, da Costa PN, LeGall J: Sequencing the gene encoding desulfovibrio desulfuricans ATCC 27774 nine-heme cytochrome c. Biochem Biophys Res Commun. 1999 Sep 7;262(3):629-34.
10555582	Matias PM, Saraiva LM, Soares CM, Coelho AV, LeGall J, Carrondo MA: Nine-haem cytochrome c from Desulfovibrio desulfuricans ATCC 27774:primary sequence determination, crystallographic refinement at 1.8 and modelling studies of its interaction with the tetrahaem cytochrome c3. J Biol Inorg Chem. 1999 Aug;4(4):478-94.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4902

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
35026

# Drug_Target_5_Name:
Nine-heme cytochrome c

# Drug_Target_5_Number_of_Residues:
326

# Drug_Target_5_PDB_ID:
1OFY

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_5_Protein_Sequence:
>Nine-heme cytochrome c
MRNGTSLLLLAAIALAGAACLTAMGGTAKAAALEPTDSGAPSAIVMFPVGEKPNPKGAAM
KPVVFNHLIHEKKIDNCETCHHTGDPVSCSTCHTVEGKAEGNYITLDRAMHATNIAKRAK
GNTPVSCVSCHEQQTKERRECAGCHAIVTPKRDEAWCATCHNITPSMTPEQMQKGINGTL
LPGDNEALAAETVLAQKTVEPVSPMLAPYKVVIDALADKYEPSNFTHRRHLTSLMERIKD
DKLAQAFHNKPEILCATCHHRSPLSLTPPKCGSCHTKEIDKANPGRPNLMAAYHLQCMGC
HKGMDVARPRDTDCTTCHKAAPKSAD

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
1-30

# Drug_Target_5_Specific_Function:
May form part of a transmembrane redox complex through which electrons are transferred to the cytoplasm for reduction of sulfate

# Drug_Target_5_SwissProt_ID:
Q9RN68

# Drug_Target_5_SwissProt_Name:
CYC9_DESDA

# Drug_Target_5_Synonyms:
9Hcc
Nine-heme cytochrome c precursor

# Drug_Target_5_Theoretical_pI:
7.97

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_60_Cellular_Location:
Not Available

# Drug_Target_60_Chromosome_Location:
Not Available

# Drug_Target_60_Drug_References:
Not Available

# Drug_Target_60_Essentiality:
Non-Essential

# Drug_Target_60_GenAtlas_ID:
Not Available

# Drug_Target_60_GenBank_ID_Gene:
L21670

# Drug_Target_60_GenBank_ID_Protein:
Not Available

# Drug_Target_60_GeneCard_ID:
Not Available

# Drug_Target_60_Gene_Name:
vhb

# Drug_Target_60_Gene_Sequence:
>441 bp
ATGTTAGACCAGCAAACCATTAACATCATCAAAGCCACTGTTCCTGTATTGAAGGAGCAT
GGCGTTACCATTACCACGACTTTTTATAAAAACTTGTTTGCCAAACACCCTGAAGTACGT
CCTTTGTTTGATATGGGTCGCCAAGAATCTTTGGAGCAGCCTAAGGCTTTGGCGATGACG
GTATTGGCGGCAGCGCAAAACATTGAAAATTTGCCAGCTATTTTGCCTGCGGTCAAAAAA
ATTGCAGTCAAACATTGTCAAGCAGGCGTGGCAGCAGCGCATTATCCGATTGTCGGTCAA
GAATTGTTGGGTGCGATTAAAGAAGTATTGGGCGATGCCGCAACCGATGACATTTTGGAC
GCGTGGGGCAAGGCTTATGGCGTGATTGCAGATGTGTTTATTCAAGTGGAAGCAGATTTG
TACGCTCAAGCGGTTGAATAA

# Drug_Target_60_General_Function:
Involved in iron ion binding

# Drug_Target_60_General_References:
2681149	Khosla C, Bailey JE: Characterization of the oxygen-dependent promoter of the Vitreoscilla hemoglobin gene in Escherichia coli. J Bacteriol. 1989 Nov;171(11):5995-6004.
2685332	Khosla C, Bailey JE: Evidence for partial export of Vitreoscilla hemoglobin into the periplasmic space in Escherichia coli. Implications for protein function. J Mol Biol. 1989 Nov 5;210(1):79-89.
3067078	Khosla C, Bailey JE: The Vitreoscilla hemoglobin gene: molecular cloning, nucleotide sequence and genetic expression in Escherichia coli. Mol Gen Genet. 1988 Sep;214(1):158-61.
3736670	Wakabayashi S, Matsubara H, Webster DA: Primary sequence of a dimeric bacterial haemoglobin from Vitreoscilla. Nature. 1986 Jul 31-Aug 6;322(6078):481-3.
9115439	Tarricone C, Galizzi A, Coda A, Ascenzi P, Bolognesi M: Unusual structure of the oxygen-binding site in the dimeric bacterial hemoglobin from Vitreoscilla sp. Structure. 1997 Apr 15;5(4):497-507.

# Drug_Target_60_HGNC_ID:
Not Available

# Drug_Target_60_HPRD_ID:
Not Available

# Drug_Target_60_ID:
4947

# Drug_Target_60_Locus:
Not Available

# Drug_Target_60_Molecular_Weight:
15775

# Drug_Target_60_Name:
Bacterial hemoglobin

# Drug_Target_60_Number_of_Residues:
146

# Drug_Target_60_PDB_ID:
3VHB

# Drug_Target_60_Pathway:
Not Available

# Drug_Target_60_Pfam_Domain_Function:
PF00042	Globin

# Drug_Target_60_Protein_Sequence:
>Bacterial hemoglobin
MLDQQTINIIKATVPVLKEHGVTITTTFYKNLFAKHPEVRPLFDMGRQESLEQPKALAMT
VLAAAQNIENLPAILPAVKKIAVKHCQAGVAAAHYPIVGQELLGAIKEVLGDAATDDILD
AWGKAYGVIADVFIQVEADLYAQAVE

# Drug_Target_60_Reaction:
Not Available

# Drug_Target_60_Signals:
None

# Drug_Target_60_Specific_Function:
This protein functions as a terminal oxidase

# Drug_Target_60_SwissProt_ID:
P04252

# Drug_Target_60_SwissProt_Name:
BAHG_VITST

# Drug_Target_60_Synonyms:
Soluble cytochrome O

# Drug_Target_60_Theoretical_pI:
5.16

# Drug_Target_60_Transmembrane_Regions:
None

# Drug_Target_61_Cellular_Location:
Cell membrane

# Drug_Target_61_Chromosome_Location:
Not Available

# Drug_Target_61_Drug_References:
Not Available

# Drug_Target_61_Essentiality:
Non-Essential

# Drug_Target_61_GenAtlas_ID:
Not Available

# Drug_Target_61_GenBank_ID_Gene:
Not Available

# Drug_Target_61_GenBank_ID_Protein:
Not Available

# Drug_Target_61_GeneCard_ID:
Not Available

# Drug_Target_61_Gene_Name:
Not Available

# Drug_Target_61_Gene_Sequence:
Not Available

# Drug_Target_61_General_Function:
Involved in iron ion binding

# Drug_Target_61_General_References:
10529373	Vandenberghe IH, Guisez Y, Ciurli S, Benini S, Van Beeumen JJ: Cytochrome c-553 from the alkalophilic bacterium Bacillus pasteurii has the primary structure characteristics of a lipoprotein. Biochem Biophys Res Commun. 1999 Oct 22;264(2):380-7.

# Drug_Target_61_HGNC_ID:
Not Available

# Drug_Target_61_HPRD_ID:
Not Available

# Drug_Target_61_ID:
4948

# Drug_Target_61_Locus:
Not Available

# Drug_Target_61_Molecular_Weight:
8991

# Drug_Target_61_Name:
Cytochrome c-553

# Drug_Target_61_Number_of_Residues:
92

# Drug_Target_61_PDB_ID:
1N9C

# Drug_Target_61_Pathway:
Not Available

# Drug_Target_61_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_61_Protein_Sequence:
>Cytochrome c-553
GGGNDTSNETDTGTSGGETAAVDAEAVVQQKCISCHGGDLTGASAPAIDKAGANYSEEEI
LDIILNGQGGMPGGIAKGAEAEAVAAWLAEKK

# Drug_Target_61_Reaction:
Not Available

# Drug_Target_61_Signals:
None

# Drug_Target_61_Specific_Function:
Natural electron acceptor for a formate dehydrogenase

# Drug_Target_61_SwissProt_ID:
P82599

# Drug_Target_61_SwissProt_Name:
CY553_BACPA

# Drug_Target_61_Synonyms:
Cytochrome c553

# Drug_Target_61_Theoretical_pI:
3.88

# Drug_Target_61_Transmembrane_Regions:
None

# Drug_Target_62_Cellular_Location:
Periplasm

# Drug_Target_62_Chromosome_Location:
Not Available

# Drug_Target_62_Drug_References:
Not Available

# Drug_Target_62_Essentiality:
Non-Essential

# Drug_Target_62_GenAtlas_ID:
Not Available

# Drug_Target_62_GenBank_ID_Gene:
X04304

# Drug_Target_62_GenBank_ID_Protein:
Not Available

# Drug_Target_62_GeneCard_ID:
Not Available

# Drug_Target_62_Gene_Name:
DVU_3171

# Drug_Target_62_Gene_Sequence:
>390 bp
ATGAGGAAACTGTTTTTCTGCGGCGTACTCGCCCTTGCCGTAGCCTTTGCGCTGCCGGTT
GTGGCCGCTCCCAAGGCCCCTGCCGACGGCCTGAAGATGGAAGCCACCAAGCAGCCCGTG
GTTTTCAACCACTCCACCCACAAGTCCGTGAAGTGTGGTGACTGCCACCACCCCGTGAAC
GGCAAGGAAGACTACCGCAAGTGCGGTACCGCCGGCTGCCACGACAGCATGGACAAGAAG
GACAAGTCCGCGAAGGGCTACTACCATGTCATGCATGACAAGAACACCAAGTTCAAGTCC
TGCGTGGGTTGCCACGTTGAAGTGGCCGGTGCCGATGCCGCCAAGAAGAAGGACCTCACC
GGCTGCAAGAAGTCCAAGTGCCACGAATAG

# Drug_Target_62_General_Function:
Involved in iron ion binding

# Drug_Target_62_General_References:
1333991	Salgueiro CA, Turner DL, Santos H, LeGall J, Xavier AV: Assignment of the redox potentials to the four haems in Desulfovibrio vulgaris cytochrome c3 by 2D-NMR. FEBS Lett. 1992 Dec 14;314(2):155-8.
1663945	Morimoto Y, Tani T, Okumura H, Higuchi Y, Yasuoka N: Effects of amino acid substitution on three-dimensional structure: an X-ray analysis of cytochrome c3 from Desulfovibrio vulgaris Hildenborough at 2 A resolution. J Biochem. 1991 Oct;110(4):532-40.
3019687	Voordouw G, Brenner S: Cloning and sequencing of the gene encoding cytochrome c3 from Desulfovibrio vulgaris (Hildenborough). Eur J Biochem. 1986 Sep 1;159(2):347-51.
4358550	Trousil EB, Campbell LL: Amino acid sequence of cytochrome c3 from Desulfovibrio vulgaris. J Biol Chem. 1974 Jan 25;249(2):386-93.
8254667	Matias PM, Frazao C, Morais J, Coll M, Carrondo MA: Structure analysis of cytochrome c3 from Desulfovibrio vulgaris Hildenborough at 1.9 A resolution. J Mol Biol. 1993 Dec 5;234(3):680-99.
8388770	Kwoh DY, Vedvick TS, McCue AF, Gevertz D: Rapid comparison of the cytochrome c3 gene from nine strains of Desulfovibrio vulgaris using polymerase chain reaction amplification. Can J Microbiol. 1993 Apr;39(4):402-11.
9710542	Messias AC, Kastrau DH, Costa HS, LeGall J, Turner DL, Santos H, Xavier AV: Solution structure of Desulfovibrio vulgaris (Hildenborough) ferrocytochrome c3: structural basis for functional cooperativity. J Mol Biol. 1998 Aug 28;281(4):719-39.
9890880	Dolla A, Arnoux P, Protasevich I, Lobachov V, Brugna M, Giudici-Orticoni MT, Haser R, Czjzek M, Makarov A, Bruschi M: Key role of phenylalanine 20 in cytochrome c3: structure, stability, and function studies. Biochemistry. 1999 Jan 5;38(1):33-41.

# Drug_Target_62_HGNC_ID:
Not Available

# Drug_Target_62_HPRD_ID:
Not Available

# Drug_Target_62_ID:
4949

# Drug_Target_62_Locus:
Not Available

# Drug_Target_62_Molecular_Weight:
13976

# Drug_Target_62_Name:
Cytochrome c3

# Drug_Target_62_Number_of_Residues:
129

# Drug_Target_62_PDB_ID:
2CTH

# Drug_Target_62_Pathway:
Not Available

# Drug_Target_62_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_62_Protein_Sequence:
>Cytochrome c3
MRKLFFCGVLALAVAFALPVVAAPKAPADGLKMEATKQPVVFNHSTHKSVKCGDCHHPVN
GKEDYRKCGTAGCHDSMDKKDKSAKGYYHVMHDKNTKFKSCVGCHVEVAGADAAKKKDLT
GCKKSKCHE

# Drug_Target_62_Reaction:
Not Available

# Drug_Target_62_Signals:
1-22

# Drug_Target_62_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_62_SwissProt_ID:
P00131

# Drug_Target_62_SwissProt_Name:
CYC3_DESVH

# Drug_Target_62_Synonyms:
Cytochrome c3 precursor

# Drug_Target_62_Theoretical_pI:
9.37

# Drug_Target_62_Transmembrane_Regions:
None

# Drug_Target_63_Cellular_Location:
Cytoplasm

# Drug_Target_63_Chromosome_Location:
Not Available

# Drug_Target_63_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_63_Essentiality:
Non-Essential

# Drug_Target_63_GenAtlas_ID:
Not Available

# Drug_Target_63_GenBank_ID_Gene:
AJ438208

# Drug_Target_63_GenBank_ID_Protein:
19571548

# Drug_Target_63_GeneCard_ID:
Not Available

# Drug_Target_63_Gene_Name:
katA

# Drug_Target_63_Gene_Sequence:
>1512 bp
ATGGAGCACCAGAAGACGACGCCGCACGCGACCGGCTCGACCCGCCAGAACGGCGCCCCG
GCCGTCAGCGACCGCCAGTCCCTGACCGTGGGCAGCGAGGGTCCCATCGTCCTGCACGAC
ACCCACCTGCTGGAGACCCACCAGCACTTCAACCGCATGAACATCCCGGAGCGCCGCCCG
CACGCCAAGGGCTCGGGCGCGTTCGGCGAGTTCGAGGTGACCGAGGACGTGTCGAAGTAC
ACCAAGGCCCTCGTGTTCCAGCCGGGCACGAAGACCGAGACCCTCCTGCGCTTCTCCACC
GTGGCCGGCGAGCTCGGCTCCCCGGACACCTGGCGCGACGTGCGCGGCTTCGCGCTGCGC
TTCTACACCGAGGAGGGCAACTACGACCTCGTCGGCAACAACACCCCGATCTTCTTCCTG
CGCGACCCCATGAAGTTCACCCACTTCATCCGCTCGCAGAAGCGCCTGCCGGACTCCGGC
CTGCGCGATGCCACCATGCAGTGGGACTTCTGGACCAACAACCCCGAGTCGGCGCACCAG
GTGACCTACCTGATGGGCCCGCGCGGCCTGCCCCGCACCTGGCGTGAGATGAACGGCTAC
GGCTCCCACACCTACCTGTGGGTCAACGCCCAGGGTGAGAAGCACTGGGTGAAGTACCAC
TTCATCTCCCAGCAGGGCGTGCACAACCTCTCGAACGACGAGGCCACCAAGATCGCCGGC
GAGAACGCCGACTTCCACCGCCAGGACCTGTTCGAGTCCATCGCCAAGGGCGACCACCCC
AAGTGGGACCTCTACATCCAGGCGATCCCCTACGAGGAGGGCAAGACCTACCGGTTCAAC
CCCTTCGACCTGACGAAGACGATCTCCCAGAAGGACTACCCGCGCATCAAGGTCGGCACG
CTGACCCTGAACCGCAACCCGGAGAACCACTTCGCGCAGATCGAGTCCGCCGCGTTCAGC
CCGAGCAACACCGTGCCGGGCATCGGCCTGTCCCCGGACCGCATGCTCCTGGGCCGCGCC
TTCGCGTACCACGACGCGCAGCTGTACCGCGTGGGCGCCCACGTGAACCAGCTGCCGGTG
AACCGTCCCAAGAACGCGGTGCACAACTACGCCTTCGAGGGCCAGATGTGGTACGACCAC
ACCGGCGACCGCTCCACCTACGTGCCGAACTCCAACGGCGACTCCTGGTCGGACGAGACC
GGCCCGGTGGACGACGGCTGGGAGGCCGACGGCACCCTGACCCGTGAGGCCCAGGCGCTG
CGCGCGGACGACGACGACTTCGGCCAGGCCGGCACCCTCGTCCGCGAGGTCTTCTCGGAC
CAGGAGCGTGACGACTTCGTGGAGACCGTGGCCGGCGCGCTGAAGGGTGTCCGCCAGGAC
GTCCAGGCCCGCGCCTTCGAGTACTGGAAGAACGTGGACGCCACGATCGGCCAGCGCATC
GAGGACGAGGTCAAGCGCCACGAGGGCGACGGCATCCCGGGCGTCGAGGCCGGCGGCGAG
GCCCGCATGTGA

# Drug_Target_63_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_63_General_References:
12454454	Murshudov GN, Grebenko AI, Brannigan JA, Antson AA, Barynin VV, Dodson GG, Dauter Z, Wilson KS, Melik-Adamyan WR: The structures of Micrococcus lysodeikticus catalase, its ferryl intermediate (compound II) and NADPH complex. Acta Crystallogr D Biol Crystallogr. 2002 Dec;58(Pt 12):1972-82. Epub 2002 Nov 23.
1426241	Murshudov GN, Melik-Adamyan WR, Grebenko AI, Barynin VV, Vagin AA, Vainshtein BK, Dauter Z, Wilson KS: Three-dimensional structure of catalase from Micrococcus lysodeikticus at 1.5 A resolution. FEBS Lett. 1992 Nov 9;312(2-3):127-31.

# Drug_Target_63_HGNC_ID:
Not Available

# Drug_Target_63_HPRD_ID:
Not Available

# Drug_Target_63_ID:
3249

# Drug_Target_63_Locus:
Not Available

# Drug_Target_63_Molecular_Weight:
56906

# Drug_Target_63_Name:
Catalase

# Drug_Target_63_Number_of_Residues:
503

# Drug_Target_63_PDB_ID:
1GWH

# Drug_Target_63_Pathway:
Not Available

# Drug_Target_63_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_63_Protein_Sequence:
>Catalase
MEHQKTTPHATGSTRQNGAPAVSDRQSLTVGSEGPIVLHDTHLLETHQHFNRMNIPERRP
HAKGSGAFGEFEVTEDVSKYTKALVFQPGTKTETLLRFSTVAGELGSPDTWRDVRGFALR
FYTEEGNYDLVGNNTPIFFLRDPMKFTHFIRSQKRLPDSGLRDATMQWDFWTNNPESAHQ
VTYLMGPRGLPRTWREMNGYGSHTYLWVNAQGEKHWVKYHFISQQGVHNLSNDEATKIAG
ENADFHRQDLFESIAKGDHPKWDLYIQAIPYEEGKTYRFNPFDLTKTISQKDYPRIKVGT
LTLNRNPENHFAQIESAAFSPSNTVPGIGLSPDRMLLGRAFAYHDAQLYRVGAHVNQLPV
NRPKNAVHNYAFEGQMWYDHTGDRSTYVPNSNGDSWSDETGPVDDGWEADGTLTREAQAL
RADDDDFGQAGTLVREVFSDQERDDFVETVAGALKGVRQDVQARAFEYWKNVDATIGQRI
EDEVKRHEGDGIPGVEAGGEARM

# Drug_Target_63_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_63_Signals:
None

# Drug_Target_63_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_63_SwissProt_ID:
P29422

# Drug_Target_63_SwissProt_Name:
CATA_MICLU

# Drug_Target_63_Synonyms:
EC 1.11.1.6

# Drug_Target_63_Theoretical_pI:
5.97

# Drug_Target_63_Transmembrane_Regions:
None

# Drug_Target_64_Cellular_Location:
Not Available

# Drug_Target_64_Chromosome_Location:
Not Available

# Drug_Target_64_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_64_Essentiality:
Non-Essential

# Drug_Target_64_GenAtlas_ID:
Not Available

# Drug_Target_64_GenBank_ID_Gene:
Not Available

# Drug_Target_64_GenBank_ID_Protein:
Not Available

# Drug_Target_64_GeneCard_ID:
Not Available

# Drug_Target_64_Gene_Name:
HBG1

# Drug_Target_64_Gene_Sequence:
Not Available

# Drug_Target_64_General_Function:
Not Available

# Drug_Target_64_General_References:
Not Available

# Drug_Target_64_HGNC_ID:
Not Available

# Drug_Target_64_HPRD_ID:
Not Available

# Drug_Target_64_ID:
7066

# Drug_Target_64_Locus:
Not Available

# Drug_Target_64_Molecular_Weight:
Not Available

# Drug_Target_64_Name:
Hemoglobin subunit gamma-1

# Drug_Target_64_Number_of_Residues:
0

# Drug_Target_64_PDB_ID:
Not Available

# Drug_Target_64_Pathway:
Not Available

# Drug_Target_64_Pfam_Domain_Function:
Not Available

# Drug_Target_64_Protein_Sequence:
Not Available

# Drug_Target_64_Reaction:
Not Available

# Drug_Target_64_Signals:
Not Available

# Drug_Target_64_Specific_Function:
Not Available

# Drug_Target_64_SwissProt_ID:
P69891

# Drug_Target_64_SwissProt_Name:
HBG1_HUMAN

# Drug_Target_64_Synonyms:
Not Available

# Drug_Target_64_Theoretical_pI:
Not Available

# Drug_Target_64_Transmembrane_Regions:
Not Available

# Drug_Target_65_Cellular_Location:
Cell inner membrane
multi-pass membrane protein

# Drug_Target_65_Chromosome_Location:
Not Available

# Drug_Target_65_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_65_Essentiality:
Non-Essential

# Drug_Target_65_GenAtlas_ID:
Not Available

# Drug_Target_65_GenBank_ID_Gene:
X56808

# Drug_Target_65_GenBank_ID_Protein:
39523

# Drug_Target_65_GeneCard_ID:
Not Available

# Drug_Target_65_Gene_Name:
fixL

# Drug_Target_65_Gene_Sequence:
>1518 bp
TTGGCGCCGACCCGCGTAACGCATCCGCCGGATGACGGCCGGGGCGAGCATTTCCGGGTC
AGGATCGAGGGATTCGGCGTCGGCACCTGGGATCTCGACCTCAAGACCTGGGCGCTGGAC
TGGTCGGATACCGCGCGGACCCTGCTCGGAATCGGGCAGGACCAGCCGGCGAGCTACGAC
CTCTTCCTGTCACGCCTCGAGCCCGACGACCGCGAGCGCGTGGAGAGCGCGATCAAGCGC
GTCTCCGAACGCGGTGGCGGCTTCGACGTGTCCTTCAGGGTCGCCGGCACCTCCAACGCA
GGACAGTGGATTCGCGCCCGGGCCGGACTCATTCGGGACGAAGCCGGCACCGCCCGCCAT
CTCAGCGGCATCTTTCTCGATATCGACGAGGAGAAGCAGGTCGAGGGTGCGCTCCGTACC
CGCGAGACCCACCTCCGCTCGATCCTCCACACAATTCCCGACGCCATGATCGTCATCGAC
GGCCACGGCATCATCCAGCTGTTCAGCACCGCCGCCGAGCGCCTGTTCGGCTGGTCCGAG
CTCGAGGCGATCGGCCAGAACGTCAACATCCTGATGCCGGAGCCCGACCGCTCCCGGCAT
GACAGCTACATTTCGCGTTACCGCACCACGAGCGATCCCCACATCATCGGCATCGGGCGC
ATCGTGACCGGCAAGCGCCGCGACGGCACCACCTTCCCGATGCACCTGTCGATCGGCGAG
ATGCAGTCCGGCGGCGAGCCCTATTTTACCGGTTTCGTCCGCGATCTCACCGAGCACCAG
CAGACCCAGGCGCGTCTCCAGGAACTGCAATCCGAGCTCGTCCACGTCTCCAGGCTGAGC
GCCATGGGCGAAATGGCGTCCGCGCTCGCGCACGAGCTCAACCAGCCGCTGGCGGCGATC
AGCAACTACATGAAGGGCTCGCGGCGGCTGCTTGCCGGCAGCAGTGATCCGAACACACCG
AAGGTCGAAAGCGCCCTGGACCGCGCCGCCGAGCAGGCGCTGCGCGCCGGCCAGATCATC
CGGCGCCTGCGCGACTTCGTTGCCCGCGGCGAATCGGAGAAGCGGGTCGAGAGTCTCTCC
AAGCTGATCGAGGAGGCCGGCGCGCTCGGGCTTGCCGGCGCGCGCGAGCAGAACGTGCAG
CTCCGCTTCAGTCTCGATCCGGGCGCCGATCTCGTTCTCGCCGACCGGGTGCAGATCCAG
CAGGTCCTGGTCAACCTGTTCCGCAACGCGCTGGAAGCGATGGCTCAGTCGCAGCGACGC
GAGCTCGTCGTCACCAACACCCCCGCCGCCGACGACATGATCGAGGTCGAAGTGTCCGAC
ACCGGCAGCGGTTTCCAGGACGACGTCATTCCGAACCTGTTTCAGACTTTCTTCACCACC
AAGGACACCGGCATGGGCGTGGGACTGTCCATCAGCCGCTCGATCATCGAAGCTCACGGC
GGGCGCATGTGGGCCGAGAGCAACGCATCGGGCGGGGCGACCTTCCGCTTCACCCTCCCG
GCAGCCGACGAGAATTGA

# Drug_Target_65_General_Function:
Signal transduction mechanisms

# Drug_Target_65_General_References:
10747783	Gong W, Hao B, Chan MK: New mechanistic insights from structural studies of the oxygen-sensing domain of Bradyrhizobium japonicum FixL. Biochemistry. 2000 Apr 11;39(14):3955-62.
12597275	Kaneko T, Nakamura Y, Sato S, Minamisawa K, Uchiumi T, Sasamoto S, Watanabe A, Idesawa K, Iriguchi M, Kawashima K, Kohara M, Matsumoto M, Shimpo S, Tsuruoka H, Wada T, Yamada M, Tabata S: Complete genomic sequence of nitrogen-fixing symbiotic bacterium Bradyrhizobium japonicum USDA110. DNA Res. 2002 Dec 31;9(6):189-97.
2000090	Anthamatten D, Hennecke H: The regulatory status of the fixL- and fixJ-like genes in Bradyrhizobium japonicum may be different from that in Rhizobium meliloti. Mol Gen Genet. 1991 Jan;225(1):38-48.
9860942	Gong W, Hao B, Mansy SS, Gonzalez G, Gilles-Gonzalez MA, Chan MK: Structure of a biological oxygen sensor: a new mechanism for heme-driven signal transduction. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15177-82.

# Drug_Target_65_HGNC_ID:
Not Available

# Drug_Target_65_HPRD_ID:
Not Available

# Drug_Target_65_ID:
2915

# Drug_Target_65_Locus:
Not Available

# Drug_Target_65_Molecular_Weight:
55653

# Drug_Target_65_Name:
Sensor protein fixL

# Drug_Target_65_Number_of_Residues:
505

# Drug_Target_65_PDB_ID:
1LT0

# Drug_Target_65_Pathway:
Not Available

# Drug_Target_65_Pfam_Domain_Function:
PF00512	HisKA
PF00989	PAS
PF02518	HATPase_c

# Drug_Target_65_Protein_Sequence:
>Sensor protein fixL
MAPTRVTHPPDDGRGEHFRVRIEGFGVGTWDLDLKTWALDWSDTARTLLGIGQDQPASYD
LFLSRLEPDDRERVESAIKRVSERGGGFDVSFRVAGTSNAGQWIRARAGLIRDEAGTARH
LSGIFLDIDEEKQVEGALRTRETHLRSILHTIPDAMIVIDGHGIIQLFSTAAERLFGWSE
LEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGTTFPMHLSIGE
MQSGGEPYFTGFVRDLTEHQQTQARLQELQSELVHVSRLSAMGEMASALAHELNQPLAAI
SNYMKGSRRLLAGSSDPNTPKVESALDRAAEQALRAGQIIRRLRDFVARGESEKRVESLS
KLIEEAGALGLAGAREQNVQLRFSLDPGADLVLADRVQIQQVLVNLFRNALEAMAQSQRR
ELVVTNTPAADDMIEVEVSDTGSGFQDDVIPNLFQTFFTTKDTGMGVGLSISRSIIEAHG
GRMWAESNASGGATFRFTLPAADEN

# Drug_Target_65_Reaction:
ATP + protein L-histidine = ADP + protein N-phospho-L-histidine

# Drug_Target_65_Signals:
None

# Drug_Target_65_Specific_Function:
Putative oxygen sensor; modulates the activity of fixJ, a transcriptional activator of nitrogen fixation fixK gene. FixL probably acts as a kinase that phosphorylates fixJ

# Drug_Target_65_SwissProt_ID:
P23222

# Drug_Target_65_SwissProt_Name:
FIXL_BRAJA

# Drug_Target_65_Synonyms:
EC 2.7.13.3

# Drug_Target_65_Theoretical_pI:
5.38

# Drug_Target_65_Transmembrane_Regions:
None

# Drug_Target_66_Cellular_Location:
Not Available

# Drug_Target_66_Chromosome_Location:
Not Available

# Drug_Target_66_Drug_References:
Not Available

# Drug_Target_66_Essentiality:
Non-Essential

# Drug_Target_66_GenAtlas_ID:
Not Available

# Drug_Target_66_GenBank_ID_Gene:
AE017222

# Drug_Target_66_GenBank_ID_Protein:
Not Available

# Drug_Target_66_GeneCard_ID:
Not Available

# Drug_Target_66_Gene_Name:
TT_P0059

# Drug_Target_66_Gene_Sequence:
>1170 bp
ATGAAGCGCCTTTCCCTGAGGGAGGCCTGGCCCTACCTGAAAGACCTCCAGCAAGATCCC
CTCGCCGTCCTGCTGGCGTGGGGCCGGGCCCACCCCCGGCTCTTCCTTCCCCTGCCCCGC
TTCCCCCTGGCCCTGATCTTTGACCCCGAGGGGGTGGAGGGGGCGCTCCTCGCCGAGGGG
ACCACCAAGGCCACCTTCCAGTACCGGGCCCTCTCCCGCCTCACGGGGAGGGGCCTCCTC
ACCGACTGGGGGGAAAGCTGGAAGGAGGCGCGCAAGGCCCTCAAAGACCCCTTCCTGCCG
AAGAACGTCCGCGGCTACCGGGAGGCCATGGAGGAGGAGGCCCGGGCCTTCTTCGGGGAG
TGGCGGGGGGAGGAGCGGGACCTGGACCACGAGATGCTCGCCCTCTCCCTGCGCCTCCTC
GGGCGGGCCCTCTTCGGGAAGCCCCTCTCCCCAAGCCTCGCGGAGCACGCCCTTAAGGCC
CTGGACCGGATCATGGCCCAGACCAGGAGCCCCCTGGCCCTCCTGGACCTGGCCGCCGAA
GCCCGCTTCCGGAAGGACCGGGGGGCCCTCTACCGCGAGGCGGAAGCCCTCATCGTCCAC
CCGCCCCTCTCCCACCTTCCCCGAGAGCGCGCCCTGAGCGAGGCCGTGACCCTCCTGGTG
GCGGGCCACGAGACGGTGGCGAGCGCCCTCACCTGGTCCTTTCTCCTCCTCTCCCACCGC
CCGGACTGGCAGAAGCGGGTGGCCGAGAGCGAGGAGGCGGCCCTCGCCGCCTTCCAGGAG
GCCCTGAGGCTCTACCCCCCCGCCTGGATCCTCACCCGGAGGCTGGAAAGGCCCCTCCTC
CTGGGAGAGGACCGGCTCCCCCCGGGCACCACCCTGGTCCTCTCCCCCTACGTGACCCAG
AGGCTCCACTTCCCCGATGGGGAGGCCTTCCGGCCCGAGCGCTTCCTGGAGGAAAGGGGG
ACCCCTTCGGGGCGCTACTTCCCCTTTGGCCTGGGGCAGAGGCTCTGCCTGGGGCGGGAC
TTCGCCCTCCTCGAGGGCCCCATCGTCCTCAGGGCCTTCTTCCGCCGCTTCCGCCTAGAC
CCCCTCCCCTTCCCCCGGGTCCTCGCCCAGGTCACCCTGAGGCCCGAAGGCGGGCTTCCC
GCGCGGCCTAGGGAGGAGGTGCGGGCGTGA

# Drug_Target_66_General_Function:
Involved in monooxygenase activity

# Drug_Target_66_General_References:
12401810	Yano JK, Blasco F, Li H, Schmid RD, Henne A, Poulos TL: Preliminary characterization and crystal structure of a thermostable cytochrome P450 from Thermus thermophilus. J Biol Chem. 2003 Jan 3;278(1):608-16. Epub 2002 Oct 24.

# Drug_Target_66_HGNC_ID:
Not Available

# Drug_Target_66_HPRD_ID:
Not Available

# Drug_Target_66_ID:
4289

# Drug_Target_66_Locus:
Not Available

# Drug_Target_66_Molecular_Weight:
44257

# Drug_Target_66_Name:
Cytochrome P450

# Drug_Target_66_Number_of_Residues:
389

# Drug_Target_66_PDB_ID:
1N97

# Drug_Target_66_Pathway:
Not Available

# Drug_Target_66_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_66_Protein_Sequence:
>Cytochrome P450
MKRLSLREAWPYLKDLQQDPLAVLLAWGRAHPRLFLPLPRFPLALIFDPEGVEGALLAEG
TTKATFQYRALSRLTGRGLLTDWGESWKEARKALKDPFLPKNVRGYREAMEEEARAFFGE
WRGEERDLDHEMLALSLRLLGRALFGKPLSPSLAEHALKALDRIMAQTRSPLALLDLAAE
ARFRKDRGALYREAEALIVHPPLSHLPRERALSEAVTLLVAGHETVASALTWSFLLLSHR
PDWQKRVAESEEAALAAFQEALRLYPPAWILTRRLERPLLLGEDRLPPGTTLVLSPYVTQ
RLHFPDGEAFRPERFLEERGTPSGRYFPFGLGQRLCLGRDFALLEGPIVLRAFFRRFRLD
PLPFPRVLAQVTLRPEGGLPARPREEVRA

# Drug_Target_66_Reaction:
Not Available

# Drug_Target_66_Signals:
None

# Drug_Target_66_Specific_Function:
Not Available

# Drug_Target_66_SwissProt_ID:
Q746J6

# Drug_Target_66_SwissProt_Name:
Q746J6_THET2

# Drug_Target_66_Synonyms:
Not Available

# Drug_Target_66_Theoretical_pI:
10.17

# Drug_Target_66_Transmembrane_Regions:
None

# Drug_Target_67_Cellular_Location:
Not Available

# Drug_Target_67_Chromosome_Location:
Not Available

# Drug_Target_67_Drug_References:
Not Available

# Drug_Target_67_Essentiality:
Non-Essential

# Drug_Target_67_GenAtlas_ID:
Not Available

# Drug_Target_67_GenBank_ID_Gene:
AE016830

# Drug_Target_67_GenBank_ID_Protein:
Not Available

# Drug_Target_67_GeneCard_ID:
Not Available

# Drug_Target_67_Gene_Name:
katA

# Drug_Target_67_Gene_Sequence:
>1437 bp
GTGAAAAATCAACATTTAACTACGTCACAAGGAAGTCCAGTTGGCGATAATCAAAATTCG
CTAACTGCAGGAGAATTTGGTCCTGTCCTAATCCAAGACGTTCATTTATTAGAAAAATTA
GCTCATTTTAATCGTGAGCGCGTACCAGAACGGGTTGTTCATGCCAAAGGTGCTGGTGCT
CATGGGATTTTCAAGGTGAGCCAATCAATGGCACAATATACTAAAGCCGATTTTTTATCT
GAAGTTGGCAAAGAAACACCTTTATTCGCTCGTTTTTCAACTGTAGCTGGAGAGTTAGGT
TCATCAGATACATTGCGTGATCCTCGCGGTTTTGCGCTTAAATTCTATACAGACGAAGGA
AATTACGACTTAGTTGGCAATAATACGCCCATTTTTTTCATTCGTGATGCAATTAAGTTT
CCAGATTTTATTCATAGCCAAAAAAGAAATCCGCGGACGCATTTGAAAAGTCCAGAAGCT
GTTTGGGATTTTTGGTCTCATTCACCGGAAAGTCTTCATCAAGTAACAATTTTAATGAGT
GATCGTGGCATTCCGTTGTCGTTCCGTCATATGCATGGTTTTGGTAGCCATACATTCAAA
TGGGTCAATGCTGCTGGAGAAGTATTTTTTGTTAAATATCACTTCAAGACGAATCAAGGA
ATCAAAAATCTAGAGAGTCAATTAGCAGAAGAAATTGCTGGGAAAAACCCAGATTTCCAT
ATTGAAGATTTGCATAATGCAATTGAAAATCAAGAATTTCCTTCTTGGACATTATCTGTG
CAAATTATCCCGTATGCAGATGCGTTAACAATGAAAGAAACACTTTTTGATGTAACAAAA
ACGGTTTCTCAAAAAGAGTATCCGCTGATTGAAGTTGGCACGATGACTTTAAATAGAAAT
CCAGAGAATTATTTTGCAGAGGTTGAACAAGTAACCTTTTCACCAGGGAATTTCGTTCCT
GGTATTGAAGCTTCTCCGGATAAATTATTGCAAGGACGTTTGTTCGCTTATGGGGACGCA
CATCGTCATCGCGTGGGCGCTAATAGTCACCAATTGCCAATCAACCAAGCAAAAGCGCCT
GTAAATAACTACCAAAAAGACGGCAATATGCGTTTTAACAATGGCAATAGCGAAATTAAT
TATGAACCAAATAGTTATACTGAAACACCAAAAGAAGATCCTACAGCGAAAATTAGTTCC
TTTGAAGTTGAAGGAAATGTTGGTAATTATAGCTATAATCAAGATCACTTTACACAAGCA
AACGCTTTGTATAATTTGCTGCCAAGCGAAGAAAAAGAAAACTTAATTAACAATATAGCG
GCATCTTTAGGTCAAGTGAAAAATCAAGAAATCATCGCGCGTCAAATTGATTTGTTCACT
AGAGTAAATCCAGAATATGGAGCACGTGTCGCACAAGCCATCAAGCAACAAGCATAA

# Drug_Target_67_General_Function:
Involved in catalase activity

# Drug_Target_67_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.

# Drug_Target_67_HGNC_ID:
Not Available

# Drug_Target_67_HPRD_ID:
Not Available

# Drug_Target_67_ID:
4952

# Drug_Target_67_Locus:
Not Available

# Drug_Target_67_Molecular_Weight:
53786

# Drug_Target_67_Name:
Catalase/peroxidase

# Drug_Target_67_Number_of_Residues:
478

# Drug_Target_67_PDB_ID:
1SI8

# Drug_Target_67_Pathway:
Not Available

# Drug_Target_67_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_67_Protein_Sequence:
>Catalase/peroxidase
MKNQHLTTSQGSPVGDNQNSLTAGEFGPVLIQDVHLLEKLAHFNRERVPERVVHAKGAGA
HGIFKVSQSMAQYTKADFLSEVGKETPLFARFSTVAGELGSSDTLRDPRGFALKFYTDEG
NYDLVGNNTPIFFIRDAIKFPDFIHSQKRNPRTHLKSPEAVWDFWSHSPESLHQVTILMS
DRGIPLSFRHMHGFGSHTFKWVNAAGEVFFVKYHFKTNQGIKNLESQLAEEIAGKNPDFH
IEDLHNAIENQEFPSWTLSVQIIPYADALTMKETLFDVTKTVSQKEYPLIEVGTMTLNRN
PENYFAEVEQVTFSPGNFVPGIEASPDKLLQGRLFAYGDAHRHRVGANSHQLPINQAKAP
VNNYQKDGNMRFNNGNSEINYEPNSYTETPKEDPTAKISSFEVEGNVGNYSYNQDHFTQA
NALYNLLPSEEKENLINNIAASLGQVKNQEIIARQIDLFTRVNPEYGARVAQAIKQQA

# Drug_Target_67_Reaction:
Not Available

# Drug_Target_67_Signals:
None

# Drug_Target_67_Specific_Function:
Not Available

# Drug_Target_67_SwissProt_ID:
Q834P5

# Drug_Target_67_SwissProt_Name:
Q834P5_ENTFA

# Drug_Target_67_Synonyms:
Not Available

# Drug_Target_67_Theoretical_pI:
6.38

# Drug_Target_67_Transmembrane_Regions:
None

# Drug_Target_68_Cellular_Location:
Not Available

# Drug_Target_68_Chromosome_Location:
Not Available

# Drug_Target_68_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_68_Essentiality:
Non-Essential

# Drug_Target_68_GenAtlas_ID:
Not Available

# Drug_Target_68_GenBank_ID_Gene:
J04832

# Drug_Target_68_GenBank_ID_Protein:
142798

# Drug_Target_68_GeneCard_ID:
Not Available

# Drug_Target_68_Gene_Name:
CYP102A1

# Drug_Target_68_Gene_Sequence:
>3150 bp
ATGACAATTAAAGAAATGCCTCAGCCAAAAACGTTTGGAGAGCTTAAAAATTTACCGTTA
TTAAACACAGATAAACCGGTTCAAGCTTTGATGAAAATTGCGGATGAATTAGGAGAAATC
TTTAAATTCGAGGCGCCTGGTCGTGTAACGCGCTACTTATCAAGTCAGCGTCTAATTAAA
GAAGCATGCGATGAATCACGCTTTGATAAAAACTTAAGTCAAGCGCTTAAATTTGTACGT
GATTTTGCAGGAGACGGGTTATTTACAAGCTGGACGCATGAAAAAAATTGGAAAAAAGCG
CATAATATCTTACTTCCAAGCTTCAGTCAGCAGGCAATGAAAGGCTATCATGCGATGATG
GTCGATATCGCCGTGCAGCTTGTTCAAAAGTGGGAGCGTCTAAATGCAGATGAGCATATT
GAAGTACCGGAAGACATGACACGTTTAACGCTTGATACAATTGGTCTTTGCGGCTTTAAC
TATCGCTTTAACAGCTTTTACCGAGATCAGCCTCATCCATTTATTACAAGTATGGTCCGT
GCACTGGATGAAGCAATGAACAAGCTGCAGCGAGCAAATCCAGACGACCCAGCTTATGAT
GAAAACAAGCGCCAGTTTCAAGAAGATATCAAGGTGATGAACGACCTAGTAGATAAAATT
ATTGCAGATCGCAAAGCAAGCGGTGAACAAAGCGATGATTTATTAACGCATATGCTAAAC
GGAAAAGATCCAGAAACGGGTGAGCCGCTTGATGACGAGAACATTCGCTATCAAATTATT
ACATTCTTAATTGCGGGACACGAAACAACAAGTGGTCTTTTATCATTTGCGCTGTATTTC
TTAGTGAAAAATCCACATGTATTACAAAAAGCAGCAGAAGAAGCAGCACGAGTTCTAGTA
GATCCTGTTCCAAGCTACAAACAAGTCAAACAGCTTAAATATGTCGGCATGGTCTTAAAC
GAAGCGCTGCGCTTATGGCCAACTGCTCCTGCGTTTTCCCTATATGCAAAAGAAGATACG
GTGCTTGGAGGAGAATATCCTTTAGAAAAAGGCGACGAACTAATGGTTCTGATTCCTCAG
CTTCACCGTGATAAAACAATTTGGGGAGACGATGTGGAAGAGTTCCGTCCAGAGCGTTTT
GAAAATCCAAGTGCGATTCCGCAGCATGCGTTTAAACCGTTTGGAAACGGTCAGCGTGCG
TGTATCGGTCAGCAGTTCGCTCTTCATGAAGCAACGCTGGTACTTGGTATGATGCTAAAA
CACTTTGACTTTGAAGATCATACAAACTACGAGCTGGATATTAAAGAAACTTTAACGTTA
AAACCTGAAGGCTTTGTGGTAAAAGCAAAATCGAAAAAAATTCCGCTTGGCGGTATTCCT
TCACCTAGCACTGAACAGTCTGCTAAAAAAGTACGCAAAAAGGCAGAAAACGCTCATAAT
ACGCCGCTGCTTGTGCTATACGGTTCAAATATGGGAACAGCTGAAGGAACGGCGCGTGAT
TTAGCAGATATTGCAATGAGCAAAGGATTTGCACCGCAGGTCGCAACGCTTGATTCACAC
GCCGGAAATCTTCCGCGCGAAGGAGCTGTATTAATTGTAACGGCGTCTTATAACGGTCAT
CCGCCTGATAACGCAAAGCAATTTGTCGACTGGTTAGACCAAGCGTCTGCTGATGAAGTA
AAAGGCGTTCGCTACTCCGTATTTGGATGCGGCGATAAAAACTGGGCTACTACGTATCAA
AAAGTGCCTGCTTTTATCGATGAAACGCTTGCCGCTAAAGGGGCAGAAAACATCGCTGAC
CGCGGTGAAGCAGATGCAAGCGACGACTTTGAAGGCACATATGAAGAATGGCGTGAACAT
ATGTGGAGTGACGTAGCAGCCTACTTTAACCTCGACATTGAAAACAGTGAAGATAATAAA
TCTACTCTTTCACTTCAATTTGTCGACAGCGCCGCGGATATGCCGCTTGCGAAAATGCAC
GGTGCGTTTTCAACGAACGTCGTAGCAAGCAAAGAACTTCAACAGCCAGGCAGTGCACGA
AGCACGCGACATCTTGAAATTGAACTTCCAAAAGAAGCTTCTTATCAAGAAGGAGATCAT
TTAGGTGTTATTCCTCGCAACTATGAAGGAATAGTAAACCGTGTAACAGCAAGGTTCGGC
CTAGATGCATCACAGCAAATCCGTCTGGAAGCAGAAGAAGAAAAATTAGCTCATTTGCCA
CTCGCTAAAACAGTATCCGTAGAAGAGCTTCTGCAATACGTGGAGCTTCAAGATCCTGTT
ACGCGCACGCAGCTTCGCGCAATGGCTGCTAAAACGGTCTGCCCGCCGCATAAAGTAGAG
CTTGAAGCCTTGCTTGAAAAGCAAGCCTACAAAGAACAAGTGCTGGCAAAACGTTTAACA
ATGCTTGAACTGCTTGAAAAATACCCGGCGTGTGAAATGAAATTCAGCGAATTTATCGCC
CTTCTGCCAAGCATACGCCCGCGCTATTACTCGATTTCTTCATCACCTCGTGTCGATGAA
AAACAAGCAAGCATCACGGTCAGCGTTGTCTCAGGAGAAGCGTGGAGCGGATATGGAGAA
TATAAAGGAATTGCGTCGAACTATCTTGCCGAGCTGCAAGAAGGAGATACGATTACGTGC
TTTATTTCCACACCGCAGTCAGAATTTACGCTGCCAAAAGACCCTGAAACGCCGCTTATC
ATGGTCGGACCGGGAACAGGCGTCGCGCCGTTTAGAGGCTTTGTGCAGGCGCGCAAACAG
CTAAAAGAACAAGGACAGTCACTTGGAGAAGCACATTTATACTTCGGCTGCCGTTCACCT
CATGAAGACTATCTGTATCAAGAAGAGCTTGAAAACGCCCAAAGCGAAGGCATCATTACG
CTTCATACCGCTTTTTCTCGCATGCCAAATCAGCCGAAAACATACGTTCAGCACGTAATG
GAACAAGACGGCAAGAAATTGATTGAACTTCTTGATCAAGGAGCGCACTTCTATATTTGC
GGAGACGGAAGCCAAATGGCACCTGCCGTTGAAGCAACGCTTATGAAAAGCTATGCTGAC
GTTCACCAAGTGAGTGAAGCAGACGCTCGCTTATGGCTGCAGCAGCTAGAAGAAAAAGGC
CGATACGCAAAAGACGTGTGGGCTGGGTAA

# Drug_Target_68_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_68_General_References:
10051560	Sevrioukova IF, Li H, Zhang H, Peterson JA, Poulos TL: Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1863-8.
11695892	Haines DC, Tomchick DR, Machius M, Peterson JA: Pivotal role of water in the mechanism of P450BM-3. Biochemistry. 2001 Nov 13;40(45):13456-65.
1727637	Boddupalli SS, Pramanik BC, Slaughter CA, Estabrook RW, Peterson JA: Fatty acid monooxygenation by P450BM-3: product identification and proposed mechanisms for the sequential hydroxylation reactions. Arch Biochem Biophys. 1992 Jan;292(1):20-8.
2544578	Ruettinger RT, Wen LP, Fulco AJ: Coding nucleotide, 5' regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase from Bacillus megaterium. J Biol Chem. 1989 Jul 5;264(19):10987-95.
8342039	Ravichandran KG, Boddupalli SS, Hasermann CA, Peterson JA, Deisenhofer J: Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science. 1993 Aug 6;261(5122):731-6.
9033595	Li H, Poulos TL: The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol. 1997 Feb;4(2):140-6.

# Drug_Target_68_HGNC_ID:
Not Available

# Drug_Target_68_HPRD_ID:
Not Available

# Drug_Target_68_ID:
2845

# Drug_Target_68_Locus:
Not Available

# Drug_Target_68_Molecular_Weight:
117783

# Drug_Target_68_Name:
Bifunctional P-450:NADPH-P450 reductase

# Drug_Target_68_Number_of_Residues:
1049

# Drug_Target_68_PDB_ID:
1JPZ

# Drug_Target_68_Pathway:
Not Available

# Drug_Target_68_Pfam_Domain_Function:
PF00067	p450
PF00175	NAD_binding_1
PF00258	Flavodoxin_1
PF00667	FAD_binding_1

# Drug_Target_68_Protein_Sequence:
>Bifunctional P-450:NADPH-P450 reductase
MTIKEMPQPKTFGELKNLPLLNTDKPVQALMKIADELGEIFKFEAPGRVTRYLSSQRLIK
EACDESRFDKNLSQALKFVRDFAGDGLFTSWTHEKNWKKAHNILLPSFSQQAMKGYHAMM
VDIAVQLVQKWERLNADEHIEVPEDMTRLTLDTIGLCGFNYRFNSFYRDQPHPFITSMVR
ALDEAMNKLQRANPDDPAYDENKRQFQEDIKVMNDLVDKIIADRKASGEQSDDLLTHMLN
GKDPETGEPLDDENIRYQIITFLIAGHETTSGLLSFALYFLVKNPHVLQKAAEEAARVLV
DPVPSYKQVKQLKYVGMVLNEALRLWPTAPAFSLYAKEDTVLGGEYPLEKGDELMVLIPQ
LHRDKTIWGDDVEEFRPERFENPSAIPQHAFKPFGNGQRACIGQQFALHEATLVLGMMLK
HFDFEDHTNYELDIKETLTLKPEGFVVKAKSKKIPLGGIPSPSTEQSAKKVRKKAENAHN
TPLLVLYGSNMGTAEGTARDLADIAMSKGFAPQVATLDSHAGNLPREGAVLIVTASYNGH
PPDNAKQFVDWLDQASADEVKGVRYSVFGCGDKNWATTYQKVPAFIDETLAAKGAENIAD
RGEADASDDFEGTYEEWREHMWSDVAAYFNLDIENSEDNKSTLSLQFVDSAADMPLAKMH
GAFSTNVVASKELQQPGSARSTRHLEIELPKEASYQEGDHLGVIPRNYEGIVNRVTARFG
LDASQQIRLEAEEEKLAHLPLAKTVSVEELLQYVELQDPVTRTQLRAMAAKTVCPPHKVE
LEALLEKQAYKEQVLAKRLTMLELLEKYPACEMKFSEFIALLPSIRPRYYSISSSPRVDE
KQASITVSVVSGEAWSGYGEYKGIASNYLAELQEGDTITCFISTPQSEFTLPKDPETPLI
MVGPGTGVAPFRGFVQARKQLKEQGQSLGEAHLYFGCRSPHEDYLYQEELENAQSEGIIT
LHTAFSRMPNQPKTYVQHVMEQDGKKLIELLDQGAHFYICGDGSQMAPAVEATLMKSYAD
VHQVSEADARLWLQQLEEKGRYAKDVWAG

# Drug_Target_68_Reaction:
NADPH + H+ + n oxidized hemoprotein = NADP+ + n reduced hemoprotein ALL_REAC (other) R00106

# Drug_Target_68_Signals:
None

# Drug_Target_68_Specific_Function:
Functions as a fatty acid monooxygenase. Catalyzes hydroxylation of medium and long-chain fatty acids at omega-1, omega-2 and omega-3 positions, with optimum chain lengths of 12-16 carbons (lauric, myristic, and palmitic acids). The reductase domain is required for electron transfer from NADP to cytochrome P450

# Drug_Target_68_SwissProt_ID:
P14779

# Drug_Target_68_SwissProt_Name:
CPXB_BACME

# Drug_Target_68_Synonyms:
Cytochrome P450(BM-3)
P450BM-3

# Drug_Target_68_Theoretical_pI:
5.03

# Drug_Target_68_Transmembrane_Regions:
None

# Drug_Target_69_Cellular_Location:
Not Available

# Drug_Target_69_Chromosome_Location:
Not Available

# Drug_Target_69_Drug_References:
Not Available

# Drug_Target_69_Essentiality:
Non-Essential

# Drug_Target_69_GenAtlas_ID:
HBB

# Drug_Target_69_GenBank_ID_Gene:
U01317

# Drug_Target_69_GenBank_ID_Protein:
455997

# Drug_Target_69_GeneCard_ID:
HBB

# Drug_Target_69_Gene_Name:
HBB

# Drug_Target_69_Gene_Sequence:
>444 bp
ATGGTGCACCTGACTCCTGAGGAGAAGTCTGCCGTTACTGCCCTGTGGGGCAAGGTGAAC
GTGGATGAAGTTGGTGGTGAGGCCCTGGGCAGGCTGCTGGTGGTCTACCCTTGGACCCAG
AGGTTCTTTGAGTCCTTTGGGGATCTGTCCACTCCTGATGCTGTTATGGGCAACCCTAAG
GTGAAGGCTCATGGCAAGAAAGTGCTCGGTGCCTTTAGTGATGGCCTGGCTCACCTGGAC
AACCTCAAGGGCACCTTTGCCACACTGAGTGAGCTGCACTGTGACAAGCTGCACGTGGAT
CCTGAGAACTTCAGGCTCCTGGGCAACGTGCTGGTCTGTGTGCTGGCCCATCACTTTGGC
AAAGAATTCACCCCACCAGTGCAGGCTGCCTATCAGAAAGTGGTGGCTGGTGTGGCTAAT
GCCCTGGCCCACAAGTATCACTAA

# Drug_Target_69_General_Function:
Involved in iron ion binding

# Drug_Target_69_General_References:
1019344	Marotta CA, Forget BG, Cohen-Solal M, Weissman SM: Nucleotide sequence analysis of coding and noncoding regions of human beta-globin mRNA. Prog Nucleic Acid Res Mol Biol. 1976;19:165-75.
10588683	Durner J, Gow AJ, Stamler JS, Glazebrook J: Ancient origins of nitric oxide signaling in biological systems. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14206-7.
1115799	Brimhall B, Jones RT, Schneider RG, Hosty TS, Tomlin G, Atkins R: Two new hemoglobins. Hemoglobin Alabama (beta39(C5)Gln leads to Lys) and hemoglobin Montgomery (alpha 48(CD 6) Leu leads to Arg). Biochim Biophys Acta. 1975 Jan 30;379(1):28-32.
1138922	Wilkinson T, Chua CG, Carrell RW, Robin H, Exner T, Lee KM, Kronenberg H: Haemoglobin Camperdown beta104(G6) arginine leads to serine. Biochim Biophys Acta. 1975 May 30;393(1):195-200.
1177322	Fermi G: Three-dimensional fourier synthesis of human deoxyhaemoglobin at 2-5 A resolution: refinement of the atomic model. J Mol Biol. 1975 Sep 15;97(2):237-56.
1247583	Garel MC, Hassan W, Coquelet MT, Goossens M, Rosa J, Arous N: Hemoglobin J Cairo: beta 65 (E9) Lys leads to Gln, A new hemoglobin variant discovered in an Egyptian family. Biochim Biophys Acta. 1976 Jan 20;420(1):97-104.
1301199	Murru S, Poddie D, Sciarratta GV, Agosti S, Baffico M, Melevendi C, Pirastu M, Cao A: A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype. Hum Mutat. 1992;1(2):124-8.
1487420	Liu JS, Molchanova TP, Gu LH, Wilson JB, Hopmeier P, Schnedl W, Balaun E, Krejs GJ, Huisman TH: Hb Graz or alpha 2 beta 2(2)(NA2)His-->Leu; a new beta chain variant observed in four families from southern Austria. Hemoglobin. 1992;16(6):493-501.
1511986	Wajcman H, Blouquit Y, Vasseur C, Le Querrec A, Laniece M, Melevendi C, Rasore A, Galacteros F: Two new human hemoglobin variants caused by unusual mutational events: Hb Zaire contains a five residue repetition within the alpha-chain and Hb Duino has two residues substituted in the beta-chain. Hum Genet. 1992 Aug;89(6):676-80.
1517102	Ramachandran M, Gu LH, Wilson JB, Kitundu MN, Adekile AD, Liu JC, McKie KM, Huisman TH: A new variant, HB Muscat [alpha 2 beta (2)32(B14)Leu----Val] observed in association with HB S in an Arabian family. Hemoglobin. 1992;16(4):259-66.
1540659	Wajcman H, Kister J, Vasseur C, Blouquit Y, Trastour JC, Cottenceau D, Galacteros F: Structure of the EF corner favors deamidation of asparaginyl residues in hemoglobin: the example of Hb La Roche-sur-Yon [beta 81 (EF5) Leu----His] Biochim Biophys Acta. 1992 Feb 14;1138(2):127-32.
1567857	Kavanaugh JS, Rogers PH, Case DA, Arnone A: High-resolution X-ray study of deoxyhemoglobin Rothschild 37 beta Trp----Arg: a mutation that creates an intersubunit chloride-binding site. Biochemistry. 1992 Apr 28;31(16):4111-21.
1634367	Harano T, Harano K, Kushida Y, Imai K, Nishinakamura R, Matsunaga T: Hb Kodaira [beta 146(HC3)His----Gln]: a new beta chain variant with an amino acid substitution at the C-terminus. Hemoglobin. 1992;16(1-2):85-91.
1787097	Harano T, Harano K, Kushida Y, Ueda S, Yoshii A, Nishinarita M: Hb Isehara (or Hb Redondo) [beta 92 (F8) His----Asn]: an unstable variant with a proximal histidine substitution at the heme contact. Hemoglobin. 1991;15(4):279-90.
1814856	Tamagnini GP, Ribeiro ML, Valente V, Ramachandran M, Wilson JB, Baysal E, Gu LH, Huisman TH: Hb Coimbra or alpha 2 beta (2)99(G1)Asp----Glu, a newly discovered highoxygen affinity variant. Hemoglobin. 1991;15(6):487-96.
1917530	Harano T, Harano K, Kushida Y, Ueda S: A new abnormal variant, Hb Yahata or beta 112(G14)Cys----Tyr, found in a Japanese: structural confirmation by DNA sequencing of the beta-globin gene. Hemoglobin. 1991;15(1-2):109-13.
1917537	Como PF, Wylie BR, Trent RJ, Bruce D, Volpato F, Wilkinson T, Kronenberg H, Holland RA, Tibben EA: A new unstable and low oxygen affinity hemoglobin variant: Hb Stanmore [beta 111(G13)Val----Ala] Hemoglobin. 1991;15(1-2):53-65.
1917539	Como PF, Hocking DR, Swinton GW, Trent RJ, Holland RA, Tibben EA, Wilkinson T, Kronenberg H: Hb Geelong [beta 139(H17)Asn----Asp] Hemoglobin. 1991;15(1-2):85-95.
2079435	Plaseska D, Wilson JB, Gu LH, Kutlar F, Huisman TH, Zeng YT, Shen M: Hb Zengcheng or alpha 2 beta(2)114(G16)Leu----Met. Hemoglobin. 1990;14(5):555-7.
2101840	Gaudry CL Jr, Pitel PA, Jue DL, Hine TK, Johnson MH, Moo-Penn WF: Hb Jacksonville [alpha 2 beta 2(54)(D5)Val----Asp]: a new unstable variant found in a patient with hemolytic anemia. Hemoglobin. 1990;14(6):653-9.
2384314	Sciarratta GV, Ivaldi G: Hb Matera [beta 55(D6)Met----Lys]: a new unstable hemoglobin variant in an Italian family. Hemoglobin. 1990;14(1):79-85.
2399911	Bardakdjian-Michau J, Fucharoen S, Delanoe-Garin J, Kister J, Lacombe C, Winichagoon P, Blouquit Y, Riou J, Wasi P, Galacteros F: Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val----Gly: a new unstable beta variant producing a beta-thalassemia intermedia phenotype in association with beta zero-thalassemia. Am J Hematol. 1990 Oct;35(2):96-9.
2513289	Moo-Penn WF, Johnson MH, Jue DL, Lonser R: Hb Hinsdale [beta 139 (H17)Asn----Lys]: a variant in the central cavity showing reduced affinity for oxygen and 2,3-diphosphoglycerate. Hemoglobin. 1989;13(5):455-64.
2581851	Lang KM, Spritz RA: Cloning specific complete polyadenylylated 3'-terminal cDNA segments. Gene. 1985;33(2):191-6.
2599880	Gilbert AT, Fleming PJ, Sumner DR, Hughes WG, Holland RA, Tibben EA: Hemoglobin Windsor or beta 11 (A8)Val----Asp: a new unstable beta-chain hemoglobin variant producing a hemolytic anemia. Hemoglobin. 1989;13(5):437-53.
2634671	Lena-Russo D, Orsini A, Vovan L, Bardakdjian-Michau J, Lacombe C, Blouquit Y, Craescu CT, Galacteros F: Hb N-Timone [alpha 2 beta 2(8)(A5)Lys----Glu]: a new fast-moving variant with normal stability and oxygen affinity. Hemoglobin. 1989;13(7-8):743-7.
3384707	Gilbert AT, Fleming PJ, Sumner DR, Hughes WG, Ip F, Kwan YL, Holland RA: Hemoglobin Randwick or beta 15 (A12)Trp----Gly: a new unstable beta-chain hemoglobin variant. Hemoglobin. 1988;12(2):149-61.
3384708	Malcorra-Azpiazu JJ, Balda-Aguirre MI, Diaz-Chico JC, Hu H, Wilson JB, Webber BB, Kutlar F, Kutlar A, Huisman TH: Hb Las Palmas or alpha 2 beta 2(49)(CD8)Ser----Phe, a mildly unstable hemoglobin variant. Hemoglobin. 1988;12(2):163-70.
3384709	Baklouti F, Giraud Y, Francina A, Richard G, Favre-Gilly J, Delaunay J: Hemoglobin Pierre-Benite [beta 90(F6)Glu----Asp], a new high affinity variant found in a French family. Hemoglobin. 1988;12(2):171-7.
3384710	Baudin-Chich V, Wajcman H, Gombaud-Saintonge G, Arous N, Riou J, Briere J, Galacteros F: Hemoglobin Brest [beta 127 (H5)Gln----Lys] a new unstable human hemoglobin variant located at the alpha 1 beta 1 interface with specific electrophoretic behavior. Hemoglobin. 1988;12(2):179-88.
3557994	Merault G, Keclard L, Garin J, Poyart C, Blouquit Y, Arous N, Galacteros F, Feingold J, Rosa J: Hemoglobin La Desirade alpha A2 beta 2 129 (H7) Ala----Val: a new unstable hemoglobin. Hemoglobin. 1986;10(6):593-605.
3623975	Indrak K, Wiedermann BF, Batek F, Wilson JB, Webber BB, Kutlar A, Huisman TH: Hb Olomouc or alpha 2 beta 2(86)(F2)Ala----Asp, a new high oxygen affinity variant. Hemoglobin. 1987;11(2):151-5.
3654265	Williamson D, Wells RM, Anderson R, Matthews J: A new unstable and low oxygen affinity hemoglobin variant: Hb J-Auckland [beta 25(B7)Gly----Asp]. Hemoglobin. 1987;11(3):221-30.
3666141	Baklouti F, Giraud Y, Francina A, Richard G, Perier C, Geyssant A, Jaubert J, Brizard C, Delaunay J: Hemoglobin Grange-Blanche [beta 27(B9) Ala----Val], a new variant with normal expression and increased affinity for oxygen. FEBS Lett. 1987 Oct 19;223(1):59-62.
3691763	Berlin G, Wranne B, Jeppsson JO: Hb Linkoping (beta 36 Pro----Thr): a new high oxygen affinity hemoglobin variant found in two families of Finnish origin. Eur J Haematol. 1987 Nov;39(5):452-6.
3707969	Huisman TH, Wilson JB, Kutlar A, Yang KG, Chen SS, Webber BB, Altay C, Martinez AV: Hb J-Antakya or alpha 2 beta (2)65(E9)Lys----Met in a Turkish family and Hb complutense or alpha 2 beta (2)127(H5)Gln----Glu in a Spanish family; correction of a previously published identification. Biochim Biophys Acta. 1986 Jun 5;871(2):229-31.
3718478	Yoshioka N, Atassi MZ: Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding sites on the beta-chain of human haemoglobin by synthetic overlapping peptides encompassing the entire chain. Biochem J. 1986 Mar 1;234(2):453-6.
3744871	Harano T, Harano K, Ueda S, Imai N, Kitazumi T: A new electrophoretically-silent hemoglobin variant: hemoglobin Kofu or alpha 2 beta 2 84 (EF8) Thr----Ile. Hemoglobin. 1986;10(4):417-20.
3754244	Ohba Y, Miyaji T, Murakami M, Kadowaki S, Fujita T, Oimomi M, Hatanaka H, Ishikawa K, Baba S, Hitaka K, et al.: Hb Himeji or beta 140 (H18) Ala----Asp. A slightly unstable hemoglobin with increased beta N-terminal glycation. Hemoglobin. 1986;10(2):109-25.
3838976	Ohba Y, Imanaka M, Matsuoka M, Hattori Y, Miyaji T, Funaki C, Shibata K, Shimokata H, Kuzuya F, Miwa S: A new unstable, high oxygen affinity hemoglobin: Hb Nagoya or beta 97 (FG4) His----Pro. Hemoglobin. 1985;9(1):11-24.
3937824	Rahbar S, Louis J, Lee T, Asmerom Y: Hemoglobin North Chicago (beta 36 [C2] proline----serine): a new high affinity hemoglobin. Hemoglobin. 1985;9(6):559-76.
4129558	Adams JG 3rd, Winter WP, Tausk K, Heller P: Hemoglobin Rush (beta 101 (g3) glutamine): a new unstable hemoglobin causing mild hemolytic anemia. Blood. 1974 Feb;43(2):261-9.
429365	Adams JG, Steinberg MH, Boxer LA, Baehner RL, Forget BG, Tsistrakis GA: The structure of hemoglobin Indianapolis [beta112(G14) arginine]. An unstable variant detectable only by isotopic labeling. J Biol Chem. 1979 May 10;254(9):3479-82.
4639022	Aksoy M, Erdem S, Efremov GD, Wilson JB, Huisman TH, Schroeder WA, Shelton JR, Shelton JB, Ulitin ON, Muftuoglu A: Hemoglobin Istanbul: substitution of glutamine for histidine in a proximal histidine (F8(92) ). J Clin Invest. 1972 Sep;51(9):2380-7.
4850241	Arcasoy A, Casey R, Lehmann H, Cavdar AO, Berki A: A new haemoglobin J from Turkey--Hb Ankara (beta10 (A7) Ala-Asp). FEBS Lett. 1974 Jun 1;42(2):121-3.
4852224	Ricco G, Pich PG, Mazza U, Rossi G, Ajmar F, Arese P, Gallo E: Hb J Sicilia: beta 65 (E9) Lys-Asn, a beta homologue of Hb Zambia. FEBS Lett. 1974 Feb 15;39(2):200-4.
6166590	Brennan SO, Wells RM, Smith H, Carrell RW: Hemoglobin Brisbane: beta68 Leu replaced by His. A new high oxygen affinity variant. Hemoglobin. 1981;5(4):325-35.
6254664	Lawn RM, Efstratiadis A, O'Connell C, Maniatis T: The nucleotide sequence of the human beta-globin gene. Cell. 1980 Oct;21(3):647-51.
635569	Bunn HF, Gabbay KH, Gallop PM: The glycosylation of hemoglobin: relevance to diabetes mellitus. Science. 1978 Apr 7;200(4337):21-7.
6434492	Rahbar S, Asmerom Y, Blume KG: A silent hemoglobin variant detected by HPLC: hemoglobin City of Hope beta 69 (E13) Gly----Ser. Hemoglobin. 1984;8(4):333-42.
6526653	Moo-Penn WF, Johnson MH, McGuffey JE, Jue DL: Hemoglobin Shelby [beta 131(H9) Gln----Lys] a correction to the structure of hemoglobin Deaconess and hemoglobin Leslie. Hemoglobin. 1984;8(6):583-93.
6618888	Lu YQ, Fan JL, Liu JF, Hu HL, Peng XH, Huang CH, Huang PY, Chen SS, Jai PC, Yang KG, et al.: Hemoglobin Jianghua [beta 120(GH3) LYS leads to ILE]: a new fast-moving variant found in China. Hemoglobin. 1983;7(4):321-6.
6629822	Jen PC, Chen LC, Chen PF, Wong Y, Chen LF, Guo YY, Chang FQ, Chow YC, Chiu Y: Hemoglobin Quin-Hai, beta 78 (EF2) Leu replaced by Arg, a new abnormal hemoglobin found in Guangdong, China. Hemoglobin. 1983;7(5):407-12.
6629823	Como PF, Kennett D, Wilkinson T, Kronenberg H: A new hemoglobin with high oxygen affinity--hemoglobin bunbury: alpha 2 beta 2 [94 (FG1) Asp replaced by Asn] Hemoglobin. 1983;7(5):413-21.
6629824	Marinucci M, Boissel JP, Massa A, Wajcman H, Tentori L, Labie D: Hemoglobin Maputo: a new beta-chain variant (alpha 2 beta 2 47 (CD6) Asp replaced by Tyr) in combination with hemoglobin S, identified by high performance liquid chromatography (HPLC). Hemoglobin. 1983;7(5):423-33.
6687721	Ohba Y, Hasegawa Y, Amino H, Miwa S, Nakatsuji T, Hattori Y, Miyaji T: Hemoglobin saitama or beta 117 (G19) His leads to Pro, a new variant causing hemolytic disease. Hemoglobin. 1983;7(1):47-56.
668922	Moo-Penn WF, Wolff JA, Simon G, Vacek M, Jue DL, Johnson MH: Hemoglobin Presbyterian: beta108 (G10) asparagine leads to lysine, A hemoglobin variant with low oxygen affinity. FEBS Lett. 1978 Aug 1;92(1):53-6.
6857757	Moo-Penn WF, Johnson MH, McGuffey JE, Jue DL, Therrell BL Jr: Hemoglobin Rio Grande [beta 8 (A5) Lys leads to Thr] a new variant found in a Mexican-American family. Hemoglobin. 1983;7(1):91-5.
7161106	Brennan SO, Williamson D, Whisson ME, Carrell RW: Hemoglobin Palmerston North beta 23 (B5) Val replaced by Phe. A new variant identified in a patient with polycythemia. Hemoglobin. 1982;6(6):569-75.
7173395	Arous N, Galacteros F, Fessas P, Loukopoulos D, Blouquit Y, Komis G, Sellaye M, Boussiou M, Rosa J: Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to Ser. A new abnormal hemoglobin present as a silent beta-thalassemia. FEBS Lett. 1982 Oct 18;147(2):247-50.
721609	Adams JG 3rd, Przywara KP, Heller P, Shamsuddin M: Hemoglobin J Altgeld Gardens. A hemoglobin variant with a substitution of the proximal histidine of the beta-chain. Hemoglobin. 1978;2(5):403-15.
7238856	Arous N, Braconnier F, Thillet J, Blouquit Y, Galacteros F, Chevrier M, Bordahandy C, Rosa J: Hemoglobin Saint Mande beta 102 (G4) asn replaced by tyr: a new low oxygen affinity variant. FEBS Lett. 1981 Apr 6;126(1):114-6.
7338468	Nakatsuji T, Miwa S, Ohba Y, Hattori Y, Miyaji T, Miyata H, Shinohara T, Hori T, Takayama J: Hemoglobin Miyashiro (beta 23[B5] val substituting for gly) an electrophoretically silent variant discovered by the isopropanol test. Hemoglobin. 1981;5(7-8):653-66.
7338469	Nakatsuji T, Miwa S, Ohba Y, Hattori Y, Miyaji T, Hino S, Matsumoto N: A new unstable hemoglobin, Hb Yokohama beta 31 (B13)Leu substituting for Pro, causing hemolytic anemia. Hemoglobin. 1981;5(7-8):667-78.
7693620	Divoky V, Svobodova M, Indrak K, Chrobak L, Molchanova TP, Huisman TH: Hb Hradec Kralove (Hb HK) or alpha 2 beta 2 115(G17)Ala-->Asp, a severely unstable hemoglobin variant resulting in a dominant beta-thalassemia trait in a Czech family. Hemoglobin. 1993 Aug;17(4):319-28.
8111050	de Castro CM, Devlin B, Fleenor DE, Lee ME, Kaufman RE: A novel beta-globin mutation, beta Durham-NC [beta 114 Leu-->Pro], produces a dominant thalassemia-like phenotype. Blood. 1994 Feb 15;83(4):1109-16.
8144352	Owen MC, Ockelford PA, Wells RM: Hb Howick [beta 37(C3)Trp-->Gly]: a new high oxygen affinity variant of the alpha 1 beta 2 contact. Hemoglobin. 1993 Dec;17(6):513-21.
826083	Ikkala E, Koskela J, Pikkarainen P, Rahiala EL, El-Hazmi MA, Nagai K, Lang A, Lehmann H: Hb Helsinki: a variant with a high oxygen affinity and a substitution at a 2,3-DPG binding site (beta82[EF6] Lys replaced by Met). Acta Haematol. 1976;56(5):257-75.
8330972	Landin B: Hb Karlskoga or alpha 2 beta (2)21(B3) Asp-->His: a new slow-moving variant found in Sweden. Hemoglobin. 1993 Jun;17(3):201-8.
8330974	Molchanova TP, Postnikov YuV, Pobedimskaya DD, Smetanina NS, Moschan AA, Kazanetz EG, Tokarev YuN, Huisman TH: Hb Alesha or alpha 2 beta (2)67(E11)Val-->Met: a new unstable hemoglobin variant identified through sequencing of amplified DNA. Hemoglobin. 1993 Jun;17(3):217-25.
8330979	Welch SG, Bateman C: Hb D-Neath or beta 121 (GH4) Glu-->Ala: a new member of the Hb D family. Hemoglobin. 1993 Jun;17(3):255-9.
8522332	Wajcman H, Girodon E, Prome D, North ML, Plassa F, Duwig I, Kister J, Bergerat JP, Oberling F, Lampert E, et al.: Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinity. Hum Genet. 1995 Dec;96(6):711-6.
8602627	Lacan P, Kister J, Francina A, Souillet G, Galacteros F, Delaunay J, Wajcman H: Hemoglobin Debrousse (beta 96[FG3]Leu-->Pro): a new unstable hemoglobin with twofold increased oxygen affinity. Am J Hematol. 1996 Apr;51(4):276-81.
8641705	Rodriguez Romero WE, Castillo M, Chaves MA, Saenz GF, Gu LH, Wilson JB, Baysal E, Smetanina NS, Leonova JY, Huisman TH: Hb Costa Rica or alpha 2 beta 2 77(EF1)His --> Arg: the first example of a somatic cell mutation in a globin gene. Hum Genet. 1996 Jun;97(6):829-33.
8718692	Lafferty J, Ali M, Matthew K, Eng B, Patterson M, Waye JS: Identification of a new high oxygen affinity hemoglobin variant: Hb Aurora [beta 139(H17) Asn-->Tyr] Hemoglobin. 1995;19(6):335-41.
8745430	Frischknecht H, Ventruto M, Hess D, Hunziker P, Rosatelli MC, Cao A, Breitenstein U, Fehr J, Tuchschmid P: HB Hinwil or beta 38(C4)Thr-->Asn: a new beta chain variant detected in a Swiss family. Hemoglobin. 1996 Feb;20(1):31-40.
8811317	Kiger L, Kister J, Groff P, Kalmes G, Prome D, Galacteros F, Wajcman H: Hb J-Europa [beta 62(E6)Ala-->Asp]: normal oxygen binding properties in a new variant involving a residue located distal to the heme. Hemoglobin. 1996 May;20(2):135-40.
891976	Arends T, Lehmann H, Plowman D, Stathopoulou R: Haemoglobin North Shore-Caracas beta 134 (H12) valine replaced by glutamic acid. FEBS Lett. 1977 Aug 15;80(2):261-5.
893142	Ohba Y, Miyaji T, Matsuoka M, Sugiyama K, Suzuki T, Sugiura T: Hemoglobin Mizuho or beta 68 (E 12) leucine leads to proline, a new unstable variant associated with severe hemolytic anemia. Hemoglobin. 1977;1(5):467-77.
9761252	Bisse E, Zorn N, Eigel A, Lizama M, Huaman-Guillen P, Marz W, Van Dorsselaer A, Wieland H: Hemoglobin Rambam (beta69[E13]Gly-->Asp), a pitfall in the assessment of diabetic control: characterization by electrospray mass spectrometry and HPLC. Clin Chem. 1998 Oct;44(10):2172-7.
9843411	Chan NL, Rogers PH, Arnone A: Crystal structure of the S-nitroso form of liganded human hemoglobin. Biochemistry. 1998 Nov 24;37(47):16459-64.
992050	Ahern E, Ahern V, Hilton T, Serjeant GR, Serjeant BE, Seakins M, Lang A, Middleton A, Lehmann H: Haemoglobin caribbean beta91 (F7) Leu replaced by Arg: a mildly haemoglobin with a low oxygen affinity. FEBS Lett. 1976 Oct 15;69(1):99-102.

# Drug_Target_69_HGNC_ID:
HGNC:4827

# Drug_Target_69_HPRD_ID:
00786

# Drug_Target_69_ID:
693

# Drug_Target_69_Locus:
11p15.5

# Drug_Target_69_Molecular_Weight:
15867

# Drug_Target_69_Name:
Hemoglobin subunit beta

# Drug_Target_69_Number_of_Residues:
146

# Drug_Target_69_PDB_ID:
1DXT

# Drug_Target_69_Pathway:
Not Available

# Drug_Target_69_Pfam_Domain_Function:
PF00042	Globin

# Drug_Target_69_Protein_Sequence:
>Hemoglobin subunit beta
VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKV
KAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGK
EFTPPVQAAYQKVVAGVANALAHKYH

# Drug_Target_69_Reaction:
Not Available

# Drug_Target_69_Signals:
None

# Drug_Target_69_Specific_Function:
Involved in oxygen transport from the lung to the various peripheral tissues

# Drug_Target_69_SwissProt_ID:
P68871

# Drug_Target_69_SwissProt_Name:
HBB_HUMAN

# Drug_Target_69_Synonyms:
Beta-globin
Hemoglobin beta chain

# Drug_Target_69_Theoretical_pI:
7.32

# Drug_Target_69_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AE013036

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
Tar4

# Drug_Target_6_Gene_Sequence:
>1809 bp
ATGAAGGGGACAATCGTCGGGACATGGATAAAGACCCTGAGGGACCTTTACGGGAATGAT
GTGGTTGATGAATCTTTAAAAAGTGTGGGTTGGGAACCAGATAGGGTAATTACACCTCTG
GAGGATATTGATGACGATGAGGTTAGGAGAATTTTTGCTAAGGTGAGTGAAAAAACTGGT
AAAAATGTCAACGAAATATGGAGAGAGGTAGGAAGGCAGAACATAAAAACTTTCAGCGAA
TGGTTTCCCTCCTATTTTGCAGGGAGAAGGCTAGTGAATTTTTTAATGATGATGGATGAG
GTACACCTACAGCTTACCAAGATGATAAAAGGAGCCACTCCTCCAAGGCTTATTGCAAAG
CCTGTTGCAAAAGATGCCATTGAAATGGAGTACGTTTCTAAAAGAAAGATGTACGATTAC
TTTTTAGGGCTTATAGAGGGTAGTTCTAAATTTTTCAAGGAAGAAATTTCAGTGGAAGAG
GTCGAAAGAGGCGAAAAAGATGGCTTTTCAAGGCTAAAAGTCAGGATAAAATTTAAAAAC
CCCGTTTTTGAGTATAAGAAAAATGTCTGGGGAAAGATACTGGGCTTTGGCTTTATAAGG
AGCAACTCTTTTAAACTTGCTTTATGGAGCTTTATCATAGGCTTTTTGGTGGTAGGATTT
GTATCTTCATGGGACCTTCTAAAAAGCTTTTCTGGCGCATTTATAATAGGAGCTTTTACG
TACATATTTTCTTATATTTTGAATATGCCTGCTAAGAATCTTCATGAATTTGTAAAAATC
ATGGGAAGCAGAAATTTAGAAGAGGAGTTTAAACTAGAAAGCGGTGACGTTTTTGAAGCT
ATTGCAGAGGAGTTAAACAGCGTAAAAGATACTATTAAGAAGGACATGCTGTTTTTAAAA
GGCGGCACAGACGACATGCACAATTTTGTTCACAGGTTTAATGAGATTGCAGAGAACATG
AAGAAGGTGTCTGAAGATATATCTTCTGTGGTGAATGATGTAGCTTCTTCTACAGTTCAT
CAGGCAGAAGAGATAGAAAGGGCTGTCGGAATACTGGACGAAAATATAAAAAAGATAAAT
GAGATTGCAGGAACTAGCAAGGAGAGCAATGAAAAACTGGAAAATTCTATAGAAAATATA
AAAAGGGCAAATACCGATGTAACAGATGTTGCCAAGGAATTATCACAGGTAGAAGTGGAT
TTTTCTAGTATATATGAGATGGGCAAGGTGCTTTCAGATAGCGCTAAAGATATCATGGCA
ATAGTCACTACTGTAGAGGAAATTTCAGATCAGACTAATTTGCTGGCGCTAAATGCGGCT
ATTGAGGCGGCGAGGGCAGGAGAAGCAGGAAGAGGGTTTGCCGTGGTAGCAGAAGAGGTG
AGGAATTTAGCTGAAAATTCGAAAAATGCGGTAAAGACCATAACAGAAAGCTTAGTCAAT
TTTACAGGTCAGGTGGAGAATCTAGCAGAGAAGATAAGTGCCCAGTTTGAAAGGCTTAAA
AAGAGCATTTCCACTCTGGAGAAGGTGGTAGAAAAAAATACAATGGCTACAGAAGAGGTT
GCAGGGATATCAAGCGTGATAGTCGAATCTGCAAACAGGCTTTATGAAGAGGCAGAGAAG
CTTTCAGAGGTCTTCGGACACCTGGAAAATCTGGCTGCTATTTCAGAAGAGAATTCGGCT
TCTTCTGAGGAAATGAGTGCCAATGTTACAGAGTATTCAAACAGAATAAGGGAATTTATA
GAGCAGATAAAGCAGATGGAGACACTTGTTACAAACTTTAAGAAGGAGCTTGATAAATAC
AAAGTTTGA

# Drug_Target_6_General_Function:
Involved in signal transducer activity

# Drug_Target_6_General_References:
11997336	Bao Q, Tian Y, Li W, Xu Z, Xuan Z, Hu S, Dong W, Yang J, Chen Y, Xue Y, Xu Y, Lai X, Huang L, Dong X, Ma Y, Ling L, Tan H, Chen R, Wang J, Yu J, Yang H: A complete sequence of the T. tengcongensis genome. Genome Res. 2002 May;12(5):689-700.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4903

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
68053

# Drug_Target_6_Name:
Methyl-accepting chemotaxis protein

# Drug_Target_6_Number_of_Residues:
602

# Drug_Target_6_PDB_ID:
1XBN

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00015	MCPsignal
PF07700	HNOB

# Drug_Target_6_Protein_Sequence:
>Methyl-accepting chemotaxis protein
MKGTIVGTWIKTLRDLYGNDVVDESLKSVGWEPDRVITPLEDIDDDEVRRIFAKVSEKTG
KNVNEIWREVGRQNIKTFSEWFPSYFAGRRLVNFLMMMDEVHLQLTKMIKGATPPRLIAK
PVAKDAIEMEYVSKRKMYDYFLGLIEGSSKFFKEEISVEEVERGEKDGFSRLKVRIKFKN
PVFEYKKNVWGKILGFGFIRSNSFKLALWSFIIGFLVVGFVSSWDLLKSFSGAFIIGAFT
YIFSYILNMPAKNLHEFVKIMGSRNLEEEFKLESGDVFEAIAEELNSVKDTIKKDMLFLK
GGTDDMHNFVHRFNEIAENMKKVSEDISSVVNDVASSTVHQAEEIERAVGILDENIKKIN
EIAGTSKESNEKLENSIENIKRANTDVTDVAKELSQVEVDFSSIYEMGKVLSDSAKDIMA
IVTTVEEISDQTNLLALNAAIEAARAGEAGRGFAVVAEEVRNLAENSKNAVKTITESLVN
FTGQVENLAEKISAQFERLKKSISTLEKVVEKNTMATEEVAGISSVIVESANRLYEEAEK
LSEVFGHLENLAAISEENSASSEEMSANVTEYSNRIREFIEQIKQMETLVTNFKKELDKY
KV

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q8RBX6

# Drug_Target_6_SwissProt_Name:
Q8RBX6_THETN

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
4.80

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_70_Cellular_Location:
Cytoplasm

# Drug_Target_70_Chromosome_Location:
Not Available

# Drug_Target_70_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_70_Essentiality:
Non-Essential

# Drug_Target_70_GenAtlas_ID:
Not Available

# Drug_Target_70_GenBank_ID_Gene:
Not Available

# Drug_Target_70_GenBank_ID_Protein:
Not Available

# Drug_Target_70_GeneCard_ID:
Not Available

# Drug_Target_70_Gene_Name:
katA

# Drug_Target_70_Gene_Sequence:
Not Available

# Drug_Target_70_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_70_General_References:
12486720	Andreoletti P, Sainz G, Jaquinod M, Gagnon J, Jouve HM: High-resolution structure and biochemical properties of a recombinant Proteus mirabilis catalase depleted in iron. Proteins. 2003 Feb 1;50(2):261-71.
7786407	Buzy A, Bracchi V, Sterjiades R, Chroboczek J, Thibault P, Gagnon J, Jouve HM, Hudry-Clergeon G: Complete amino acid sequence of Proteus mirabilis PR catalase. Occurrence of a methionine sulfone in the close proximity of the active site. J Protein Chem. 1995 Feb;14(2):59-72.
7791219	Gouet P, Jouve HM, Dideberg O: Crystal structure of Proteus mirabilis PR catalase with and without bound NADPH. J Mol Biol. 1995 Jun 23;249(5):933-54.
8901874	Gouet P, Jouve HM, Williams PA, Andersson I, Andreoletti P, Nussaume L, Hajdu J: Ferryl intermediates of catalase captured by time-resolved Weissenberg crystallography and UV-VIS spectroscopy. Nat Struct Biol. 1996 Nov;3(11):951-6.

# Drug_Target_70_HGNC_ID:
Not Available

# Drug_Target_70_HPRD_ID:
Not Available

# Drug_Target_70_ID:
3625

# Drug_Target_70_Locus:
Not Available

# Drug_Target_70_Molecular_Weight:
55615

# Drug_Target_70_Name:
Catalase

# Drug_Target_70_Number_of_Residues:
484

# Drug_Target_70_PDB_ID:
1MQF

# Drug_Target_70_Pathway:
Not Available

# Drug_Target_70_Pfam_Domain_Function:
PF00199	Catalase

# Drug_Target_70_Protein_Sequence:
>Catalase
MEKKKLTTAAGAPVVDNNNVITAGPRGPMLLQDVWFLEKLAHFDREVIPERRMHAKGSGA
FGTFTVTHDITKYTRAKIFSEVGKKTEMFARFSTVAGERGAADAERDIRGFALKFYTEEG
NWDMVGNNTPVFYLRDPLKFPDLNHIVKRDPRTNMRNMAYKWDFFSHLPESLHQLTIDMS
DRGLPLSYRFVHGFGSHTYSFINKDNERFWVKFHFRCQQGIKNLMDDEAEALVGKDRESS
QRDLFEAIERGDYPRWKLQIQIMPEKEASTVPYNPFDLTKVWPHADYPLMDVGYFELNRN
PDNYFSDVEQAAFSPANIVPGISFSPDKMLQGRLFSYGDAHRYRLGVNHHQIPVNAPKCP
FHNYHRDGAMRVDGNSGNGITYEPNSGGVFQEQPDFKEPPLSIEGAADHWNHREDEDYFS
QPRALYELLSDDEHQRMFARIAGELSQASKETQQRQIDLFTKVHPEYGAGVEKAIKVLEG
KDAK

# Drug_Target_70_Reaction:
2 H2O2 = O2 + 2 H2O

# Drug_Target_70_Signals:
None

# Drug_Target_70_Specific_Function:
Decomposes hydrogen peroxide into water and oxygen; serves to protect cells from the toxic effects of hydrogen peroxide

# Drug_Target_70_SwissProt_ID:
P42321

# Drug_Target_70_SwissProt_Name:
CATA_PROMI

# Drug_Target_70_Synonyms:
EC 1.11.1.6

# Drug_Target_70_Theoretical_pI:
6.56

# Drug_Target_70_Transmembrane_Regions:
None

# Drug_Target_71_Cellular_Location:
Periplasm

# Drug_Target_71_Chromosome_Location:
Not Available

# Drug_Target_71_Drug_References:
Not Available

# Drug_Target_71_Essentiality:
Non-Essential

# Drug_Target_71_GenAtlas_ID:
Not Available

# Drug_Target_71_GenBank_ID_Gene:
AJ245540

# Drug_Target_71_GenBank_ID_Protein:
Not Available

# Drug_Target_71_GeneCard_ID:
Not Available

# Drug_Target_71_Gene_Name:
nrfA

# Drug_Target_71_Gene_Sequence:
>1524 bp
ATGACAAAATTCAAGTTGTTACTTGCGGGATCACTGGTCGCGATCGTCTCTATGGGGTTA
CTCGCGAGCAATATCAACGAAAGAGAGAAGGAGCGAGTCGCTCTCAACAAAACAGCCCAC
AGCCAAGGCATCAAGGGCAAGGCAATGAGCGAGGAGTGGGCGAGATACTATCCAAGACAA
TTTGATTCTTGGAAAAAGACCAAAGAGAGCGACAATATTACCGATATGCTCAAAGAGAAG
CCCGCCCTTGTGGTGGCTTGGGCTGGATATCCCTTCTCTAAGGACTACAATGCTCCAAGA
GGCCACTACTACGCCCTGCAGGATAATATCAACACCCTAAGAACAGGGGCACCCGTGGAT
GGCAAAACAGGTCCTCTCCCAAGCGCCTGCTGGACTTGCAAATCTCCTGATGTTCCTAGA
ATCATTGAGCAAGATGGAGAGCTAGAATATTTCACGGGCAAGTGGGCTAAATATGGAGAT
GAGATTGTCAACACGATTGGCTGCTACAACTGTCACGACGATAAGAGTGCTGAGCTCAAA
TCCAAAGTGCCCTATCTTGATCGAGGCCTCAGTGCAGCAGGCTTTAAAACCTTTGCCGAA
TCGACTCACCAAGAGAAGCGATCCCTTGTATGCGCCCAGTGCCATGTGGAGTATTACTTC
AAAAAGACAGAGTGGAAAGATGACAAAGGCGTAGATAAAACCGCAATGGTCGTCACGCTT
CCTTGGTCGAAGGGAATCTCCACTGAGCAGATGGAGGCCTACTATGATGAGATCAACTTC
GCCGACTGGACGCATGGAATCTCTAAGACTCCTATGCTCAAAGCCCAGCACCCTGATTGG
GAGCTCTACAAAACGGGAATCCATGGACAAAAAGGGGTCTCTTGTGCGGATTGCCATATG
CCCTACACTCAAGAGGGAGCGGTGAAATACTCTGATCACAAAGTCGGCAATCCCCTTGAT
AACATGGACAAGAGCTGCATGAACTGCCACCGAGAGAGCGAGCAGAAACTCAAAGATATC
GTGAAGCAAAAGTTTGAGCGCAAAGAGTTCTTGCAAGATATCGCGTTTGACAATATTGGC
AAAGCCCACCTAGAGACCGGCAAAGCGATGGAGCTTGGCGCCACGGATGCTGAGCTTAAA
GAGATTCGCACCCACATCCGACACGCCCAGTGGAGAGCGGATATGGCGATTGCTGGACAT
GGCTCTTTCTTCCACGCTCCTGAAGAGGTGCTAAGACTTCTTGCTTCAGGCAACGAAGAG
GCTCAAAAAGCTAGAATCAAGCTCGTCAAGGTGCTCGCTAAGTATGGCGCGATCGACTAT
GTCGCTCCTGATTTCGAGACCAAAGAGAAAGCCCAAAAACTAGCCAAAGTGGATATGGAA
GCCTTCATCGCTGAGAAACTCAAGTTCAAGCAGACGCTAGAGCAAGAGTGGAAAAAGCAA
GCCATCGCCAAAGGGCGACTCAATCCTGAGTCTCTCAAAGGAGTGGATGAGAAGTCTTCT
TACTACGATAAAACCAAAAAATAA

# Drug_Target_71_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_71_General_References:
10672190	Simon J, Gross R, Einsle O, Kroneck PM, Kroger A, Klimmek O: A NapC/NirT-type cytochrome c (NrfH) is the mediator between the quinone pool and the cytochrome c nitrite reductase of Wolinella succinogenes. Mol Microbiol. 2000 Feb;35(3):686-96.
10984487	Einsle O, Stach P, Messerschmidt A, Simon J, Kroger A, Huber R, Kroneck PM: Cytochrome c nitrite reductase from Wolinella succinogenes. Structure at 1.6 A resolution, inhibitor binding, and heme-packing motifs. J Biol Chem. 2000 Dec 15;275(50):39608-16.
14500908	Baar C, Eppinger M, Raddatz G, Simon J, Lanz C, Klimmek O, Nandakumar R, Gross R, Rosinus A, Keller H, Jagtap P, Linke B, Meyer F, Lederer H, Schuster SC: Complete genome sequence and analysis of Wolinella succinogenes. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11690-5. Epub 2003 Sep 19.

# Drug_Target_71_HGNC_ID:
Not Available

# Drug_Target_71_HPRD_ID:
Not Available

# Drug_Target_71_ID:
4953

# Drug_Target_71_Locus:
Not Available

# Drug_Target_71_Molecular_Weight:
57512

# Drug_Target_71_Name:
Cytochrome c-552

# Drug_Target_71_Number_of_Residues:
507

# Drug_Target_71_PDB_ID:
1FS9

# Drug_Target_71_Pathway:
Not Available

# Drug_Target_71_Pfam_Domain_Function:
PF02335	Cytochrom_C552

# Drug_Target_71_Protein_Sequence:
>Cytochrome c-552
MTKFKLLLAGSLVAIVSMGLLASNINEREKERVALNKTAHSQGIEGKAMSEEWARYYPRQ
FDSWKKTKESDNITDMLKEKPALVVAWAGYPFSKDYNAPRGHYYALQDNINTLRTGAPVD
GKTGPLPSACWTCKSPDVPRIIEQDGELEYFTGKWAKYGDEIVNTIGCYNCHDDKSAELK
SKVPYLDRGLSAAGFKTFAESTHQEKRSLVCAQCHVEYYFKKTEWKDDKGVDKTAMVVTL
PWSKGISTEQMEAYYDEINFADWTHGISKTPMLKAQHPDWELYKTGIHGQKGVSCADCHM
PYTQEGAVKYSDHKVGNPLDNMDKSCMNCHRESEQKLKDIVKQKFERKEFLQDIAFDNIG
KAHLETGKAMELGATDAELKEIRTHIRHAQWRADMAIAGHGSFFHAPEEVLRLLASGNEE
AQKARIKLVKVLAKYGAIDYVAPDFETKEKAQKLAKVDMEAFIAEKLKFKQTLEQEWKKQ
AIAKGRLNPESLKGVDEKSSYYDKTKK

# Drug_Target_71_Reaction:
Not Available

# Drug_Target_71_Signals:
1-22

# Drug_Target_71_Specific_Function:
Plays a role in nitrite reduction

# Drug_Target_71_SwissProt_ID:
Q9S1E5

# Drug_Target_71_SwissProt_Name:
NRFA_WOLSU

# Drug_Target_71_Synonyms:
Ammonia-forming cytochrome c nitrite reductase
Cytochrome c nitrite reductase
Cytochrome c-552 precursor
EC 1.7.2.2

# Drug_Target_71_Theoretical_pI:
8.10

# Drug_Target_71_Transmembrane_Regions:
None

# Drug_Target_72_Cellular_Location:
Endoplasmic reticulum membrane

# Drug_Target_72_Chromosome_Location:
1

# Drug_Target_72_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_72_Essentiality:
Non-Essential

# Drug_Target_72_GenAtlas_ID:
Not Available

# Drug_Target_72_GenBank_ID_Gene:
M29874

# Drug_Target_72_GenBank_ID_Protein:
181296

# Drug_Target_72_GeneCard_ID:
CYP2B6

# Drug_Target_72_Gene_Name:
CYP2B6

# Drug_Target_72_Gene_Sequence:
>1476 bp
ATGGAACTCAGCGTCCTCCTCTTCCTTGCACTCCTCACAGGACTCTTGCTACTCCTGGTT
CAGCGCCACCCTAACACCCATGACCGCCTCCCACCAGGGCCCCGCCCTCTGCCCCTTTTG
GGAAACCTTCTGCAGATGGATAGAAGAGGCCTACTCAAATCCTTTCTGAGGTTCCGAGAG
AAATATGGGGACGTCTTCACGGTACACCTGGGACCGAGGCCCGTGGTCATGCTGTGTGGA
GTAGAGGCCATACGGGAGGCCCTTGTGGACAAGGCTGAGGCCTTCTCTGGCCGGGGAAAA
ATCGCCATGGTCGACCCATTCTTCCGGGGATATGGTGTGATCTTTGCCAATGGAAACCGC
TGGAAGGTGCTTCGGCGATTCTCTGTGACCACTATGAGGGACTTCGGGATGGGAAAGCGG
AGTGTGGAGGAGCGGATTCAGGAGGAGGCTCAGTGTCTGATAGAGGAGCTTCGGAAATCC
AAGGGGGCCCTCATGGACCCCACCTTCCTCTTCCAGTCCATTACCGCCAACATCATCTGC
TCCATCGTCTTTGGAAAACGATTCCACTACCAAGATCAAGAGTTCCTGAAGATGCTGAAC
TTGTTCTACCAGACTTTTTCACTCATCAGCTCTGTATTCGGCCAGCTGTTTGAGCTCTTC
TCTGGCTTCTTGAAATACTTTCCTGGGGCACACAGGCAAGTTTACAAAAACCTGCAGGAA
ATCAATGCTTACATTGGCCACAGTGTGGAGAAGCACCGTGAAACCCTGGACCCCAGCGCC
CCCAAGGACCTCATCGACACCTACCTGCTCCACATGGAAAAAGAGAAATCCAACGCACAC
AGTGAATTCAGCCACCAGAACCTCAACCTCAACACGCTCTCGCTCTTCTTTGCTGGCACT
GAGACCACCAGCACCACTCTCCGCTACGGCTTCCTGCTCATGCTCAAATACCCTCATGTT
GCAGAGAGAGTCTACAGGGAGATTGAACAGGTGATTGGCCCACATCGCCCTCCAGAGCTT
CATGACCGAGCCAAAATGCCATACACAGAGGCAGTCATCTATGAGATTCAGAGATTTTCC
GACCTTCTCCCCATGGGTGTGCCCCACATTGTCACCCAACACACCAGCTTCCGAGGGTAC
ATCATCCCCAAGGACACAGAAGTATTTCTCATCCTGAGCACTGCTCTCCATGACCCACAC
TACTTTGAAAAACCAGACGCCTTCAATCCTGACCACTTTCTGGATGCCAATGGGGCACTG
AAAAAGACTGAAGCTTTTATCCCCTTCTCCTTAGGGAAGCGGATTTGTCTTGGTGAAGGC
ATCGCCCGTGCGGAATTGTTCCTCTTCTTCACCACCATCCTCCAGAACTTCTCCATGGCC
AGCCCCGTGGCCCCAGAAGACATCGATCTGACACCCCAGGAGTGTGGTGTGGGCAAAATA
CCCCCAACATACCAGATCCGCTTCCTGCCCCGCTGA

# Drug_Target_72_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_72_General_References:
10768437	Thum T, Borlak J: Gene expression in distinct regions of the heart. Lancet. 2000 Mar 18;355(9208):979-83.
11243870	Ariyoshi N, Miyazaki M, Toide K, Sawamura Yi, Kamataki T: A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation. Biochem Biophys Res Commun. 2001 Mar;281(5):1256-60.
11470993	Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM: Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. 2001 Jul;11(5):399-415.
12642465	Jinno H, Tanaka-Kagawa T, Ohno A, Makino Y, Matsushima E, Hanioka N, Ando M: Functional characterization of cytochrome P450 2B6 allelic variants. Drug Metab Dispos. 2003 Apr;31(4):398-403.
12721789	Saito S, Iida A, Sekine A, Kawauchi S, Higuchi S, Ogawa C, Nakamura Y: Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population. J Hum Genet. 2003;48(5):249-70. Epub 2003 Apr 29.
15057824	Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, Denys M, Detter JC, Escobar J, Flowers D, Fotopulos D, Garcia C, Georgescu AM, Glavina T, Gomez M, Gonzales E, Groza M, Hammon N, Hawkins T, Haydu L, Ho I, Huang W, Israni S, Jett J, Kadner K, Kimball H, Kobayashi A, Larionov V, Leem SH, Lopez F, Lou Y, Lowry S, Malfatti S, Martinez D, McCready P, Medina C, Morgan J, Nelson K, Nolan M, Ovcharenko I, Pitluck S, Pollard M, Popkie AP, Predki P, Quan G, Ramirez L, Rash S, Retterer J, Rodriguez A, Rogers S, Salamov A, Salazar A, She X, Smith D, Slezak T, Solovyev V, Thayer N, Tice H, Tsai M, Ustaszewska A, Vo N, Wagner M, Wheeler J, Wu K, Xie G, Yang J, Dubchak I, Furey TS, DeJong P, Dickson M, Gordon D, Eichler EE, Pennacchio LA, Richardson P, Stubbs L, Rokhsar DS, Myers RM, Rubin EM, Lucas SM: The DNA sequence and biology of human chromosome 19. Nature. 2004 Apr 1;428(6982):529-35.
2573390	Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, Gonzalez FJ: cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry. 1989 Sep 5;28(18):7340-8.
2813061	Miles JS, McLaren AW, Wolf CR: Alternative splicing in the human cytochrome P450IIB6 gene generates a high level of aberrant messages. Nucleic Acids Res. 1989 Oct 25;17(20):8241-55.

# Drug_Target_72_HGNC_ID:
GNC:2615

# Drug_Target_72_HPRD_ID:
Not Available

# Drug_Target_72_ID:
6030

# Drug_Target_72_Locus:
19q13.2

# Drug_Target_72_Molecular_Weight:
56277.8

# Drug_Target_72_Name:
Cytochrome P450 2B6

# Drug_Target_72_Number_of_Residues:
491

# Drug_Target_72_PDB_ID:
Not Available

# Drug_Target_72_Pathway:
Clopidogrel Pathway	SMP00260
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_72_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_72_Protein_Sequence:
>Cytochrome P450 2B6
MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFRE
KYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNR
WKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIIC
SIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKYFPGAHRQVYKNLQE
INAYIGHSVEKHRETLDPSAPKDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGT
ETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFS
DLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGAL
KKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKI
PPTYQIRFLPR

# Drug_Target_72_Reaction:
Not Available

# Drug_Target_72_Signals:
None

# Drug_Target_72_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics

# Drug_Target_72_SwissProt_ID:
P20813

# Drug_Target_72_SwissProt_Name:
CP2B6_HUMAN

# Drug_Target_72_Synonyms:
CYPIIB6
P450 IIB1

# Drug_Target_72_Theoretical_pI:
8.44

# Drug_Target_72_Transmembrane_Regions:
None

# Drug_Target_73_Cellular_Location:
Not Available

# Drug_Target_73_Chromosome_Location:
Not Available

# Drug_Target_73_Drug_References:
Not Available

# Drug_Target_73_Essentiality:
Non-Essential

# Drug_Target_73_GenAtlas_ID:
Not Available

# Drug_Target_73_GenBank_ID_Gene:
Not Available

# Drug_Target_73_GenBank_ID_Protein:
Not Available

# Drug_Target_73_GeneCard_ID:
Not Available

# Drug_Target_73_Gene_Name:
Not Available

# Drug_Target_73_Gene_Sequence:
Not Available

# Drug_Target_73_General_Function:
Involved in iron ion binding

# Drug_Target_73_General_References:
6273892	Ambler RP, Bartsch RG, Daniel M, Kamen MD, McLellan L, Meyer TE, Van Beeumen J: Amino acid sequences of bacterial cytochromes c' and c-556. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6854-7.
8612077	Tahirov TH, Misaki S, Meyer TE, Cusanovich MA, Higuchi Y, Yasuoka N: Concerted movement of side chains in the haem vicinity observed on ligand binding in cytochrome c' from rhodobacter capsulatus. Nat Struct Biol. 1996 May;3(5):459-64.
8676382	Tahirov TH, Misaki S, Meyer TE, Cusanovich MA, Higuchi Y, Yasuoka N: High-resolution crystal structures of two polymorphs of cytochrome c' from the purple phototrophic bacterium rhodobacter capsulatus. J Mol Biol. 1996 Jun 14;259(3):467-79.

# Drug_Target_73_HGNC_ID:
Not Available

# Drug_Target_73_HPRD_ID:
Not Available

# Drug_Target_73_ID:
4385

# Drug_Target_73_Locus:
Not Available

# Drug_Target_73_Molecular_Weight:
13206

# Drug_Target_73_Name:
Cytochrome c'

# Drug_Target_73_Number_of_Residues:
129

# Drug_Target_73_PDB_ID:
Not Available

# Drug_Target_73_Pathway:
Not Available

# Drug_Target_73_Pfam_Domain_Function:
PF01322	Cytochrom_C_2

# Drug_Target_73_Protein_Sequence:
>Cytochrome c'
ADTKEVLEAREAYFKSLGKSMKAMTGVAKSFDAEAAKAEAAALEKILATDVAPLFPAGTS
STDLPGQTEAKAAIWTNMADFGAKGKAMNDAGAEVIAAANAGDATAFGAALQKLGGTCKA
CHDDYREED

# Drug_Target_73_Reaction:
Not Available

# Drug_Target_73_Signals:
None

# Drug_Target_73_Specific_Function:
Cytochrome c' is the most widely occurring bacterial c- type cytochrome. Cytochromes c' are high-spin proteins and the heme has no sixth ligand. Their exact function is not known

# Drug_Target_73_SwissProt_ID:
P00147

# Drug_Target_73_SwissProt_Name:
CYCP_RHOCA

# Drug_Target_73_Synonyms:
Not Available

# Drug_Target_73_Theoretical_pI:
4.50

# Drug_Target_73_Transmembrane_Regions:
None

# Drug_Target_74_Cellular_Location:
Not Available

# Drug_Target_74_Chromosome_Location:
Not Available

# Drug_Target_74_Drug_References:
Not Available

# Drug_Target_74_Essentiality:
Non-Essential

# Drug_Target_74_GenAtlas_ID:
Not Available

# Drug_Target_74_GenBank_ID_Gene:
AF183259

# Drug_Target_74_GenBank_ID_Protein:
Not Available

# Drug_Target_74_GeneCard_ID:
Not Available

# Drug_Target_74_Gene_Name:
Not Available

# Drug_Target_74_Gene_Sequence:
>270 bp
AATGAAACCGAAGCCACGCTCCCCGTCTTCACCCTCGAACAGGTGGCGGAGCACCACAGT
CCGGATGACTGCTGGATGGCCATTCACGGCAAGGTCTATGACCTCACCCCCTACGTGCCG
AATCATCCCGGACCGGCGGGCATGATGCTGGTCTGGTGCGGGCAGGAGAGCACCGAGGCC
TGGGAAACCAAGAGCTACGGCGAACCTCACAGCAGTCTCGCGGCACGTCTGCTCCAGCGC
TATCTTATCGGCACCCTGGAAGAAATCACT

# Drug_Target_74_General_Function:
Involved in heme binding

# Drug_Target_74_General_References:
10585439	Kostanjevecki V, Leys D, Van Driessche G, Meyer TE, Cusanovich MA, Fischer U, Guisez Y, Van Beeumen J: Structure and characterization of Ectothiorhodospira vacuolata cytochrome b(558), a prokaryotic homologue of cytochrome b(5). J Biol Chem. 1999 Dec 10;274(50):35614-20.

# Drug_Target_74_HGNC_ID:
Not Available

# Drug_Target_74_HPRD_ID:
Not Available

# Drug_Target_74_ID:
4954

# Drug_Target_74_Locus:
Not Available

# Drug_Target_74_Molecular_Weight:
10229

# Drug_Target_74_Name:
Soluble cytochrome b558

# Drug_Target_74_Number_of_Residues:
91

# Drug_Target_74_PDB_ID:
1CXY

# Drug_Target_74_Pathway:
Not Available

# Drug_Target_74_Pfam_Domain_Function:
PF00173	Cyt-b5

# Drug_Target_74_Protein_Sequence:
>Soluble cytochrome b558
MNETEATLPVFTLEQVAEHHSPDDCWMAIHGKVYDLTPYVPNHPGPAGMMLVWCGQESTE
AWETKSYGEPHSSLAARLLQRYLIGTLEEIT

# Drug_Target_74_Reaction:
Not Available

# Drug_Target_74_Signals:
None

# Drug_Target_74_Specific_Function:
Not Available

# Drug_Target_74_SwissProt_ID:
P82291

# Drug_Target_74_SwissProt_Name:
CYB5_ECTVA

# Drug_Target_74_Synonyms:
Not Available

# Drug_Target_74_Theoretical_pI:
4.42

# Drug_Target_74_Transmembrane_Regions:
None

# Drug_Target_75_Cellular_Location:
Not Available

# Drug_Target_75_Chromosome_Location:
Not Available

# Drug_Target_75_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_75_Essentiality:
Non-Essential

# Drug_Target_75_GenAtlas_ID:
Not Available

# Drug_Target_75_GenBank_ID_Gene:
BA000022

# Drug_Target_75_GenBank_ID_Protein:
1651938

# Drug_Target_75_GeneCard_ID:
Not Available

# Drug_Target_75_Gene_Name:
pbsA1

# Drug_Target_75_Gene_Sequence:
>723 bp
CTAGCCTTCGGAGGTGGCGAGGCCAACTTCGGTGCTGCCTTGACTGCGGCGACGGGTGAG
GCTGTTGAACACCATAATGCCGATCGCCTTGATCAGGTTGCCTTCAAGTTCGTTGAACAT
TTTCATGTTCATGGCAAAGGCGTCATTGGCTTCATCCACAATCCGTTCGGCGGTGGCTTG
GTCAATGGGCAGATCATTCATAGCTTGACGGTAGGTATTTTTAAAAGCCTTTTCGTCATC
AATGTCGGCAAATTCATAGAAAGCTGTGCCACCATCGTGGAGATTCATGGCATTTTGGGC
AATTTTCTTGAGAATTTGACCGCCGGAAAGATCCCCCAGGTAACGGGTGTAGGAATGGGC
CACCAACAATTCAGGGGCCGTAGCGGCCACTTGCCGGACTCGGTCCACATAGGCTTGGCC
AGCGGCAGAAATTTTCACTTCTTGCCGCCAGTTGGAGCCGTAATAGAATTGCAGGTCTTG
CTCTAGGCTTTGTTTGCGGTTGAGTTCGGGGAAGTAAATGTGGCTGAGGATGGGATGGTC
CTTAAATTTTGCCATTTCCTCTTCCATGGCACTGTAGACAAAGTAGAGATTGCCAACCAG
CTTACGGTAGGAATTTTTCTCGACAACGCCCTTGAGGAAGCATTTGACAAAGCCGACGTT
CTCCGCCATGGAGTGGGATTTTTTCGTCCCTTCCCGCAACTGGGAAGCTAAGTTGACACT
CAT

# Drug_Target_75_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_75_General_References:
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.

# Drug_Target_75_HGNC_ID:
Not Available

# Drug_Target_75_HPRD_ID:
Not Available

# Drug_Target_75_ID:
3391

# Drug_Target_75_Locus:
Not Available

# Drug_Target_75_Molecular_Weight:
27051

# Drug_Target_75_Name:
Heme oxygenase 1

# Drug_Target_75_Number_of_Residues:
240

# Drug_Target_75_PDB_ID:
1WE1

# Drug_Target_75_Pathway:
Not Available

# Drug_Target_75_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_75_Protein_Sequence:
>Heme oxygenase 1
MSVNLASQLREGTKKSHSMAENVGFVKCFLKGVVEKNSYRKLVGNLYFVYSAMEEEMAKF
KDHPILSHIYFPELNRKQSLEQDLQFYYGSNWRQEVKISAAGQAYVDRVRQVAATAPELL
VAHSYTRYLGDLSGGQILKKIAQNAMNLHDGGTAFYEFADIDDEKAFKNTYRQAMNDLPI
DQATAERIVDEANDAFAMNMKMFNELEGNLIKAIGIMVFNSLTRRRSQGSTEVGLATSEG

# Drug_Target_75_Reaction:
heme + 3 AH2 + 3 O2 = biliverdin + Fe2+ + CO + 3 A + 3 H2O

# Drug_Target_75_Signals:
None

# Drug_Target_75_Specific_Function:
Catalyzes the opening of the heme ring with the release of iron. Key enzyme in the synthesis of the chromophoric part of the photosynthetic antennae

# Drug_Target_75_SwissProt_ID:
P72849

# Drug_Target_75_SwissProt_Name:
HO1_SYNY3

# Drug_Target_75_Synonyms:
EC 1.14.99.3

# Drug_Target_75_Theoretical_pI:
6.69

# Drug_Target_75_Transmembrane_Regions:
None

# Drug_Target_76_Cellular_Location:
Cytoplasm

# Drug_Target_76_Chromosome_Location:
Not Available

# Drug_Target_76_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_76_Essentiality:
Non-Essential

# Drug_Target_76_GenAtlas_ID:
Not Available

# Drug_Target_76_GenBank_ID_Gene:
BX842574

# Drug_Target_76_GenBank_ID_Protein:
1550642

# Drug_Target_76_GeneCard_ID:
Not Available

# Drug_Target_76_Gene_Name:
cyp51

# Drug_Target_76_Gene_Sequence:
>1356 bp
TTAAACTCCCGTTCGCCGGCGGTAGCGCACGCAAGCGGGCTGGGCCAACTGCACCACCAT
CTTCGAATGGTCGTTACGATAGCTTTCTGGCGGTTGCGCCATCTCAAACTCATACTCGCG
CAACAACACCGAGAAGATCGCTTTGATCTGCATGATGGCGAACGCCGCCCCCACGCAACG
ATGCCGGCCGGCGCCGAACGGAATCCACGTCCAGCGGTTGAGCAGATCTTCCTGGCGCGG
CTGCTCGTATCGTGCTGGCACGAAGTCGTGGGGATCGGGGAAGTCTTCGGGGATCCGGTT
GGAGATCGCCGGGGAGGCCGCCACCAGATCGCCCTCATGAATCCGGTGGCCTTGCACCTC
GAACTCGCCCTTGGCCACTCGCATGAGGATGATCAGCGGAGGGTGCAGGCGCAGCGTCTC
TTTCAGCACGTTTTCCAGCTGCGGAATCTGGCGCAGCGCATGGAAACTCACCGATCGGCC
GTCGCCGTACAGCTCGTCGAGTTCGTCGATCACGGCCGCGTAGGCGTCGCGATGGCGCAT
CAACTCGATCAGCGTCCACGAAGCCGTACCCGAGCTGGTGTGATGGCCGGCGAACATCAT
CGAGATGAACATGCCGGTGATCTCGTCGGCCGAGAACCGGGGAGTGCCGGTCTCAGCCTT
GACGGCGATGAGCACGTCGAGCATGTCACGGTCGCTCTTGTCGGTGGGTGGGTTGGCGAT
CCGGCCGTTCATGATGTCCGCAACCAGTGCCACCAGACCATTGCGGGCTTCGTCGCGGCG
ACGGAAGCTCTCGATCGGCAGATACGGGTCGACGTAGGCTAGTGGGTCGGTGCCGCGCTC
CAACTCGTGATAGAGCTTGGCGAATCGCCCGTCGAGCTGGTCGCGGAACTTCTTGCCGAT
CAGGCAGGCCGAGGAGGTGTAGATGGTCAGCTCGGCGAAGAAGTCCAGCAGATCGATCTC
GCCGGCCTCACCCCAGTCGGCGATCATCCGTCGGACTTGATCTTCGATGGTGGCAGCGTG
GCCCTTCATCTGCTCGCCGCGTAGCGCGGCATTGTGCAGCATCTCTTTACGCCGTTCCGG
GCTGGCGTCGAACACCACGCCCTCGCCGAAGATCGGCGTCATGAACGGGTATGCCTTGGC
CTGGTCCAGGTCGTCGTCGCCCGCCCGGAAGAAGAATTCGTTGGCGTGCGAGCCGGACAG
CAGCACGACCTGCTTCCCGGCCAGCTGGAAGGTACCGACGTCTCCGCATTCGTCGCGGAC
CCGTTGCATCAGCCCGATCGGATCGGTGCGGAACTCCTCGAGGTGGCCGTGTTCGTCGTG
GCCACCCGAAACCCGGGGTAGTGCAACAGCGCTCAT

# Drug_Target_76_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_76_General_References:
10430874	Bellamine A, Mangla AT, Nes WD, Waterman MR: Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8937-42.
11160374	Bellamine A, Mangla AT, Dennis AL, Nes WD, Waterman MR: Structural requirements for substrate recognition of Mycobacterium tuberculosis 14 alpha-demethylase: implications for sterol biosynthesis. J Lipid Res. 2001 Jan;42(1):128-36.
11248033	Podust LM, Poulos TL, Waterman MR: Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3068-73.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.
9756611	Aoyama Y, Horiuchi T, Gotoh O, Noshiro M, Yoshida Y: CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. J Biochem (Tokyo). 1998 Oct;124(4):694-6.

# Drug_Target_76_HGNC_ID:
Not Available

# Drug_Target_76_HPRD_ID:
Not Available

# Drug_Target_76_ID:
3163

# Drug_Target_76_Locus:
Not Available

# Drug_Target_76_Molecular_Weight:
50878

# Drug_Target_76_Name:
Cytochrome P450 51

# Drug_Target_76_Number_of_Residues:
451

# Drug_Target_76_PDB_ID:
1EA1

# Drug_Target_76_Pathway:
Not Available

# Drug_Target_76_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_76_Protein_Sequence:
>Cytochrome P450 51
MSAVALPRVSGGHDEHGHLEEFRTDPIGLMQRVRDECGDVGTFQLAGKQVVLLSGSHANE
FFFRAGDDDLDQAKAYPFMTPIFGEGVVFDASPERRKEMLHNAALRGEQMKGHAATIEDQ
VRRMIADWGEAGEIDLLDFFAELTIYTSSACLIGKKFRDQLDGRFAKLYHELERGTDPLA
YVDPYLPIESFRRRDEARNGLVALVADIMNGRIANPPTDKSDRDMLDVLIAVKAETGTPR
FSADEITGMFISMMFAGHHTSSGTASWTLIELMRHRDAYAAVIDELDELYGDGRSVSFHA
LRQIPQLENVLKETLRLHPPLIILMRVAKGEFEVQGHRIHEGDLVAASPAISNRIPEDFP
DPHDFVPARYEQPRQEDLLNRWTWIPFGAGRHRCVGAAFAIMQIKAIFSVLLREYEFEMA
QPPESYRNDHSKMVVQLAQPACVRYRRRTGV

# Drug_Target_76_Reaction:
obtusifoliol + 3 O2 + 3 NADPH + 3 H+ = 4alpha-methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol + formate + 3 NADP+ + 4 H2O

# Drug_Target_76_Signals:
None

# Drug_Target_76_Specific_Function:
Its precise biological substrate is not known. Catalyzes C14-demethylation of lanosterol, 24,25-dihydrolanosterol and obtusifoliol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene- 3-beta-ol

# Drug_Target_76_SwissProt_ID:
P0A512

# Drug_Target_76_SwissProt_Name:
CP51_MYCTU

# Drug_Target_76_Synonyms:
CYPLI
EC 1.14.13.70
Lanosterol 14-alpha demethylase
P450-14DM
P450-LIA1
Sterol 14- alpha demethylase

# Drug_Target_76_Theoretical_pI:
5.71

# Drug_Target_76_Transmembrane_Regions:
None

# Drug_Target_77_Cellular_Location:
Not Available

# Drug_Target_77_Chromosome_Location:
Not Available

# Drug_Target_77_Drug_References:
Not Available

# Drug_Target_77_Essentiality:
Non-Essential

# Drug_Target_77_GenAtlas_ID:
Not Available

# Drug_Target_77_GenBank_ID_Gene:
AB091400

# Drug_Target_77_GenBank_ID_Protein:
Not Available

# Drug_Target_77_GeneCard_ID:
Not Available

# Drug_Target_77_Gene_Name:
qbdA

# Drug_Target_77_Gene_Sequence:
>2073 bp
ATGAAAAAACCTTTGCGTACTTCATTGCTGATGCTGTGCCTGGCCACCCCGCTGGCAGCC
CTTGCCGCCGGGGTGGACGAGGCCGCCATCCGCGCCACCGAACAGGCCGGCGGCGAGTGG
CTCAGCCACGGCCGCACCTATGCCGAACAACGCTTCAGCCCGCTCAAACAGATCGACGCC
AGCAACGTCAGGTCACTGGGCCTGGCCTGGTACATGGACCTGGACAACACCCGCGGCCTG
GAGGCGACACCGCTGTTCCACGACGGGGTGATCTACACCTCGATGTCCTGGAGCCGGGTG
ATCGCGGTCGACGCCGCCAGCGGCAAGGAGCTGTGGCGCTACGACCCCGAGGTGGCCAAG
GTCAAGGCCCGTACCTCGTGCTGCGACGCGGTCAACCGCGGCGTGGCACTCTGGGGCGAC
AAGGTCTACGTCGGCACCCTGGACGGGCGTCTGATCGCCCTCGACGCCAAGACCGGCAAG
GCCATCTGGAGCCAGCAGACCACCGACCCGGCCAAGCCCTACAGCATCACCGGCGCGCCA
CGGGTGGTCAAAGGCAAGGTCATCATCGGCAACGGCGGCGCCGAATACGGCGTGCGCGGC
TTCGTCTCGGCCTATGACGCCGACACCGGCAAACTGGCCTGGCGCTTCTACACCGTACCG
GGCGACCCGGCGCTGCCCTACGAGCACCCCGAACTGCGCGAAGCGGCCAAGACCTGGCAG
GGCGACCAGTACTGGAAGCTCGGCGGTGGCGGCACGGTGTGGGACAGCATGGCCTACGAC
CCCGAGCTGGACCTGCTCTACGTCGGCACCGGCAACGGCTCGCCGTGGAACCGCGAGGTG
CGCAGCCCGGGCGGTGGCGACAACCTGTACCTGTCGTCGATCCTCGCCATCCGCCCCGAC
ACCGGCAAGCTGGCCTGGCACTACCAGGTCACCCCGGGCGACAGCTGGGACTTCACCGCC
ACCCAGCAGATCACCCTGGCCGAGCTGAACATCGACGGCAAACCGCGCAAGGTCCTGATG
CAGGCGCCTAAAAACGGCTTCTTCTACGTGCTCGACCGCACCAACGGCAAGCTGATCTCG
GCCGAGAAGTTCGGCAAGGTCACCTGGGCCGAGAAGGTCGACCTCGCCACCGGCCGGCCG
GTCGAGGCCCCTGGGGTGCGCTACGAAAAAGAGCCCATCGTGATGTGGCCCAGCCCCTTC
GGCGCGCACAACTGGCATTCGATGTCGTTCAACCCCGGCACCGGCCTGGTGTACATCCCC
TACCAGGAAGTGCCCGGTGTGTACCGCAACGAAGGCAAGGACTTCGTTACCCGCAAGGCA
TTCAACACCGCCGCCGGCTTTGCCGACGCCACCGACGTGCCGGCCGCCGTGGTCAGCGGC
GCCTTGCTGGCCTGGGACCCGGTCAAGCAGAAGGCCGCCTGGAAGGTGCCGTACCCCACG
CACTGGAACGGCGGCACCCTGAGCACCGCCGGCAACCTGGTGTTCCAGGGCACTGCGGCG
GGGCAGATGCATGCCTATTCCGCCGACAAGGGCGAGGCGCTGTGGCAGTTCGAGGCGCAA
AGCGGCATCGTTGCCGCGCCCATGACCTTCGAACTGGCCGGGCGTCAGTACGTGGCGATC
ATGGCCGGCTGGGGCGGCGTGGCCACCCTGACCGGCGGCGAGTCGATGAACCTGCCGGGC
ATGAAGAACCGCAGCCGCCTGCTGGTGTTCGCCCTCGATGGCAAGGCGCAGTTGCCGCCA
CCGGCCCCGGCGCCCGCCAAGGTCGAGCGCGTGCCCCAGCCCGTCACCGCAGCACCCGAG
CAGGTGCAGGCCGGCAAGCAGCTGTATGGCCAGTTCTGCAGCGTGTGCCACGGCATGGGC
ACCATCAGCGGCGGTTTGATTCCCGACCTGCGCCAGTCCAGCGACGCCACCCGCGAGCAC
TTCCAGCAGATCGTCCTGCAGGGCGCGCTCAAGCCACTGGGCATGCCGTCGTTCGACGAC
TCGCTCAAGCCCGAGGAGGTCGAGCAGATCAAGCTCTACGTGATGTCGCGCGAGTACGAG
GACTACATGGCGCGGCACAAAGCCGCACCCTGA

# Drug_Target_77_General_Function:
Involved in iron ion binding

# Drug_Target_77_General_References:
12057198	Chen ZW, Matsushita K, Yamashita T, Fujii TA, Toyama H, Adachi O, Bellamy HD, Mathews FS: Structure at 1.9 A resolution of a quinohemoprotein alcohol dehydrogenase from Pseudomonas putida HK5. Structure. 2002 Jun;10(6):837-49.
12843671	Toyama H, Fujii T, Aoki N, Matsushita K, Adachi O: Molecular cloning of quinohemoprotein alcohol dehydrogenase, ADH IIB, from Pseudomonas putida HK5. Biosci Biotechnol Biochem. 2003 Jun;67(6):1397-400.

# Drug_Target_77_HGNC_ID:
Not Available

# Drug_Target_77_HPRD_ID:
Not Available

# Drug_Target_77_ID:
4956

# Drug_Target_77_Locus:
Not Available

# Drug_Target_77_Molecular_Weight:
74970

# Drug_Target_77_Name:
Quinohemoprotein alcohol dehydrogenase ADH IIB

# Drug_Target_77_Number_of_Residues:
690

# Drug_Target_77_PDB_ID:
1KV9

# Drug_Target_77_Pathway:
Not Available

# Drug_Target_77_Pfam_Domain_Function:
PF01011	PQQ

# Drug_Target_77_Protein_Sequence:
>Quinohemoprotein alcohol dehydrogenase ADH IIB
MKKPLRTSLLMLCLATPLAALAAGVDEAAIRATEQAGGEWLSHGRTYAEQRFSPLKQIDA
SNVRSLGLAWYMDLDNTRGLEATPLFHDGVIYTSMSWSRVIAVDAASGKELWRYDPEVAK
VKARTSCCDAVNRGVALWGDKVYVGTLDGRLIALDAKTGKAIWSQQTTDPAKPYSITGAP
RVVKGKVIIGNGGAEYGVRGFVSAYDADTGKLAWRFYTVPGDPALPYEHPELREAAKTWQ
GDQYWKLGGGGTVWDSMAYDPELDLLYVGTGNGSPWNREVRSPGGGDNLYLSSILAIRPD
TGKLAWHYQVTPGDSWDFTATQQITLAELNIDGKPRKVLMQAPKNGFFYVLDRTNGKLIS
AEKFGKVTWAEKVDLATGRPVEAPGVRYEKEPIVMWPSPFGAHNWHSMSFNPGTGLVYIP
YQEVPGVYRNEGKDFVTRKAFNTAAGFADATDVPAAVVSGALLAWDPVKQKAAWKVPYPT
HWNGGTLSTAGNLVFQGTAAGQMHAYSADKGEALWQFEAQSGIVAAPMTFELAGRQYVAI
MAGWGGVATLTGGESMNLPGMKNRSRLLVFALDGKAQLPPPAPAPAKVERVPQPVTAAPE
QVQAGKQLYGQFCSVCHGMGTISGGLIPDLRQSSDATREHFQQIVLQGALKPLGMPSFDD
SLKPEEVEQIKLYVMSREYEDYMARHKAAP

# Drug_Target_77_Reaction:
Not Available

# Drug_Target_77_Signals:
None

# Drug_Target_77_Specific_Function:
Not Available

# Drug_Target_77_SwissProt_ID:
Q8GR64

# Drug_Target_77_SwissProt_Name:
Q8GR64_PSEPU

# Drug_Target_77_Synonyms:
Not Available

# Drug_Target_77_Theoretical_pI:
7.62

# Drug_Target_77_Transmembrane_Regions:
None

# Drug_Target_78_Cellular_Location:
Microsome
microsomal membrane
peripheral membrane protein

# Drug_Target_78_Chromosome_Location:
Not Available

# Drug_Target_78_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_78_Essentiality:
Non-Essential

# Drug_Target_78_GenAtlas_ID:
PTGS2

# Drug_Target_78_GenBank_ID_Gene:
L15326

# Drug_Target_78_GenBank_ID_Protein:
291988

# Drug_Target_78_GeneCard_ID:
PTGS2

# Drug_Target_78_Gene_Name:
PTGS2

# Drug_Target_78_Gene_Sequence:
>1815 bp
ATGCTCGCCCGCGCCCTGCTGCTGTGCGCGGTCCTGGCGCTCAGCCATACAGCAAATCCT
TGCTGTTCCCACCCATGTCAAAACCGAGGTGTATGTATGAGTGTGGGATTTGACCAGTAT
AAGTGCGATTGTACCCGGACAGGATTCTATGGAGAAAACTGCTCAACACCGGAATTTTTG
ACAAGAATAAAATTATTTCTGAAACCCACTCCAAACACAGTGCACTACATACTTACCCAC
TTCAAGGGATTTTGGAACGTTGTGAATAACATTCCCTTCCTTCGAAATGCAATTATGAGT
TATGTGTTGACATCCAGATCACATTTGATTGACAGTCCACCAACTTACAATGCTGACTAT
GGCTACAAAAGCTGGGAAGCCTTCTCTAACCTCTCCTATTATACTAGAGCCCTTCCTCCT
GTGCCTGATGATTGCCCGACTCCCTTGGGTGTCAAAGGTAAAAAGCAGCTTCCTGATTCA
AATGAGATTGTGGAAAAATTGCTTCTAAGAAGAAAGTTCATCCCTGATCCCCAGGGCTCA
AACATGATGTTTGCATTCTTTGCCCAGCACTTCACGCATCAGTTTTTCAAGACAGATCAT
AAGCGAGGGCCAGCTTTCACCAACGGGCTGGGCCATGGGGTGGACTTAAATCATATTTAC
GGTGAAACTCTGGCTAGACAGCGTAAACTGCGCCTTTTCAAGGATGGAAAAATGAAATAT
CAGATAATTGATGGAGAGATGTATCCTCCCACAGTCAAAGATACTCAGGCAGAGATGATC
TACCCTCCTCAAGTCCCTGAGCATCTACGGTTTGCTGTGGGGCAGGAGGTCTTTGGTCTG
GTGCCTGGTCTGATGATGTATGCCACAATCTGGCTGCGGGAACACAACAGAGTATGCGAT
GTGCTTAAACAGGAGCATCCTGAATGGGGTGATGAGCAGTTGTTCCAGACAAGCAGGCTA
ATACTGATAGGAGAGACTATTAAGATTGTGATTGAAGATTATGTGCAACACTTGAGTGGC
TATCACTTCAAACTGAAATTTGACCCAGAACTACTTTTCAACAAACAATTCCAGTACCAA
AATCGTATTGCTGCTGAATTTAACACCCTCTATCACTGGCATCCCCTTCTGCCTGACACC
TTTCAAATTCATGACCAGAAATACAACTATCAACAGTTTATCTACAACAACTCTATATTG
CTGGAACATGGAATTACCCAGTTTGTTGAATCATTCACCAGGCAAATTGCTGGCAGGGTT
GCTGGTGGTAGGAATGTTCCACCCGCAGTACAGAAAGTATCACAGGCTTCCACTGACCAG
AGCAGGCAGATGAAATACCAGTCTTTTAATGAGTACCGCAAACGCTTTATGCTGAAGCCC
TATGAATCATTTGAAGAACTTACAGGAGAAAAGGAAATGTCTGCAGAGTTGGAAGCACTC
TATGGTGACATCGATGCTGTGGAGCTGTATCCTGCCCTTCTGGTAGAAAAGCCTCGGCCA
GATGCCATCTTTGGTGAAACCATGGTAGAAGTTGGAGCACCATTCTCCTTGAAAGGACTT
ATGGGTAATGTTATATGTTCTCCTGCCTACTGGAAGCCAAGCACTTTTGGTGGAGAAGTG
GGTTTTCAAATCATCAACACTGCCTCAATTCAGTCTCTCATCTGCAATAACGTGAAGGGC
TGTCCCTTTACTTCATTCAGTGTTCCAGATCCAGAGCTCATTAAAACAGTCACCATCAAT
GCAAGTTCTTCCCGCTCCGGACTAGATGATATCAATCCCACAGTACTACTAAAAGAACGT
TCGACTGAACTGTAG

# Drug_Target_78_General_Function:
Involved in peroxidase activity

# Drug_Target_78_General_References:
1380156	Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384-8.
7945196	Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T: Structure of the human cyclo-oxygenase-2 gene. Biochem J. 1994 Sep 15;302 ( Pt 3):723-7.
8181472	Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T: Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 1994 May 1;221(3):889-97.
8473346	Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993 Apr 25;268(12):9049-54.

# Drug_Target_78_HGNC_ID:
HGNC:9605

# Drug_Target_78_HPRD_ID:
02599

# Drug_Target_78_ID:
290

# Drug_Target_78_Locus:
1q25.2-q25.3

# Drug_Target_78_Molecular_Weight:
68997

# Drug_Target_78_Name:
Prostaglandin G/H synthase 2

# Drug_Target_78_Number_of_Residues:
604

# Drug_Target_78_PDB_ID:
Not Available

# Drug_Target_78_Pathway:
Acetylsalicylic Acid Pathway	SMP00083
Bromfenac Pathway	SMP00102
Celecoxib Pathway	SMP00096
Diclofenac Pathway	SMP00093
Diflunisal Pathway	SMP00289
Etodolac Pathway	SMP00084
Ibuprofen Pathway	SMP00086
Indomethacin Pathway	SMP00104
Ketoprofen Pathway	SMP00085
Ketorolac Pathway	SMP00098
Mefanamic Acid Pathway	SMP00109
Meloxicam Pathway	SMP00106
Nabumetone Pathway	SMP00114
Naproxen Pathway	SMP00120
Oxaprozin Pathway	SMP00113
Piroxicam Pathway	SMP00077
Rofecoxib Pathway	SMP00087
Sulindac Pathway	SMP00094
Suprofen Pathway	SMP00101
Valdecoxib Pathway	SMP00116

# Drug_Target_78_Pfam_Domain_Function:
PF00008	EGF
PF03098	An_peroxidase

# Drug_Target_78_Protein_Sequence:
>Prostaglandin G/H synthase 2 precursor
MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFL
TRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADY
GYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGS
NMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKY
QIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCD
VLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQ
NRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRV
AGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEAL
YGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEV
GFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKER
STEL

# Drug_Target_78_Reaction:
arachidonate + AH2 + 2 O2 = prostaglandin H2 + A + H2O

# Drug_Target_78_Signals:
1-17

# Drug_Target_78_Specific_Function:
May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity

# Drug_Target_78_SwissProt_ID:
P35354

# Drug_Target_78_SwissProt_Name:
PGH2_HUMAN

# Drug_Target_78_Synonyms:
COX-2
Cyclooxygenase- 2
EC 1.14.99.1
PGH synthase 2
PGHS-2
PHS II
Prostaglandin G/H synthase 2 precursor
Prostaglandin H2 synthase 2
Prostaglandin-endoperoxide synthase 2

# Drug_Target_78_Theoretical_pI:
7.41

# Drug_Target_78_Transmembrane_Regions:
None

# Drug_Target_79_Cellular_Location:
Not Available

# Drug_Target_79_Chromosome_Location:
Not Available

# Drug_Target_79_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_79_Essentiality:
Non-Essential

# Drug_Target_79_GenAtlas_ID:
Not Available

# Drug_Target_79_GenBank_ID_Gene:
AB006424

# Drug_Target_79_GenBank_ID_Protein:
3599632

# Drug_Target_79_GeneCard_ID:
Not Available

# Drug_Target_79_Gene_Name:
cypC

# Drug_Target_79_Gene_Sequence:
>1254 bp
ATGAATGAGCAGATTCCACATGACAAAAGTCTCGATAACAGTCTGACACTGCTGAAGGAA
GGGTATTTATTTATTAAAAACAGAACAGAGCGCTACAATTCAGATCTGTTTCAGGCCCGT
TTGTTGGGAAAAAACTTTATTTGCATGACTGGCGCTGAGGCGGCGAAGGTGTTTTATGAT
ACGGATCGATTCCAGCGGCAGAACGCTTTGCCTAAGCGGGTGCAGAAATCGCTGTTTGGT
GTTAATGCGATTCAGGGAATGGATGGCAGCGCGCATATCCATCGGAAGATGCTTTTTCTG
TCATTGATGACACCGCCGCATCAAAAACGTTTGGCTGAGTTGATGACAGAGGAGTGGAAA
GCAGCAGTCACAAGATGGGAGAAGGCAGATGAGGTTGTGTTATTTGAAGAAGCAAAAGAA
ATCCTGTGCCGGGTAGCGTGCTATTGGGCAGGTGTTCCGTTGAAGGAAACGGAAGTCAAA
GAGAGAGCGGATGACTTCATTGACATGGTCGACGCGTTCGGTGCTGTGGGACCGCGGCAT
TGGAAAGGAAGAAGAGCAAGGCCGCGTGCGGAAGAGTGGATTGAAGTCATGATTGAAGAT
GCTCGTGCCGGCTTGCTGAAAACGACTTCCGGAACAGCGCTGCATGAAATGGCTTTTCAC
ACACAAGAAGATGGAAGCCAGCTGGATTCCCGCATGGCAGCCATTGAGCTGATTAATGTA
CTGCGGCCTATTGTCGCCATTTCTTACTTTCTGGTGTTTTCAGCTTTGGCGCTTCATGAG
CATCCGAAGTATAAGGAATGGCTGCGGTCTGGAAACAGCCGGGAAAGAGAAATGTTTGTG
CAGGAGGTCCGCAGATATTATCCGTTCGGCCCGTTTTTAGGGGCGCTTGTCAAAAAAGAT
TTTGTATGGAATAACTGTGAGTTTAAGAAGGGCACATCGGTGCTGCTTGATTTATATGGA
ACGAACCACGACCCTCGTCTATGGGATCATCCCGATGAATTCCGGCCGGAACGATTTGCG
GAGCGGGAAGAAAATCTGTTTGATATGATTCCTCAAGGCGGGGGGCACGCCGAGAAAGGC
CACCGCTGTCCAGGGGAAGGCATTACAATTGAAGTCATGAAAGCGAGCCTGGATTTCCTC
GTCCATCAGATTGAATACGATGTTCCGGAACAATCACTGCATTACAGTCTCGCCAGAATG
CCATCATTGCCTGAAAGCGGCTTCGTAATGAGCGGAATCAGACGAAAAAGTTAA

# Drug_Target_79_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_79_General_References:
10529095	Matsunaga I, Ueda A, Fujiwara N, Sumimoto T, Ichihara K: Characterization of the ybdT gene product of Bacillus subtilis: novel fatty acid beta-hydroxylating cytochrome P450. Lipids. 1999 Aug;34(8):841-6.
12519760	Lee DS, Yamada A, Sugimoto H, Matsunaga I, Ogura H, Ichihara K, Adachi S, Park SY, Shiro Y: Substrate recognition and molecular mechanism of fatty acid hydroxylation by cytochrome P450 from Bacillus subtilis. Crystallographic, spectroscopic, and mutational studies. J Biol Chem. 2003 Mar 14;278(11):9761-7. Epub 2003 Jan 7.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_79_HGNC_ID:
Not Available

# Drug_Target_79_HPRD_ID:
Not Available

# Drug_Target_79_ID:
3570

# Drug_Target_79_Locus:
Not Available

# Drug_Target_79_Molecular_Weight:
48110

# Drug_Target_79_Name:
Cytochrome P450 152A1

# Drug_Target_79_Number_of_Residues:
417

# Drug_Target_79_PDB_ID:
1IZO

# Drug_Target_79_Pathway:
Not Available

# Drug_Target_79_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_79_Protein_Sequence:
>Cytochrome P450 152A1
MNEQIPHDKSLDNSLTLLKEGYLFIKNRTERYNSDLFQARLLGKNFICMTGAEAAKVFYD
TDRFQRQNALPKRVQKSLFGVNAIQGMDGSAHIHRKMLFLSLMTPPHQKRLAELMTEEWK
AAVTRWEKADEVVLFEEAKEILCRVACYWAGVPLKETEVKERADDFIDMVDAFGAVGPRH
WKGRRARPRAEEWIEVMIEDARAGLLKTTSGTALHEMAFHTQEDGSQLDSRMAAIELINV
LRPIVAISYFLVFSALALHEHPKYKEWLRSGNSREREMFVQEVRRYYPFGPFLGALVKKD
FVWNNCEFKKGTSVLLDLYGTNHDPRLWDHPDEFRPERFAEREENLFDMIPQGGGHAEKG
HRCPGEGITIEVMKASLDFLVHQIEYDVPEQSLHYSLARMPSLPESGFVMSGIRRKS

# Drug_Target_79_Reaction:
Not Available

# Drug_Target_79_Signals:
None

# Drug_Target_79_Specific_Function:
Catalyzes the alpha- and beta-hydroxylation of myristic acid in the presence of hydrogen peroxide

# Drug_Target_79_SwissProt_ID:
O31440

# Drug_Target_79_SwissProt_Name:
CYPC_BACSU

# Drug_Target_79_Synonyms:
EC 1.14.-.-
Fatty acid beta- hydroxylase
P450BsBeta

# Drug_Target_79_Theoretical_pI:
6.93

# Drug_Target_79_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AE017180

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
GSU1996

# Drug_Target_7_Gene_Sequence:
>1032 bp
ATGAAAATGCGTCTCAACGGGGTCGTGACGGGTATCGTGTCGCTGGTTCTGCTTGTGGCG
GTTGTGGCAATGGCCAAGGAGACGAAAAATGTTCCTTTCAAGCTCAAAAACGCCGCACCG
GTCATCTTCAGCCACGATATTCACCTGAAAAAGTATAACAACAACTGTCGAATTTGTCAC
ATCGCTCTCTTTGACCTGCGGAAGCCGAAACGTTACACGATGCTCGACATGGAAAAGGGC
AAGTCCTGCGGCGCCTGCCACACGGGCATGAAAGCTTTCAGTGTTGCGGACGACTCCCAG
TGCGTGCGCTGTCACAGTGGCTCAGCACGCCCCGTGGCCTACCGGATGAAGGGTGCCGGA
GAAGCGGTGTTCAGCCACGAAGTCCACGTCCCCATGCTGGAGGGCAAGTGCCGAACCTGC
CACTCGAACCGTGAGATCACCGGCGGCCGTAACGTGACCATGGCCCAGATGGAAAAGGGC
AAATCGTGCGGGGCCTGTCACAATGACAAGATGGCGTTCACCGTTGCCGGCAACTGCGGC
AAGTGCCACAAGGGCATGACCCCGCCGAAAACGGTGAACTTCAAAATGAAGGGCGTGGCG
GATGCGGCCTTCAGCCACGAATTCCACCTGGGCATGTACAAGTGCAATGAGTGCCACACC
AAGCTCTTCGCCTATAAGGCCGGCGCCAAGCGCTTCACCATGGCCGACATGGACAAGGGC
AAGTCCTGCGGCGCCTGCCACAACGGCAAGGACGCCTTCTCTTCCGCCAGCGACTGCGGC
AAATGCCATCCGGGTCTGAAGCCGGCCAAACTCACCTACAAGACCAGCGTGGGTGAAGCC
TACTTCGACCATGATATTCACCTGAGCATGTTCAAGTGCGCCGACTGCCACACCAAGGTC
TTCAAGTACCGCAAGGGCTCTGCGCCGGCGACCATGGCCGACATGGAGAAGGGCAAATCG
TGCGGTGTCTGCCATAACGGCAAGGATGCCTTCAGCGTGGCCGATGACTGTGTGAAGTGC
CACAACATGTAA

# Drug_Target_7_General_Function:
Not Available

# Drug_Target_7_General_References:
Not Available

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
4904

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
37451

# Drug_Target_7_Name:
Cytochrome c family protein

# Drug_Target_7_Number_of_Residues:
343

# Drug_Target_7_PDB_ID:
1RWJ

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
Not Available

# Drug_Target_7_Protein_Sequence:
>Cytochrome c family protein
MKMRLNGVVTGIVSLVLLVAVVAMAKETKNVPFKLKNAAPVIFSHDIHLKKYNNNCRICH
IALFDLRKPKRYTMLDMEKGKSCGACHTGMKAFSVADDSQCVRCHSGSARPVAYRMKGAG
EAVFSHEVHVPMLEGKCRTCHSNREITGGRNVTMAQMEKGKSCGACHNDKMAFTVAGNCG
KCHKGMTPPKTVNFKMKGVADAAFSHEFHLGMYKCNECHTKLFAYKAGAKRFTMADMDKG
KSCGACHNGKDAFSSASDCGKCHPGLKPAKLTYKTSVGEAYFDHDIHLSMFKCADCHTKV
FKYRKGSAPATMADMEKGKSCGVCHNGKDAFSVADDCVKCHNM

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Not Available

# Drug_Target_7_SwissProt_ID:
Q74BP5

# Drug_Target_7_SwissProt_Name:
Q74BP5_GEOSL

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
9.31

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_80_Cellular_Location:
Not Available

# Drug_Target_80_Chromosome_Location:
Not Available

# Drug_Target_80_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_80_Essentiality:
Non-Essential

# Drug_Target_80_GenAtlas_ID:
Not Available

# Drug_Target_80_GenBank_ID_Gene:
X60379

# Drug_Target_80_GenBank_ID_Protein:
48942

# Drug_Target_80_GeneCard_ID:
Not Available

# Drug_Target_80_Gene_Name:
eryF

# Drug_Target_80_Gene_Sequence:
>1221 bp
ATGACGACCGTTCCCGATCTCGAAAGCGACTCCTTCCACGTCGACTGGTACCGCACCTAC
GCCGAGCTGCGCGAGACCGCGCCGGTGACGCCGGTGCGCTTCCTCGGCCAGGACGCGTGG
CTGGTCACCGGCTACGACGAGGCGAAGGCCGCGCTGAGCGACCTGCGCCTGAGCAGCGAC
CCGAAGAAGAAGTACCCGGGCGTGGAGGTCGAGTTCCCGGCATACCTCGGTTTCCCCGAG
GACGTGCGGAACTACTTCGCCACCAACATGGGCACCAGCGACCCGCCGACCCACACCCGG
CTGCGCAAGCTGGTGTCGCAGGAGTTCACCGTCCGCCGCGTGGAGGCGATGCGGCCCCGC
GTCGAGCAGATCACCGCGGAGCTGCTCGACGAGGTGGGCGACTCCGGCGTGGTCGACATC
GTCGACCGCTTCGCCCACCCGCTGCCCATCAAGGTCATCTGCGAGCTGCTCGGCGTCGAC
GAGAAGTACCGCGGGGAGTTCGGGCGGTGGAGCTCGGAGATCCTGGTCATGGACCCGGAG
CGGGCCGAACAGCGCGGGCAGGCGGCCAGGGAGGTCGTCAACTTCATCCTCGACCTGGTC
GAGCGCCGCCGCACCGAGCCCGGCGACGACCTGCTGTCCGCGCTGATCAGGGTCCAGGAC
GACGATGACGGTCGGCTCAGCGCCGACGAGCTGACCTCCATCGCGCTGGTGCTGCTGCTG
GCCGGTTTCGAGGCGTCGGTGAGCCTCATCGGGATCGGCACCTACCTGCTGCTCACCCAC
CCGGACCAGGACCAGCTCGCGCTGGTGCGGCGGGACCCGTCGGCGCTGCCCAACGCCGTC
GAGGAGATCCTGCGCTACATCGCTCCGCCGGAGACCACCACGCGCTTCGCCGCGGAGGAG
GTGGAGATCCGGGGTGTCGCGATCCCCCAGTACAGCACGGTGCTGGTCGCGAACGGCGCG
GCCAACCGCGACCCGAAGCAGTTCCCGGACCCCCACCGCTTCGACGTCACCCGCGACACC
CGCGGCCACCTGTCGTTCGGGCAGGGCATCCACTTCTGCATGGGCCGGCCGCTGGCCAAG
CTGGAGGGCGAGGTGGCGCTGCGGGCGCTGTTCGGCCGCTTCCCCGCTCTGTCGCTGGGA
ATCGACGCCGACGACGTGGTGTGGCGGCGTTCGCTGCTGCTGCGGGGCATCGACCACCTA
CCGGTGCGGCTCGACGGATGA

# Drug_Target_80_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_80_General_References:
10716705	Cupp-Vickery J, Anderson R, Hatziris Z: Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3050-5.
11469860	Cupp-Vickery JR, Garcia C, Hofacre A, McGee-Estrada K: Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF. J Mol Biol. 2001 Aug 3;311(1):101-10.
1840640	Haydock SF, Dowson JA, Dhillon N, Roberts GA, Cortes J, Leadlay PF: Cloning and sequence analysis of genes involved in erythromycin biosynthesis in Saccharopolyspora erythraea: sequence similarities between EryG and a family of S-adenosylmethionine-dependent methyltransferases. Mol Gen Genet. 1991 Nov;230(1-2):120-8.
2011746	Weber JM, Leung JO, Swanson SJ, Idler KB, McAlpine JB: An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea. Science. 1991 Apr 5;252(5002):114-7.
7749919	Cupp-Vickery JR, Poulos TL: Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol. 1995 Feb;2(2):144-53.

# Drug_Target_80_HGNC_ID:
Not Available

# Drug_Target_80_HPRD_ID:
Not Available

# Drug_Target_80_ID:
2972

# Drug_Target_80_Locus:
Not Available

# Drug_Target_80_Molecular_Weight:
45100

# Drug_Target_80_Name:
6-deoxyerythronolide B hydroxylase

# Drug_Target_80_Number_of_Residues:
404

# Drug_Target_80_PDB_ID:
1Z8O

# Drug_Target_80_Pathway:
Not Available

# Drug_Target_80_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_80_Protein_Sequence:
>6-deoxyerythronolide B hydroxylase
MTTVPDLESDSFHVDWYRTYAELRETAPVTPVRFLGQDAWLVTGYDEAKAALSDLRLSSD
PKKKYPGVEVEFPAYLGFPEDVRNYFATNMGTSDPPTHTRLRKLVSQEFTVRRVEAMRPR
VEQITAELLDEVGDSGVVDIVDRFAHPLPIKVICELLGVDEKYRGEFGRWSSEILVMDPE
RAEQRGQAAREVVNFILDLVERRRTEPGDDLLSALIRVQDDDDGRLSADELTSIALVLLL
AGFEASVSLIGIGTYLLLTHPDQLALVRRDPSALPNAVEEILRYIAPPETTTRFAAEEVE
IGGVAIPQYSTVLVANGAANRDPKQFPDPHRFDVTRDTRGHLSFGQGIHFCMGRPLAKLE
GEVALRALFGRFPALSLGIDADDVVWRRSLLLRGIDHLPVRLDG

# Drug_Target_80_Reaction:
Not Available

# Drug_Target_80_Signals:
None

# Drug_Target_80_Specific_Function:
Conversion of 6-deoxyerythronolide B (6-DEB) to erythronolide B (EB) by the insertion of an oxygen at the 6S position of 6-DEB

# Drug_Target_80_SwissProt_ID:
Q00441

# Drug_Target_80_SwissProt_Name:
CPXJ_SACEN

# Drug_Target_80_Synonyms:
6-DEB hydroxylase
CYPCVIIA1
Cytochrome P450 107A1
EC 1.-.-.-
Erythomycin A biosynthesis hydrolase
P450eryF

# Drug_Target_80_Theoretical_pI:
4.69

# Drug_Target_80_Transmembrane_Regions:
None

# Drug_Target_81_Cellular_Location:
Plastid

# Drug_Target_81_Chromosome_Location:
Not Available

# Drug_Target_81_Drug_References:
Not Available

# Drug_Target_81_Essentiality:
Non-Essential

# Drug_Target_81_GenAtlas_ID:
Not Available

# Drug_Target_81_GenBank_ID_Gene:
AB052598

# Drug_Target_81_GenBank_ID_Protein:
Not Available

# Drug_Target_81_GeneCard_ID:
Not Available

# Drug_Target_81_Gene_Name:
psbV

# Drug_Target_81_Gene_Sequence:
>492 bp
ATGTTAAAAAAATGCGTTTGGCTTGCGGTCGCTCTCTGCCTCTGCCTCTGGCAATTCACC
ATGGGCACAGCACTGGCCGCCGAACTGACCCCTGAAGTCTTGACTGTCCCCCTCAACAGC
GAGGGCAAAACGATTACGCTGACGGAAAAACAATACCTAGAGGGTAAGCGCCTCTTCCAG
TATGCCTGTGCCTCCTGCCACGTGGGGGGGATCACGAAAACGAACCCCAGCTTGGATTTG
CGTACGGAAACCCTTGCCCTAGCCACGCCGCCCCGGGATAACATTGAAGGCTTGGTGGAC
TACATGAAGAACCCCACCACCTACGATGGTGAGCAAGAAATTGCTGAGGTGCACCCCAGT
CTGCGCAGTGCCGACATTTTTCCGAAAATGCGGAACTTGACGGAGAAGGATTTGGTGGCG
ATCGCCGGCCATATTCTCGTCGAGCCCAAAATCTTGGGTGATAAATGGGGCGGTGGCAAA
GTGTATTACTAA

# Drug_Target_81_General_Function:
Involved in iron ion binding

# Drug_Target_81_General_References:
1314738	Shen JR, Ikeuchi M, Inoue Y: Stoichiometric association of extrinsic cytochrome c550 and 12 kDa protein with a highly purified oxygen-evolving photosystem II core complex from Synechococcus vulcanus. FEBS Lett. 1992 Apr 20;301(2):145-9.

# Drug_Target_81_HGNC_ID:
Not Available

# Drug_Target_81_HPRD_ID:
Not Available

# Drug_Target_81_ID:
4959

# Drug_Target_81_Locus:
Not Available

# Drug_Target_81_Molecular_Weight:
18027

# Drug_Target_81_Name:
Cytochrome c-550

# Drug_Target_81_Number_of_Residues:
163

# Drug_Target_81_PDB_ID:
1W5C

# Drug_Target_81_Pathway:
Not Available

# Drug_Target_81_Pfam_Domain_Function:
Not Available

# Drug_Target_81_Protein_Sequence:
>Cytochrome c-550
MLKKCVWLAVALCLCLWQFTMGTALAAELTPEVLTVPLNSEGKTITLTEKQYLEGKRLFQ
YACASCHVGGITKTNPSLDLRTETLALATPPRDNIEGLVDYMKNPTTYDGEQEIAEVHPS
LRSADIFPKMRNLTEKDLVAIAGHILVEPKILGDKWGGGKVYY

# Drug_Target_81_Reaction:
Not Available

# Drug_Target_81_Signals:
1-26

# Drug_Target_81_Specific_Function:
Low-potential cytochrome c that plays a role in water oxidation complex of photosystem II

# Drug_Target_81_SwissProt_ID:
P0A387

# Drug_Target_81_SwissProt_Name:
CY550_THEVL

# Drug_Target_81_Synonyms:
Cytochrome c-550 precursor
Cytochrome c550
Low-potential cytochrome c

# Drug_Target_81_Theoretical_pI:
6.25

# Drug_Target_81_Transmembrane_Regions:
None

# Drug_Target_82_Cellular_Location:
Not Available

# Drug_Target_82_Chromosome_Location:
Not Available

# Drug_Target_82_Drug_References:
Not Available

# Drug_Target_82_Essentiality:
Non-Essential

# Drug_Target_82_GenAtlas_ID:
Not Available

# Drug_Target_82_GenBank_ID_Gene:
AL939131

# Drug_Target_82_GenBank_ID_Protein:
Not Available

# Drug_Target_82_GeneCard_ID:
Not Available

# Drug_Target_82_Gene_Name:
SCO7417

# Drug_Target_82_Gene_Sequence:
>1224 bp
TCAGGCCAGCCTGACCGGCAGTTCGAACAGGTCGTTCTGCGTGACCACCGGCTTGTTGCG
CAGCTCCGCGGCCGGCACCGCCAGGTCCAGGTGCGGGAAGCGGGCGTACAGGGCCGGGAG
CGCCACGCCCGCCTCCATCCGGGACAGGGCCGCACCGGGGCACACGTGCGGGCCGTGGCC
GAAGGAGATGTGCCGGTTCCCGGACGTGCGGGTGAGGTCGAACCGGTCCGCCGTCGGACC
GTGGGCGCGCTCGTCGCGGCCCAGCGCGCCGTACGAGACGATGAGCGCGTCCCCGGCGGG
TATCACCCGGTCGCCGACCGGGACGTCCTCGGCCGCGAACCGGATCAGGACGTGCGAGGT
GGGCGTCGAGAAGCGCAGCGTCTCCTCGACCACCGCGGACCACTCCGCCTCGCCGGAGAG
CACCAGCGCCCGCTGCTCGGGATGGGTGGACAGGTTGACCACGGCGTTCACGATGAGCGA
GATCGTCGTCTCGTGACCGGCGGCCACCATCAGCTGGAGGGTCGAGACGATCTCCGCGTC
GGTGAGGTGATCGCCGTTCTCGGACGCCTGGATCAGCGCGCTCGTCAGGTCGTCGCCCGG
TGCGGCGCGTTTCGCGGCGACCGTGTCGGTCATGATCGAGGCCAGCTCGGTGAGGGTCGC
CACGACCTCCTCCGGCGGGGTCTGCGTCGAGAAGAACTTCTCGAACAGCACCTTCAGCCG
CGGCAGCCGCGCCTCCTCGATGCCCATCAGGTCGGCGACGACGTACATCGGCAGCGGATA
GGCGAAGGCCGCCTTGAGATCCACGACGCCGCCGTCCGCGGGCAGTTCGTCGAGCAGGCG
GTCGGTCAGCTCGGTGATCCGCCCCCGCATGTGCTCCACCCGGCGCACCGTGAGCGCCTG
CGCCACCAGGGTGCGCAGCCGGCGGTGCTCGGCGCCGTCCACCGTGAGCATCGAGCGGCC
CGGGTTGGCCAGCCCGATCAGCGGCCAGTCGGCGGGGATCTCGCCGCGCCGCCAGGCGCC
CCACACGTTGATGTCCTTGACCAGCCGCGGGTCCGTGAGCAGGGCCTTGGCCTCCGCGTG
GTGGGTGACCGCCCAGACGGGCACGCCGCCCGGCAGCTCCACGGCGGCGAGCGGTCCGGC
CGCACGCAGCCGAGCGCTCTCGCCGTCCAGGTCGGTGACGAACGGGTCCAGCGGGATCCG
GGCTTCTTCGGTGCCGGTCGTCAT

# Drug_Target_82_General_Function:
Involved in monooxygenase activity

# Drug_Target_82_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.
12519772	Podust LM, Kim Y, Arase M, Neely BA, Beck BJ, Bach H, Sherman DH, Lamb DC, Kelly SL, Waterman MR: The 1.92-A structure of Streptomyces coelicolor A3(2) CYP154C1. A new monooxygenase that functionalizes macrolide ring systems. J Biol Chem. 2003 Apr 4;278(14):12214-21. Epub 2003 Jan 7.

# Drug_Target_82_HGNC_ID:
Not Available

# Drug_Target_82_HPRD_ID:
Not Available

# Drug_Target_82_ID:
4960

# Drug_Target_82_Locus:
Not Available

# Drug_Target_82_Molecular_Weight:
43877

# Drug_Target_82_Name:
Putative cytochrome P450-family protein

# Drug_Target_82_Number_of_Residues:
407

# Drug_Target_82_PDB_ID:
1GWI

# Drug_Target_82_Pathway:
Not Available

# Drug_Target_82_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_82_Protein_Sequence:
>Putative cytochrome P450-family protein
MTTGTEEARIPLDPFVTDLDGESARLRAAGPLAAVELPGGVPVWAVTHHAEAKALLTDPR
LVKDINVWGAWRRGEIPADWPLIGLANPGRSMLTVDGAEHRRLRTLVAQALTVRRVEHMR
GRITELTDRLLDELPADGGVVDLKAAFAYPLPMYVVADLMGIEEARLPRLKVLFEKFFST
QTPPEEVVATLTELASIMTDTVAAKRAAPGDDLTSALIQASENGDHLTDAEIVSTLQLMV
AAGHETTISLIVNAVVNLSTHPEQRALVLSGEAEWSAVVEETLRFSTPTSHVLIRFAAED
VPVGDRVIPAGDALIVSYGALGRDERAHGPTADRFDLTRTSGNRHISFGHGPHVCPGAAL
SRMEAGVALPALYARFPHLDLAVPAAELRNKPVVTQNDLFELPVRLA

# Drug_Target_82_Reaction:
Not Available

# Drug_Target_82_Signals:
None

# Drug_Target_82_Specific_Function:
Not Available

# Drug_Target_82_SwissProt_ID:
Q9L142

# Drug_Target_82_SwissProt_Name:
Q9L142_STRCO

# Drug_Target_82_Synonyms:
Not Available

# Drug_Target_82_Theoretical_pI:
5.17

# Drug_Target_82_Transmembrane_Regions:
None

# Drug_Target_83_Cellular_Location:
Secreted protein

# Drug_Target_83_Chromosome_Location:
Not Available

# Drug_Target_83_Drug_References:
Not Available

# Drug_Target_83_Essentiality:
Non-Essential

# Drug_Target_83_GenAtlas_ID:
Not Available

# Drug_Target_83_GenBank_ID_Gene:
X81195

# Drug_Target_83_GenBank_ID_Protein:
Not Available

# Drug_Target_83_GeneCard_ID:
Not Available

# Drug_Target_83_Gene_Name:
hasA

# Drug_Target_83_Gene_Sequence:
>567 bp
ATGGCATTTTCAGTCAATTATGACAGCAGCTTCGGCGGTTACAGCATTCATGACTATCTG
GGCCAGTGGGCTTCGACATTCGGTGATGTCAATCACACCAACGGCAATGTCACCGACGCC
AACAGCGGCGGCTTCTATGGCGGCAGCCTGTCCGGTAGTCAGTATGCCATCAGTAGCACG
GCAAACCAGGTGACCGCCTTCGTGGCGGGCGGCAACCTGACCTACACGCTGTTCAACGAA
CCGGCGCATACCTTGTACGGCCAACTGGATTCCCTGTCCTTCGGCGACGGTTTGAGCGGT
GGCGATACATCGCCGTACAGCATCCAGGTGCCTGACGTCAGCTTCGGCGGCCTGAACCTC
AGCAGCCTGCAGGCGCAGGGTCATGATGGCGTGGTGCACCAGGTGGTGTACGGCCTGATG
TCCGGCGATACCGGCGCGCTGGAGACCGCGCTGAACGGCATCCTCGACGACTACGGCCTG
AGCGTCAACTCCACCTTCGATCAGGTGGCGGCGGCGACGGCGGTGGGCGTGCAGCACGCC
GACAGCCCGGAACTGCTGGCGGCCTGA

# Drug_Target_83_General_Function:
Not Available

# Drug_Target_83_General_References:
10360351	Arnoux P, Haser R, Izadi N, Lecroisey A, Delepierre M, Wandersman C, Czjzek M: The crystal structure of HasA, a hemophore secreted by Serratia marcescens. Nat Struct Biol. 1999 Jun;6(6):516-20.
10966573	Arnoux P, Haser R, Izadi-Pruneyre N, Lecroisey A, Czjzek M: Functional aspects of the heme bound hemophore HasA by structural analysis of various crystal forms. Proteins. 2000 Nov 1;41(2):202-10.
7937909	Letoffe S, Ghigo JM, Wandersman C: Iron acquisition from heme and hemoglobin by a Serratia marcescens extracellular protein. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9876-80.
9171402	Ghigo JM, Letoffe S, Wandersman C: A new type of hemophore-dependent heme acquisition system of Serratia marcescens reconstituted in Escherichia coli. J Bacteriol. 1997 Jun;179(11):3572-9.
9188703	Izadi N, Henry Y, Haladjian J, Goldberg ME, Wandersman C, Delepierre M, Lecroisey A: Purification and characterization of an extracellular heme-binding protein, HasA, involved in heme iron acquisition. Biochemistry. 1997 Jun 10;36(23):7050-7.

# Drug_Target_83_HGNC_ID:
Not Available

# Drug_Target_83_HPRD_ID:
Not Available

# Drug_Target_83_ID:
4961

# Drug_Target_83_Locus:
Not Available

# Drug_Target_83_Molecular_Weight:
19283

# Drug_Target_83_Name:
Hemophore HasA

# Drug_Target_83_Number_of_Residues:
188

# Drug_Target_83_PDB_ID:
1DKH

# Drug_Target_83_Pathway:
Not Available

# Drug_Target_83_Pfam_Domain_Function:
PF06438	HasA

# Drug_Target_83_Protein_Sequence:
>Hemophore HasA
MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGNVTDANSGGFYGGSLSGSQYAISST
ANQVTAFVAGGNLTYTLFNEPAHTLYGQLDSLSFGDGLSGGDTSPYSIQVPDVSFGGLNL
SSLQAQGHDGVVHQVVYGLMSGDTGALETALNGILDDYGLSVNSTFDQVAAATAVGVQHA
DSPELLAA

# Drug_Target_83_Reaction:
Not Available

# Drug_Target_83_Signals:
None

# Drug_Target_83_Specific_Function:
Can bind free heme and also acquire it from hemoglobin. Conveys heme from hemoglobin to the HasR receptor which releases it into the bacterium. HasR alone can take up heme but the synergy between HasA and HasR increases heme uptake 100-fold

# Drug_Target_83_SwissProt_ID:
Q54450

# Drug_Target_83_SwissProt_Name:
HASA_SERMA

# Drug_Target_83_Synonyms:
Heme acquisition system protein A

# Drug_Target_83_Theoretical_pI:
3.72

# Drug_Target_83_Transmembrane_Regions:
None

# Drug_Target_84_Cellular_Location:
Not Available

# Drug_Target_84_Chromosome_Location:
Not Available

# Drug_Target_84_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_84_Essentiality:
Non-Essential

# Drug_Target_84_GenAtlas_ID:
Not Available

# Drug_Target_84_GenBank_ID_Gene:
Not Available

# Drug_Target_84_GenBank_ID_Protein:
Not Available

# Drug_Target_84_GeneCard_ID:
Not Available

# Drug_Target_84_Gene_Name:
cycA

# Drug_Target_84_Gene_Sequence:
Not Available

# Drug_Target_84_General_Function:
Energy production and conversion

# Drug_Target_84_General_References:
9281430	Than ME, Hof P, Huber R, Bourenkov GP, Bartunik HD, Buse G, Soulimane T: Thermus thermophilus cytochrome-c552: A new highly thermostable cytochrome-c structure obtained by MAD phasing. J Mol Biol. 1997 Aug 29;271(4):629-44.

# Drug_Target_84_HGNC_ID:
Not Available

# Drug_Target_84_HPRD_ID:
Not Available

# Drug_Target_84_ID:
3291

# Drug_Target_84_Locus:
Not Available

# Drug_Target_84_Molecular_Weight:
14173

# Drug_Target_84_Name:
Cytochrome c-552

# Drug_Target_84_Number_of_Residues:
131

# Drug_Target_84_PDB_ID:
1R0Q

# Drug_Target_84_Pathway:
Not Available

# Drug_Target_84_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_84_Protein_Sequence:
>Cytochrome c-552
QADGAKIYAQCAGCHQQNGQGIPGAFPPLAGHVAEILAKEGGREYLILVLLYGLQGQIEV
KGMKYNGVMSSFAQLKDEEIAAVLNHIATAWGDAKKVKGFKPFTAEEVKKLRAKKLTPQQ
VLAERKKLGLK

# Drug_Target_84_Reaction:
Not Available

# Drug_Target_84_Signals:
None

# Drug_Target_84_Specific_Function:
This monoheme basic protein appears to function as an electron donor to cytochrome oxidase in T.thermophilus

# Drug_Target_84_SwissProt_ID:
P04164

# Drug_Target_84_SwissProt_Name:
CY552_THETH

# Drug_Target_84_Synonyms:
Cytochrome c552

# Drug_Target_84_Theoretical_pI:
10.02

# Drug_Target_84_Transmembrane_Regions:
None

# Drug_Target_85_Cellular_Location:
Periplasm

# Drug_Target_85_Chromosome_Location:
Not Available

# Drug_Target_85_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_85_Essentiality:
Non-Essential

# Drug_Target_85_GenAtlas_ID:
Not Available

# Drug_Target_85_GenBank_ID_Gene:
Y09718

# Drug_Target_85_GenBank_ID_Protein:
1770204

# Drug_Target_85_GeneCard_ID:
Not Available

# Drug_Target_85_Gene_Name:
Not Available

# Drug_Target_85_Gene_Sequence:
>384 bp
ATGTTCAAGCACACGCTCATCGCCCTGACGCTCCTCGCGGCCGCGACCCTGTTCAGTCTG
CCCGCCTTCTCCCAGGAGGACATGACTCATGTGCCCACGGACGCCTTCGGCAAGCTGGAA
CGTCCGGCAGCCGTGTTCAACCACGACGAGCACAACGAGAAAGCCGGCATAGAGAGCTGC
AACGCCTGCCACCATGTCTGGGTCAACGGCGTGCTCGCCGAGGACGAGGATTCGGTCGGC
ACGCCCTGTTCCGATTGCCATGCCCTGGAGCAGGACGGCGACACGCCCGGCCTGCAGGAC
GCCTACCACCAGCAGTGCTGGGGCTGCCACGAGAAGCAGGCCAAGGGGCCGGTCATGTGC
GGCGAATGCCACGTGAAGAATTAG

# Drug_Target_85_General_Function:
Involved in iron ion binding

# Drug_Target_85_General_References:
10398589	Norager S, Legrand P, Pieulle L, Hatchikian C, Roth M: Crystal structure of the oxidised and reduced acidic cytochrome c3from Desulfovibrio africanus. J Mol Biol. 1999 Jul 23;290(4):881-902.
8573595	Pieulle L, Haladjian J, Bonicel J, Hatchikian EC: Biochemical studies of the c-type cytochromes of the sulfate reducer Desulfovibrio africanus. Characterization of two tetraheme cytochromes c3 with different specificity. Biochim Biophys Acta. 1996 Jan 11;1273(1):51-61.
9392524	Magro V, Pieulle L, Forget N, Guigliarelli B, Petillot Y, Hatchikian EC: Further characterization of the two tetraheme cytochromes c3 from Desulfovibiro africanus: nucleotide sequences, EPR spectroscopy and biological activity. Biochim Biophys Acta. 1997 Oct 17;1342(2):149-63.

# Drug_Target_85_HGNC_ID:
Not Available

# Drug_Target_85_HPRD_ID:
Not Available

# Drug_Target_85_ID:
3375

# Drug_Target_85_Locus:
Not Available

# Drug_Target_85_Molecular_Weight:
13857

# Drug_Target_85_Name:
Acidic cytochrome c3

# Drug_Target_85_Number_of_Residues:
127

# Drug_Target_85_PDB_ID:
3CAR

# Drug_Target_85_Pathway:
Not Available

# Drug_Target_85_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_85_Protein_Sequence:
>Acidic cytochrome c3 precursor
MFKHTLIALTLLAAATLFSLPAFSQEDMTHVPTDAFGKLERPAAVFNHDEHNEKAGIESC
NACHHVWVNGVLAEDEDSVGTPCSDCHALEQDGDTPGLQDAYHQQCWGCHEKQAKGPVMC
GECHVKN

# Drug_Target_85_Reaction:
Not Available

# Drug_Target_85_Signals:
1-24

# Drug_Target_85_Specific_Function:
Exchanges electrons specifically with the basic cytochrome c3

# Drug_Target_85_SwissProt_ID:
P94690

# Drug_Target_85_SwissProt_Name:
CYC3A_DESAF

# Drug_Target_85_Synonyms:
Acidic cytochrome c3 precursor

# Drug_Target_85_Theoretical_pI:
4.90

# Drug_Target_85_Transmembrane_Regions:
None

# Drug_Target_86_Cellular_Location:
Not Available

# Drug_Target_86_Chromosome_Location:
Not Available

# Drug_Target_86_Drug_References:
Not Available

# Drug_Target_86_Essentiality:
Non-Essential

# Drug_Target_86_GenAtlas_ID:
Not Available

# Drug_Target_86_GenBank_ID_Gene:
AL939114

# Drug_Target_86_GenBank_ID_Protein:
Not Available

# Drug_Target_86_GeneCard_ID:
Not Available

# Drug_Target_86_Gene_Name:
SCO2884

# Drug_Target_86_Gene_Sequence:
>1227 bp
ATGGCGACCCAGCAGCCCGCCCTCGTCCTCGACCCCACCGGCGCCGACCACCACACCGAG
CACCGCACCCTGCGGGAGGGCGGCCCGGCCACCTGGGTGGACGTCCTCGGGGTGCAGGCC
TGGTCGGTCAGCGACCCCGTCCTCCTCAAGCAGCTGCTCACCAGCTCCGACGTCTCCAAG
GACGCCCGGGCGCACTGGCCCGCCTTCGGGGAGGTCGTCGGCACCTGGCCGCTGGCCCTG
TGGGTGGCGGTGGAGAACATGTTCACCGCGTACGGGCCCAATCACCGCAAGCTGCGCCGG
CTGGTGGCGCCCGCCTTCAGCGCCCGTCGCGTCGACGCGATGCGGCCGGCCGTCGAGGCG
ATGGTGACCGGTCTCGTCGACCGGCTCGCCGAGCTTCCCGCCGGTGAGCCGGTGGACCTG
CGGCAGGAGCTGGCCTACCCGCTGCCCATCGCGGTGATCGGTCACCTCATGGGCGTGCCT
CAGGACCGGCGCGACGGCTTCCGCGCCCTCGTGGACGGCGTCTTCGACACCACCCTGGAC
CAGGCCGAGGCCCAGGCCAACACCGCGCGCCTGTACGAGGTCCTCGACCAGCTCATCGCG
GCCAAGCGCGCCACCCCGGGCGACGACATGACCTCGCTGCTCATAGCCGCGCGGGACGAC
GAGGGGGACGGCGACCGGCTCTCCCCCGAGGAGCTGCGCGACACCCTGCTGCTGATGATC
AGCGCCGGGTACGAGACCACCGTCAACGTCATCGACCAGGCCGTGCACACCCTGCTGACC
CGCCCCGACCAGCTCGCGCTGGTCCGCAAGGGCGAGGTCACCTGGGCGGACGTGGTGGAG
GAGACGCTGCGCCACGAACCGGCGGTCAAGCACCTGCCGCTGCGGTACGCGGTCACCGAC
ATCGCCCTGCCGGACGGGCGGACCATCGCCCGCGGGGAGCCGATCCTCGCCTCGTACGCC
GCCGCCAACCGCCATCCGGACTGGCACGAGGACGCCGACACCTTCGACGCGACCCGCACC
GTCAAGGAGCACCTGGCCTTCGGCCACGGCGTCCACTTCTGCCTGGGCGCGCCGCTGGCC
CGCATGGAGGTCACCCTCGCGCTGGAGAGTCTCTTCGGCCGCTTCCCGGACCTCCGCCTC
GCCGATCCGGCCGAGGAGCTGCCGCCCGTGCCCTCCCTGATCAGCAACGGCCACCAGCGG
CTCCCGGTCCTGCTGCACGCCGGCTGA

# Drug_Target_86_General_Function:
Involved in monooxygenase activity

# Drug_Target_86_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.

# Drug_Target_86_HGNC_ID:
Not Available

# Drug_Target_86_HPRD_ID:
Not Available

# Drug_Target_86_ID:
4963

# Drug_Target_86_Locus:
Not Available

# Drug_Target_86_Molecular_Weight:
44662

# Drug_Target_86_Name:
Putative cytochrome P450

# Drug_Target_86_Number_of_Residues:
408

# Drug_Target_86_PDB_ID:
1ODO

# Drug_Target_86_Pathway:
Not Available

# Drug_Target_86_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_86_Protein_Sequence:
>Putative cytochrome P450
MATQQPALVLDPTGADHHTEHRTLREGGPATWVDVLGVQAWSVSDPVLLKQLLTSSDVSK
DARAHWPAFGEVVGTWPLALWVAVENMFTAYGPNHRKLRRLVAPAFSARRVDAMRPAVEA
MVTGLVDRLAELPAGEPVDLRQELAYPLPIAVIGHLMGVPQDRRDGFRALVDGVFDTTLD
QAEAQANTARLYEVLDQLIAAKRATPGDDMTSLLIAARDDEGDGDRLSPEELRDTLLLMI
SAGYETTVNVIDQAVHTLLTRPDQLALVRKGEVTWADVVEETLRHEPAVKHLPLRYAVTD
IALPDGRTIARGEPILASYAAANRHPDWHEDADTFDATRTVKEHLAFGHGVHFCLGAPLA
RMEVTLALESLFGRFPDLRLADPAEELPPVPSLISNGHQRLPVLLHAG

# Drug_Target_86_Reaction:
Not Available

# Drug_Target_86_Signals:
None

# Drug_Target_86_Specific_Function:
Not Available

# Drug_Target_86_SwissProt_ID:
Q9KZR7

# Drug_Target_86_SwissProt_Name:
Q9KZR7_STRCO

# Drug_Target_86_Synonyms:
Not Available

# Drug_Target_86_Theoretical_pI:
5.07

# Drug_Target_86_Transmembrane_Regions:
None

# Drug_Target_87_Cellular_Location:
Not Available

# Drug_Target_87_Chromosome_Location:
Not Available

# Drug_Target_87_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_87_Essentiality:
Non-Essential

# Drug_Target_87_GenAtlas_ID:
Not Available

# Drug_Target_87_GenBank_ID_Gene:
BX842579

# Drug_Target_87_GenBank_ID_Protein:
1449345

# Drug_Target_87_GeneCard_ID:
Not Available

# Drug_Target_87_Gene_Name:
cyp121

# Drug_Target_87_Gene_Sequence:
>1191 bp
ATGACCGCGACCGTTCTGCTCGAGGTCCCGTTCTCTGCACGTGGGGATCGGATTCCTGAC
GCCGTCGCAGAATTACGAACCCGCGAGCCTATCCGCAAGGTACGGACCATTACCGGCGCC
GAAGCCTGGCTCGTCTCCTCGTATGCACTGTGCACACAGGTGCTCGAGGATCGGCGTTTT
TCCATGAAGGAAACCGCCGCTGCCGGCGCCCCCCGCCTGAACGCGCTGACTGTTCCACCC
GAAGTGGTCAACAACATGGGAAACATCGCCGACGCGGGACTGCGCAAGGCGGTGATGAAA
GCGATCACACCCAAGGCACCCGGGTTGGAGCAATTCCTACGAGACACCGCGAACTCGCTG
CTGGACAACCTGATTACCGAGGGCGCACCAGCCGATCTGCGCAATGACTTCGCCGACCCG
CTGGCCACTGCCCTGCACTGCAAGGTTCTGGGCATCCCGCAAGAAGACGGCCCGAAGCTG
TTCCGTAGCTTGAGTATCGCTTTCATGAGTTCGGCCGACCCGATCCCCGCCGCGAAGATC
AACTGGGATCGCGACATCGAATACATGGCCGGAATTCTGGAAAACCCAAACATCACGACC
GGCCTCATGGGTGAGCTCAGCCGCCTCCGGAAAGATCCCGCCTACTCGCACGTCTCCGAC
GAACTATTCGCGACCATCGGCGTCACTTTCTTCGGTGCCGGCGTCATCTCAACCGGCAGC
TTCCTCACCACCGCGCTGATATCGCTGATACAACGCCCGCAACTTCGGAACTTGTTGCAC
GAGAAGCCGGAACTGATCCCGGCCGGTGTAGAGGAACTGCTGCGGATCAATCTCTCCTTC
GCCGACGGGTTACCGCGCCTGGCCACCGCCGACATCCAGGTCGGCGACGTGCTGGTCCGC
AAGGGGGAGCTGGTGCTGGTGCTGCTCGAGGGCGCCAACTTCGATCCCGAGCACTTCCCT
AACCCGGGCAGCATCGAACTCGACCGGCCCAACCCCACCTCGCACCTCGCGTTCGGCCGC
GGCCAACACTTCTGTCCTGGATCAGCTCTCGGTCGCCGCCACGCACAGATCGGCATCGAA
GCGCTGTTGAAAAAGATGCCCGGCGTCGACCTGGCTGTGCCCATCGACCAATTGGTCTGG
CGCACCCGATTCCAAAGACGCATCCCCGAACGCCTTCCGGTGCTCTGGTAG

# Drug_Target_87_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_87_General_References:
11914502	Mowat CG, Leys D, McLean KJ, Rivers SL, Richmond A, Munro AW, Ortiz Lombardia M, Alzari PM, Reid GA, Chapman SK, Walkinshaw MD: Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr. 2002 Apr;58(Pt 4):704-5. Epub 2002 Mar 22.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
12435731	Leys D, Mowat CG, McLean KJ, Richmond A, Chapman SK, Walkinshaw MD, Munro AW: Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450. J Biol Chem. 2003 Feb 14;278(7):5141-7. Epub 2002 Nov 14.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_87_HGNC_ID:
Not Available

# Drug_Target_87_HPRD_ID:
Not Available

# Drug_Target_87_ID:
3411

# Drug_Target_87_Locus:
Not Available

# Drug_Target_87_Molecular_Weight:
43257

# Drug_Target_87_Name:
Cytochrome P450 121

# Drug_Target_87_Number_of_Residues:
396

# Drug_Target_87_PDB_ID:
1N4G

# Drug_Target_87_Pathway:
Not Available

# Drug_Target_87_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_87_Protein_Sequence:
>Cytochrome P450 121
MTATVLLEVPFSARGDRIPDAVAELRTREPIRKVRTITGAEAWLVSSYALCTQVLEDRRF
SMKETAAAGAPRLNALTVPPEVVNNMGNIADAGLRKAVMKAITPKAPGLEQFLRDTANSL
LDNLITEGAPADLRNDFADPLATALHCKVLGIPQEDGPKLFRSLSIAFMSSADPIPAAKI
NWDRDIEYMAGILENPNITTGLMGELSRLRKDPAYSHVSDELFATIGVTFFGAGVISTGS
FLTTALISLIQRPQLRNLLHEKPELIPAGVEELLRINLSFADGLPRLATADIQVGDVLVR
KGELVLVLLEGANFDPEHFPNPGSIELDRPNPTSHLAFGRGQHFCPGSALGRRHAQIGIE
ALLKKMPGVDLAVPIDQLVWRTRFQRRIPERLPVLW

# Drug_Target_87_Reaction:
Not Available

# Drug_Target_87_Signals:
None

# Drug_Target_87_Specific_Function:
Not Available

# Drug_Target_87_SwissProt_ID:
P0A514

# Drug_Target_87_SwissProt_Name:
CP121_MYCTU

# Drug_Target_87_Synonyms:
EC 1.14.-.-
P450 MT2

# Drug_Target_87_Theoretical_pI:
6.64

# Drug_Target_87_Transmembrane_Regions:
222-242

# Drug_Target_88_Cellular_Location:
Not Available

# Drug_Target_88_Chromosome_Location:
Not Available

# Drug_Target_88_Drug_References:
Not Available

# Drug_Target_88_Essentiality:
Non-Essential

# Drug_Target_88_GenAtlas_ID:
Not Available

# Drug_Target_88_GenBank_ID_Gene:
BX572597

# Drug_Target_88_GenBank_ID_Protein:
Not Available

# Drug_Target_88_GeneCard_ID:
Not Available

# Drug_Target_88_Gene_Name:
cycA

# Drug_Target_88_Gene_Sequence:
>420 bp
TTACTTGAGGGTGGCCAGATAGGCGACCACGTCCTTACGCTGCTGCTCGTTGGCGAGCTT
GAAGGTCATCTTGGTGACACCGACCGCCTGATCAGCCTTACCCTTATCGGTCAGGAACTT
CTTCAGGAACGCGTTCGGATCGTTCAGGTAGTTGATGATGTTGTCGGCGGTCCAGACCAG
ACCCGCTTCACCCGAATTGTGGTTCAGCGGCGAATAGGTGAAGCCAGCCGCGGTACCGGC
CTTACGACCGACGACGCCGCCCAGAGCCGGACCGACCATGTTCTTGTCGGCGCGGTGGCA
GGTCATGCACTGTTTGAACACCGCCTCACCCGCCTTGGCGTCCTGGGCCGAGGCAGTGCC
GATCGACAGAGATCCGGCGGTAGCGGCGATGCTGAGAATTGTGAGAAGTTTTTTGACCAC

# Drug_Target_88_General_Function:
Involved in iron ion binding

# Drug_Target_88_General_References:
221822	Ambler RP, Daniel M, Hermoso J, Meyer TE, Bartsch RG, Kamen MD: Cytochrome c2 sequence variation among the recognised species of purple nonsulphur photosynthetic bacteria. Nature. 1979 Apr 12;278(5705):659-60.

# Drug_Target_88_HGNC_ID:
Not Available

# Drug_Target_88_HPRD_ID:
Not Available

# Drug_Target_88_ID:
4964

# Drug_Target_88_Locus:
Not Available

# Drug_Target_88_Molecular_Weight:
14633

# Drug_Target_88_Name:
Cytochrome c2

# Drug_Target_88_Number_of_Residues:
139

# Drug_Target_88_PDB_ID:
1I8P

# Drug_Target_88_Pathway:
Not Available

# Drug_Target_88_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_88_Protein_Sequence:
>Cytochrome c2
MVKKLLTILSIAATAGSLSIGTASAQDAKAGEAVFKQCMTCHRADKNMVGPALGGVVGRK
AGTAAGFTYSPLNHNSGEAGLVWTADNIINYLNDPNAFLKKFLTDKGKADQAVGVTKMTF
KLANEQQRKDVVAYLATLK

# Drug_Target_88_Reaction:
Not Available

# Drug_Target_88_Signals:
1-25

# Drug_Target_88_Specific_Function:
Cytochrome c2 is found mainly in purple, non-sulfur, photosynthetic bacteria where it functions as the electron donor to the oxidized bacteriochlorophyll in the photophosphorylation pathway. However, it may also have a role in the respiratory chain and is found in some non-photosynthetic bacteria

# Drug_Target_88_SwissProt_ID:
P00091

# Drug_Target_88_SwissProt_Name:
CYC22_RHOPA

# Drug_Target_88_Synonyms:
Cytochrome c2 precursor

# Drug_Target_88_Theoretical_pI:
10.14

# Drug_Target_88_Transmembrane_Regions:
None

# Drug_Target_89_Cellular_Location:
Periplasm

# Drug_Target_89_Chromosome_Location:
Not Available

# Drug_Target_89_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_89_Essentiality:
Non-Essential

# Drug_Target_89_GenAtlas_ID:
Not Available

# Drug_Target_89_GenBank_ID_Gene:
M63807

# Drug_Target_89_GenBank_ID_Protein:
145081

# Drug_Target_89_GeneCard_ID:
Not Available

# Drug_Target_89_Gene_Name:
hmcA

# Drug_Target_89_Gene_Sequence:
>1638 bp
ATGAGGAACGGAAGGACACTGCTGCGATGGGCGGGAGTGTTGGCTGCCACCGCCATCATC
GGCGTCGGCGGTTTCTGGTCACAGGGGACGACCAAGGCCCTCCCCGAAGGGCCCGGCGAA
AAACGCGCCGACCTGATCGAGATCGGGGCCATGGAACGCTTCGGGAAGCTTGATCTTCCC
AAGGTGGCGTTCCGCCACGACCAGCACACCACCGCCGTGACGGGCATGGGCAAGGACTGC
GCCGCCTGTCACAAGAGCAAGGACGGCAAGATGTCGCTGAAGTTCATGCGGCTTGACGAC
AACAGCGCCGCTGAACTCAAGGAAATCTACCACGCCAACTGTATCGGCTGTCATACCGAC
CTCGCCAAGGCCGGTAAGAAGACCGGCCCGCAGGACGGCGAATGCCGCTCGTGCCACAAC
CCGAAGCCCTCTGCCGCCTCGTCGTGGAAGGAGATAGGCTTCGACAAGTCGCTGCACTAC
CGTCACGTGGCGTCCAAGGCCATCAAGCCCGTGGGCGACCCGCAGAAGAACTGCGGCGCT
TGCCACCACGTCTATGACGAAGCTTCCAAGAAGCTCGTATGGGGTAAGAACAAGGAAGAC
TCGTGCCGCGCCTGTCACGGCGAGAAGCCCGTGGACAAGCGTCCCGCGCTCGACACCGCC
GCCCACACCGCGTGCATCAGCTGCCACATGGACGTCGCCAAGACCAAGGCCGAGACCGGC
CCGGTCAACTGCGCCGGCTGCCACGCCCCCGAGGCGCAGGCCAAGTTCAAGGTGGTACGC
GAAGTGCCCCGCCTCGACCGCGGTCAGCCCGACGCCGCCCTCATCCTGCCCGTACCCGGC
AAGGATGCCCCGCGCGAGATGAAGGGCACCATGAAGCCGGTCGCCTTCGACCACAAGGCC
CACGAAGCCAAGGCCAACGACTGCCGCACCTGCCACCATGTGCGCATCGACACCTGCACC
GCCTGCCATACCGTGAACGGTACCGCAGACAGCAAGTTCGTCCAGCTTGAAAAGGCCATG
CACCAGCCCGACTCCATGCGCAGCTGCGTGGGTTGTCACAACACCCGCGTCCAGCAGCCC
ACCTGTGCCGGTTGCCACGGCTTCATCAAGCCCACGAAGAGCGATGCCCAGTGCGGCGTG
TGCCACGTGGCCGCCCCCGGCTTCGACGCCAAGCAGGTCGAAGCGGGCGCATTGCTGAAC
CTCAAGGCAGAGCAGCGTTCGCAGGTTGCCGCCTCCATGCTGTCGGCCCGTCCGCAGCCC
AAGGGCACCTTCGACCTCAATGACATCCCCGAAAAGGTCGTCATCGGCTCCATCGCCAAG
GAATACCAGCCCAGCGAGTTCCCGCACCGCAAGATCGTGAAGACGCTCATCGCCGGTATC
GGTGAAGACAAGCTGGCCGCCACCTTCCACATCGAGAAGGGCACGCTGTGCCAGGGCTGC
CACCACAACAGCCCCGCCAGCCTCACCCCGCCCAAATGCGCGAGCTGCCACGGCAAGCCC
TTCGACGCCGACAGGGGCGACCGTCCCGGTCTCAAGGCCGCCTACCACCAGCAGTGCATG
GGCTGCCACGACCGGATGAAGATCGAAAAGCCGGCGAACACCGCCTGCGTCGATTGCCAC
AAGGAACGCGCGAAATAG

# Drug_Target_89_General_Function:
Involved in iron ion binding

# Drug_Target_89_General_References:
12356749	Matias PM, Coelho AV, Valente FM, Placido D, LeGall J, Xavier AV, Pereira IA, Carrondo MA: Sulfate respiration in Desulfovibrio vulgaris Hildenborough. Structure of the 16-heme cytochrome c HmcA AT 2.5-A resolution and a view of its role in transmembrane electron transfer. J Biol Chem. 2002 Dec 6;277(49):47907-16. Epub 2002 Sep 27.
1313289	Bruschi M, Bertrand P, More C, Leroy G, Bonicel J, Haladjian J, Chottard G, Pollock WB, Voordouw G: Biochemical and spectroscopic characterization of the high molecular weight cytochrome c from Desulfovibrio vulgaris Hildenborough expressed in Desulfovibrio desulfuricans G200. Biochemistry. 1992 Mar 31;31(12):3281-8.
1846136	Pollock WB, Loutfi M, Bruschi M, Rapp-Giles BJ, Wall JD, Voordouw G: Cloning, sequencing, and expression of the gene encoding the high-molecular-weight cytochrome c from Desulfovibrio vulgaris Hildenborough. J Bacteriol. 1991 Jan;173(1):220-8.
2163671	Tan JA, Cowan JA: Coordination and redox properties of a novel triheme cytochrome from Desulfovibrio vulgaris (Hildenborough). Biochemistry. 1990 May 22;29(20):4886-92.
7925451	Verhagen MF, Pierik AJ, Wolbert RB, Mallee LF, Voorhorst WG, Hagen WR: Axial coordination and reduction potentials of the sixteen hemes in high-molecular-mass cytochrome c from Desulfovibrio vulgaris (Hildenborough). Eur J Biochem. 1994 Oct 1;225(1):311-9.
8335628	Rossi M, Pollock WB, Reij MW, Keon RG, Fu R, Voordouw G: The hmc operon of Desulfovibrio vulgaris subsp. vulgaris Hildenborough encodes a potential transmembrane redox protein complex. J Bacteriol. 1993 Aug;175(15):4699-711.

# Drug_Target_89_HGNC_ID:
Not Available

# Drug_Target_89_HPRD_ID:
Not Available

# Drug_Target_89_ID:
3189

# Drug_Target_89_Locus:
Not Available

# Drug_Target_89_Molecular_Weight:
58902

# Drug_Target_89_Name:
High-molecular-weight cytochrome c

# Drug_Target_89_Number_of_Residues:
545

# Drug_Target_89_PDB_ID:
1GWS

# Drug_Target_89_Pathway:
Not Available

# Drug_Target_89_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02085	Cytochrom_CIII

# Drug_Target_89_Protein_Sequence:
>High-molecular-weight cytochrome c precursor
MRNGRTLLRWAGVLAATAIIGVGGFWSQGTTKALPEGPGEKRADLIEIGAMERFGKLDLP
KVAFRHDQHTTAVTGMGKDCAACHKSKDGKMSLKFMRLDDNSAAELKEIYHANCIGCHTD
LAKAGKKTGPQDGECRSCHNPKPSAASSWKEIGFDKSLHYRHVASKAIKPVGDPQKNCGA
CHHVYDEASKKLVWGKNKEDSCRACHGEKPVDKRPALDTAAHTACISCHMDVAKTKAETG
PVNCAGCHAPEAQAKFKVVREVPRLDRGQPDAALILPVPGKDAPREMKGTMKPVAFDHKA
HEAKANDCRTCHHVRIDTCTACHTVNGTADSKFVQLEKAMHQPDSMRSCVGCHNTRVQQP
TCAGCHGFIKPTKSDAQCGVCHVAAPGFDAKQVEAGALLNLKAEQRSQVAASMLSARPQP
KGTFDLNDIPEKVVIGSIAKEYQPSEFPHRKIVKTLIAGIGEDKLAATFHIEKGTLCQGC
HHNSPASLTPPKCASCHGKPFDADRGDRPGLKAAYHQQCMGCHDRMKIEKPANTACVDCH
KERAK

# Drug_Target_89_Reaction:
Not Available

# Drug_Target_89_Signals:
1-31

# Drug_Target_89_Specific_Function:
HMWC (high-molecular-weight cytochrome c), ORF2, ORF3, ORF4, ORF5 and ORF6 in the HMC operon form a transmembrane protein complex that allows electron flow from the periplasmic hydrogenase to the cytoplasmic enzymes that catalyze reduction of sulfates

# Drug_Target_89_SwissProt_ID:
P24092

# Drug_Target_89_SwissProt_Name:
HMWC_DESVH

# Drug_Target_89_Synonyms:
Cytochrome CC3
High-molecular-weight cytochrome c precursor

# Drug_Target_89_Theoretical_pI:
8.67

# Drug_Target_89_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
Not Available

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
Not Available

# Drug_Target_8_Gene_Sequence:
Not Available

# Drug_Target_8_General_Function:
Involved in iron ion binding

# Drug_Target_8_General_References:
2823792	Ambler RP, Meyer TE, Cusanovich MA, Kamen MD: The amino acid sequence of the cytochrome c2 from the phototrophic bacterium Rhodopseudomonas globiformis. Biochem J. 1987 Aug 15;246(1):115-20.
8809072	Benning MM, Meyer TE, Holden HM: Molecular structure of a high potential cytochrome c2 isolated from Rhodopila globiformis. Arch Biochem Biophys. 1996 Sep 15;333(2):338-48.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4905

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
11610

# Drug_Target_8_Name:
Cytochrome c2

# Drug_Target_8_Number_of_Residues:
106

# Drug_Target_8_PDB_ID:
1HRO

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_8_Protein_Sequence:
>Cytochrome c2
GSAPPGDPVEGKHLFHTICILCHTDIKGRNKVGPSLYGVVGRHSGIEPGYNYSEANIKSG
IVWTPDVLFKYIEHPQKIVPGTKMGYPGQPDPQKRADIIAYLETLK

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
P00080

# Drug_Target_8_SwissProt_Name:
CYC2_RHOGL

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
8.68

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_90_Cellular_Location:
Not Available

# Drug_Target_90_Chromosome_Location:
Not Available

# Drug_Target_90_Drug_References:
Not Available

# Drug_Target_90_Essentiality:
Non-Essential

# Drug_Target_90_GenAtlas_ID:
Not Available

# Drug_Target_90_GenBank_ID_Gene:
M83692

# Drug_Target_90_GenBank_ID_Protein:
Not Available

# Drug_Target_90_GeneCard_ID:
Not Available

# Drug_Target_90_Gene_Name:
bfr

# Drug_Target_90_Gene_Sequence:
>471 bp
ATGAAAGGCGATAAGATAGTCATCCAACACCTCAACAAGATCCTCGGTAACGAGTTGATC
GCGATCAACCAGTACTTCCTACATGCACGCATGTATGAAGACTGGGGGCTGGAGAAACTC
GGCAAGCATGAGTATCACGAATCCATCGATGAGATGAAGCATGCCGACAAATTGATCAAG
CGTATTCTGTTTCTCGAGGGCCTGCCCAACCTCCAGGAGCTCGGCAAGCTTCTCATCGGT
GAACACACTAAGGAAATGCTCGAGTGTGATCTGAAACTTGAGCAAGCAGGGTTGCCCGAC
CTGAAGGCCGCCATTGCCTACTGCGAAAGCGTTGGGGACTATGCCAGCCGCGAATTGCTA
GAAGACATCCTTGAATCCGAAGAAGACCATATCGATTGGCTGGAAACCCAGCTGGACTTG
ATCGATAAGATCGGCCTGGAAAATTATCTGCAATCGCAAATGGATGAGTAA

# Drug_Target_90_General_Function:
Involved in binding

# Drug_Target_90_General_References:
1549605	Grossman MJ, Hinton SM, Minak-Bernero V, Slaughter C, Stiefel EI: Unification of the ferritin family of proteins. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2419-23.
1904771	Andrews SC, Findlay JB, Guest JR, Harrison PM, Keen JN, Smith JM: Physical, chemical and immunological properties of the bacterioferritins of Escherichia coli, Pseudomonas aeruginosa and Azotobacter vinelandii. Biochim Biophys Acta. 1991 May 30;1078(1):111-6.

# Drug_Target_90_HGNC_ID:
Not Available

# Drug_Target_90_HPRD_ID:
Not Available

# Drug_Target_90_ID:
4965

# Drug_Target_90_Locus:
Not Available

# Drug_Target_90_Molecular_Weight:
18105

# Drug_Target_90_Name:
Bacterioferritin

# Drug_Target_90_Number_of_Residues:
156

# Drug_Target_90_PDB_ID:
1SOF

# Drug_Target_90_Pathway:
Not Available

# Drug_Target_90_Pfam_Domain_Function:
PF00210	Ferritin

# Drug_Target_90_Protein_Sequence:
>Bacterioferritin
MKGDKIVIQHLNKILGNELIAINQYFLHARMYEDWGLEKLGKHEYHESIDEMKHADKLIK
RILFLEGLPNLQELGKLLIGEHTKEMLECDLKLEQAGLPDLKAAIAYCESVGDYASRELL
EDILESEEDHIDWLETQLDLIDKIGLENYLQSQMDE

# Drug_Target_90_Reaction:
Not Available

# Drug_Target_90_Signals:
None

# Drug_Target_90_Specific_Function:
May perform analogous functions in iron detoxification and storage to that of animal ferritins

# Drug_Target_90_SwissProt_ID:
P22759

# Drug_Target_90_SwissProt_Name:
BFR_AZOVI

# Drug_Target_90_Synonyms:
BFR
Cytochrome b-557.5

# Drug_Target_90_Theoretical_pI:
4.35

# Drug_Target_90_Transmembrane_Regions:
None

# Drug_Target_91_Cellular_Location:
Periplasm

# Drug_Target_91_Chromosome_Location:
Not Available

# Drug_Target_91_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_91_Essentiality:
Non-Essential

# Drug_Target_91_GenAtlas_ID:
Not Available

# Drug_Target_91_GenBank_ID_Gene:
U75413

# Drug_Target_91_GenBank_ID_Protein:
1654415

# Drug_Target_91_GeneCard_ID:
Not Available

# Drug_Target_91_Gene_Name:
nirS

# Drug_Target_91_Gene_Sequence:
>1791 bp
ATGAGACAAAGGACTCCATTCGCCAGACCCGGCCTCCTGGCCTCGGCAGCCCTGGCCCTT
GTCCTTGGACCGCTTGCGGCCGCGGCACAGGAACAGGTCGCCCCGCCAAAGGATCCAGCC
GCCGCGCTGGAGGACCACAAGACGCGCACCGACAATCGCTATGAGCCCTCGCTGGACAAC
CTTGCGCAGCAGGATGTCGCGGCTCCCGGGGCCCCCGAGGGTGTCACGGCCCTGTCCGAT
GCCCAATACAACGAGGCCAACAAGATCTATTTCGAACGCTGCGCCGGCTGCCACGGCGTG
TTGCGCAAAGGCGCGACCGGCAAGGCGCTGACCCCTGACCTGACCCGCGATCTGGGCTTT
GACTACCTGCAAAGCTTCATCACCTACGCCTCGCCGGCGGGGATGCCGAACTGGGGCACC
TCGGGCGAGTTGTCGGCCGAGCAGGTCGACCTGATGGCCAACTACCTGCTTCTGGACCCG
GCCGCGCCGCCGGAATTCGGCATGAAGGAGATGCGCGAATCCTGGAAGGTGCATGTCGCG
CCGGAAGACCGGCCGACCCAGCAGGAAAACGACTGGGATCTGGAAAACCTGTTCAGCGTC
ACCCTGCGCGACGCCGGCCAGATCGCGCTGATCGACGGCACCACCTATGAGATCAAGTCG
GTCCTCGACACCGGCTATGCGGTCCATATCAGCCGGCTGTCCGCATCGGGCCGCTACCTG
TTCGTGATCGGCCGCGACGGCAAGGTCAACATGATCGACCTGTGGATGAAGGAGCCCACC
ACCGTTGCCGAGATCAAGATCGGCTCGGAGGCGCGTTCCATCGAGACCTCGAAGATGGAG
GGCTGGGAGGACAAATACGCCATCGCCGGGGCCTATTGGCCGCCGCAATACGTCATCATG
GACGGCGAGACGCTGGAGCCGAAAAAGATCCAGTCCACGCGCGGCATGACCTATGACGAG
CAGGAATATCACCCCGAGCCGCGCGTCGCCGCGATCCTCGCCAGCCATTACCGGCCCGAG
TTCATCGTGAACGTCAAGGAAACGGGCAAGATCCTGCTGGTCGACTATACCGACCTCGAC
AACCTCAAGACCACCGAGATCAGCGCCGAACGCTTCCTGCACGACGGCGGCCTGGACGGC
TCGCACCGCTATTTCATCACCGCGGCGAACGCCCGCAACAAGCTGGTGGTGATCGACACC
AAGGAAGGCAAGCTGGTCGCGATCGAGGATACCGGCGGCCAGACCCCGCATCCGGGCCGC
GGCGCGAACTTCGTCCACCCGACCTTCGGGCCGGTCTGGGCGACCTCGCATATGGGCGAC
GATTCGGTGGCGCTGATCGGCACCGATCCCGAGGGCCATCCCGACAATGCCTGGAAGATC
CTCGACAGCTTCCCGGCGTTGGGGGGCGGCTCGCTGTTCATCAAGACGCACCCGAACTCG
CAATATCTCTATGTCGATGCGACCCTGAACCCCGAGGCCGAGATTTCCGGCTCGGTCGCG
GTGTTCGACATCAAGGCGATGACGGGCGACGGTTCGGACCCCGAGTTCAAGACCCTGCCC
ATCGCCGAATGGGCCGGCATCACCGAAGGCCAGCCCCGCGTCGTGCAGGGCGAGTTCAAC
AAGGACGGCACCGAGGTCTGGTTCAGCGTCTGGAACGGCAAGGACCAGGAATCGGCGCTG
GTCGTGGTGGACGACAAGACGCTGGAACTTAAGCACGTCATCAAGGACGAGCGGCTGGTG
ACGCCCACCGGCAAGTTCAACGTCTACAACACCATGACCGACACCTATTGA

# Drug_Target_91_General_Function:
Energy production and conversion

# Drug_Target_91_General_References:
10708389	Saunders NF, Ferguson SJ, Baker SC: Transcriptional analysis of the nirS gene, encoding cytochrome cd1 nitrite reductase, of Paracoccus pantotrophus LMD 92.63. Microbiology. 2000 Feb;146 ( Pt 2):509-16.
10827177	Jafferji A, Allen JW, Ferguson SJ, Fulop V: X-ray crystallographic study of cyanide binding provides insights into the structure-function relationship for cytochrome cd1 nitrite reductase from Paracoccus pantotrophus. J Biol Chem. 2000 Aug 18;275(33):25089-94.
10998233	Sjogren T, Svensson-Ek M, Hajdu J, Brzezinski P: Proton-coupled structural changes upon binding of carbon monoxide to cytochrome cd1: a combined flash photolysis and X-ray crystallography study. Biochemistry. 2000 Sep 12;39(36):10967-74.
11237728	Gordon EH, Steensma E, Ferguson SJ: The cytochrome c domain of dimeric cytochrome cd(1) of Paracoccus pantotrophus can be produced at high levels as a monomeric holoprotein using an improved c-type cytochrome expression system in Escherichia coli. Biochem Biophys Res Commun. 2001 Mar 2;281(3):788-94.
11278884	Sjogren T, Hajdu J: Structure of the bound dioxygen species in the cytochrome oxidase reaction of cytochrome cd1 nitrite reductase. J Biol Chem. 2001 Apr 20;276(16):13072-6. Epub 2001 Jan 26.
11373294	Sjogren T, Hajdu J: The Structure of an alternative form of Paracoccus pantotrophus cytochrome cd(1) nitrite reductase. J Biol Chem. 2001 Aug 3;276(31):29450-5. Epub 2001 May 23.
7736589	Fulop V, Moir JW, Ferguson SJ, Hajdu J: The anatomy of a bifunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell. 1995 May 5;81(3):369-77.
9199411	Baker SC, Saunders NF, Willis AC, Ferguson SJ, Hajdu J, Fulop V: Cytochrome cd1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to beta-propeller folds. J Mol Biol. 1997 Jun 13;269(3):440-55.
9311786	Williams PA, Fulop V, Garman EF, Saunders NF, Ferguson SJ, Hajdu J: Haem-ligand switching during catalysis in crystals of a nitrogen-cycle enzyme. Nature. 1997 Sep 25;389(6649):406-12.

# Drug_Target_91_HGNC_ID:
Not Available

# Drug_Target_91_HPRD_ID:
Not Available

# Drug_Target_91_ID:
3284

# Drug_Target_91_Locus:
Not Available

# Drug_Target_91_Molecular_Weight:
65384

# Drug_Target_91_Name:
Nitrite reductase

# Drug_Target_91_Number_of_Residues:
596

# Drug_Target_91_PDB_ID:
1HCM

# Drug_Target_91_Pathway:
Not Available

# Drug_Target_91_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_91_Protein_Sequence:
>Nitrite reductase precursor
MRQRTPFARPGLLASAALALVLGPLAASAQEQVAPPKDPAAALEDHKTRTDNRYEPSLDN
LAQQDVAAPGAPEGVSALSDAQYNEANKIYFERCAGCHGVLRKGATGKALTPDLTRDLGF
DYLQSFITYGSPAGMPNWGTSGELSAEQVDLMANYLLLDPAAPPEFGMKEMRESWKVHVA
PEDRPTQQENDWDLENLFSVTLRDAGQIALIDGATYEIKSVLDTGYAVHISRLSASGRYL
FVIGRDGKVNMIDLWMKEPTTVAEIKIGSEARSIETSKMEGWEDKYAIAGAYWPPQYVIM
DGETLEPKKIQSTRGMTYDEQEYHPEPRVAAILASHYRPEFIVNVKETGKILLVDYTDLD
NLKTTEISAERFLHDGGLDGSHRYFITAANARNKLVVIDTKEGKLVAIEDTGGQTPHPGR
GANFVHPTFGPVWATSHMGDDSVALIGTDPEGHPDNAWKILDSFPALGGGSLFIKTHPNS
QYLYVDATLNPEAEISGSVAVFDIKAMTGDGSDPEFKTLPIAEWAGITEGQPRVVQGEFN
KDGTEVWFSVWNGKDQESALVVVDDKTLELKHVIKDERLVTPTGKFNVYNTMTDTY

# Drug_Target_91_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_91_Signals:
1-29

# Drug_Target_91_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_91_SwissProt_ID:
P72181

# Drug_Target_91_SwissProt_Name:
NIRS_PARPN

# Drug_Target_91_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_91_Theoretical_pI:
4.59

# Drug_Target_91_Transmembrane_Regions:
None

# Drug_Target_92_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_92_Chromosome_Location:
Not Available

# Drug_Target_92_Drug_References:
Not Available

# Drug_Target_92_Essentiality:
Non-Essential

# Drug_Target_92_GenAtlas_ID:
CYP2C9

# Drug_Target_92_GenBank_ID_Gene:
AY341248

# Drug_Target_92_GenBank_ID_Protein:
Not Available

# Drug_Target_92_GeneCard_ID:
Not Available

# Drug_Target_92_Gene_Name:
CYP2C9

# Drug_Target_92_Gene_Sequence:
>1473 bp
ATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG
AGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA
AATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC
TATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT
GAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC
CCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG
AAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC
ATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG
GCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC
ATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG
TTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT
CCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG
AAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT
CAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT
GAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG
ACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA
GCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA
GACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC
CTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC
ATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA
TTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG
AAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG
GCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT
CTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG
CCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA

# Drug_Target_92_General_Function:
Involved in monooxygenase activity

# Drug_Target_92_General_References:
1445376	Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T: Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int. 1992 Sep;27(6):1073-81.
1857342	Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP: Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol. 1991 Jul;40(1):69-79.
2827463	Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet. 1988 Jan;42(1):26-37.
2963808	Yasumori T, Kawano S, Nagata K, Shimada M, Yamazoe Y, Kato R: Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem. 1987 Nov;102(5):1075-82.
3032244	Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094-9.
3079764	Shimada T, Misono KS, Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909-21.
3196692	Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40.
3243766	Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6.
3697070	Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4.

# Drug_Target_92_HGNC_ID:
HGNC:2623

# Drug_Target_92_HPRD_ID:
Not Available

# Drug_Target_92_ID:
4757

# Drug_Target_92_Locus:
10q24

# Drug_Target_92_Molecular_Weight:
55629

# Drug_Target_92_Name:
Cytochrome P450 2C9

# Drug_Target_92_Number_of_Residues:
490

# Drug_Target_92_PDB_ID:
1R9O

# Drug_Target_92_Pathway:
Clopidogrel Pathway	SMP00260
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_92_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_92_Protein_Sequence:
>Cytochrome P450 2C9
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV
YGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW
KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS
IIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM
KSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE
TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID
LLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK
KSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP
PFYQLCFIPV

# Drug_Target_92_Reaction:
Not Available

# Drug_Target_92_Signals:
None

# Drug_Target_92_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S- warfarin, diclofenac, phenytoin, tolbutamide and losartan

# Drug_Target_92_SwissProt_ID:
P11712

# Drug_Target_92_SwissProt_Name:
CP2C9_HUMAN

# Drug_Target_92_Synonyms:
(R)-limonene 6-monooxygenase
(S)- limonene 7-monooxygenase
(S)-limonene 6-monooxygenase
CYPIIC9
EC 1.14.13.48
EC 1.14.13.49
EC 1.14.13.80
P-450MP
P450 MP-4/MP-8
P450 PB-1
S- mephenytoin 4-hydroxylase

# Drug_Target_92_Theoretical_pI:
7.99

# Drug_Target_92_Transmembrane_Regions:
None

# Drug_Target_93_Cellular_Location:
Cytoplasm

# Drug_Target_93_Chromosome_Location:
Not Available

# Drug_Target_93_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_93_Essentiality:
Non-Essential

# Drug_Target_93_GenAtlas_ID:
Not Available

# Drug_Target_93_GenBank_ID_Gene:
X74334

# Drug_Target_93_GenBank_ID_Protein:
460999

# Drug_Target_93_GeneCard_ID:
Not Available

# Drug_Target_93_Gene_Name:
hmp

# Drug_Target_93_Gene_Sequence:
>1212 bp
ATGCTGACCCAGAAAACAAAAGACATCGTAAAGGCCACCGCACCGGTGCTGGCCGAACAC
GGCTACGACATCATCAAGTGCTTCTATCAGCGCATGTTCGAAGCGCATCCCGAACTGAAG
AATGTGTTCAACATGGCCCACCAGGAACAGGGCCAGCAGCAGCAGGCGCTGGCACGGGCG
GTCTATGCCTATGCGGAGAATATCGAGGACCCAAACAGTCTGATGGCCGTCCTGAAGAAC
ATCGCCAACAAGCATGCAAGTCTCGGCGTCAAACCGGAACAGTACCCCATTGTTGGAGAA
CACCTACTGGCCGCCATCAAGGAAGTGTTGGGCAATGCCGCAACCGACGACATCATTTCC
GCTTGGGCGCAAGCCTACGGGAATCTGGCCGATGTCCTGATGGGCATGGAGAGCGAGTTG
TATGAGCGCTCTGCGGAACAACCCGGTGGCTGGAAGGGGTGGCGCACCTTTGTGATTCGT
GAGAAGCGCCCCGAGAGCGATGTGATCACGTCATTCATCCTTGAGCCTGCCGATGGTGGT
CCCGTGGTGAACTTCGAACCCGGACAATACACCAGCGTCGCAATCGATGTGCCCGCGCTC
GGGTTGCAGCAGATTCGCCAATACAGCCTGTCGGATATGCCGAACGGGCGCACGTATCGC
ATCTCGGTGAAGCGCGAGGGCGGCGGGCCGCAGCCTCCGGGCTATGTTTCGAACCTGTTG
CATGATCACGTGAATGTTGGGGATCAGGTCAAGCTGGCTGCGCCCTATGGAAGCTTCCAT
ATCGACGTTGACGCCAAGACACCCATTGTCCTGATCAGCGGTGGCGTTGGGCTGACACCG
ATGGTCAGCATGCTCAAAGTGGCATTGCAGGCCCCACCGAGGCAAGTTGTATTCGTGCAT
GGCGCACGTAACAGCGCAGTACACGCGATGCGCGACAGGCTGCGCGAAGCGGCGAAGACC
TATGAAAACCTTGACCTCTTTGTTTTCTATGACCAACCGCTACCGGAAGATGTCCAGGGA
CGGGACTATGATTATCCGGGCTTAGTCGATGTGAAGCAGATCGAGAAATCGATCCTGCTG
CCAGACGCCGACTACTACATCTGCGGTCCGATTCCGTTCATGCGAATGCAGCATGATGCC
CTGAAGAATCTCGGCATTCATGAGGCACGCATTCATTACGAAGTGTTTGGTCCCGACCTG
TTTGCTGAGTAG

# Drug_Target_93_General_Function:
Energy production and conversion

# Drug_Target_93_General_References:
10336624	Ollesch G, Kaunzinger A, Juchelka D, Schubert-Zsilavecz M, Ermler U: Phospholipid bound to the flavohemoprotein from Alcaligenes eutrophus. Eur J Biochem. 1999 Jun;262(2):396-405.
12948488	Schwartz E, Henne A, Cramm R, Eitinger T, Friedrich B, Gottschalk G: Complete nucleotide sequence of pHG1: a Ralstonia eutropha H16 megaplasmid encoding key enzymes of H(2)-based ithoautotrophy and anaerobiosis. J Mol Biol. 2003 Sep 12;332(2):369-83.
1594608	Zhu H, Riggs AF: Yeast flavohemoglobin is an ancient protein related to globins and a reductase family. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5015-9.
8125952	Cramm R, Siddiqui RA, Friedrich B: Primary sequence and evidence for a physiological function of the flavohemoprotein of Alcaligenes eutrophus. J Biol Chem. 1994 Mar 11;269(10):7349-54.
8557026	Ermler U, Siddiqui RA, Cramm R, Friedrich B: Crystal structure of the flavohemoglobin from Alcaligenes eutrophus at 1.75 A resolution. EMBO J. 1995 Dec 15;14(24):6067-77.

# Drug_Target_93_HGNC_ID:
Not Available

# Drug_Target_93_HPRD_ID:
Not Available

# Drug_Target_93_ID:
3102

# Drug_Target_93_Locus:
Not Available

# Drug_Target_93_Molecular_Weight:
44783

# Drug_Target_93_Name:
Flavohemoprotein

# Drug_Target_93_Number_of_Residues:
403

# Drug_Target_93_PDB_ID:
1CQX

# Drug_Target_93_Pathway:
Not Available

# Drug_Target_93_Pfam_Domain_Function:
PF00042	Globin
PF00175	NAD_binding_1
PF00970	FAD_binding_6

# Drug_Target_93_Protein_Sequence:
>Flavohemoprotein
MLTQKTKDIVKATAPVLAEHGYDIIKCFYQRMFEAHPELKNVFNMAHQEQGQQQQALARA
VYAYAENIEDPNSLMAVLKNIANKHASLGVKPEQYPIVGEHLLAAIKEVLGNAATDDIIS
AWAQAYGNLADVLMGMESELYERSAEQPGGWKGWRTFVIREKRPESDVITSFILEPADGG
PVVNFEPGQYTSVAIDVPALGLQQIRQYSLSDMPNGRSYRISVKREGGGPQPPGYVSNLL
HDHVNVGDQVKLAAPYGSFHIDVDAKTPIVLISGGVGLTPMVSMLKVALQAPPRQVVFVH
GARNSAVHAMRDRLREAAKTYENLDLFVFYDQPLPEDVQGRDYDYPGLVDVKQIEKSILL
PDADYYICGPIPFMRMQHDALKNLGIHEARIHYEVFGPDLFAE

# Drug_Target_93_Reaction:
2 nitric oxide + 2 O2 + NAD(P)H = 2 nitrate + NAD(P)+ + H+

# Drug_Target_93_Signals:
None

# Drug_Target_93_Specific_Function:
In the presence of oxygen and NADH, FHP has NADH oxidase activity, which leads to the generation of superoxide and H(2)O(2), both in vitro and in vivo, and it has been suggested that FHP might act as an amplifier of superoxide stress. Under anaerobic conditions, FHP also exhibits nitric oxide reductase and FAD reductase activities. However, all these reactions are much lower than NOD activity

# Drug_Target_93_SwissProt_ID:
P39662

# Drug_Target_93_SwissProt_Name:
HMP_CUPNH

# Drug_Target_93_Synonyms:
EC 1.14.12.17
FHP
Flavohemoglobin
Hemoglobin-like protein
NO oxygenase
NOD
Nitric oxide dioxygenase

# Drug_Target_93_Theoretical_pI:
5.57

# Drug_Target_93_Transmembrane_Regions:
None

# Drug_Target_94_Cellular_Location:
Not Available

# Drug_Target_94_Chromosome_Location:
Not Available

# Drug_Target_94_Drug_References:
Not Available

# Drug_Target_94_Essentiality:
Non-Essential

# Drug_Target_94_GenAtlas_ID:
Not Available

# Drug_Target_94_GenBank_ID_Gene:
BX572600

# Drug_Target_94_GenBank_ID_Protein:
Not Available

# Drug_Target_94_GeneCard_ID:
Not Available

# Drug_Target_94_Gene_Name:
cycA

# Drug_Target_94_Gene_Sequence:
>441 bp
ATGAAATTGAGAATTGCTACTATCGCCGGGCTGGTTGTGCTGGGCAGCGGCTTCGCGGTC
GCGCAGACCGACGTGATTGCGCAGCGCAAGGCGATCCTGAAGCAGATGGGCGAGGCGACC
AAGCCGATCGCCGCGATGCTGAAGGGCGAGGCGAAGTTCGACCAGGCGGTGGTGCAGAAG
TCGCTGGCCGCGATCGCCGACGACTCCAAGAAGCTGCCGGCGCTGTTCCCGGCCGACTCC
AAGACCGGTGGCGACACAGCGGCGCTGCCGAAGATTTGGGAAGACAAGGCGAAGTTCGAC
GACCTGTTCGCCAAGCTGGCCGCTGCGGCCACCGCGGCGCAGGGCACGATCAAGGATGAA
GCCTCGCTCAAGGCGAACATCGGCGGCGTGCTCGGCAACTGCAAGTCGTGCCACGACGAC
TTCCGCGCCAAGAAGAGCTAA

# Drug_Target_94_General_Function:
Involved in iron ion binding

# Drug_Target_94_General_References:
12407175	Lee JC, Engman KC, Tezcan FA, Gray HB, Winkler JR: Structural features of cytochrome c' folding intermediates revealed by fluorescence energy-transfer kinetics. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14778-82. Epub 2002 Oct 29.
6273892	Ambler RP, Bartsch RG, Daniel M, Kamen MD, McLellan L, Meyer TE, Van Beeumen J: Amino acid sequences of bacterial cytochromes c' and c-556. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6854-7.
9826513	Shibata N, Iba S, Misaki S, Meyer TE, Bartsch RG, Cusanovich MA, Morimoto Y, Higuchi Y, Yasuoka N: Basis for monomer stabilization in Rhodopseudomonas palustris cytochrome c' derived from the crystal structure. J Mol Biol. 1998 Dec 4;284(3):751-60.

# Drug_Target_94_HGNC_ID:
Not Available

# Drug_Target_94_HPRD_ID:
Not Available

# Drug_Target_94_ID:
4967

# Drug_Target_94_Locus:
Not Available

# Drug_Target_94_Molecular_Weight:
15201

# Drug_Target_94_Name:
Cytochrome c'

# Drug_Target_94_Number_of_Residues:
146

# Drug_Target_94_PDB_ID:
1A7V

# Drug_Target_94_Pathway:
Not Available

# Drug_Target_94_Pfam_Domain_Function:
PF01322	Cytochrom_C_2

# Drug_Target_94_Protein_Sequence:
>Cytochrome c'
MKLRIATIAGLVVLGSGFAVAQTDVIAQRKAILKQMGEATKPIAAMLKGEAKFDQAVVQK
SLAAIADDSKKLPALFPADSKTGGDTAALPKIWEDKAKFDDLFAKLAAAATAAQGTIKDE
ASLKANIGGVLGNCKSCHDDFRAKKS

# Drug_Target_94_Reaction:
Not Available

# Drug_Target_94_Signals:
1-21

# Drug_Target_94_Specific_Function:
Cytochrome c' is the most widely occurring bacterial c- type cytochrome. Cytochromes c' are high-spin proteins and the heme has no sixth ligand. Their exact function is not known

# Drug_Target_94_SwissProt_ID:
P00149

# Drug_Target_94_SwissProt_Name:
CYCP_RHOPA

# Drug_Target_94_Synonyms:
Cytochrome c' precursor

# Drug_Target_94_Theoretical_pI:
10.09

# Drug_Target_94_Transmembrane_Regions:
None

# Drug_Target_95_Cellular_Location:
Not Available

# Drug_Target_95_Chromosome_Location:
Not Available

# Drug_Target_95_Drug_References:
Not Available

# Drug_Target_95_Essentiality:
Non-Essential

# Drug_Target_95_GenAtlas_ID:
Not Available

# Drug_Target_95_GenBank_ID_Gene:
AF187324

# Drug_Target_95_GenBank_ID_Protein:
Not Available

# Drug_Target_95_GeneCard_ID:
Not Available

# Drug_Target_95_Gene_Name:
cytc3

# Drug_Target_95_Gene_Sequence:
>387 bp
GTGAAAAAAACTCTTGCTCTTACCTGTATGCTGGCCCTGCTTCTTGCCGTGAGCGCCTGG
GCCGCGCCTGCCGTGCCTGACAAGCCTGTCGAAGTCAAAGGCTCGCAAAAGACAGTCATG
TTCCCCCACGCTCCCCACGAAAAAGTGGAATGCGTGACCTGCCACCACCTGGTGGACGGC
AAGGAAAGCTATGCCAAATGCGGCAGCTCCGGCTGCCATGACGATCTGACCGCCAAAAAG
GGCGAAAAGAGCCTGTACTACGTCGTTCACGCCAAGGGCGAACTCAAGCATACGAGCTGC
CTTGCCTGTCACAGCAAGGTGGTGGCTGAAAAGCCCGAGCTCAAGAAAGACCTTACCGGT
TGCGCCAAGTCCAAGTGTCATCCGTAG

# Drug_Target_95_General_Function:
Involved in iron ion binding

# Drug_Target_95_General_References:
11551953	Louro RO, Bento I, Matias PM, Catarino T, Baptista AM, Soares CM, Carrondo MA, Turner DL, Xavier AV: Conformational component in the coupled transfer of multiple electrons and protons in a monomeric tetraheme cytochrome. J Biol Chem. 2001 Nov 23;276(47):44044-51. Epub 2001 Sep 10.

# Drug_Target_95_HGNC_ID:
Not Available

# Drug_Target_95_HPRD_ID:
Not Available

# Drug_Target_95_ID:
4968

# Drug_Target_95_Locus:
Not Available

# Drug_Target_95_Molecular_Weight:
13795

# Drug_Target_95_Name:
Cytochrome c3

# Drug_Target_95_Number_of_Residues:
128

# Drug_Target_95_PDB_ID:
1GMB

# Drug_Target_95_Pathway:
Not Available

# Drug_Target_95_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_95_Protein_Sequence:
>Cytochrome c3
MKKTLALTCMLALLLAVSAWAAPAVPDKPVEVKGSQKTVMFPHAPHEKVECVTCHHLVDG
KESYAKCGSSGCHDDLTAKKGEKSLYYVVHAKGELKHTSCLACHSKVVAEKPELKKDLTG
CAKSKCHP

# Drug_Target_95_Reaction:
Not Available

# Drug_Target_95_Signals:
1-21

# Drug_Target_95_Specific_Function:
Not Available

# Drug_Target_95_SwissProt_ID:
Q9L915

# Drug_Target_95_SwissProt_Name:
Q9L915_DESDE

# Drug_Target_95_Synonyms:
Cytochrome c3 precursor

# Drug_Target_95_Theoretical_pI:
8.65

# Drug_Target_95_Transmembrane_Regions:
None

# Drug_Target_96_Cellular_Location:
Cytoplasm

# Drug_Target_96_Chromosome_Location:
Not Available

# Drug_Target_96_Drug_References:
Not Available

# Drug_Target_96_Essentiality:
Non-Essential

# Drug_Target_96_GenAtlas_ID:
Not Available

# Drug_Target_96_GenBank_ID_Gene:
X58872

# Drug_Target_96_GenBank_ID_Protein:
Not Available

# Drug_Target_96_GeneCard_ID:
Not Available

# Drug_Target_96_Gene_Name:
hmp

# Drug_Target_96_Gene_Sequence:
>1191 bp
ATGCTTGACGCTCAAACCATCGCTACAGTAAAAGCCACCATCCCTTTACTGGTGGAAACG
GGGCCAAAGTTAACCGCCCATTTCTACGACCGTATGTTTACTCATAACCCAGAACTCAAA
GAAATTTTTAACATGAGTAACCAGCGTAATGGCGATCAACGTGAAGCCCTGTTTAACGCT
ATTGCCGCCTACGCCAGTAATATTGAAAACCTGCCTGCGCTGCTGCCAGCGGTAGAAAAA
ATCGCGCAGAAGCACACCAGCTTCCAGATCAAACCGGAACAGTACAACATCGTCGGTGAA
CACCTGTTGGCAACGCTGGACGAAATGTTCAGCCCGGGGCAGGAAGTGCTGGACGCGTGG
GGTAAAGCCTATGGTGTACTGGCTAATGTATTTATCAATCGCGAGGCGGAAATCTATAAC
GAAAACGCCAGCAAAGCCGGTGGTTGGGAAGGTACTCGCGATTTCCGCATTGTGGCTAAA
ACACCGCGCAGCGCGCTTATCACCAGCTTCGAACTGGAGCCGGTCGACGGTGGCGCAGTG
GCAGAATACCGTCCGGGGCAATATCTCGGCGTCTGGCTGAAGCCGGAAGGTTTCCCACAT
CAGGAAATTCGTCAGTACTCTTTGACTCGCAAACCGGATGGCAAAGGCTATCGTATTGCG
GTGAAACGCGAAGAGGGTGGGCAGGTATCCAACTGGTTGCACAATCACGCCAATGTTGGC
GATGTCGTGAAACTGGTCGCTCCGGCAGGTGATTTCTTTATGGCTGTCGCAGATGACACA
CCAGTGACGTTAATCTCTGCCGGTGTTGGTCAAACGCCAATGCTGGCAATGCTCGACACG
CTGGCAAAAGCAGGCCACACAGCACAAGTGAACTGGTTCCATGCGGCAGAAAATGGCGAT
GTTCACGCCTTTGCCGATGAAGTTAAGGAACTGGGGCAGTCACTGCCGCGCTTTACCGCG
CACACCTGGTATCGTCAGCCGAGCGAAGCCGATCGCGCTAAAGGTCAGTTTGATAGCGAA
GGTCTGATGGATTTGAGCAAACTGGAAGGTGCGTTCAGCGATCCGACAATGCAGTTCTAT
CTCTGCGGCCCGGTTGGCTTCATGCAGTTTACCGCGAAACAGTTAGTGGATCTGGGCGTG
AAGCAGGAAAACATTCATTACGAATGCTTTGGCCCGCATAAGGTGCTGTAA

# Drug_Target_96_General_Function:
Involved in oxidoreductase activity

# Drug_Target_96_General_References:
1325799	Orii Y, Ioannidis N, Poole RK: The oxygenated flavohaemoglobin from Escherichia coli: evidence from photodissociation and rapid-scan studies for two kinetic and spectral forms. Biochem Biophys Res Commun. 1992 Aug 31;187(1):94-100.
1601132	Andrews SC, Shipley D, Keen JN, Findlay JB, Harrison PM, Guest JR: The haemoglobin-like protein (HMP) of Escherichia coli has ferrisiderophore reductase activity and its C-terminal domain shares homology with ferredoxin NADP+ reductases. FEBS Lett. 1992 May 18;302(3):247-52.
2034230	Vasudevan SG, Armarego WL, Shaw DC, Lilley PE, Dixon NE, Poole RK: Isolation and nucleotide sequence of the hmp gene that encodes a haemoglobin-like protein in Escherichia coli K-12. Mol Gen Genet. 1991 Apr;226(1-2):49-58.
6190704	Plamann MD, Stauffer GV: Characterization of the Escherichia coli gene for serine hydroxymethyltransferase. Gene. 1983 Apr;22(1):9-18.
8292013	Eschenbrenner M, Coves J, Fontecave M: Ferric reductases in Escherichia coli: the contribution of the haemoglobin-like protein. Biochem Biophys Res Commun. 1994 Jan 14;198(1):127-31.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9724711	Gardner PR, Gardner AM, Martin LA, Salzman AL: Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10378-83.

# Drug_Target_96_HGNC_ID:
Not Available

# Drug_Target_96_HPRD_ID:
Not Available

# Drug_Target_96_ID:
4969

# Drug_Target_96_Locus:
Not Available

# Drug_Target_96_Molecular_Weight:
43868

# Drug_Target_96_Name:
Flavohemoprotein

# Drug_Target_96_Number_of_Residues:
396

# Drug_Target_96_PDB_ID:
1GVH

# Drug_Target_96_Pathway:
Not Available

# Drug_Target_96_Pfam_Domain_Function:
PF00042	Globin
PF00175	NAD_binding_1
PF00970	FAD_binding_6

# Drug_Target_96_Protein_Sequence:
>Flavohemoprotein
MLDAQTIATVKATIPLLVETGPKLTAHFYDRMFTHNPELKEIFNMSNQRNGDQREALFNA
IAAYASNIENLPALLPAVEKIAQKHTSFQIKPEQYNIVGEHLLATLDEMFSPGQEVLDAW
GKAYGVLANVFINREAEIYNENASKAGGWEGTRDFRIVAKTPRSALITSFELEPVDGGAV
AEYRPGQYLGVWLKPEGFPHQEIRQYSLTRKPDGKGYRIAVKREEGGQVSNWLHNHANVG
DVVKLVAPAGDFFMAVADDTPVTLISAGVGQTPMLAMLDTLAKAGHTAQVNWFHAAENGD
VHAFADEVKELGQSLPRFTAHTWYRQPSEADRAKGQFDSEGLMDLSKLEGAFSDPTMQFY
LCGPVGFMQFTAKQLVDLGVKQENIHYECFGPHKVL

# Drug_Target_96_Reaction:
Not Available

# Drug_Target_96_Signals:
None

# Drug_Target_96_Specific_Function:
Various electron acceptors are also reduced by HMP in vitro, including dihydropterine, ferrisiderophores, ferric citrate, cytochrome c, nitrite, S-nitrosoglutathione, and alkylhydroperoxides. However, it is unknown if these reactions are of any biological significance in vivo

# Drug_Target_96_SwissProt_ID:
P24232

# Drug_Target_96_SwissProt_Name:
HMP_ECOLI

# Drug_Target_96_Synonyms:
EC 1.14.12.17
Flavohemoglobin
HMP
Hemoglobin-like protein
NO oxygenase
NOD
Nitric oxide dioxygenase

# Drug_Target_96_Theoretical_pI:
5.57

# Drug_Target_96_Transmembrane_Regions:
None

# Drug_Target_97_Cellular_Location:
Not Available

# Drug_Target_97_Chromosome_Location:
Not Available

# Drug_Target_97_Drug_References:
Not Available

# Drug_Target_97_Essentiality:
Non-Essential

# Drug_Target_97_GenAtlas_ID:
Not Available

# Drug_Target_97_GenBank_ID_Gene:
AJ316232

# Drug_Target_97_GenBank_ID_Protein:
Not Available

# Drug_Target_97_GeneCard_ID:
Not Available

# Drug_Target_97_Gene_Name:
nrfA

# Drug_Target_97_Gene_Sequence:
>1542 bp
ATGAATAAGCGAATTGTGACCACGGCCCTGGCGTTGGCCACGCTGCTGGGCGTAGCTTTG
CTCAGCGGCTGTCAGGATGTTTCCACAGAGCTGAAGGCCCCCAAGTACAAAACGGGCATT
GCTGAAACGGAAACCAAGATGTCGGCCTTCAAGGGCCAGTTTCCGCAGCAGTATGCTTCG
TACATGAAAAATAACGAAGACAGGATCATGACCGACTATAAAGGCTCGGTTCCCTACCAC
AAGAATGACAATGTGAATCCCCTGCCCAAGGGCTTCAAACATGCCCAGCCCTACCTGAAA
AACCTCTGGCTGGGCTATCCGTTCATGTATGAATATAATGAAACGCGCGGCCACACCTAT
GCCATTGACGACTTCCTGAATATTGACCGCATCAACCGTTTCGCGGCCGACGGTAAGGGC
AACCTGCCAGCCACCTGCTGGAACTGCAAAACCCCCAAAATGATGGAATGGGTGTCCCAG
TACGGCGACAAGTTCTGGTCTATGGATGTCAACGAGTTCCGCGCCAAAGACAAGATCAAC
GCGCATGATGAAACCATCGGCTGCGCCAACTGTCACGATCCGGCCACTATGGAACTGCGC
CTCTACTCCGAACCGCTCAAGGACTGGCTCAAGCGCAGCGGCAAGGACTGGCAGAAGATG
AGCCGCAACGAAAAGCGCACCCTGGTCTGCGCCCAGTGCCACGTGGAATACTATTTTACC
CACAAGGACAACGGCCCGGCCGCAAAGCCCGTATTCCCCTGGGATAACGGCTTCAACCCC
GAAGACATGTACCAGTATTACAAGGGTCACGGAGCCAAGGGCCCCGACGGCAAGCCCGGT
CCCTTTGTGGACTGGGTACACGCTGCCTCCAAGGTTCCCATGATCAAGATGCAGCACCCC
GAATACGAAACCTTCCAGGATGGTCCCCACGGCGCGGCCGGCGTTTCCTGCGCGGACTGC
CACATGCAGTACGTGCGTGAAGACGGCAAAAAGATCTCCAGCCACTGGATGACCTCGCCC
ATGAAGGATCCTGAAATGCGCGCCTGCCGCCAATGCCACGCCGACAAGACCGGCGAATAC
CTGCGCCAGCGCGTGCTGTACACCCAGCAGAAGACCTTTGACCAGCTGCTCAAGGCTCAG
GAAATGTCCGTCAAGGCTCACGAGGCCGTGCGGCTTGCCAATGCCTATGAAGGCCACCGC
GCCGCCAACTACGAAGCCCTTATGGCCGAAGCACGCGAAATGGTACGCAAGGGCCAGCTG
TTCTGGGACTACGTTTCAGCTGAAAACAGCGTGGGCTTCCACAACCCGGCCAAGGCTCTT
GATACGCTCATGACCAGTATGGAGTGCAGCCAGAAGGCCGTTGACCTGGCCACCGAGGCC
ACTGACTTCGGCATCGCCCCCGCCCTTGCCGGAGACATCAAGAAGCTGGTTCCGCCCATT
CTTACGCTGAGCCGCAAGCTCCAGCAGGACCCGGAATTCCTCAAGCAGAACCCCTGGACC
AGACTGCTGCCCGCTCTGCCCAAGGCCGAGCAAGTCTGGGAG

# Drug_Target_97_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_97_General_References:
12618432	Cunha CA, Macieira S, Dias JM, Almeida G, Goncalves LL, Costa C, Lampreia J, Huber R, Moura JJ, Moura I, Romao MJ: Cytochrome c nitrite reductase from Desulfovibrio desulfuricans ATCC 27774. The relevance of the two calcium sites in the structure of the catalytic subunit (NrfA). J Biol Chem. 2003 May 9;278(19):17455-65. Epub 2003 Mar 4.

# Drug_Target_97_HGNC_ID:
Not Available

# Drug_Target_97_HPRD_ID:
Not Available

# Drug_Target_97_ID:
4970

# Drug_Target_97_Locus:
Not Available

# Drug_Target_97_Molecular_Weight:
58621

# Drug_Target_97_Name:
Cytochrome c nitrite reductase catalytic subunit

# Drug_Target_97_Number_of_Residues:
514

# Drug_Target_97_PDB_ID:
1OAH

# Drug_Target_97_Pathway:
Not Available

# Drug_Target_97_Pfam_Domain_Function:
PF02335	Cytochrom_C552

# Drug_Target_97_Protein_Sequence:
>Cytochrome c nitrite reductase catalytic subunit
MNKRIVTTALALATLLGVALLSGCQDVSTELKAPKYKTGIAETETKMSAFKGQFPQQYAS
YMKNNEDRIMTDYKGSVPYHKNDNVNPLPKGFKHAQPYLKNLWLGYPFMYEYNETRGHTY
AIDDFLNIDRINRFAADGKGNLPATCWNCKTPKMMEWVSQYGDKFWSMDVNEFRAKDKIN
AHDETIGCANCHDPATMELRLYSEPLKDWLKRSGKDWQKMSRNEKRTLVCAQCHVEYYFT
HKDNGPAAKPVFPWDNGFNPEDMYQYYKGHGAKGPDGKPGPFVDWVHAASKVPMIKMQHP
EYETFQDGPHGAAGVSCADCHMQYVREDGKKISSHWMTSPMKDPEMRACRQCHADKTGEY
LRQRVLYTQQKTFDQLLKAQEMSVKAHEAVRLANAYEGHRAANYEALMAEAREMVRKGQL
FWDYVSAENSVGFHNPAKALDTLMTSMECSQKAVDLATEATDFGIAPALAGDIKKLVPPI
LTLSRKLQQDPEFLKQNPWTRLLPALPKAEQVWE

# Drug_Target_97_Reaction:
Not Available

# Drug_Target_97_Signals:
None

# Drug_Target_97_Specific_Function:
Not Available

# Drug_Target_97_SwissProt_ID:
Q8VNU2

# Drug_Target_97_SwissProt_Name:
Q8VNU2_DESDE

# Drug_Target_97_Synonyms:
Not Available

# Drug_Target_97_Theoretical_pI:
8.02

# Drug_Target_97_Transmembrane_Regions:
None

# Drug_Target_98_Cellular_Location:
Not Available

# Drug_Target_98_Chromosome_Location:
Not Available

# Drug_Target_98_Drug_References:
Not Available

# Drug_Target_98_Essentiality:
Non-Essential

# Drug_Target_98_GenAtlas_ID:
Not Available

# Drug_Target_98_GenBank_ID_Gene:
AF127653

# Drug_Target_98_GenBank_ID_Protein:
Not Available

# Drug_Target_98_GeneCard_ID:
Not Available

# Drug_Target_98_Gene_Name:
hmcA

# Drug_Target_98_Gene_Sequence:
>972 bp
ATGAGGAACGGCACATCACTGCTTTTGCTGGCGGCTCTGGCCCTGGCGGGCGCGGCGTGT
CTGACGGCGCTCGGAGCTGGAACGGCCACGGCCGCAGCTTTGGAGCCGACAGACAGCGGC
GCGCCGTCGGCCATTGTCATGTTTCCGGTAAGCGCCAAGCCCAATCCCAAGGGCGCGGCC
ATGAAACCCGCTGTTTTCAATCATCTCGCTCATGAGAAAAAGATTGCAAACTGCGAAACA
TGCCACCACACCGGCGATCCTGTGGCCTGTAGCACCTGCCACACTACGGAAGGCAAGGCG
GAAGGCAATTTCGTGACGCTTGACCGCGCCATGCATGCCACAAATATCGCCAAACGCGCC
AAGGGCAACACCCCTGTGAGCTGCGTGAGCTGTCATGAACAGCAAACCAAAGAACGGCGC
GAATGCGCGGGCTGCCACGCCATTGTGACGCCCAAGCGCGACCAGGCATGGTGCGCCACC
TGCCACAATGTTACGTCTTCCATGACGCCGGAGCAGATGCAACAGGGCATCAAGGGCAAA
CTGCCCCCCGACCAGAACGAGGCCCTGGCCGCTGAAACCGTGCTGAACCACAAGCCCGTG
CAGCCCCTTACTGCCATGCAGGGCCCCTACAAGGTGAGCATTGATGCGCTGGCCGACAAG
TACGAGCCCAGCAACTTCACGCACCGCCGCCATATGGCCTCCCTTATGGAACGCATCAAG
GGCGACAAGCTGGCCGAAGCTTTCCACAACAAACCCGAGACTCTGTGCGCCACATGCCAC
CACAGAAGCCCGCTTTCGGCTACGCCTCCCAAGTGCGGCAGTTGTCACACCAAGGAAATC
GACCCCGCCAATCCCAACCGTCCCAACCTCAAGGCCGCCTATCACCTCCAGTGCATGGGT
TGCCACCAGGGTATGAACGTGGGTCGTCCTAAGAACACCGACTGCACCACTTGTCATAAG
GCCCGCCCGTAG

# Drug_Target_98_General_Function:
Involved in iron ion binding

# Drug_Target_98_General_References:
11170457	Umhau S, Fritz G, Diederichs K, Breed J, Welte W, Kroneck PM: Three-dimensional structure of the nonaheme cytochrome c from Desulfovibrio desulfuricans Essex in the Fe(III) state at 1.89 A resolution. Biochemistry. 2001 Feb 6;40(5):1308-16.
11170458	Fritz G, Griesshaber D, Seth O, Kroneck PM: Nonaheme cytochrome c, a new physiological electron acceptor for [Ni,Fe] hydrogenase in the sulfate-reducing bacterium Desulfovibrio desulfuricans Essex: primary sequence, molecular parameters, and redox properties. Biochemistry. 2001 Feb 6;40(5):1317-24.

# Drug_Target_98_HGNC_ID:
Not Available

# Drug_Target_98_HPRD_ID:
Not Available

# Drug_Target_98_ID:
4971

# Drug_Target_98_Locus:
Not Available

# Drug_Target_98_Molecular_Weight:
34514

# Drug_Target_98_Name:
Nonaheme cytochrome c

# Drug_Target_98_Number_of_Residues:
323

# Drug_Target_98_PDB_ID:
1DUW

# Drug_Target_98_Pathway:
Not Available

# Drug_Target_98_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_98_Protein_Sequence:
>Nonaheme cytochrome c
MRNGTSLLLLAALALAGAACLTALGAGTATAAALEPTDSGAPSAIVMFPVSAKPNPKGAA
MKPAVFNHLAHEKKIANCETCHHTGDPVACSTCHTTEGKAEGNFVTLDRAMHATNIAKRA
KGNTPVSCVSCHEQQTKERRECAGCHAIVTPKRDQAWCATCHNVTSSMTPEQMQQGIKGK
LPPDQNEALAAETVLNHKPVQPLTAMQGPYKVSIDALADKYEPSNFTHRRHMASLMERIK
GDKLAEAFHNKPETLCATCHHRSPLSATPPKCGSCHTKEIDPANPNRPNLKAAYHLQCMG
CHQGMNVGRPKNTDCTTCHKARP

# Drug_Target_98_Reaction:
Not Available

# Drug_Target_98_Signals:
1-31

# Drug_Target_98_Specific_Function:
Not Available

# Drug_Target_98_SwissProt_ID:
Q9XCU0

# Drug_Target_98_SwissProt_Name:
Q9XCU0_DESDE

# Drug_Target_98_Synonyms:
Nonaheme cytochrome c precursor

# Drug_Target_98_Theoretical_pI:
8.50

# Drug_Target_98_Transmembrane_Regions:
None

# Drug_Target_99_Cellular_Location:
Not Available

# Drug_Target_99_Chromosome_Location:
Not Available

# Drug_Target_99_Drug_References:
Not Available

# Drug_Target_99_Essentiality:
Non-Essential

# Drug_Target_99_GenAtlas_ID:
Not Available

# Drug_Target_99_GenBank_ID_Gene:
AE004091

# Drug_Target_99_GenBank_ID_Protein:
Not Available

# Drug_Target_99_GeneCard_ID:
Not Available

# Drug_Target_99_Gene_Name:
PA3967

# Drug_Target_99_Gene_Sequence:
>393 bp
ATGAACGCCGCCGACCGCGTCATGCAGAGTTATGGACGCTGCTGTGCCAGCACCGGATTC
TTCGATGATTTCTACCGGCATTTCCTTGCCAGTTCCCCGCAGATTCGCGCCAAGTTCGCC
ACCACCGACATGACTGCGCAGAAACACCTGCTGCGTGCCGGAATCATGAACCTGGTGATG
TACGCCCGCGGCATGTCCGACAGCAAGCTGCGCGCACTCGGCGCCAGCCATTCGCGCGCC
GCGCTGGATATCCGCCCGGAACTCTACGACCTGTGGCTGGACGCCCTGCTGATGGCGGTC
GCCGAGCACGACCGCGACTGCGACGCCGAGACCCGCGACGCCTGGCGCGACGTGATGGGT
CGCGGCATCGCCGTGATCAAGTCGTACTACTGA

# Drug_Target_99_General_Function:
Involved in iron ion binding

# Drug_Target_99_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_99_HGNC_ID:
Not Available

# Drug_Target_99_HPRD_ID:
Not Available

# Drug_Target_99_ID:
4747

# Drug_Target_99_Locus:
Not Available

# Drug_Target_99_Molecular_Weight:
14705

# Drug_Target_99_Name:
Hypothetical protein

# Drug_Target_99_Number_of_Residues:
130

# Drug_Target_99_PDB_ID:
1TU9

# Drug_Target_99_Pathway:
Not Available

# Drug_Target_99_Pfam_Domain_Function:
PF00042	Globin

# Drug_Target_99_Protein_Sequence:
>Hypothetical protein
MNAADRVMQSYGRCCASTGFFDDFYRHFLASSPQIRAKFATTDMTAQKHLLRAGIMNLVM
YARGMSDSKLRALGASHSRAALDIRPELYDLWLDALLMAVAEHDRDCDAETRDAWRDVMG
RGIAVIKSYY

# Drug_Target_99_Reaction:
Not Available

# Drug_Target_99_Signals:
None

# Drug_Target_99_Specific_Function:
Not Available

# Drug_Target_99_SwissProt_ID:
Q9HX49

# Drug_Target_99_SwissProt_Name:
Q9HX49_PSEAE

# Drug_Target_99_Synonyms:
Not Available

# Drug_Target_99_Theoretical_pI:
8.07

# Drug_Target_99_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
U73860

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
hmuO

# Drug_Target_9_Gene_Sequence:
>648 bp
ATGACCACTGCAACCGCAGGCCTCGCTGTCGAACTCAAGCAGTCCACCGCACAAGCCCAC
GAAAAAGCTGAGCACTCCACCTTCATGAGCGACCTGCTAAAAGGTCGCTTGGGGGTAGCG
GAATTTACTCGTCTGCAGGAGCAAGCATGGTTGTTCTACACGGCACTAGAGCAGGCAGTA
GATGCCGTGCGTGCCAGCGGATTTGCGGAGTCCCTTCTCGATCCCGCTCTCAACCGTGCT
GAGGTTTTGGCACGCGACCTAGACAAGCTAAACGGTAGTAGTGAGTGGCGATCACGCATC
ACAGCATCGCCAGCTGTTATTGATTACGTGAATCGTCTTGAAGAAATCCGCGACAATGTT
GACGGCCCAGCGCTAGTTGCTCACCACTACGTGCGCTACCTCGGGGATCTCTCGGGCGGA
CAGGTTATCGCACGTATGATGCAGCGCCACTACGGCGTTGATCCTGAAGCCCTAGGTTTC
TACCACTTCGAGGGGATCGCCAAGCTCAAGGTCTACAAGGATGAGTACCGTGAAAAGCTC
AACAACCTAGAGCTTAGCGATGAACAGCGTGAGCACCTTTTGAAAGAAGCAACCGATGCT
TTCGTTTTCAACCACCAAGTTTTCGCAGATTTGGGTAAAGGCCTGTAA

# Drug_Target_9_General_Function:
Involved in heme oxygenase (decyclizing) activity

# Drug_Target_9_General_References:
14602910	Cerdeno-Tarraga AM, Efstratiou A, Dover LG, Holden MT, Pallen M, Bentley SD, Besra GS, Churcher C, James KD, De Zoysa A, Chillingworth T, Cronin A, Dowd L, Feltwell T, Hamlin N, Holroyd S, Jagels K, Moule S, Quail MA, Rabbinowitsch E, Rutherford KM, Thomson NR, Unwin L, Whitehead S, Barrell BG, Parkhill J: The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129. Nucleic Acids Res. 2003 Nov 15;31(22):6516-23.
9006041	Schmitt MP: Utilization of host iron sources by Corynebacterium diphtheriae: identification of a gene whose product is homologous to eukaryotic heme oxygenases and is required for acquisition of iron from heme and hemoglobin. J Bacteriol. 1997 Feb;179(3):838-45.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4813

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
24116

# Drug_Target_9_Name:
Heme oxygenase

# Drug_Target_9_Number_of_Residues:
215

# Drug_Target_9_PDB_ID:
1V8X

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01126	Heme_oxygenase

# Drug_Target_9_Protein_Sequence:
>Heme oxygenase
MTTATAGLAVELKQSTAQAHEKAEHSTFMSDLLEGRLGVAEFTRLQEQAWLFYTALEQAA
DAVRASGFAESLLDPALNRAEVLARDLDKLNDGSEWRSRITASPAVIDYVNRLEEIRDNV
DGPALVAHHYVRYLGDLSGGQVIARMMQRHYGVDPEALGFYHFEGIAKLKVYKDEYREKL
NNLELSDEQRENLLKEATDAFVFNHQVFADLGKGL

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Allows the bacteria to use the host heme as an iron source. Involved in the oxidation of heme and subsequent release of iron from the heme moiety

# Drug_Target_9_SwissProt_ID:
P71119

# Drug_Target_9_SwissProt_Name:
HMUO_CORDI

# Drug_Target_9_Synonyms:
EC 1.14.99.3

# Drug_Target_9_Theoretical_pI:
4.79

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03014
